Citrus Sinensis ID: 006563
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 640 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.931 | 0.761 | 0.503 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.962 | 0.755 | 0.537 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.971 | 0.731 | 0.470 | 1e-169 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.970 | 0.745 | 0.457 | 1e-163 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.959 | 0.728 | 0.462 | 1e-161 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.970 | 0.733 | 0.454 | 1e-158 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.956 | 0.714 | 0.439 | 1e-155 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.968 | 0.733 | 0.443 | 1e-155 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.973 | 0.730 | 0.445 | 1e-153 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.976 | 0.736 | 0.435 | 1e-148 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/640 (50%), Positives = 438/640 (68%), Gaps = 44/640 (6%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
+ A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR+
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 75 TPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNT-----SITMKNPVVQLMDSGNLVLTD- 127
+PL D SG L V+ G + L + R+ I WSS++ +++NP+VQ++D+GNLV+ +
Sbjct: 81 SPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNS 140
Query: 128 GNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
G+ +WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G P
Sbjct: 141 GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVP 200
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SR 246
Q L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R
Sbjct: 201 QFFLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTR 259
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
+ +N +G + R W W A +D CD Y++CG+ C N S C CL+GFV
Sbjct: 260 MQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVA 319
Query: 307 KSPN-----NWSEGCVRERELKCRNG-DEFPKYVKLKLPDTSSSWFNASMNLKECSELCS 360
K+P +WSEGCVR +L C G D F K KLKLPDT +SW++ +M+L EC ++C
Sbjct: 320 KTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCL 379
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
+NC+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS ++ ++
Sbjct: 380 RNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESS--- 436
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNK 480
R +KQ +ED+EL D ++++AT F++ NK
Sbjct: 437 -------------------RVSSRKQ-------EEEDLELPFLDLDTVSEATSGFSAGNK 470
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG+GGFGPVYKGTL GQE+AVKRLS+ S QG+EEFKNE+ LIA+LQHRNLVK+LG C+
Sbjct: 471 LGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVD 530
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+E MLIYEY PNKSLD FIFD+ R LDW KR+ I+ GIARG+LYLH+DSR+RIIHRD
Sbjct: 531 EEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRD 590
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LKASNVLLD+DMN KISDFG+AR GGDE + NT +VVGT
Sbjct: 591 LKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 638 bits (1646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/642 (53%), Positives = 446/642 (69%), Gaps = 26/642 (4%)
Query: 21 ITPSQSIRDGETLVSVNGTFELGFFSPGTSAK---RYLGIWYKRVSPRTVAWVANRETPL 77
ITP + ++DG+TL S + F+LGFFS + R+LG+WY + P V WVANR PL
Sbjct: 28 ITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPL 85
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITM-----KNPVVQLMDSGNLVLTDGNYN 131
SG LN++S G + L DG + WSS++S T NP++++ SGNL+ +DG
Sbjct: 86 YGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDGE-E 144
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVL 191
++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK++ DP+PG+F+L +DT G PQL+L
Sbjct: 145 AVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLIL 204
Query: 192 RKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRLWV 249
RK S YR GSWNGL FTG P + L DYKF + EV Y + VSRL +
Sbjct: 205 RKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHRIVSRLVL 264
Query: 250 NQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNS--SRRCDCLEGFVPK 307
N +G + R I S+Q+ W LA AP D CD YS+CGA A C NS + C CL+GF PK
Sbjct: 265 NNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPK 323
Query: 308 SPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNA--SMNLKECSELCS 360
S W + GCV E C D F K+ LKLPDTS SW++A M L++C CS
Sbjct: 324 SGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCS 383
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+ GQD+YIR+ + ++ VG++
Sbjct: 384 SNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMV 443
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH--MKEDMELWEFDFASIAKATDNFASY 478
+ SV+ +A+ +V C +K +K+ +ED++L FD +I+ ATD+F+
Sbjct: 444 VGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYV 503
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIA+LQHRNLV+LLGCC
Sbjct: 504 NFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCC 563
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
IQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+KR++I+ G+ARGILYLHQDSR+RIIH
Sbjct: 564 IQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIH 623
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
RDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++T++VVGT
Sbjct: 624 RDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 594 bits (1532), Expect = e-169, Method: Compositional matrix adjust.
Identities = 314/668 (47%), Positives = 428/668 (64%), Gaps = 46/668 (6%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
SA + + S +I T+VS FELGFF PG ++ YLGIWYK +S RT WVANR+
Sbjct: 28 SANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRD 87
Query: 75 TPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS 132
TPL+ G L ++ +V+LD D WS+N T +++P+V +L+D+GN VL D ++
Sbjct: 88 TPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSA 147
Query: 133 ---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+LWQSFD P DTLLP MKLG + KTG +R + SWKS +DP+ G+FS ++T GFP++
Sbjct: 148 PDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEI 207
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AKGPAVSRLW 248
L YR+G WNG+ F+G P ++ + + F ++ EV Y K SRL
Sbjct: 208 FLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMV-FNFTTSKEEVTYSFRITKSDVYSRLS 266
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ SGL+ R W W +YAP D+CD Y CG C +N+S C+C++GF P++
Sbjct: 267 ISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRN 326
Query: 309 PNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNC 363
P W S+GCVR+ L C GD F + K+KLPDT+++ + + +KEC + C ++C
Sbjct: 327 PQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDC 386
Query: 364 SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGII 420
+CTA+AN+D+ GSGC+ W G+L D++ Y GGQDLY+R+A+ E R+ + K +G
Sbjct: 387 NCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSS 446
Query: 421 I-ASVLLMAMFIVASLFCIWRKKLKKQGLTKMS----------------------HMK-- 455
I SVLL+ FI+ F +W++K K+ L + H+
Sbjct: 447 IGVSVLLLLSFII---FFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRE 503
Query: 456 ---EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+D+EL +F +A AT+NF++ NKLG+GGFG VYKG L++GQE+AVKRLSK S QG
Sbjct: 504 NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQG 563
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+EFKNEV LIARLQH NLV+LL CC+ A E MLIYEY+ N SLD +FD++R + L+WQ
Sbjct: 564 TDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQ 623
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ GIARG+LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMARIFG DE +
Sbjct: 624 MRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEA 683
Query: 633 NTHKVVGT 640
NT KVVGT
Sbjct: 684 NTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 574 bits (1479), Expect = e-163, Method: Compositional matrix adjust.
Identities = 303/662 (45%), Positives = 410/662 (61%), Gaps = 41/662 (6%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D I QS+RDGE ++S F GFFS G S RY+GIWY ++S +T+ WVANR+ P+
Sbjct: 20 DTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPIN 79
Query: 79 DQSGLLNVTSKG---IVLLDGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNYNSL 133
D SG++ +++G + D + WS+N S +M P V L D GNLVL D
Sbjct: 80 DTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRS 139
Query: 134 LWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK 193
W+SFDHP DT LP M+LG K G+DR L+SWKS DP G+ L ++ GFPQL+L K
Sbjct: 140 FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYK 199
Query: 194 GSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQS 252
G +R GSW G ++G P + + + FV NE+EV + +V +R VN++
Sbjct: 200 GVTPWWRMGSWTGHRWSGVPEMPIGY-IFNNSFVNNEDEVSFTYGVTDASVITRTMVNET 258
Query: 253 GLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR--RCDCLEGFVPKSPN 310
G + R W ++ W + P ++CD Y+ CG N C + SS+ C CL GF PK P
Sbjct: 259 GTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPR 318
Query: 311 NW-----SEGCVRERELK-CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+W S GC +++ C D F K ++K+PDTS + + ++ LKEC + C KNCS
Sbjct: 319 HWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCS 378
Query: 365 CTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE------RGRSVTKKQ 416
C AYA++ + +RG GCL W G ++D + Y + GQD YIR+ E R K++
Sbjct: 379 CVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRR 438
Query: 417 VGIIIASVLLMAMFIVASLFCIWRKKLKK------------------QGLTKMSHMKEDM 458
V +I+ S++ M + LFC+ R++ K + +
Sbjct: 439 VLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNR 498
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL FD +I AT+NF+S NKLG GGFGPVYKG L EIAVKRLS+ SGQGMEEFKN
Sbjct: 499 ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKN 558
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + + LDW KR+ IV
Sbjct: 559 EVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIV 618
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GIARGILYLHQDSR+RIIHRDLKASN+LLD++M PKISDFGMARIFGG++++ T +VV
Sbjct: 619 RGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVV 678
Query: 639 GT 640
GT
Sbjct: 679 GT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 568 bits (1463), Expect = e-161, Method: Compositional matrix adjust.
Identities = 304/657 (46%), Positives = 416/657 (63%), Gaps = 43/657 (6%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+ PL+ +
Sbjct: 33 TESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSN 92
Query: 82 GLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNSLLWQSFD 139
G L ++ +V+ D DR WS+N T +++PV +L+D+GN +L D N N LLWQSFD
Sbjct: 93 GTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSN-NRLLWQSFD 151
Query: 140 HPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQY 199
P DTLL MKLG + KTG +R L SWK+ +DP+ GEFS ++T FP+ + + Y
Sbjct: 152 FPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILY 211
Query: 200 RAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLWVNQSGLVLRS 258
R+G WNG+ F+ P + V Y F ++ EV Y K SRL++N +GL+ R
Sbjct: 212 RSGPWNGMRFSSVPGTIQ-VDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRL 270
Query: 259 IWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNW-----S 313
W W +Y+P D CD Y VCG C +NS C C++GF P + W S
Sbjct: 271 TWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDGS 330
Query: 314 EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDV 373
GC+R+ L C D F + ++KLPDT+++ + + LK C E C ++C+CTA+AN+D+
Sbjct: 331 AGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADI 390
Query: 374 ERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIII-ASVLLMAM 429
GGSGC++W +++DM+ Y GGQDLY+R+A+ E R +K +G I S+LL+
Sbjct: 391 RNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLS 450
Query: 430 FIVASLFCIWRKKLKK--------------------------QGLTKMSHMKEDMELWEF 463
F++ F W++K K+ +G T E +EL
Sbjct: 451 FVI---FHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLL 507
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LI
Sbjct: 508 ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLI 567
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
A+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR I+ GIAR
Sbjct: 568 AKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 627
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
G+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT +VVGT
Sbjct: 628 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 303/666 (45%), Positives = 414/666 (62%), Gaps = 45/666 (6%)
Query: 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRET 75
A+N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+
Sbjct: 27 ASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDN 86
Query: 76 PLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS- 132
PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D GN VL D N
Sbjct: 87 PLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKP 146
Query: 133 --LLWQSFDHPCDTLLPGMKLGRNFKTG-MDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
LWQSFD P DTLL MK+G + K+G +R L SWK+ +DP+ G+FS + T GFP+
Sbjct: 147 SGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEF 206
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLW 248
+ + YR+G W G F+ P +K V D F N +V Y K S L
Sbjct: 207 YIYNKESITYRSGPWLGNRFSSVPGMKP-VDYIDNSFTENNQQVVYSYRVNKTNIYSILS 265
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ +GL+ R W W +Y+P D CD Y CG C N+S C+C++GF P +
Sbjct: 266 LSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMN 325
Query: 309 PN----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+ S GCVR+ +L C D F + K++LPDT+ + + + LKEC E C K C+
Sbjct: 326 EQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCN 385
Query: 365 CTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIII 421
CTA+AN+D+ GGSGC++W G L D++ Y GGQDLY+R+A+ E R +KK +G I
Sbjct: 386 CTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSI 445
Query: 422 -ASVLLMAMFIVASLFCIWRKKLKK--------------------------QGLTKMSHM 454
S+LL+ FI+ F W++K K+ + T +
Sbjct: 446 GVSILLLLSFII---FHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENK 502
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
+ +EL ++ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +
Sbjct: 503 TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTD 562
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF NEV LIA+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR
Sbjct: 563 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 635 HKVVGT 640
+VVGT
Sbjct: 683 RRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 550 bits (1418), Expect = e-155, Method: Compositional matrix adjust.
Identities = 291/662 (43%), Positives = 420/662 (63%), Gaps = 50/662 (7%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +TLVS FE+GFF T+++ YLG+WYK+VS RT WVANR+ PL++
Sbjct: 39 TESLTISSNKTLVSPGSIFEVGFFR--TNSRWYLGMWYKKVSDRTYVWVANRDNPLSNAI 96
Query: 82 GLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVV-QLMDSGNLVLTDGNYN---SLLWQ 136
G L ++ +VLLD ++ ++W++ T ++PVV +L+ +GN V+ D + N LWQ
Sbjct: 97 GTLKISGNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQ 156
Query: 137 SFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSV 196
SFD+P DTLLP MKLG N KTG++R L+SW+S +DP+ G FS ++T P+ L + +
Sbjct: 157 SFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENF 216
Query: 197 LQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQSGLV 255
+R+G WNG+ F+G P + + Y F+ N EV Y + SRL + G
Sbjct: 217 PMHRSGPWNGIRFSGIPE-DQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF 275
Query: 256 LRSIWSSQQDVWFLAYYAPLD-RCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNWSE 314
R W +W + +P+D +CD Y +CG A C N+S C+C++GF P++ W +
Sbjct: 276 QRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQ 335
Query: 315 -----GCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYA 369
GC+R +L C +GD F + K+KLP+T+ + + S+ +KEC + C +C+CTA+A
Sbjct: 336 RVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFA 394
Query: 370 NSDVERGGSGCLLWFGDLMDMKEYNDG---GQDLYIRIASERGRSVTKKQ--VGIIIASV 424
N+D+ GGSGC++W L D++ Y GQDLY+R+A+ + KK+ G II+
Sbjct: 395 NADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAA---DIAKKRNASGKIISLT 451
Query: 425 LLMAMFIVASLFCIWRKKLKKQGLTKMS--------------------------HMKEDM 458
+ +++ ++ +FC+W++K K+ + +S + E++
Sbjct: 452 VGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEEL 511
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL + ++ KAT+NF+S NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF N
Sbjct: 512 ELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMN 571
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EVTLIARLQH NLV++LGCCI+ DE MLIYEY+ N SLD ++F + R + L+W +R I
Sbjct: 572 EVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDIT 631
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G+ARG+LYLHQDSR RIIHRDLK SN+LLD +M PKISDFGMARIF DE + NT KVV
Sbjct: 632 NGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVV 691
Query: 639 GT 640
GT
Sbjct: 692 GT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 548 bits (1411), Expect = e-155, Method: Compositional matrix adjust.
Identities = 298/672 (44%), Positives = 427/672 (63%), Gaps = 52/672 (7%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+++ I SQS++DG+ + S F GFFS G S RY+GIWY +VS +T+ WVANR+ P
Sbjct: 21 SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80
Query: 77 LTDQSGLLNVTSKGIVLL----DGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNY 130
+ D SGL+ +++G + + +G + I WS++ ++ P V +L D GNLVL D
Sbjct: 81 INDTSGLIKFSTRGNLCVYASGNGTEPI-WSTDVIDMIQEPALVAKLSDLGNLVLLDPVT 139
Query: 131 NSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190
W+SF+HP +TLLP MK G ++G+DR ++SW+S DP G + I+ GFPQ++
Sbjct: 140 GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMM 199
Query: 191 LRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV---YYECDAKGPAVSRL 247
+ KG L +R GSW G ++G P + N + + FV N +EV Y DA +R+
Sbjct: 200 MYKGLTLWWRTGSWTGQRWSGVPEMT-NKFIFNISFVNNPDEVSITYGVLDAS--VTTRM 256
Query: 248 WVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRR--CDCLEGFV 305
+N++G + R W+ + W + AP D+CD+Y+ CG N C + S+ + C CL G+
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 306 PKSPNNW-----SEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELC 359
PK+P +W S+GC R + NG E F K ++K+P+TS+ + ++ LKEC + C
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRC 376
Query: 360 SKNCSCTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRI-ASERGR-----S 411
KNCSC AYA++ + + G GCL W G+++D + Y GQD Y+R+ SE R +
Sbjct: 377 LKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGA 436
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG-----------------------L 448
KK++ +I+ S++ + M ++ S C RK+ ++ L
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
++ EL F+ ++IA AT+NFA NKLG GGFGPVYKG L G EIAVKRLSK
Sbjct: 497 EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKS 556
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
SGQGMEEFKNEV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + +
Sbjct: 557 SGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAE 616
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
LDW KR+ I+ GI RGILYLHQDSR+RIIHRDLKASNVLLDN+M PKI+DFG+ARIFGG+
Sbjct: 617 LDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGN 676
Query: 629 EIQTNTHKVVGT 640
+I+ +T++VVGT
Sbjct: 677 QIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 543 bits (1398), Expect = e-153, Method: Compositional matrix adjust.
Identities = 298/669 (44%), Positives = 407/669 (60%), Gaps = 46/669 (6%)
Query: 12 LGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVA 71
L S + T S +I +T+VS G FELGFF YLGIWYK++S RT WVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVV-QLMDSGNLVLTDGNY 130
NR+TPL++ G+L +++ +V+LD D WS+N + +++ VV +L+D+GN VL
Sbjct: 87 NRDTPLSNPIGILKISNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 131 NS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
N LWQSFD P DTLLP MKLGR+ K G++R ++SWKS DP+ G F ++T G P
Sbjct: 147 NESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLP 206
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGP-AVSR 246
+ + YR+G W+GL F+G +++ + Y F N EV Y + SR
Sbjct: 207 EFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDII-YNFTENREEVAYTFRVTDHNSYSR 265
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
L +N G + +W Q W + ++ P D CDLY +CG A C ++S C+C++GF P
Sbjct: 266 LTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQP 325
Query: 307 KSPNNWSEG-----CVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK 361
SP +W+ G C R+ +L C D F + + +K+P T+++ + + LKEC E C
Sbjct: 326 LSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKT 384
Query: 362 NCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS----ERGRSVTKKQV 417
+C+CTAYANSD+ GGSGC++W G+ D++ Y GQDL++R+A+ ER K
Sbjct: 385 HCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIRGKIIG 444
Query: 418 GIIIASVLLMAMFIVASLFCIWRKKLKKQGLTK--MSHMKEDMEL--------------- 460
II S++L+ FI+ +C W+KK K+ T + + EL
Sbjct: 445 LIIGISLMLVLSFII---YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRRLL 501
Query: 461 --------WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+F ++ AT+NF+ N LG GGFG VYKG L++GQEIAVKRLS+ S QG
Sbjct: 502 GEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQG 561
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDW 571
EFKNEV LIARLQH NLV+LL CCI ADE +LIYEY+ N SLD +F+ +++ L+W
Sbjct: 562 TNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNW 621
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q R I+ GIARG+LYLHQDSR +IIHRDLKASNVLLD +M PKISDFGMARIF DE +
Sbjct: 622 QTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETE 681
Query: 632 TNTHKVVGT 640
NT KVVGT
Sbjct: 682 ANTRKVVGT 690
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1358), Expect = e-148, Method: Compositional matrix adjust.
Identities = 298/685 (43%), Positives = 403/685 (58%), Gaps = 60/685 (8%)
Query: 9 LFILGASAANDNITPSQSIRDG---ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
F+ +S A + I +S+RDG + LVS TFELGFFSPG+S R+LGIWY + +
Sbjct: 17 FFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDK 76
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSN---TSITMKNPVVQLMDSG 121
V WVANR TP++DQSG+L +++ G +VLLDG++ WSSN ++ N VV + D+G
Sbjct: 77 AVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTG 136
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
N VL++ + + +W+SF+HP DT LP M++ N +TG + SW+S DP+PG +SL +
Sbjct: 137 NFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGV 196
Query: 182 DTHGFPQLVLRKGS-VLQYRAGSWNGLGFTGTP--PLKENVPLCDYKFVINENE---VYY 235
D G P++VL +G+ ++R+G WN FTG P L N L +K +E VY+
Sbjct: 197 DPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNY-LYGFKLSSPPDETGSVYF 255
Query: 236 ECDAKGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNS 294
P+V R V +G W+ W P CD Y+ CG C
Sbjct: 256 TYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKG 315
Query: 295 SRR-CDCLEGFVPKSPNNWSEGCVRERELKCRNG-----DEFPKYVKLKLPDTSSSWFNA 348
S C C+ G+ S NWS GC R LKC DEF +KLPD N
Sbjct: 316 SNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNL 375
Query: 349 SMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASER 408
++ ++C E C +NCSC AY+ GG GC++W DL+D++++ GG L+IR+A
Sbjct: 376 -VDPEDCRERCLRNCSCNAYSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSE 430
Query: 409 GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------GLTKM 451
K ++ +I+A VL+ + I +WR K KK LTK
Sbjct: 431 VGENRKTKIAVIVA-VLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 452 SHMKEDM----------------ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV 495
EL F +IA AT++F N+LG GGFGPVYKG L
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 496 EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555
+G+EIAVKRLS SGQG++EFKNE+ LIA+LQHRNLV+LLGCC + +E ML+YEYMPNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615
LDFF+FD+ + +DW+ R I+ GIARG+LYLH+DSR+RIIHRDLK SNVLLD +MNPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 616 ISDFGMARIFGGDEIQTNTHKVVGT 640
ISDFGMARIFGG++ + NT +VVGT
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 640 | ||||||
| 255575986 | 1597 | ATP binding protein, putative [Ricinus c | 0.996 | 0.399 | 0.600 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.990 | 0.780 | 0.582 | 0.0 | |
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.987 | 0.760 | 0.583 | 0.0 | |
| 224122966 | 783 | predicted protein [Populus trichocarpa] | 0.942 | 0.770 | 0.581 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.979 | 0.762 | 0.554 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.992 | 0.776 | 0.552 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.948 | 0.774 | 0.575 | 0.0 | |
| 224122810 | 810 | predicted protein [Populus trichocarpa] | 0.985 | 0.779 | 0.555 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.989 | 0.358 | 0.542 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.996 | 0.398 | 0.551 | 0.0 |
| >gi|255575986|ref|XP_002528889.1| ATP binding protein, putative [Ricinus communis] gi|223531688|gb|EEF33513.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/656 (60%), Positives = 487/656 (74%), Gaps = 18/656 (2%)
Query: 1 MLGAYSCLLFILGASAANDN-ITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWY 59
M+ Y LLF+ S + N I PSQS++DGETLVS +G FELGFF+P S RYLGIWY
Sbjct: 1 MVWVYLFLLFLSHTSVSGLNTINPSQSVKDGETLVSADGGFELGFFNPNNSENRYLGIWY 60
Query: 60 KRVSPRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLM 118
K VS V WVANRETPLT+ SG+L+ T +GI +LLDG++ WSS + +NP+VQL+
Sbjct: 61 KEVSAYAVVWVANRETPLTESSGVLSFTKEGILILLDGKNNTIWSSKKAKNSQNPLVQLL 120
Query: 119 DSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPG 175
DSGNLV+ DGN +S LWQSFD PCDT LPGMK+GRNF TG D ++SWKS ++P G
Sbjct: 121 DSGNLVVKDGNDSSSDNFLWQSFDSPCDTFLPGMKIGRNFLTGQDWFITSWKSADNPGKG 180
Query: 176 EFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYY 235
+FSLWID GFPQLVLR G+ YR GSWNGL FTGTP + ++ +F + +N VYY
Sbjct: 181 QFSLWIDPDGFPQLVLRNGTSKYYRLGSWNGLYFTGTPQVPQD--FLKLEFELTKNGVYY 238
Query: 236 ECDAKGPA--VSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTN 293
+ G + ++RL+VN+SG V R + W Y+APLD+CD Y VCGA +C N
Sbjct: 239 GYEVHGYSKLMTRLFVNRSGFVQRFARVDRTVGWRNIYFAPLDQCDKYDVCGAYMKCNIN 298
Query: 294 -SSRRCDCLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNL 352
+S C CLEGFV +SP NWS+GCVR+ L C GD F Y++LKLPDTS SW+N +M+L
Sbjct: 299 DNSPNCVCLEGFVFRSPKNWSDGCVRKTPLHCEKGDVFQTYIRLKLPDTSGSWYNTTMSL 358
Query: 353 KECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSV 412
EC ELCS NCSCTAYANS++ GGSGCLLWFG+L+D++EY +GGQ++YIR++S +
Sbjct: 359 SECKELCSTNCSCTAYANSNISNGGSGCLLWFGELVDIREYTEGGQEIYIRMSSSKPDQT 418
Query: 413 TKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHM--------KEDMELWEFD 464
K +G + + +L+ M +V SL I +K+ + QGLTK SH+ KE+MEL FD
Sbjct: 419 KNKLIGTTVGAAVLIGMLVVGSLVYIRKKEQRMQGLTKGSHINDYENNAGKEEMELPIFD 478
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIA 524
F +I KATDNF++ NKLG+GGFGPVYKG L +GQEIAVKRLSK SGQG+ EF+NEV LI+
Sbjct: 479 FTAIVKATDNFSNNNKLGQGGFGPVYKGILTDGQEIAVKRLSKSSGQGLTEFENEVILIS 538
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+LQHRNLVKLLG CIQ DE MLIYE+MPNKSLDFF+FD+ R FLDW RIHI+ GIARG
Sbjct: 539 KLQHRNLVKLLGYCIQKDEKMLIYEFMPNKSLDFFVFDEMRCKFLDWDLRIHIIDGIARG 598
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LYLHQDSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGGD+ + NT+KV GT
Sbjct: 599 LLYLHQDSRLRIIHRDLKASNVLLDKDMNPKISDFGMARIFGGDQTEANTNKVAGT 654
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/654 (58%), Positives = 477/654 (72%), Gaps = 20/654 (3%)
Query: 4 AYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
YS IL S+A D + +QS+RDGETLVS G+FELGFF+P S RYLG+WYK+ S
Sbjct: 9 VYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK-S 67
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
P+TV WVANR P++++ G LNVTS+GI VLL+G + I WSSNTS T++NPV QL+DSGN
Sbjct: 68 PQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSGN 127
Query: 123 LVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
LV+ DGN N + LWQSFD+PCDTLLPGMKLG N TG++ LSSWK +PAPG+F+L
Sbjct: 128 LVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQFTL 187
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA 239
ID G+PQL+LRK + + YR GSWNG FTG P LK + P+ ++FV N NEVY++ +
Sbjct: 188 GIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPD-PIYTFEFVFNRNEVYFKFEL 246
Query: 240 KGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ +V SRL V SGLV WS Q + W++ A +DRC+ Y++CGANARC +NSS C
Sbjct: 247 QNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPVC 306
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
DCL+GF+ KSP NW+ GC+R L C + D F Y +KLPDTSSSW++ S +L
Sbjct: 307 DCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLV 366
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERG---- 409
EC LC +NCSC AYAN D GSGCL WFGDL+D + +GGQD+YIR+A+ +
Sbjct: 367 ECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTG 426
Query: 410 --RSVTKKQVGIIIASVLL-MAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFA 466
+ K G+I +V+L ++ I+ +FCI R+K +K G + +E+MEL D
Sbjct: 427 EKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFE-DRKEEEMELPMLDLT 485
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+I ATDNF+S KLGEGGFG VYKG L+EGQEIAVKRLSK SGQG+ EFKNEV LIA+L
Sbjct: 486 TIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKL 545
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
QHRNLVKLLGCCI DE MLIYEYMPN+SLD FIFD R FLDW KR HI+ GIARG+L
Sbjct: 546 QHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLL 605
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLHQDSR+RIIHRD+KASN+LLDN++NPKISDFG+AR+FGGD+ + NT +VVGT
Sbjct: 606 YLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGT 659
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/658 (58%), Positives = 469/658 (71%), Gaps = 26/658 (3%)
Query: 8 LLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTV 67
L I A+ D +TP QSIRDG+ LVS +G+FELGFFSPG S RYLGIWY+++S TV
Sbjct: 16 FLLISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTV 75
Query: 68 AWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLT 126
WVANRETPL D SG L VT +GI +LL+ WSSN S T +NPV++L+DSGNLV+
Sbjct: 76 VWVANRETPLNDSSGALIVTDQGILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVK 135
Query: 127 DGNYNS--LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTH 184
D N NS LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS NDPA GEF+ ID
Sbjct: 136 DINDNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPR 195
Query: 185 GFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV 244
G Q++L +G + YR G+WNG +TGTP L+ N+ L Y F+ E+YY+ D +V
Sbjct: 196 GNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNM-LYTYGFISTATEMYYKFDLINSSV 254
Query: 245 -SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEG 303
SR+ +N SG R W ++ + W LD+CD Y++CGA C N C CLEG
Sbjct: 255 ASRIVMNSSGAAQRFTWITRTNSWARFSAVLLDQCDDYALCGAYGSCNVNKQPVCACLEG 314
Query: 304 FVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSEL 358
F+PKSP +WS +GCVR +L C GD F ++ +KLPD SW + S LKEC +L
Sbjct: 315 FIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDL 374
Query: 359 CSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS------ERGRSV 412
C KNCSC AYANSD+ GGSGCLLWF +L+D +E GGQDLYIRIA+ E+ RS
Sbjct: 375 CLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSS 434
Query: 413 TKKQVGIIIASVLLMAMFIV-ASLFCIWRKKLKKQGLTKMSHM---------KEDMELWE 462
KKQ+GII+ +++ + +V A + RKKLKKQ K SH+ KEDMEL
Sbjct: 435 DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPT 494
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
FD ++IA ATDNF+S NKLGEGGFG VYKGTL+EGQE+AVKRLSK SGQG+ EFKNEV L
Sbjct: 495 FDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVIL 554
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
IA+LQHRNLVKLLGCCI+ DE +LIYEYMPNKSLD+FIFD+ DW+ I+IVGGIA
Sbjct: 555 IAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIA 614
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
RG+LYLHQDSR+RIIHRDLKA+NVLLDN MNPKISDFG+AR FGGD+ + NT+K+VGT
Sbjct: 615 RGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGT 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122966|ref|XP_002330408.1| predicted protein [Populus trichocarpa] gi|222871793|gb|EEF08924.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/641 (58%), Positives = 459/641 (71%), Gaps = 38/641 (5%)
Query: 8 LLFILGASAANDNITPSQSIRDGET-LVSVNGTFELGFFSPGTSAKRYLGIWYKR--VSP 64
LLF+ A A DNIT ++SI+DGE+ LVS GTFELGFFSPG S R+LG+WYK +
Sbjct: 21 LLFLSLAFATQDNITSNESIKDGESPLVSAGGTFELGFFSPGNSMNRFLGVWYKNELSTH 80
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
+ V WVANRE PL D+SG LN T +G++LL +G + WSSN + +++PV+QL+DSGNL
Sbjct: 81 KEVIWVANREIPLKDRSGFLNFTQQGVLLLFNGNNERIWSSNKTTNVESPVMQLLDSGNL 140
Query: 124 VLTDGNYNS-LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
V+ DG N+ +LWQSF++PCDT LPGM +G N +TG+DR+L SWKS +DP PG+FS ID
Sbjct: 141 VVIDGKDNNFILWQSFEYPCDTFLPGMMIGGNSQTGVDRNLISWKSADDPGPGQFSFGID 200
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN--EVYYECDAK 240
GFPQLV+R G++ R GSWNG FTGTP L + L Y F++N+ + YE
Sbjct: 201 RQGFPQLVIRNGTLKHCRLGSWNGKRFTGTPDLPRDQFL-KYDFILNKTHADYSYEILRP 259
Query: 241 GPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARC-TTNSSRRCD 299
G ++RL VNQSG V R + Q + W Y AP D CD YSVCGA+ C + S C
Sbjct: 260 GALLTRLIVNQSGFVERFMRPIQNNNWTSIYSAPRDLCDNYSVCGAHMICKMVDQSHNCT 319
Query: 300 CLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
CLEGF PKS +WS GC R L C +G F + LKLPDTS SW++ SM+L EC ++C
Sbjct: 320 CLEGFEPKSHTDWSRGCARRSALNCTHG-IFQNFTGLKLPDTSLSWYDTSMSLVECKDMC 378
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGI 419
KNCSCTAYANS++ SGC+LWFG+L+DM+E++ GGQDLYIR+ +T
Sbjct: 379 LKNCSCTAYANSNITGEASGCILWFGELVDMREFSTGGQDLYIRMPPPLKTGLT------ 432
Query: 420 IIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYN 479
F IWRKK +KQ ++EDMEL F A+I KATDNF+S N
Sbjct: 433 ----------------FYIWRKKQRKQ------EIEEDMELPSFHLATIVKATDNFSSNN 470
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+GGFGPVYKGTL++GQEIAVKRLSK S QG+ EFKNEV LIA+LQHRNLVKLLGCCI
Sbjct: 471 KLGQGGFGPVYKGTLIDGQEIAVKRLSKSSRQGLTEFKNEVILIAKLQHRNLVKLLGCCI 530
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q DE MLIYE+MPNKSLD+FIFDQ R FLDWQ+R I+GGIARG+LYLHQDSR+RIIHR
Sbjct: 531 QGDEVMLIYEFMPNKSLDYFIFDQTRNKFLDWQRRNLIIGGIARGLLYLHQDSRLRIIHR 590
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
DLKASN+LLD DMNPKISDFGMAR+FG D+I+ +T+KVVGT
Sbjct: 591 DLKASNILLDKDMNPKISDFGMARLFGVDQIEADTNKVVGT 631
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/673 (55%), Positives = 465/673 (69%), Gaps = 46/673 (6%)
Query: 11 ILGASAAN-DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAW 69
+L SAA + + P QS++DGETL+S +G FELGFFS G S RYLGIWYKR+ +TV W
Sbjct: 1 MLRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVW 60
Query: 70 VANRETPLTDQSGLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVVQLMDSGNLVLTDG 128
V NRE P D G+L V +G+++L + I WSSN+S T KNPV+QL+DSGNL++ DG
Sbjct: 61 VGNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDG 120
Query: 129 NYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHG 185
N N+ ++WQSFD P +TLLP MKLG N G++R+L+SWKSI+DPA G FS ID G
Sbjct: 121 NGNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 186 FPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV- 244
FPQL ++KG +Q R+G WNGL FTG+P L N P+ ++ FV N++E+YY + K +V
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPN-PVFNFSFVSNKHEIYYSYELKNTSVV 239
Query: 245 SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGF 304
SRL V++ G + R W + W L + P D+CD Y +CGA A C NS C CLEGF
Sbjct: 240 SRLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGF 299
Query: 305 VPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
VPKSP ++WS+GCVR EL C GD F K +KLPDTSSSW + SM+LKEC +C
Sbjct: 300 VPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMC 359
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSVTKKQVG 418
+NCSC AYANSD+ GSGCLLWF L+DM+++ +GGQDLYIRIA SE + + +
Sbjct: 360 LRNCSCLAYANSDIR--GSGCLLWFDHLIDMRKFTEGGQDLYIRIAASELAKGKSHGKRV 417
Query: 419 IIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------------GLTKMSHM- 454
II S L++ M + A ++ +K K+ GL K +++
Sbjct: 418 AIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIE 477
Query: 455 -------KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSK 507
KED EL FD +I AT NF++YNKLGEGGFGPVYKGTL++GQEIAVKRLS+
Sbjct: 478 NYGDNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSE 537
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT 567
SGQG +EFKNEV LIARLQHRNLVKLLGCCI DE MLIYEYMPNKSLD FIFD+ R+
Sbjct: 538 TSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSM 597
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
LDW I+GGIARG+LYLHQDSR+RIIHRDLKASN+LLD DMNPKISDFG+AR FG
Sbjct: 598 LLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGK 657
Query: 628 DEIQTNTHKVVGT 640
D+ NT +VVGT
Sbjct: 658 DQNAANTKRVVGT 670
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/657 (55%), Positives = 476/657 (72%), Gaps = 22/657 (3%)
Query: 5 YSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSP 64
+S ++ IL S A D+IT +Q I+DGET++S G FELGF GTS +YLGIWYK+V+P
Sbjct: 11 FSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYKKVTP 70
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
RTV WVANRE P+TD SG L VT +G +V+L+G + + WSSN+S + +NP QL+DSGNL
Sbjct: 71 RTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQLLDSGNL 130
Query: 124 VLTDGN---YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
V+ GN ++ LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS +DP+ G+F+
Sbjct: 131 VIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYG 190
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAK 240
+D G PQL LR GS + +R+G WNG+ F G P L+ N P+ +Y FV NE E+Y+
Sbjct: 191 LDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPN-PVFNYSFVFNEKEMYFTYKLV 249
Query: 241 GPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+V SRL +N +G V R IW + W + A D CD Y++CGA + C + S RC
Sbjct: 250 NSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTCNIHRSPRCG 309
Query: 300 CLEGFVPKSPN-----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKE 354
C++GFVPK P +WS GCVR+ L C+ GD F KY +KLPDT +SWFN SMNLKE
Sbjct: 310 CMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKE 369
Query: 355 CSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTK 414
C+ LC +NCSC+AY NSD++ GGSGCLLWFGDL+D+KE+ + GQD YIR+A+ +++K
Sbjct: 370 CASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMAASELDAISK 429
Query: 415 --KQVGIIIASVLLMAMFIVASLFCIW--RKKLKKQGLTKMSH-------MKEDMELWEF 463
K+ +I+++V + M +++ + ++ +K+LK++G T++++ +ED+EL F
Sbjct: 430 VTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGAETNERQEDLELPLF 489
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+I AT NF+ NKLGEGGFGPVYKG L +G+EIAVKRLSK S QG++EFKNEV I
Sbjct: 490 XLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYI 549
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++LQHRNLVKLLGCCI +E MLIYEYMPNKSL+FFIFD ++ LDW KR I+ GIAR
Sbjct: 550 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIAR 609
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
G+LYLHQDSR+RIIHRDLKA NVLLDN+MNP+ISDFGMAR FGG+E T +VVGT
Sbjct: 610 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/650 (57%), Positives = 455/650 (70%), Gaps = 43/650 (6%)
Query: 2 LGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKR 61
L YS LL + S A D I+P Q I DG+T+VS FELGFFSPG+S +RYLGIWYK+
Sbjct: 15 LFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKK 74
Query: 62 VSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
S TV WVANRE P+ D SG+L T++G ++LL+G + WSSN + NPV QL++S
Sbjct: 75 FSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQLLES 134
Query: 121 GNLVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEF 177
GNLV+ DGN + S LWQSFD+P DT LP MKLGRN TG+D +SSWKS++DPA GE+
Sbjct: 135 GNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEY 194
Query: 178 SLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYEC 237
SL ID G+ QLV +KG +Q+RAGSWNG+ FTG L+ N P+ Y+FV+N+ EVY+
Sbjct: 195 SLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPN-PVYRYEFVLNDKEVYFNF 253
Query: 238 DAKGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR 296
+ +V SR VN SG+V R W SQ W + D+CD YS CG+NA+C + S
Sbjct: 254 ELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNIDKSP 313
Query: 297 RCDCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMN 351
C CL+GF PKS +WS GCVR L C G+ F K+ +KLPDTSSSW+N S++
Sbjct: 314 VCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNTSIS 373
Query: 352 LKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRS 411
LKEC ELC K CSC AYAN+DV GGSGCLLWFGDL+DM+E+ + GQDLYIR+A+ S
Sbjct: 374 LKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTGQDLYIRMAA----S 429
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH-MKEDMELWEFDFASIAK 470
K I+ + SH KE++EL D ++IAK
Sbjct: 430 YLGKMKNIL--------------------------EMDYDSHSRKEELELPIIDLSTIAK 463
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
AT NF+S KLGEGGFG VYKGTL GQ+IAVKRLS SGQG+EEFKNEV LIA+LQHRN
Sbjct: 464 ATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRN 522
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKLLGCCI+ DE MLIYEYMPNKSLD+FIFDQ+R+ LDW RI I+ GIARG+LYLHQ
Sbjct: 523 LVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQ 582
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
DSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGG++ + NT +VVGT
Sbjct: 583 DSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANTKRVVGT 632
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122810|ref|XP_002330369.1| predicted protein [Populus trichocarpa] gi|222871754|gb|EEF08885.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/655 (55%), Positives = 457/655 (69%), Gaps = 24/655 (3%)
Query: 6 SCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
S + IL S A + I P QS+RDGETLVS +G+FELGFFSP S +YLG+W + SP+
Sbjct: 8 SFFISILTTSTALEIINPGQSLRDGETLVSSSGSFELGFFSPQGSTSKYLGLWLDK-SPQ 66
Query: 66 TVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSIT--MKNPVVQLMDSGN 122
TV WVANRE L+D G+LN+T++GI +LL+ + I WSSN+S + +NPV QL+DSGN
Sbjct: 67 TVLWVANRENSLSDNMGVLNITTQGILILLNSTNHIVWSSNSSASRNTQNPVAQLLDSGN 126
Query: 123 LVLTDGN-YN--SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
V+ +GN YN LWQSFDHPCDTLLPGM++G NF T +DR LSSWKS DPA GEF+
Sbjct: 127 FVVREGNDYNPAKFLWQSFDHPCDTLLPGMRIGVNFVTRIDRFLSSWKSPEDPARGEFTF 186
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTP-PLKENVPLCDYKFVINENEVYYECD 238
ID G+PQ++L+KG+ +R G W G+ FT P P+ + +FV+N EVY+E
Sbjct: 187 GIDPQGYPQVLLKKGNRTVFRGGPWTGIKFTSNPRPIPNQI--STNEFVLNNQEVYFEYR 244
Query: 239 AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ S+L ++ GL W+ + W + D+C+ Y CG N RC + C
Sbjct: 245 IQSSVSSKLTLSPLGLAQSLTWNDRAQDWVIVENGQYDQCEEYEFCGPNTRCEITRTPIC 304
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
CL+GF P SP ++WS GC R L C + D F KY KLPDTS+S F+ S++LK
Sbjct: 305 VCLDGFTPMSPVDWNFSDWSGGCHRRTPLNCSDKDGFLKYTANKLPDTSTSSFDKSIDLK 364
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSV 412
EC LC KNCSCTAY N D GGSGCL+WFGDL+DM+ GQD+Y+R+A SE G +
Sbjct: 365 ECERLCLKNCSCTAYTNLDFRAGGSGCLIWFGDLIDMRRSTGDGQDVYVRVAASELGANA 424
Query: 413 ------TKKQVGIII-ASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDF 465
TK + GII A+ L M M + +FC R+ L K + KED+EL D
Sbjct: 425 KKRNLSTKLKAGIIASAAALGMGMLLAGMMFCRRRRNLGKNDRLEEVR-KEDIELPIVDL 483
Query: 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
++IA ATDNF+S NKLGEGGFGPVYKG L+EGQEIAVK LSK S QGM+EFKNEV IA+
Sbjct: 484 STIAHATDNFSSSNKLGEGGFGPVYKGILIEGQEIAVKSLSKSSVQGMDEFKNEVKFIAK 543
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
LQHRNLVKLLG CIQ DE+MLIYEYMPNKSLDFFIFDQAR LDW KR++I+GGIARG+
Sbjct: 544 LQHRNLVKLLGYCIQEDENMLIYEYMPNKSLDFFIFDQARRKLLDWTKRMNIIGGIARGL 603
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LYLHQDSR+R+IHRD+KASN+LLDN++NPKISDFG+AR+F GDE + NTH+V+GT
Sbjct: 604 LYLHQDSRLRVIHRDIKASNILLDNELNPKISDFGLARMFRGDETEANTHRVIGT 658
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/647 (54%), Positives = 457/647 (70%), Gaps = 14/647 (2%)
Query: 5 YSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSP 64
+S +L +L S A D I +Q+I DGET+ S G+FELGFFSPG S RYLGIWYK+ S
Sbjct: 11 FSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKASK 70
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
+ V WVANRE+P+TD SG+L VT GI VL++G + I W+S +S + ++P QL++SGNL
Sbjct: 71 KPVVWVANRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLESGNL 130
Query: 124 VLTDGN---YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
V+ +GN + LWQSFD+PCDTLLPGMKLGRN G+DR+LSSWKS +DP+ G F+ W
Sbjct: 131 VMRNGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGNFTYW 190
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-A 239
ID GFPQL+LR G + +R G WNG+ F+G P L N P+ Y++V NE E+YY
Sbjct: 191 IDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTIN-PVYSYEYVSNEKEIYYIYSLV 249
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ RL + G RSIW+ +++ W L A D+CD Y++CG N C + S C+
Sbjct: 250 NSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSPNCE 309
Query: 300 CLEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKE 354
C++GF PK +NW S GCVR L C+ GD F KY +KLPDT SSWFN SMNLKE
Sbjct: 310 CMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMNLKE 369
Query: 355 CSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTK 414
C+ LC NCSCTAYANSD+ GGSGCLLWFGDL+D++++ + GQ+ Y+R+A+ + +
Sbjct: 370 CASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFTENGQEFYVRMAAADLETTKE 429
Query: 415 KQVGIIIASVLLMAMFIVASL-FCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATD 473
K++G + S+ + ++ + + L F + + K G + + +E +EL FD ++ AT+
Sbjct: 430 KRLGNRLNSIFVNSLILHSILHFAAYMEHNSKGG--ENNEGQEHLELPLFDLDTLLNATN 487
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
NF+S NKLGEGGFGPVYKG L EGQEIAVK +SK S QG++EFKNEV IA+LQHRNLVK
Sbjct: 488 NFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIAKLQHRNLVK 547
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLGCCI E +LIYE+MPNKSLD FIFDQ R LDW KR I+ GIA+G+LYLH+DSR
Sbjct: 548 LLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQGLLYLHRDSR 607
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+RIIHRDLKA N+LLDN+M PKISDFG+ FGG+EI+TNT +V T
Sbjct: 608 LRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVART 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/666 (55%), Positives = 467/666 (70%), Gaps = 28/666 (4%)
Query: 2 LGAYSCLLFILGA---SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIW 58
+GA LL + S A D I +Q +RDGE L S G+FELGFFSP S +RYLGIW
Sbjct: 1 MGALPTLLLVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIW 60
Query: 59 YKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRD-RIFWSSNTSITMKNPVVQ 116
YK+VS TV WVANRE PL D SG+L VT +G + +L+G + I WSSN+S + +NP Q
Sbjct: 61 YKKVSTMTVVWVANREIPLNDSSGVLKVTDQGTLAILNGSNTNILWSSNSSRSARNPTAQ 120
Query: 117 LMDSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
L+DSGNLV+ DGN ++ LWQSFD+PC+TLLPGMKLGRN TG+DR+LS+WKS++DP+
Sbjct: 121 LLDSGNLVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPS 180
Query: 174 PGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV 233
G F+ +D G+PQL+LRKGS + +R+G WNGL F+G P L N P+ Y+FV NE E+
Sbjct: 181 KGNFTYRLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSN-PVYTYEFVFNEKEM 239
Query: 234 YYECD-AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTT 292
Y+ + VSRL +N G R W + W L AP+D CD Y++CG C
Sbjct: 240 YFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTHGWILYSSAPMDSCDSYALCGVYGSCNI 299
Query: 293 NSSRRCDCLEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFN 347
N S +C+C+EGFVPK PN+W S GCVR L C+NG+ F K+ +KLPDT +SWFN
Sbjct: 300 NRSPKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFN 359
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE 407
SM+LKEC+ +C NCSCTAY N D+ GGSGCLLWFGDL+D++E+N+ GQ+LY+R+A+
Sbjct: 360 RSMDLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAAS 419
Query: 408 R-------GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLK------KQGLTKMSHM 454
G KK+ +I+ SV + + ++ L ++ K K G
Sbjct: 420 ELGMHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQ 479
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
KED+EL FDFA+++KAT++F+ +NKLGEGGFG VYKGTL E QEIAVKRLSK SGQG+
Sbjct: 480 KEDVELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLN 539
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EFKNEV I++LQHRNLV+LLG CI +E MLIYEYMPNKSLD FIFD+ R+ LDW KR
Sbjct: 540 EFKNEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKR 599
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR+RIIHRDLKA NVLLD +M PKISDFG+AR FGG+E + NT
Sbjct: 600 FLIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANT 659
Query: 635 HKVVGT 640
+VVGT
Sbjct: 660 KRVVGT 665
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 640 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.607 | 0.496 | 0.475 | 1.1e-174 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.912 | 0.716 | 0.530 | 5e-163 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.678 | 0.510 | 0.416 | 3.6e-161 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.675 | 0.512 | 0.409 | 4.8e-157 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.726 | 0.548 | 0.382 | 3.5e-152 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.668 | 0.504 | 0.398 | 4.3e-143 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.689 | 0.531 | 0.354 | 1.1e-133 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.971 | 0.775 | 0.440 | 1.8e-133 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.973 | 0.771 | 0.429 | 2.3e-133 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.976 | 0.777 | 0.428 | 3.4e-132 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 1.1e-174, Sum P(2) = 1.1e-174
Identities = 192/404 (47%), Positives = 277/404 (68%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR++P
Sbjct: 23 ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSP 82
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTS-----ITMKNPVVQLMDSGNLVLTD-GN 129
L D SG L V+ G + L + R+ I WSS++S +++NP+VQ++D+GNLV+ + G+
Sbjct: 83 LYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSGD 142
Query: 130 YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G PQ
Sbjct: 143 DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQF 202
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLW 248
L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R+
Sbjct: 203 FLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTRMQ 261
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
+N +G + R W W A +D CD Y++CG+ C N S C CL+GFV K+
Sbjct: 262 LNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKT 321
Query: 309 PN-----NWSEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELCSKN 362
P +WSEGCVR +L C G++ F K KLKLPDT +SW++ +M+L EC ++C +N
Sbjct: 322 PQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRN 381
Query: 363 CSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS 406
C+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS
Sbjct: 382 CTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLAS 425
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 5.0e-163, P = 5.0e-163
Identities = 322/607 (53%), Positives = 415/607 (68%)
Query: 53 RYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITM-- 110
R+LG+WY N T L+ + L DG + WSS++S T
Sbjct: 63 RFLGLWYMEPFAVVWVANRNNPLYGTSGFLNLSSLGD-LQLFDGEHKALWSSSSSSTKAS 121
Query: 111 ---KNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK 167
NP++++ SGNL+ +DG ++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK
Sbjct: 122 KTANNPLLKISCSGNLISSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWK 180
Query: 168 SINDPAPGEFSLWIDTHGFPQLVLRKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYK 225
++ DP+PG+F+L +DT G PQL+LRK S YR GSWNGL FTG P + L DYK
Sbjct: 181 TLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYK 240
Query: 226 FVINENEVYYECDAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCG 285
F + EV Y + VSRL +N +G + R I S+Q+ W LA AP D CD YS+CG
Sbjct: 241 FTSSAQEVNYSWTPRHRIVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICG 299
Query: 286 ANARCTTNSSRR--CDCLEGFVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKL 338
A A C NS C CL+GF PKS W+ GCV E C D F K+ LKL
Sbjct: 300 AYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKL 359
Query: 339 PDTSSSWFNAS--MNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDG 396
PDTS SW++A M L++C CS NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+
Sbjct: 360 PDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF 419
Query: 397 GQDLYIRIASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ--GLT-KMSH 453
GQD+YIR+ + ++ VG+++ SV+ +A+ +V +F +RKK+ K+ G +
Sbjct: 420 GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVV-VFACFRKKIMKRYRGENFRKGI 478
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM 513
+ED++L FD +I+ ATD+F+ N LG GGFGPVYKG L +GQEIAVKRLS SGQG+
Sbjct: 479 EEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGV 538
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
EEFKNEV LIA+LQHRNLV+LLGCCIQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+K
Sbjct: 539 EEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKK 598
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
R++I+ G+ARGILYLHQDSR+RIIHRDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++
Sbjct: 599 RMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESS 658
Query: 634 THKVVGT 640
T++VVGT
Sbjct: 659 TNRVVGT 665
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 3.6e-161, Sum P(2) = 3.6e-161
Identities = 189/454 (41%), Positives = 280/454 (61%)
Query: 8 LLFILGASAAND-NITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF + +AN + + S +I T+VS FELGFF PG ++ YLGIWYK +S RT
Sbjct: 20 ILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRT 79
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+TPL+ G L ++ +V+LD D WS+N T +++P+V +L+D+GN V
Sbjct: 80 YVWVANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFV 139
Query: 125 LTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
L D ++ +LWQSFD P DTLLP MKLG + KTG +R + SWKS +DP+ G+FS +
Sbjct: 140 LRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKL 199
Query: 182 DTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AK 240
+T GFP++ L YR+G WNG+ F+G P ++ + + F ++ EV Y K
Sbjct: 200 ETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMV-FNFTTSKEEVTYSFRITK 258
Query: 241 GPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDC 300
SRL ++ SGL+ R W W +YAP D+CD Y CG C +N+S C+C
Sbjct: 259 SDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNC 318
Query: 301 LEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKEC 355
++GF P++P W S+GCVR+ L C GD F + K+KLPDT+++ + + +KEC
Sbjct: 319 IKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKEC 378
Query: 356 SELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSV 412
+ C ++C+CTA+AN+D+ GSGC+ W G+L D++ Y GGQDLY+R+A+ E R+
Sbjct: 379 EQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNR 438
Query: 413 TKKQVGIIIA-SVLLMAMFIVASLFCIWRKKLKK 445
+ K +G I SVLL+ FI+ F +W++K K+
Sbjct: 439 SAKIIGSSIGVSVLLLLSFII---FFLWKRKQKR 469
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 4.8e-157, Sum P(2) = 4.8e-157
Identities = 185/452 (40%), Positives = 275/452 (60%)
Query: 8 LLFILGASAAND-NITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF+ + + N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT
Sbjct: 18 ILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRT 77
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+ PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D+GN +
Sbjct: 78 YVWVANRDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFL 137
Query: 125 LTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTH 184
L D N N LLWQSFD P DTLL MKLG + KTG +R L SWK+ +DP+ GEFS ++T
Sbjct: 138 LRDSN-NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 185 GFPQL-VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGP 242
FP+ + K S+L YR+G WNG+ F+ P + V Y F ++ EV Y K
Sbjct: 197 EFPEFYICSKESIL-YRSGPWNGMRFSSVPGTIQ-VDYMVYNFTASKEEVTYSYRINKTN 254
Query: 243 AVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLE 302
SRL++N +GL+ R W W +Y+P D CD Y VCG C +NS C C++
Sbjct: 255 LYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIK 314
Query: 303 GFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSE 357
GF P + W S GC+R+ L C D F + ++KLPDT+++ + + LK C E
Sbjct: 315 GFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 358 LCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTK 414
C ++C+CTA+AN+D+ GGSGC++W +++DM+ Y GGQDLY+R+A+ E R +
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 415 KQVGIIIA-SVLLMAMFIVASLFCIWRKKLKK 445
K +G I S+LL+ F++ F W++K K+
Sbjct: 435 KIIGSSIGVSILLLLSFVI---FHFWKRKQKR 463
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 3.5e-152, Sum P(2) = 3.5e-152
Identities = 186/486 (38%), Positives = 280/486 (57%)
Query: 8 LLFI-LGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF+ A+N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT
Sbjct: 18 ILFLAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRT 77
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+ PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D GN V
Sbjct: 78 YVWVANRDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 125 LTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTG-MDRHLSSWKSINDPAPGEFSLW 180
L D N LWQSFD P DTLL MK+G + K+G +R L SWK+ +DP+ G+FS
Sbjct: 138 LRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTK 197
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA- 239
+ T GFP+ + + YR+G W G F+ P +K V D F N +V Y
Sbjct: 198 LRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKP-VDYIDNSFTENNQQVVYSYRVN 256
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
K S L ++ +GL+ R W W +Y+P D CD Y CG C N+S C+
Sbjct: 257 KTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICN 316
Query: 300 CLEGFVPKSPN----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKEC 355
C++GF P + + S GCVR+ +L C D F + K++LPDT+ + + + LKEC
Sbjct: 317 CIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKEC 376
Query: 356 SELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSV 412
E C K C+CTA+AN+D+ GGSGC++W G L D++ Y GGQDLY+R+A+ E R
Sbjct: 377 EERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIK 436
Query: 413 TKKQVGIIIA-SVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKA 471
+KK +G I S+LL+ FI+ F W++K +K+ +T + + + + + + KA
Sbjct: 437 SKKIIGSSIGVSILLLLSFII---FHFWKRK-QKRSITIQTPIVDLVRSQDSLMNELVKA 492
Query: 472 TDNFAS 477
+ ++ S
Sbjct: 493 SRSYTS 498
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
Identities = 182/457 (39%), Positives = 258/457 (56%)
Query: 10 FILGASAANDNITPSQSIRDG---ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
F+ +S A + I +S+RDG + LVS TFELGFFSPG+S R+LGIWY + +
Sbjct: 18 FLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKA 77
Query: 67 VAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSN--TSITMKNP-VVQLMDSGN 122
V WVANR TP++DQSG+L +++ G +VLLDG++ WSSN +S T N VV + D+GN
Sbjct: 78 VVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGN 137
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
VL++ + + +W+SF+HP DT LP M++ N +TG + SW+S DP+PG +SL +D
Sbjct: 138 FVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVD 197
Query: 183 THGFPQLVLRKGS-VLQYRAGSWNGLGFTGTP--PLKENVPLCDYKFVINENE---VYYE 236
G P++VL +G+ ++R+G WN FTG P L N L +K +E VY+
Sbjct: 198 PSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNY-LYGFKLSSPPDETGSVYFT 256
Query: 237 CDAKGPAVS-RLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSS 295
P+V R V +G W+ W P CD Y+ CG C S
Sbjct: 257 YVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGS 316
Query: 296 RR-CDCLEGFVPKSPNNWSEGCVRERELKC-RN---G-DEFPKYVKLKLPDTSSSWFNAS 349
C C+ G+ S NWS GC R LKC RN G DEF +KLPD N
Sbjct: 317 NGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNL- 375
Query: 350 MNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SER 408
++ ++C E C +NCSC AY S V GG GC++W DL+D++++ GG L+IR+A SE
Sbjct: 376 VDPEDCRERCLRNCSCNAY--SLV--GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEV 431
Query: 409 GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKK 445
G + K ++ +I+A VL+ + I +WR K KK
Sbjct: 432 GEN-RKTKIAVIVA-VLVGVILIGIFALLLWRFKRKK 466
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 1.1e-133, Sum P(2) = 1.1e-133
Identities = 169/477 (35%), Positives = 252/477 (52%)
Query: 8 LLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTV 67
+ F L A D IT S RD ET+VS + TF GFFSP S RY GIW+ + +TV
Sbjct: 12 ICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTV 71
Query: 68 AWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMK-NPV-VQLMDSGNLV 124
WVAN +P+ D SG+++++ +G +V++DGR ++ WS+N + + N +L+++GNLV
Sbjct: 72 VWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLV 131
Query: 125 L--TDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
L T + +LW+SF+HP + LP M L + KTG L SWKS DP+PG +S +
Sbjct: 132 LLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLI 191
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGP 242
FP+LV+ K +L +R+G WNG F G P + + L + + A
Sbjct: 192 PLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNT 251
Query: 243 AVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTN--SSRRCDC 300
+ ++ G V + W+ W P +CD Y+ CG A C N S+ C C
Sbjct: 252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311
Query: 301 LEGFVPKS-----PNNWSEGCVRERELKC---------RNGDEFPKYVKLKLPDTSSSWF 346
+ GF P+S NW++GCVR+ L+C R D F + K+K+P
Sbjct: 312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQ--- 368
Query: 347 NASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS 406
+ N ++C E C KNCSCTAY+ +RG GCLLW G+LMDM+E++ G YIR+A
Sbjct: 369 RSGANEQDCPESCLKNCSCTAYS---FDRG-IGCLLWSGNLMDMQEFSGTGVVFYIRLAD 424
Query: 407 ERGRSVTKKQVGIIIASVLLMAMFIVAS--LFCIWR--KKLKKQGLTKMSHMKEDME 459
+ T + I+I LL+ F+ A + +W+ K +K T++ + E ME
Sbjct: 425 SEFKKRTNRS--IVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRL--LNERME 477
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1308 (465.5 bits), Expect = 1.8e-133, P = 1.8e-133
Identities = 293/665 (44%), Positives = 401/665 (60%)
Query: 5 YSCLLF-ILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
++C LF L S + ITP+ + G+TL S NG FELGFFSP S Y+GIW+K +
Sbjct: 4 FACFLFSTLLLSFSYAAITPTSPLSIGQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGII 63
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGN 122
PRTV WVANRE +TD + L ++S G +LL DG+ WS+ + +L DSGN
Sbjct: 64 PRTVVWVANRENSVTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSSAELSDSGN 123
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
L++ D LWQSF+H DT+LP L N TG R LSSWKS DP PGEF +I
Sbjct: 124 LLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYIT 183
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN---EVYYECDA 239
T PQ + +GS +R+G W FTG P E+ + F + ++ VY+
Sbjct: 184 TQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESYT---HPFSVQQDANGSVYFSHLQ 240
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ S L + G L+ + D W L P + CD Y VCG C + +C
Sbjct: 241 RNFKRSLLVLTSEGS-LKVTHHNGTD-WVLNIDVPANTCDFYGVCGPFGLCVMSIPPKCK 298
Query: 300 CLEGFVPK-----SPNNWSEGCVRERELKC------RNGDEFPKYVKLKLPDTSSSWFNA 348
C +GFVP+ NW+ GCVR EL C R+ + F +K PD F +
Sbjct: 299 CFKGFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFYE--FVS 356
Query: 349 SMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS-E 407
S + +EC + C NCSC A+A + G GCL+W +LMD+ +++ GG+ L IR+AS E
Sbjct: 357 SGSAEECYQSCLHNCSCLAFAYIN----GIGCLIWNQELMDVMQFSVGGELLSIRLASSE 412
Query: 408 RGRSVTKKQVGIIIASVLLMAMFIV--ASLFCIWRKKLKKQGL-TKMS-------HMK-E 456
G + KK IIAS++ +++F+ ++ F WR +LK + +K+S +K E
Sbjct: 413 MGGNQRKKT---IIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSE 469
Query: 457 DME-LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE 515
D+ L+ F+ +I AT+NF+ NKLG+GGFGPVYKG L +G+EIAVKRLS SGQG EE
Sbjct: 470 DVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEE 529
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F NE+ LI++LQH NLV++LGCCI+ +E +L+YE+M NKSLD FIFD + +DW KR
Sbjct: 530 FMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRF 589
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I+ GIARG+LYLH+DSR+RIIHRD+K SN+LLD+ MNPKISDFG+AR++ G + Q NT
Sbjct: 590 SIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTR 649
Query: 636 KVVGT 640
++VGT
Sbjct: 650 RIVGT 654
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1307 (465.1 bits), Expect = 2.3e-133, P = 2.3e-133
Identities = 285/664 (42%), Positives = 393/664 (59%)
Query: 4 AYSCLL-FILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRV 62
AY L F + +S+A IT + G+TL S NG +ELGFF+ S +Y+GIW+K +
Sbjct: 10 AYLLLSSFFISSSSAG--ITKESPLPIGQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGI 67
Query: 63 SPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSG 121
PR V WVANRE P+TD + L +++ G +LL +G+ + WSS ++ +L D+G
Sbjct: 68 IPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSGEALVSNGSRAELSDTG 127
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
NL++ D LWQSFDH DT+LP L N TG + LSSWKS DP+ G+F L I
Sbjct: 128 NLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQI 187
Query: 182 DTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEVYYECDA 239
Q+++ KGS YR+G W FTG P + + P+ + + Y
Sbjct: 188 TPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGSLTYL--N 245
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ + R + G S W + D W L + AP CD Y VCG C + +C
Sbjct: 246 RNDRLQRTMLTSKGTQELS-WHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCT 303
Query: 300 CLEGFVPK-----SPNNWSEGCVRERELKCRNGDEFPKYV-------KLKLPDTSSSWFN 347
C +GFVPK NW+ GCVR EL C+ G+ KY ++K PD F
Sbjct: 304 CFKGFVPKLIEEWKRGNWTGGCVRRTELYCQ-GNSTGKYANVFHPVARIKPPDFYE--FA 360
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-S 406
+ +N++EC + C NCSC A+A D G GCL+W DLMD ++++GG+ L IR+A S
Sbjct: 361 SFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGGELLSIRLARS 416
Query: 407 ERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG--LTKMSHM--KEDMELWE 462
E G + KK + I S+ L+ + + FC WR ++K T S + + D++ +
Sbjct: 417 ELGGNKRKKAITASIVSLSLVVIIAFVA-FCFWRYRVKHNADITTDASQVSWRNDLKPQD 475
Query: 463 ------FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEF 516
FD +I AT+NF+ NKLG+GGFGPVYKG L +G+EIAVKRLS SGQG EEF
Sbjct: 476 VPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEF 535
Query: 517 KNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
NE+ LI++LQH+NLV++LGCCI+ +E +LIYE+M N SLD F+FD + +DW KR+
Sbjct: 536 MNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLD 595
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I+ GIARGI YLH+DS +++IHRDLK SN+LLD MNPKISDFG+AR++ G E Q NT +
Sbjct: 596 IIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRR 655
Query: 637 VVGT 640
VVGT
Sbjct: 656 VVGT 659
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1296 (461.3 bits), Expect = 3.4e-132, P = 3.4e-132
Identities = 284/663 (42%), Positives = 388/663 (58%)
Query: 2 LGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKR 61
L ++ LF L + +++ IT + G+TL S N +ELGFFSP + +Y+GIW+K
Sbjct: 8 LHLFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKD 67
Query: 62 VSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
PR V WVANRE P+TD + L ++S G ++LL+G+ WSS + + +L DS
Sbjct: 68 TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFSSSGCRAELSDS 127
Query: 121 GNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
GNL + D LWQSFDH DTLL L N T R L+SWKS DP+PG+F
Sbjct: 128 GNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFLGQ 187
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEV-YYEC 237
I Q + +GS +R+G W FTG P + E+ P ++ V + Y++
Sbjct: 188 ITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQDVNGSGYLTYFQR 247
Query: 238 DAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRR 297
D K +SR+ + G + ++ W L Y AP CD Y CG C + S
Sbjct: 248 DYK---LSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPM 302
Query: 298 CDCLEGFVPKSPN-----NWSEGCVRERELKC------RNGDEFPKYVKLKLPDTSSSWF 346
C C GFVPKS NW+ GCVR EL C + D+F + +K PD F
Sbjct: 303 CKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE--F 360
Query: 347 NASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA- 405
+S+N +EC + C NCSC A+A G GCL+W DLMD +++ G+ L IR+A
Sbjct: 361 ASSVNAEECHQRCVHNCSCLAFAYIK----GIGCLVWNQDLMDAVQFSATGELLSIRLAR 416
Query: 406 SERGRSVTKKQVGIIIASVLLMAMFIVASL--FCIWRKKLKKQGLTKMSHMKEDMELWE- 462
SE + KK I+AS++ + +F++ F +WR +++ K D++ +
Sbjct: 417 SELDGNKRKKT---IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQDV 473
Query: 463 -----FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFK 517
FD +I AT+NF+ NKLG+GGFG VYKG L +G+EIAVKRLS SGQG EEF
Sbjct: 474 PGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 533
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
NE+ LI++LQHRNLV++LGCCI+ +E +LIYE+M NKSLD F+FD + +DW KR I
Sbjct: 534 NEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDI 593
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ GIARG+LYLH DSR+R+IHRDLK SN+LLD MNPKISDFG+AR++ G E Q NT +V
Sbjct: 594 IQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 653
Query: 638 VGT 640
VGT
Sbjct: 654 VGT 656
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5031 | 0.9312 | 0.7611 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_134000023 | hypothetical protein (812 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 640 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-31 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-31 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-26 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 9e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 8e-43
Identities = 62/150 (41%), Positives = 83/150 (55%), Gaps = 10/150 (6%)
Query: 480 KLGEGGFGPVYKGTL-----VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + M++ EYMP L ++ R L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
IHRDL A N L+ ++ KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 59/163 (36%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + ++ EYM L ++ + L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
IHRDL A N L+ ++ KISDFG++R D+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 57/172 (33%), Positives = 87/172 (50%), Gaps = 15/172 (8%)
Query: 479 NKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L E+AVK L + S + ++F E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C + + L+ EYM L ++ F + L + + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
L + +HRDL A N L+ D+ KISDFG++R ++ D + T +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 57/150 (38%), Positives = 84/150 (56%), Gaps = 11/150 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL ++AVK L +G+ + EEF E +++ +L H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C Q + ++ EYMP L F+ + L + + + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+HRDL A N L+ ++ KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 57/163 (34%), Positives = 87/163 (53%), Gaps = 10/163 (6%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LGEGGFG VY + G+++A+K + K S +EE E+ ++ +L H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + L + + I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 599 RDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGT 640
RDLK N+LLD+D K++DFG++++ D+ T +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 56/165 (33%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ RL H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
D L+ EY L ++ +R L + I I RG+ YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRDLK N+LLD + KI+DFG+A+ ++ VGT
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 61/111 (54%), Positives = 69/111 (62%), Gaps = 3/111 (2%)
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
+TV WVANR PLTD S L + S G +VL DG R+ WSSNTS V L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
LVL D + +LWQSFDHP DTLLPG K G N G R L+SWKS DP+
Sbjct: 61 LVLYDNS-GKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
KLGEG FG VY + G+ +A+K + K + E E+ ++ +L+H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
D+ L+ EY L + + R + + R + I + YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS---KGI 118
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+HRDLK N+LLD D + K++DFG+AR E VGT
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG VY + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 536 GCCIQADESML-IY-EYMPNKSLDFFIFDQARATFLDWQKRIHI------VGGIARGILY 587
G +++ L I+ EY+ SL ++ L ++ I G+ Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL---------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH I+HRD+K +N+L+D+D K++DFG A+ G E T V GT
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 56/119 (47%), Positives = 70/119 (58%), Gaps = 4/119 (3%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S + G+TLVS FELGFF ++ Y I YK S RTV WVANR+ P S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNPSGS-SCT 58
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141
L + S G +V+ DG + WSSNT+ N V+ L+D GNLVL D + N LWQSFD+P
Sbjct: 59 LTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNF-LWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 57/118 (48%), Positives = 74/118 (62%), Gaps = 5/118 (4%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S ++ G+TLVS N FELGFF+ Y I YK S RTV WVANR+ P++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYK-SSSRTVVWVANRDNPVSD-SCT 57
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
L + S G +VL DG R+ WSSNT+ N V+ L+D GNLV+ D + + LWQSFD+
Sbjct: 58 LTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD-SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 479 NKLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 533 KLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
K G C + LI EY+P+ SL ++ Q ++ ++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
R IHRDL A N+L++++ KISDFG+A++
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-26
Identities = 36/67 (53%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLW 383
C GD F + +KLPDT+++ + S+ LKEC + C NCSCTAYA +D+ RGGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADI-RGGSGCLIW 59
Query: 384 FGDLMDM 390
G+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 41/111 (36%), Positives = 60/111 (54%), Gaps = 2/111 (1%)
Query: 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYE-CDAKGPAVSRLWVNQSGLVLR 257
+R+G WNG+ F+G P +++ Y F N EVYY SRL ++ G + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKL-SYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 258 SIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
W W L + AP D+CD+Y CG C N+S +C+C++GFVPK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 35/177 (19%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+ +G G FG VYKG L G +A+K++S K + ++ E+ L+ L+H N+VK +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG------------IAR 583
G +D +I EY N SL ++ I G + +
Sbjct: 66 GSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYVYQVLQ 110
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
G+ YLH+ +IHRD+KA+N+L D K++DFG+A + VVGT
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVK 533
LGEG FG V+ G L + +AVK L + + + F+ E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKR----------IHIVGGIA 582
G C + D ++++EYM + L+ F+ A FL + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
G++YL + +HRDL N L+ D+ KI DFGM+R D T+ ++V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 58/169 (34%), Positives = 85/169 (50%), Gaps = 24/169 (14%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
LGEG FG VYKG L +A+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVGG 580
LLG C + + +++EY+ + L F+ D+ + LD +HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 54/153 (35%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ GT ++AVK L G+ M E F E ++ +L+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
C + + ++ EYM SL DF + + L + + + IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
IHRDL A N+L+ ++ KI+DFG+AR+ DE
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 21/184 (11%)
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
D S + + + K+GEG G VYK T G+E+A+K++ + Q E NE+ +
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL------DFFIFDQARATFLDWQKRIH 576
+ +H N+V + DE ++ EYM SL +F ++ + +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------- 120
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
+ + +G+ YLH +IHRD+K+ N+LL D + K++DFG A + ++ +
Sbjct: 121 VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNS 175
Query: 637 VVGT 640
VVGT
Sbjct: 176 VVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 17/166 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ + +H N+VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRM 594
++ DE ++ E+ SL + T + Q + + + +L YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---N 117
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRD+KA+N+LL +D K+ DFG++ D NT +VGT
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNT--MVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 22/168 (13%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG +G VYK G+ +A+K++ ++ + E++L+ L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + L++EY + L ++ + + K I+ + RG+ Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIK--SIMYQLLRGLAYCHS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
RI+HRDLK N+L++ D K++DFG+AR F G ++T TH+VV
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-24
Identities = 35/81 (43%), Positives = 51/81 (62%), Gaps = 5/81 (6%)
Query: 325 RNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWF 384
+ D F K +KLPD +S+ +++L+EC E C NCSCTAYA ++ G GCLLW
Sbjct: 9 GSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWN 63
Query: 385 GDLMDMKEYNDGGQDLYIRIA 405
G L +++ + GG LY+R+A
Sbjct: 64 GLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + +A+K L GS +F E +++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G ++ M+I EYM N SLD F+ + + + ++ GIA G+ YL S M
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+HRDL A N+L+++++ K+SDFG++R E T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 25/172 (14%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
++GEG +G VYK G+ +A+K++ ME K E+ L+ +L+H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQKLRHP 58
Query: 530 NLVKLLGCCIQADES--MLIYEYMPNKSLDFF-IFDQARATFLDWQKRIHIVGGIARGIL 586
N+V+L + +++EYM + D + D F + Q + + + G+
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
YLH I+HRD+K SN+L++ND K++DFG+AR + T++V+
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 20/159 (12%)
Query: 481 LGEGGFGPVYKGT-LVEGQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARA----TFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + + LI + MP L ++ + L+W +I A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
R++HRDL A NVL+ + KI+DFG+A++ DE
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 49/143 (34%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G GQ++AVK L K + F E +++ L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+ ++ EYM SL ++ + RA + +++ + G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 601 LKASNVLLDNDMNPKISDFGMAR 623
L A NVL+ D+ K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (248), Expect = 1e-22
Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-R 529
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKL L+ EY+ SL+ + R L + + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD----EIQTNTHKVVGT 640
IIHRD+K N+LLD + K+ DFG+A++ I VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 4/163 (2%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
F KLG G FG V++G +A+K L ++F+ EV + RL+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C + +I E M SL F+ L I + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
IHRDL A N+L+ D+ K++DFG+AR+ D ++ K+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 25/179 (13%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ +L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-------TFLDW--QKRIHIVGGI 581
++K + + ++ EY L I Q + LDW Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ YLH SR +I+HRD+K N+ L ++ K+ DFG++++ T VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 55/156 (35%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 479 NKLGEGGFGPVYKGTLVE--GQEI--AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + G+E+ AVK L + G +EF E +++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L+G C + + ML+ E P L ++ + D ++ H +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLES--- 113
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HRDL A NVLL N KISDFGM+R G
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+G FG VYKG L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+Q ++ E +P F + + L +K + + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 599 RDLKASNVLLDNDMNPKISDFGMAR 623
RDL A N L+ + KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 30/173 (17%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K + +E E +++R+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILY 587
L Q +E + L+ EY P L + F + RA F I + Y
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEY 108
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH + II+RDLK N+LLD D + K++DFG+A+ + +TNT GT
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEG +G VYK GQ +A+K + + ++E E++++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ + ++ EY S + D + L ++ I+ +G+ YLH +
Sbjct: 68 FKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKK 120
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IHRD+KA N+LL+ + K++DFG++ + NT V+GT
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 59/160 (36%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 481 LGEGGFGPVYKGTLV-------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLV 532
LG G FG VY+GT +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----LDWQKRIHIVGGIARGILYL 588
KLLG C+ + +I E M L ++ D F L ++ + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 589 HQDSRMRIIHRDLKASNVLL-----DNDMNPKISDFGMAR 623
Q M IHRDL A N L+ D D KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-Q 527
D+F +GEG F V E +E A+K L K + ++ K E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
H ++KL Q +E++ + EY PN L +I D+ F I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEI 111
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ YLH IIHRDLK N+LLD DM+ KI+DFG A++ + +
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 53/159 (33%), Positives = 95/159 (59%), Gaps = 10/159 (6%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V++G L + G++ +A+K L G + + ++F +E +++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + +M+I EYM N +LD ++ D F +Q + ++ GIA G+ YL S M
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQ-LVGMLRGIAAGMKYL---SDMN 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+HRDL A N+L+++++ K+SDFG++R+ D T T
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 56/151 (37%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q + +I EYM N SL DF + L K I + IA G+ ++ R IH
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
RDL+A+N+L+ + KI+DFG+AR+ +E
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 52/165 (31%), Positives = 85/165 (51%), Gaps = 28/165 (16%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQ---HRNLV 532
++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 533 KLLGCC--IQADESMLIYEYMPNKSLDFFIFDQARATFLD---------WQKRIHIVGGI 581
+LL C + D + + L F DQ AT+L + ++ +
Sbjct: 65 RLLDVCHGPRTDRELKLT-------LVFEHVDQDLATYLSKCPKPGLPPETIK-DLMRQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
RG+ +LH RI+HRDLK N+L+ +D KI+DFG+ARI+
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D SI KLG G FG V++G +AVK L G+ ++F E
Sbjct: 1 WEIDRTSIQLL-------RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEA 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVG 579
++ +L+H L++L C + ++ E M SL ++ RA L + I +
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAA 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+A G+ YL IHRDL A NVL+ + K++DFG+AR+ D
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 481 LGEGGFGPVYKGTLVEG----QEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQARAT---FLDWQKRIHIVGGIARGI 585
+G C +A M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
YL S IHRDL A N +L DM ++DFG+++ I+ GD
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 20/160 (12%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG P+ T G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 533 KLLGCCIQA--DESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
K G C A L+ EY+P SL D+ + R LD +K + I +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL- 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
R +HRDL N+L++++ KI DFG+ ++ D+
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLG 536
K+GEG +G VYK + G+ +A+K++ E+ L+ L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E+M D + + R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+HRDLK N+L++ + K++DFG+AR FG + TH VV
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV 160
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 58/163 (35%), Positives = 94/163 (57%), Gaps = 20/163 (12%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG V EG+ + A+K L++ +G + EF +E ++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP+ L ++ + L+W +I A+G++YL +
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
R++HRDL A NVL+ + + KI+DFG+AR+ GDE + N
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 56/151 (37%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ + +I EYM SL DF D+ L K I IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
RDL+A+NVL+ + KI+DFG+AR+ +E
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 45/155 (29%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
++G G FG V+ G +E +++A+K + +G+ E+F E ++ +L H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ L++E+M + L ++ +A+ + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
DL A N L+ + K+SDFGM R D+ ++T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 55/170 (32%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 480 KLGEGGFGPVYKGTLVEGQ----EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKL 534
KLG+G FG V +G +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG----IARGILYLHQ 590
G + M++ E P SL + A FL I + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVV 638
R IHRDL A N+LL +D KI DFG+ R D H V
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 59/154 (38%), Positives = 78/154 (50%), Gaps = 21/154 (13%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNL 531
LGEG FG P GT G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 532 VKLLGCCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
VK GCC Q + + LI EY+P SL ++ L+ + + I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
IHRDL A NVLLDND KI DFG+A+
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 59/172 (34%), Positives = 93/172 (54%), Gaps = 16/172 (9%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR 529
++ K+GEG +G VYKG GQ +A+K++ S+ G + E++L+ LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
N+V L +Q LI+E++ K LD Q ++D + + I +GIL
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQ----YMDAELVKSYLYQILQGIL 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ H R++HRDLK N+L+DN K++DFG+AR F G ++ TH+VV
Sbjct: 116 FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 57/182 (31%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 474 NFASYNKLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHI 577
H ++VK G C++ D ++++EYM + L+ F+ R L + +HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
IA G++YL + +HRDL N L+ ++ KI DFGM+R D T+ ++V
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 638 VG 639
G
Sbjct: 179 GG 180
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 29/175 (16%)
Query: 480 KLGEGGFGPVY-------------KGTLVEGQE--IAVKRL-SKGSGQGMEEFKNEVTLI 523
KLGEG FG V+ +GQ +AVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-QARATF--------LDWQKR 574
+RL++ N+++LLG C+ D +I EYM N L+ F+ + +TF +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
+++ IA G+ YL + + +HRDL N L+ N KI+DFGM+R ++ GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 25/171 (14%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI----VGGIARGIL----YLH 589
+ E ++ EYM SL + +K I + IAR IL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRD+K SN+L+++ KI+DFG++++ + + VGT
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 25/178 (14%)
Query: 480 KLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF---------IFDQARATF---LDWQKRIHIVGGI 581
G C + ++++EYM + L+ F I L + + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
A G++YL + + +HRDL N L+ + KI DFGM+R D T+ ++V G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 182
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G + +AVK L K +EEF E
Sbjct: 1 WEMERTDITM-------KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 52
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R ++ +++
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMAT 111
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
I+ + YL + + IHRDL A N L+ + K++DFG++R+ GD
Sbjct: 112 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 58/170 (34%), Positives = 86/170 (50%), Gaps = 24/170 (14%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLV 532
+LGE FG VYKG L + Q +A+K L K G EEFK+E + +RLQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVG 579
LLG + +I+ Y + L F+ D+ + L+ +HIV
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
IA G+ +L S ++H+DL NVL+ + +N KISD G+ R ++ D
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ GT ++AVK L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ D L + + +A G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629
DL+++N+L+ + + KI+DFG+AR+ +E
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 33/176 (18%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHRNLV 532
KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 533 KLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
LL L++E+M +KS+ + A RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLM--------TLRG 114
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVV 638
+ YLH + I+HRDLK +N+L+ +D K++DFG+AR FG ++ TH+VV
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 536 ----GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G +L+ EYMP+ L + D+ R K + + +G+ Y+H +
Sbjct: 67 VFPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHAN 118
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I+HRDLK +N+L+ D KI+DFG+AR+F +E + +H+V
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 52/151 (34%), Positives = 86/151 (56%), Gaps = 16/151 (10%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG---GIARGILYLHQDS 592
G ++ M+I E+M N +LD F+ Q F I +VG GIA G+ YL S
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL-RQNDGQF----TVIQLVGMLRGIAAGMKYL---S 123
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
M +HRDL A N+L+++++ K+SDFG++R
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
+G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-------------------LDWQKR 574
LLG C L++EYM L+ F+ ++ L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
+ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG G FG V+ G ++A+K + +G+ ++F E ++ +L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
++ EYM N L ++ + R L + + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDE 629
L A N L+ D K+SDFG+AR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEG-------QEIAVKRL-SKGSGQGMEEFKNEVTL 522
D+ LG G FG VY+G L G ++AVK L S Q +F E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIV 578
+++ H+N+V+L+G + ++ E M L F+ + R + L + +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMAR-IFGGD 628
+A+G YL ++ IHRD+ A N LL KI+DFGMAR I+
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 48/150 (32%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT +A+K L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ + +L + + + IA G+ Y+ RM +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629
DL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 480 KLGEGGFGPVY-------KGTLVEGQEI----------AVKRLSKG-SGQGMEEFKNEVT 521
KLGEG FG V+ + + AVK L S E+F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQK 573
+++RL N+ +LLG C +I EYM N L+ F+ + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+++ IA G+ YL + +HRDL N L+ + KI+DFGM+R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 23/179 (12%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKR-----------IHIVGG 580
G C D ++++EYM + L+ F+ +D Q R +HI
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + H ++
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 50/144 (34%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG V+KGTL + +AVK + Q ++ +F +E ++ + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E +P DF F + + L ++ + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 600 DLKASNVLLDNDMNPKISDFGMAR 623
DL A N L+ + KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 53/157 (33%), Positives = 87/157 (55%), Gaps = 18/157 (11%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVG---GIARGILYLHQD 591
G ++ M++ EYM N SLD F+ + T I +VG GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV------IQLVGMLRGIASGMKYL--- 122
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
S M +HRDL A N+L+++++ K+SDFG++R+ D
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 53/169 (31%), Positives = 93/169 (55%), Gaps = 11/169 (6%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
NF K+GEG +G VYK + G+ +A+K RL + E++L+ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 531 LVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+VKLL I + + L++E++ ++ L F+ D + + + + + +G+ + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 9/163 (5%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNL 531
NF KLGEG + VYKG G+ +A+K + + +G E++L+ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V+L ++ ML++EYM +K L ++ LD + +GI + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
R++HRDLK N+L++ K++DFG+AR FG I NT
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNT 156
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 54/169 (31%), Positives = 90/169 (53%), Gaps = 23/169 (13%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
K+GEG +G VYK + G+ +A+K++ +E E++L+ L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-DQARATFLDWQKRIHIVGGIARGILYLH 589
+V+LL ++ L++E++ LD + D + T LD + + +GI Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
R++HRDLK N+L+D + K++DFG+AR F G ++T TH+VV
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKLL 535
+LG+G FG VY E E+ A+K++ K EE N EV + +L H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE ++EYM +L + D+ F + R I+ I +G+ ++H+
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGFF- 121
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMAR 623
HRDLK N+L+ KI+DFG+AR
Sbjct: 122 --HRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 30/160 (18%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQG-------MEEFKNEVTLIARLQHRN 530
+G G FG VY G G+ +AVK+ L S ++ E+ L+ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HIVGGIARG 584
+V+ LG + AD + EY+P S+ A L+ + V I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 585 ILYLHQDSRMR-IIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ YLH R IIHRD+K +N+L+DN KISDFG+++
Sbjct: 119 LNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI---AVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG FG V +G L + I AVK +++ + ME+F +E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 536 GCCIQADES------MLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARG 584
G C+Q ES ++I +M + L F+ D +L Q + + IA G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMTDIASG 124
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGD 628
+ YL S IHRDL A N +L+ +MN ++DFG++ +I+ GD
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 24/155 (15%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKR-----LSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCIQADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-----IARGILYL 588
GC ++ DE++ I+ EYMP S + DQ +A + V I G+ YL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGS----VKDQLKA----YGALTETVTRKYTRQILEGVEYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 57/178 (32%), Positives = 85/178 (47%), Gaps = 26/178 (14%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGE FG +YKG L Q +A+K L + Q EF+ E +L+A L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF--------------DQARATFLDWQKRIHIVG 579
LLG Q +++EY+ L F+ D + LD +HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--EIQTNT 634
IA G+ YL S +H+DL A N+L+ ++ KISD G++R I+ D +Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 43/173 (24%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG FG VYK + G+ +A+K++ M K+ E+ ++ +L+H N
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIKILKKLKHPN 68
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIH------- 576
+V L+ + E D + L+ +
Sbjct: 69 VVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118
Query: 577 -IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ + GI YLH++ I+HRD+KA+N+L+DN KI+DFG+AR + G
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 54/151 (35%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ T + ++AVK + GS +E F E ++ LQH LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ +I E+M SL DF D+ L K I IA G+ ++ Q + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
RDL+A+N+L+ + KI+DFG+AR+ +E
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 60/177 (33%), Positives = 93/177 (52%), Gaps = 24/177 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQHR 529
D + K+GEG +G VYK V + IA+K++ + +G+ E++L+ +QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 530 NLVKLLGCCIQADESMLIYEYMP-------NKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
N+V+L L++EY+ + S DF + T+L +Q I
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-YQ--------IL 112
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVV 638
RGI Y H S R++HRDLK N+L+D N K++DFG+AR F G ++T TH+VV
Sbjct: 113 RGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV 165
|
Length = 294 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 32/177 (18%)
Query: 480 KLGEGGFGPVYKGTLVEGQE------------------IAVKRL-SKGSGQGMEEFKNEV 520
KLGEG FG V+ EG E +AVK L + +F E+
Sbjct: 12 KLGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQ 572
+++RL+ N+++LL CI +D +I EYM N L+ F+ ++A + +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
I + IA G+ YL S + +HRDL N L+ + KI+DFGM+R ++ GD
Sbjct: 131 TLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 38/184 (20%)
Query: 480 KLGEGGFGPVYKGTLVEGQE-----------------IAVKRL-SKGSGQGMEEFKNEVT 521
KLGEG FG V+ +V Q+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ----------------AR 565
+++RL+ N+++LLG C+ D +I EYM N L+ F+
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-I 624
+ + +H+ IA G+ YL S + +HRDL N L+ ++ KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 625 FGGD 628
+ GD
Sbjct: 189 YAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F NK+G+G FG V+K + + A+K+ LSK + + EE +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD---WQKRIHIVGGIARGILY 587
+++ + + ++ EY N L + Q + W+ I I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 57/172 (33%), Positives = 92/172 (53%), Gaps = 21/172 (12%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEI----AVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + EG+++ A+K L + S + +E +E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARAT---FLDWQKRIHI 577
++A + + ++ +LLG C+ + LI + MP L D+ + L+W +I
Sbjct: 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
A+G+ YL + R++HRDL A NVL+ + KI+DFG+A++ G DE
Sbjct: 119 ----AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 52/153 (33%), Positives = 86/153 (56%), Gaps = 19/153 (12%)
Query: 481 LGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+G+G FG VY GTL+ +GQ+I AVK L++ + + +E+F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 536 GCCIQADES-MLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVG---GIARGILYLHQ 590
G C+ ++ S +++ YM + L FI + T D ++G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD------LIGFGLQVAKGMEYLAS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +HRDL A N +LD K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT ++A+K L G+ E F E ++ +L+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E+M SL F+ + +L + + + IA G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629
DL+A+N+L+ +++ KI+DFG+AR+ +E
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
RG+ YL Q + IHRDL A N+L+ + KI+DFG++R
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 37/171 (21%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
F N++GEG +G VY+ G+ +A+K++ M+ ++ E+TL+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 525 RLQHRNLVKLLGCCI--QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR---IHIVG 579
L+H N+V+L + D L+ EY +Q A+ LD V
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 580 GIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
+ RG+ YLH++ IIHRDLK SN+LL + KI+DFG+AR +G
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 481 LGEGGFGPVY----KGTLVEGQE--IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG G FG V+ KG EG E + VK L K + ++ EF+ E+ + +L H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C +A+ +I EY L F+ ++ + L ++++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
L S R +HRDL A N L+ + K+S +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 481 LGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG+G FG VY+G +A+K +++ + EF NE +++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF----DQARATFLD---WQKRIHIVGGIARGIL 586
LLG ++++ E M L ++ + L QK I + IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
YL + +HRDL A N ++ D+ KI DFGM R
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNL 531
F +G+G FG VYK Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
K G ++ + +I EY S D + LD I+ + G+ YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
IHRD+KA+N+LL + + K++DFG++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 24/155 (15%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKRLS-----KGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY+G L +G AVK +S + + +++ + E+ L+++LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 535 LGCCIQADESMLIY-EYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
LG + ++++ I+ E +P SL + F + Q I G+ YL
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------ILLGLEYL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H +HRD+K +N+L+D + K++DFGMA+
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V G ++A+K + +GS +EF E ++ +L H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM N L ++ + + + + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629
DL A N L+D+ K+SDFG++R DE
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 23/166 (13%)
Query: 481 LGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LG G F Y+ GTL+ +++ R + + +E + E+ L+ARL H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI--VGGIARGILYLHQD 591
+LG + L E+M S+ + + +++ + I + RG+ YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 592 SRMRIIHRDLKASNVLLDND-MNPKISDFGMA-----RIFGGDEIQ 631
+IIHRD+K +N+L+D+ +I+DFG A + G E Q
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 31/171 (18%)
Query: 481 LGEGGFGPVYKGTLVEGQ------EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V K T + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI---------------------FDQARATFLDWQ 572
L G C Q +LI EY SL F+ D L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I I+RG+ YL + M+++HRDL A NVL+ KISDFG++R
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 481 LGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ + E +P SL + + + Q I I G+ YLH + +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 600 DLKASNVLLDNDMNP-KISDFGMARIFGG 627
D+K NVL++ KISDFG ++ G
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V+ G ++A+K +++G+ E+F E ++ +L H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E+M N L ++ + R L + + + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629
DL A N L+ + K+SDFGM R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 23/174 (13%)
Query: 453 HMKEDM---ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG 508
H++ D+ E+WE +LG+G FG VYK E G A K +
Sbjct: 3 HVRRDLDPNEVWEI--------------IGELGDGAFGKVYKAKNKETGALAAAKVIETK 48
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
S + +E++ E+ ++A H +VKLLG + ++ E+ P ++D + + R
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-L 107
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+ Q ++ I + + YLH M+IIHRDLKA NVLL D + K++DFG++
Sbjct: 108 TEPQIQV-ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 53/186 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 531 LVKLLGCCIQADESM-------LIYEYMP---------NKSLDFFIFDQARATFLDWQKR 574
++ LL I S ++ E M + L D FL +Q
Sbjct: 61 IIGLLD--ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT----DDHIQYFL-YQ-- 111
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN- 633
I RG+ YLH +IHRDLK SN+L++++ + KI DFG+AR DE +
Sbjct: 112 ------ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 634 -THKVV 638
T VV
Sbjct: 163 LTEYVV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 50/175 (28%), Positives = 88/175 (50%), Gaps = 10/175 (5%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
SI + Y K+G+G G V+ V GQE+A+K+++ E NE+ ++
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LH + ++IHRD+K+ NVLL D + K++DFG ++ + +T +VGT
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 40/172 (23%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRNLV 532
LGEG FG V K V E +AVK L + + + + +E+ ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 533 KLLGCCIQADESMLIYEY----------------MPNKSLDFFIFDQARATFLD-----W 571
LLG C Q ++ EY S D + T D +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
Q +ARG+ +L + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 140 Q--------VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG VYK E G A K + S + +E+F E+ +++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
++ ++ E+ +LD I + + Q R + + + +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHR 127
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
DLKA N+LL D + K++DFG++ +Q +GT
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR-DTFIGT 166
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 54/177 (30%), Positives = 94/177 (53%), Gaps = 24/177 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRL---SKGSGQGMEEFKNEVTLIARLQH 528
D + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ +LQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 529 RNLVKL----LGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIH-IVGGI 581
N+V + +G + D+ ++ EY+ + KSL + + FL Q + ++ +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQL 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G+ +LH + I+HRDLK SN+LL+N KI DFG+AR + G ++ T VV
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 31/169 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLS---------KGSGQGM-EEFKNEVTLIARLQHR 529
+G+G +G VY V G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
N+V+ LG + + EY+P S+ + F++ F Q + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR----IFGGDE 629
+ YLH I+HRDLKA N+L+D D KISDFG+++ I+ D+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 40/185 (21%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFK-----NEVTLIARLQHRNLV 532
+G+G FG V K +I V K + G+ M E + +EV ++ L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIV 62
Query: 533 KLLG---------------CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+ C D + LI + + +++ + I
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------------YIEEEFIWRI 110
Query: 578 VGGIARGILYLH--QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ + + H D ++HRDLK +N+ LD + N K+ DFG+A+I G D T+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 636 KVVGT 640
VGT
Sbjct: 171 --VGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 47/174 (27%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGSGQ-GMEEFKNEVT 521
IA + D + L EG FG ++ G L++ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 522 LIARLQHRNLVKLLGCCIQ-ADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRI 575
L+ L H+N++ +L CI+ + ++Y YM +L F + + L Q+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
H+ IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R +F D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 48/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+GEG FG V +G GQ++AVK + + F E ++ +L H+NLV+LLG I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E M +L F+ + RA + + + +A G+ YL +++HR
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARI 624
DL A N+L+ D K+SDFG+AR+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ +IHRD+KA N+LL K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F+ ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ +IHRD+KA N+LL K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ K+GEG G V T G+++AVK++ Q E NEV ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
++ + DE ++ E++ +L D T ++ ++ + + + + +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFG 620
+IHRD+K+ ++LL +D K+SDFG
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI-VGGIARGILYLHQDSRM 594
G + ++ + EY +L + + + I + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARI 624
I+HRD+K +N+ LD++ K+ DFG A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 18/154 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLS------KGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G +G VY G +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFI--FDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
+ LG C+ + + E++P S+ + F F + K+ I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAYLH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ ++HRD+K +NV+L + K+ DFG AR
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLS-KGSGQGMEEFK-NEVTLIARLQHRN 530
+ K+GEG +G V+K E EI A+KR+ +G+ E+ L+ L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V+L + L++EY ++ L + FD +D + + + +G+ + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHS 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
++HRDLK N+L++ + K++DFG+AR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G G ++AVK + + + F E +++ +L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 541 ADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ I EYM SL ++ + R + L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMAR 623
DL A NVL+ D K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
NF K+G+G F VYK L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGI 585
H N++K L I+ +E ++ E L I F + + + + V + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ-LCSAL 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
++H RI+HRD+K +NV + K+ D G+ R F T H +VGT
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 55/173 (31%), Positives = 77/173 (44%), Gaps = 29/173 (16%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K G+ M NE ++ ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHIVGGIARGILY 587
D+ L+ M L + I F +ARA F Q I G+ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LHQ RI++RDLK NVLLD+ N +ISD G+A G GT
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR-------IHIVGGIAR 583
++ GC ++ + L+ EY + D L+ K+ I G +
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDI----------LEVHKKPLQEVEIAAICHGALQ 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
G+ YLH R IHRD+KA N+LL K++DFG A +
Sbjct: 127 GLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 44/173 (25%)
Query: 480 KLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQHRNLV 532
+G G +G VYK G+E A+K+ KG + E+ L+ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ--------KRIHIVGGIAR- 583
L+ ++ +Y +FD A WQ KR+ I + +
Sbjct: 66 SLVEVFLE-HADKSVY----------LLFDYAEHDL--WQIIKFHRQAKRVSIPPSMVKS 112
Query: 584 -------GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIF 625
G+ YLH + ++HRDLK +N+L+ + KI D G+AR+F
Sbjct: 113 LLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F +++G G FG VY T E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ +IHRD+KA N+LL K++DFG A
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+G G FG V+ LV ++I V++++K + NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
++ M++ EY P +L +I + + LD +H I + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 595 RIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HRDLK N+LLD + M KI DFG+++I ++ + VVGT
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 50/168 (29%), Positives = 88/168 (52%), Gaps = 11/168 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D RA D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ IHRD+KA+NVLL + K++DFG+A +I+ NT VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGT---LVEGQ---EIAVKRL-SKGSGQGM 513
WEF +N + LG G FG V + T L + ++AVK L
Sbjct: 30 WEF-------PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER 82
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
E +E+ +++ L H N+V LLG C ++I EY L F+ + R +FL +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLE 141
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +A+G+ +L + IHRDL A NVLL + KI DFG+AR
Sbjct: 142 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
T F +GEG +G VYK + ++ ++ EE K E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 530 NLVKLLGCCIQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HI 577
N+ G I+ D+ L+ E S + D + KR+ +I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGL-RKKGKRLKEEWIAYI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ RG+ YLH++ ++IHRD+K N+LL + K+ DFG++ + NT
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--F 173
Query: 638 VGT 640
+GT
Sbjct: 174 IGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG VYKG +E+ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKS-LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ G ++ + +I EY+ S LD T++ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
R IHRD+KA+NVLL + K++DFG+A +I+ NT VGT
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
++G G +G VYK + E+ A+K + G E + E++++ +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
++ D+ ++ EY SL I+ R L + ++ +G+ YLH+ I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-LSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 598 HRDLKASNVLLDNDMNPKISDFGMA 622
HRD+K +N+LL D + K++DFG++
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I+ A F + + + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
HQ+ RI++RDLK N+LLD+ + +ISD G+A
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGC 537
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
C Q ++ E + + DF F + L ++ I +V A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 598 HRDLKASNVLLDNDMNPKISDFGMAR 623
HRDL A N L+ KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRNLVKL 534
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ L++EY+ L+ +A L + + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMAR 623
IIHRD+K N+L+ K+ DFG AR
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 481 LGEGGFGP--VYK----GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG +Y+ +LV +E+ + RLS+ + + NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 535 LGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D ++LI EY +L + + + + + + + I + Y+H+
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HRD+K N+ L K+ DFG+++I G + T VVGT
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 15/158 (9%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 534 LLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G C + + LI E++P+ SL ++ L Q + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
SR + +HRDL A NVL++++ KI DFG+ + D+
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG V+KG + EG I A+K + SG Q +E + + + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
LG C A L+ + P SL + + LD Q+ ++ IA+G+ YL +
Sbjct: 75 LGICPGA-SLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
R++HR+L A N+LL +D +I+DFG+A + D+ +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 21/167 (12%)
Query: 482 GEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
G+G FG V V+ + A+K ++K +N E ++ L H LV L
Sbjct: 9 GKGAFGKVCI---VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
Q +E+M L+ + + L + + + F + Q + I I + YLH
Sbjct: 66 WYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHS--- 118
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRD+K N+LLD + I+DF +A D T T GT
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 55/158 (34%), Positives = 74/158 (46%), Gaps = 30/158 (18%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G L +++ KRL K +G E E ++A++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRIHIVGGIARG 584
Q + L+ M L + I F + RA F Q I G
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISG 109
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+ +LHQ RII+RDLK NVLLDND N +ISD G+A
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 479 NKLGEGGFGPVYKG---TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+++G G FG V G + + VK L + + F EV L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDS 592
LG CI++ +L+ E+ P L ++ QK + + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
IH DL N L D++ KI D+G+A
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 471 ATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK--NEVTLIARLQ 527
A ++ + KLGEG + VYKG + + GQ +A+K +S + +G+ F E +L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+V LL I E++ ++EYM + I Q + R+ + + RG+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLA 117
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
Y+H I+HRDLK N+L+ K++DFG+AR
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 20/161 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSL-DFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP L D+ ++ R L+W +I A+G+ YL +
Sbjct: 75 LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+R++HRDL A NVL+ + + KI+DFG+AR+ DE +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 23/181 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQ 527
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 528 HRNLVKLLGCCIQADESM----------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
HRN+V L +++ L++EYM + + + + F + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIK-SF 121
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + G+ Y H+ + +HRD+K SN+LL+N K++DFG+AR++ +E + T+KV
Sbjct: 122 MKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 638 V 638
+
Sbjct: 179 I 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V + L Q++AVK L S +EEF E + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQ---ARATFLDWQKRIHIVGGIARGI 585
+G +++ M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
YL S IHRDL A N +L+ +M ++DFG+++ I+ GD
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 31/172 (18%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KLGEG + VYKG + + GQ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVG----GIARGILYL 588
I +++ L++EY+ D ++D H V + RG+ Y
Sbjct: 70 DIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT--HKVV 638
HQ R++HRDLK N+L+ K++DFG+AR + + T ++VV
Sbjct: 120 HQ---RRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV 165
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 36/162 (22%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARL-Q 527
KLG+G +G V+K + +A+K++ + F+N E+ + L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 528 HRNLVKLLGCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIH---IVGGI 581
H N+VKLL I+A+ IY EYM L I RA L + +H I+ +
Sbjct: 66 HPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANIL---EDVHKRYIMYQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ + Y+H S +IHRDLK SN+LL++D K++DFG+AR
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN----- 518
F ++ + T+ + +G G FG V + GQ +A+K++ M+ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 519 ----EVTLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQK 573
E+ L+ L+H N++ L I E + + E + D +R L+ Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP--LEKQF 109
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ + I RG+ Y+H ++HRDLK SN+L++ + + KI DFG+ARI
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 44/144 (30%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ E+ ++D + + R + Q R+ + + YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMA 622
RDLKA N+L D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 33/187 (17%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYK----GTLVEGQE----IAVKRLS-KGSG 510
WEF D LGEG FG V + G + +AVK L +
Sbjct: 6 KWEF-------PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 511 QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------- 560
+ + + +E+ L+ + +H+N++ LLG C Q +I EY +L F+
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 561 --FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
FD + L ++ + +ARG+ YL +SR R IHRDL A NVL+ D KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKI 175
Query: 617 SDFGMAR 623
+DFG+AR
Sbjct: 176 ADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 480 KLGEGGFGPVY---KGTLVEGQEIAV-KRLSKGSGQGMEEFKN--EVTLIARLQHRNLVK 533
+LG+G FG VY V + + V K + G E + E L+++L H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGILYLHQD 591
++ D +I EY + LD + T + Q + G+ Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV-CEWFIQLLLGVHYMHQ- 124
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
RI+HRDLKA N+ L N++ KI DFG++R+ G
Sbjct: 125 --RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 10/175 (5%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LH + ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCI 539
+G G +G VYKG V+ ++A ++ +G EE K E+ ++ + HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 540 QA------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D+ L+ E+ S+ I + L + +I I RG+ +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMA 622
++IHRD+K NVLL + K+ DFG++
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 474 NFASYNKLGEGGFGPVYK-GTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 531 LVK-----LLGC--CIQADESMLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIV 578
++ L G CI + EY P L I + + W+ I ++
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
RG+ LH+ +I+HRDLK++N+LL + KI D G++++ + +T +
Sbjct: 114 ----RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QI 162
Query: 639 GT 640
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 9/167 (5%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G VY + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE L+ Y+ SL + LD ++ + +G+ YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGM-ARIF-GGDEIQTNTHKVVGT 640
IHRD+KA N+LL D + KI+DFG+ A + GGD + VGT
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 4e-12
Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 10/175 (5%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LH + ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
+LG G G V K G+ +AVK + K E+ ++ + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQ 590
G + + EYM SLD I + + + I+G IA +L YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLKGLTYLH- 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +IIHRD+K SN+L+++ K+ DFG++
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 51/183 (27%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 474 NFASYNKLGEGGFGPVYK-------GTLVEGQEIAVKRLSKGSG-----QGMEEFKNEVT 521
+A LG G FG VYK L+ +EI V + G + + + +EVT
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 522 LI-ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFI-FDQARATFLDWQKRI-HI 577
+I +L+H N+V+ ++ D ++ + + L + F + + F ++RI +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH++ R I+HRDL +N++L D I+DFG+A+ + T+ V
Sbjct: 119 FVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---V 173
Query: 638 VGT 640
VGT
Sbjct: 174 VGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F K+G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ IHRD+KA+NVLL K++DFG+A +I+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 23/161 (14%)
Query: 480 KLGEGGFGPVY----KGTLVEGQE--IAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY KG + + E +A+K +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFD----------QARATFLDWQKRIHIVGGIA 582
+LLG Q +++I E M L ++ QA + +K I + G IA
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL---KKMIQMAGEIA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
G+ YL+ + + +HRDL A N ++ D KI DFGM R
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRN 530
+ ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 531 LVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL 586
+VK G + S + EY SLD I+ + + RI ++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR----GGRIGEKVLGKIAESVL 115
Query: 587 ----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
YLH +IIHRD+K SN+LL K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--FKNEVTLIARLQHRNLVKLLG 536
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E++ + LD + LD + + I RGI + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTN 633
IHRD+K N+L+ K+ DFG AR + E+ T+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC +E L EYMP S I DQ +A L I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V KG + ++I A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C +A+ ML+ E L+ F+ + + + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HRDL A NVLL N KISDFG+++ G D+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 24/168 (14%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI--AVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V + + +G ++ A+K L + S +F E+ ++ +L H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C + EY P +L DF F + A+ L Q+ + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
G+ YL S + IHRDL A NVL+ ++ KI+DFG++R G+E+
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV 171
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + + + KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ +V L D L+ M L F I++ F + ++ + I G+ L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQ 631
H+++ ++RDLK N+LLD+ + +ISD G+A +I G+ I+
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
S+ K+GEG G V T G+++AVK++ Q E NEV ++ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ + DE ++ E++ +L D T ++ ++ + + R + YLH
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG- 138
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFG 620
+IHRD+K+ ++LL +D K+SDFG
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
D++ KLGEG + VYKG + V G+ +A+K RL + G + E +L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V LL I E++ L++EY+ + D+ ++ + + RG+ Y+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYI 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
HQ I+HRDLK N+L+ + K++DFG+AR
Sbjct: 120 HQ---RYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC E L E+MP S I DQ ++ L I G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/168 (33%), Positives = 78/168 (46%), Gaps = 31/168 (18%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLV 532
LG+G FG V KGT + AVK L K +E E ++A +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L C Q + + + EY+ L F I FD+ RA F I G+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--------AAEIVLGLQ 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQT 632
+LH+ II+RDLK NVLLD++ + KI+DFGM + I GG T
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D ++ + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQ 631
H R RI++RDLK N+LLD+ + +ISD G+A I G+ I+
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D Q+ I + G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
R RI++RDLK N+LLD+ + +ISD G+A
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 18/153 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCI-QADESMLIY-EYMPNKSLDFFIFDQARA--TFLDWQKRIHIVGGIARGILYLHQ 590
GC +A++++ I+ EYMP S+ DQ +A + R + I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKY-TRQILEGMSYLHS 124
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 21/170 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + +KLGEG + VYKG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L I ++S+ L++EY+ +K L ++ D + + K + + RG+
Sbjct: 62 KHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
Y H R +++HRDLK N+L++ K++DFG+AR I T T+
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTY 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 18/158 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + KLGEG + V+KG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + D+S+ L++EY+ +K L ++ D + + I RG+
Sbjct: 62 KHANIVTLHDI-VHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
Y H R +++HRDLK N+L++ K++DFG+AR
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-11
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 326 NGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLW- 383
+ D F + KLP S + +L+EC+ C NCSC ++ + G GCLLW
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTYN---NGTKGCLLWS 57
Query: 384 FGDLMDMKEYNDGGQDLYIRI 404
L D + + GG DLY +I
Sbjct: 58 ESSLGDARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 536 GCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
Q DE + L EY+P DF + R ++ + LH +
Sbjct: 68 -YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IHRDLK N L+D + K++DFG+++ I T + VVG+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGS 161
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 38/161 (23%)
Query: 479 NKLGEGGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRN 530
N++G G G VYK T G+ A+K + G + + E+ ++ + H N
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPN 133
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIHIVGGIAR 583
+VK E ++ E+M SL+ F+ D AR I+ GIA
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA- 182
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
YLH R I+HRD+K SN+L+++ N KI+DFG++RI
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ---HRNLVK 533
++G G +G VYK G +A+K + + + EV L+ RL+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 534 LLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L+ C + + L++E++ ++ L ++ D+ L + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
H + I+HRDLK N+L+ + K++DFG+ARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 49/178 (27%), Positives = 88/178 (49%), Gaps = 28/178 (15%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQH---R 529
+ +G G +G VY+G V G+ +A+K ++ + + + + EV L+++L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL--- 586
N+ K G ++ +I EY S+ + +A + +K I + I R +L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA-EKYISV---IIREVLVAL 114
Query: 587 -YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK---VVGT 640
Y+H+ +IHRD+KA+N+L+ N N K+ DFG+A + N+ K VGT
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 474 NFASYNKLGEGGFGPVY--KGTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHR 529
+ K+GEG FG +Y K + + +K L+K + E K EV L+A+++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V + ++ EY L I Q F + Q V I+ G+ ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV-QISLGLKHIH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIF 625
+I+HRD+K+ N+ L N M K+ DFG+AR
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 59/181 (32%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTL 522
+ + + +GEG +G V T G ++A+K++S F++ E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLREIKI 56
Query: 523 IARLQHRNLVKLLGCCIQAD--ESM----LIYEYMP-------------NKSLDFFIFDQ 563
+ R +H N++ +L I+ ES ++ E M N + +F++
Sbjct: 57 LRRFKHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ- 114
Query: 564 ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 115 -----------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
Query: 624 I 624
I
Sbjct: 155 I 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 481 LGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K SG+ M + E+ + ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
L+ M L + I++ L+ ++ IH I GIL+LH M
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMA 622
I++RD+K NVLLD+ N ++SD G+A
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 25/162 (15%)
Query: 480 KLGEGGFGPVYKGT---LVEGQ---EIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY+G +++G+ +AVK +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-----------WQKRIHIVGGI 581
+LLG + ++++ E M + L ++ R+ + Q+ I + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
A G+ YL+ + +HRDL A N ++ +D KI DFGM R
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-11
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 24/168 (14%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
RG+ YL S+ + IHRDL A N+L+ + KI+DFG++R G E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 164
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN 518
+WE D + + + +G G +G V + G+++A+K+LS+ Q K
Sbjct: 10 VWEVP--------DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKR 60
Query: 519 ---EVTLIARLQHRNLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARA 566
E+ L+ + H N++ LL A L+ M N +
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
FL +Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 121 QFLVYQ--------ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 28/155 (18%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNE--VTLIA-RLQHRN 530
LG G FG V YK T G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
LV L C D + EY L I F + RA F + G+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
YLH++ +I++RDLK N+LLD + KI+DFG+
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 480 KLGEGGFGPVYKGTLVEG---QEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDSR 593
G C + +L+ E+ P L ++ +A + + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMA 622
IH DL N LL D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 33/166 (19%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRIHIVGGIAR--- 583
N+V L+ C Y K + +F+ A L + + I +
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
DNF K+GEG G V T+ G+ +AVK++ Q E NEV ++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V++ + DE ++ E++ +L D T ++ ++ + + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+IHRD+K+ ++LL +D K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K L I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE 519
L + D +++ F +G G +G VYKG V+ ++A ++ + EE K E
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE 62
Query: 520 VTLIARL-QHRNLVKLLGCCI------QADESMLIYEYMPNKSL-DFFIFDQARATFLDW 571
+ ++ + HRN+ G I D+ L+ E+ S+ D + A DW
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+I I RG+ +LH ++IHRD+K NVLL + K+ DFG++
Sbjct: 123 IA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 37/183 (20%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKG----SGQGMEEFKNEVTLIA 524
D+F LG G FG V +KG+ G+ A+K LSK Q +E NE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQ 56
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHI 577
++H LV L G L+ EY+P + F F + A F Q
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQ----- 109
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH + I++RDLK N+LLD+D KI+DFG A+ ++ T+ +
Sbjct: 110 ---VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTL 158
Query: 638 VGT 640
GT
Sbjct: 159 CGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 480 KLGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKL 534
+GEG FG VY+G + E ++I AVK + + E+F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G + + ++ E P L ++ Q LD I ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMAR 623
R +HRD+ A NVL+ + K+ DFG++R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLS-KGSGQ 511
WEF + D LGEG FG V + E +AVK L + +
Sbjct: 10 WEF-------SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI---------- 560
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 561 -FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+D AR + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 618 DFGMAR 623
DFG+AR
Sbjct: 180 DFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG + +AVK L + +E E ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ F+ T + + +H V + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HRDL A NVLL KISDFG+++ G DE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----------FDQAR--ATFLDWQKRIHI 577
++ LLG C Q ++ EY +L ++ FD + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 56/159 (35%), Positives = 76/159 (47%), Gaps = 33/159 (20%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V KGT + A+K L K +E+ E T++ R +H
Sbjct: 3 LGKGSFGKVMLAELKGT---NEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E + + EY+ L F I FD+ARA F + I G
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +LH+ II+RDLK NVLLD D + KI+DFGM +
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 57/163 (34%), Positives = 80/163 (49%), Gaps = 31/163 (19%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTL-------IARLQHRNLV 532
LG+G FG V L E G+ AVK L K +++ E T+ +AR H L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L CC Q D + E++ L F I FD+ARA F + I ++
Sbjct: 60 QLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALM 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGG 627
+LH II+RDLK NVLLD++ + K++DFGM + IF G
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 484 GGFGPVYKGTLVE----GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLLG 536
G +G V+ L + G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 537 CCIQADESM-LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q +++ L+ EY+P SL + D+ A + I + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS 111
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFG------MARIFGGDEIQTNTHKVVGT 640
+ IIHRDLK N+L+D++ + K++DFG + R ++ + ++VGT
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 481 LGEGGFGPVYKG--TLVEGQE--IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG + +G L +E +A+ L G S + F E + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + + M++ EYM N +LD F+ + L + + ++ G+A G+ YL S M
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFG 620
+H+ L A VL+++D+ KIS F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 40/163 (24%), Positives = 76/163 (46%), Gaps = 31/163 (19%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++F ++G G +G VYK V G+ A+K + G+ + E+ ++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA--------- 582
V G ++ D+ + E+ SL Q H+ G ++
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL---------------QDIYHVTGPLSESQIAYVSR 113
Query: 583 ---RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+G+ YLH +M HRD+K +N+LL ++ + K++DFG++
Sbjct: 114 ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
+ + +KLGEG + V+KG + + +A+K RL G + EV+L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V L I + + L++EY+ + D + + + + RG+ Y
Sbjct: 64 NIVTLHDI-IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H + +I+HRDLK N+L++ K++DFG+AR
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 477 SYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+Y K+GEG G V G+++AVK + Q E NEV ++ QH+N+V++
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ +E ++ E++ +L I Q R L+ ++ + + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG--- 137
Query: 596 IIHRDLKASNVLLDNDMNPKISDFG 620
+IHRD+K+ ++LL D K+SDFG
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFG 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 40/176 (22%), Positives = 80/176 (45%), Gaps = 28/176 (15%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQGMEEFKN------------EVTLI 523
LGEG +G V K + G+ +A+K+ + + S ++ + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGG 580
++H N++ L+ ++ D L+ + M + K +D + + Q + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-ILLQ 127
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I G+ LH+ +HRDL +N+ +++ KI+DFG+AR +G K
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + ++AVK L S + + + + +E+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHI 577
++ LLG C Q +I EY +L ++ Q L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 30/163 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL----- 534
LG G G V+ + + +AVK++ Q ++ E+ +I RL H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 535 ---------LGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGGIA 582
+G + + ++ EYM L+ + A +Q +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LL 124
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624
RG+ Y+H + ++HRDLK +NV ++ D+ KI DFG+ARI
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 31/162 (19%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ ++G G +G VYK + G+ AVK + G + E+ ++ +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA---------- 582
G + ++ + EY SL Q H+ G ++
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSL---------------QDIYHVTGPLSELQIAYVCRE 114
Query: 583 --RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+G+ YLH +M HRD+K +N+LL ++ + K++DFG+A
Sbjct: 115 TLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 19/174 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM---EEFKNEVTLIARLQH 528
D+ +G G FG V+ + A+K ++ + + NE ++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 529 RNLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
+++L + D+ L + EY+P L F + + F + + I +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY-ASEIVCALE 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH I++RDLK N+LLD + + K++DFG A+ +++ T + GT
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 33/166 (19%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLS-KGSGQGME-EFKNEVTLIARLQ---HRNLV 532
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 533 KLLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDW--------QKRIHIVG 579
+L C + + L++E++ DQ T+LD + ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 26/105 (24%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E L+ + H +++++ + + ++ +P+ S D + + R+ L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I G+ YLH RIIHRD+K N+ +++ I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 481 LGEGGFGPVYKGTLVE----GQ----EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G F ++KG E G+ E+ +K L K E F +++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G C+ DES+++ EY+ SLD ++ + W ++ + +A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 593 RMRIIHRDLKASNVLL-----DNDMNP---KISDFGMA 622
+ H ++ A NVLL NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 59/168 (35%)
Query: 494 LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRNLVKLLGCCIQADES 544
V GQ +A+K+LS+ F+N E+ L+ + H+N++ LL
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------- 83
Query: 545 MLIYEYMPNKSLDFF--------------------IFDQARATFLDWQKRIHIVGGIARG 584
+ P KSL+ F D R ++L +Q + G
Sbjct: 84 -----FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------MLCG 130
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
I +LH IIHRDLK SN+++ +D KI DFG+AR G + T
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 54/168 (32%), Positives = 74/168 (44%), Gaps = 31/168 (18%)
Query: 481 LGEGGFGPVY----KGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG V KGT E+ A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKVMLAERKGT----DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
L C Q D + EY+ L + I F + A F IA G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAEIAIGLF 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQT 632
+LH II+RDLK NV+LD + + KI+DFGM + IFGG +T
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 475 FASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQHRNL 531
+ S ++G G +G V G+++A+K+LS+ S + E+TL+ +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 532 VKLLGCCIQA---DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ LL A DE Y MP D + L K ++V + G+ Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYI 133
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 23/167 (13%)
Query: 481 LGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
LG+G F +YKG L GQE++V GS F +L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKL G C+ DE++++ EY+ LD F+ + L W ++ + +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 591 DSRMRIIHRDLKASNVLL----DNDMNP---KISDFGMARIFGGDEI 630
+++H ++ N+L+ N+ K+SD G+ E
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 55/170 (32%), Positives = 78/170 (45%), Gaps = 33/170 (19%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V+ KGT Q A+K L K + + E T++ + +H
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E++ + EY+ L F I FD RATF I G
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--------AAEIICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ +LH I++RDLK N+LLD D + KI+DFGM + + +T T
Sbjct: 109 LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 25/58 (43%), Positives = 37/58 (63%), Gaps = 3/58 (5%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I RG+ YLH I+HRD+K N+L++++ KI DFG+AR+ DE + T +VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ TD + +G+G +G VYK T +G AVK L S EE + E ++
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQS 74
Query: 526 L-QHRNLVKLLGCCIQADESM-----LIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIV 578
L H N+VK G +AD+ + L+ E S+ + LD +I+
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G G+ +LH + RIIHRD+K +N+LL + K+ DFG++ ++ NT V
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 189
Query: 639 GT 640
GT
Sbjct: 190 GT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG GGFG V + + + A+K + K G +E +E ++ H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + + ++ EY + + + R F ++ R + + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGG--ELWTILRDRGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
II+RDLK N+LLD++ K+ DFG A+ + T GT
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEE------FKNEVTLI 523
D + K+GEG +G VYK G+ +A+K RL M+E E++L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 524 ARLQHRN-LVKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQAR--ATFLDWQKR 574
L +V+LL +E L++EY+ + L F+ R L +
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + +G+ + H+ ++HRDLK N+L+D KI+D G+ R F +++
Sbjct: 113 KSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSY 168
Query: 634 THKVV 638
TH++V
Sbjct: 169 THEIV 173
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
+G G FG V K G +AVKR+ S + + ++ ++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 538 CIQADESMLIYEYMPNKSLDFF---IFDQARATFLDWQKRIHIVGGIA----RGILYLHQ 590
+ + + E M + SLD F +++ ++ + I+G IA + + YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+ ++IIHRD+K SN+LLD + N K+ DFG++
Sbjct: 126 E--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRL--SKGSGQGMEEFKNEVTLIARLQH 528
+ K+GEG FG K LV +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDWQKRIHIVGGIAR 583
N+V+ + ++ +Y L I Q F LDW +I +
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ 112
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
+ ++H +I+HRD+K+ N+ L D K+ DFG+AR+
Sbjct: 113 ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-------EVTLIARLQHRNL 531
K+GEG +G V+K E GQ +A+K+ + E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L+ + + L++EY + L+ + + I+ + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ IHRD+K N+L+ K+ DFG ARI G
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 21/153 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
CC Q + + + EY+ L F I FD+ R+ F + +++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY--------AAEVTLALMFLHR 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+I+RDLK N+LLD + + K++DFGM +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
C Q E + + E++ L F I FD RATF + I G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE--------IVCGLQFLHS 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQT 632
II+RDLK NV+LD D + KI+DFGM + +FG + T
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 47/141 (33%), Positives = 71/141 (50%), Gaps = 25/141 (17%)
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
V G +AVK+LS+ F+N+ A+ +R LV LL C + L+ + P K
Sbjct: 44 VLGINVAVKKLSR-------PFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQK 93
Query: 555 SLDFF--------IFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602
SL+ F + D Q LD ++ +++ + GI +LH IIHRDLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 603 ASNVLLDNDMNPKISDFGMAR 623
SN+++ +D KI DFG+AR
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 451 MSHMKEDMELWEFDFA-SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKG 508
MS K D + + S + + +G G G V + + +A+K+LS+
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR- 59
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF--------I 560
F+N+ A+ +R LV L+ C + L+ + P KSL+ F +
Sbjct: 60 ------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 561 FD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
D Q LD ++ +++ + GI +LH IIHRDLK SN+++ +D KI
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 617 SDFGMARIFG 626
DFG+AR G
Sbjct: 168 LDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKL 534
K+GEG F V K + G+ A+K + K + +E+ N E+ + RL H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 535 LGCCIQADESM----LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYL 588
+ D L++E M D +++ + R L ++ + + + + ++
Sbjct: 64 --IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H++ I HRD+K N+L+ +D K++DFG R
Sbjct: 117 HRNG---IFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 420 IIASVL--LMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFA- 476
I L + + +VA F R + L ++ + ED WE F +K + +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGR-NNLELKRVEN--ED-GTWELQFFD-SKVSKSITI 685
Query: 477 --------SYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N + G G YKG ++ G + VK ++ + +E+ + +LQ
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQ 741
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N+VKL+G C + LI+EY+ K+L + + L W++R I GIA+ + +
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRF 795
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
LH ++ +L +++D P +
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ RG+ Y+H + +IHRDLK SN+L++ D +I DFGMAR
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 22/160 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEE---FKNEVTLIARLQH 528
D+F +G G FG V+ + ++ A+K L K + + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 529 RNLVKLLGCCIQADESM-LIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIA 582
+VKL Q +E + L+ EYMP L +F + A F IA
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IA 108
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+L L ++ IHRD+K N+L+D D + K++DFG+
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + +I+ G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+ +LH ++ II+RD+K N+LLD++ + ++DFG+++ F DE++
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIA---VKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQD 591
G C++A +L++EY L ++ + + L Q+ + IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH-- 116
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVV 638
+ +H DL N L +D+ K+ D+G+ + D I+T K V
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV 163
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 26/157 (16%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+GEG FG + LV+ Q+ A+K RL K S +E+ + E L+A+++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYL 588
+AD + ++ EY L I Q T L W ++ + G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
H+ R++HRD+K+ N+ L + K+ DFG AR+
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 474 NFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ G G+ A+K L K + + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + R++I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYI-AEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +LHQ + II+RD+K N+LLD++ + ++DFG+++ F +E + + GT
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 23/155 (14%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLGC 537
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 538 CIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
A +E L+ M N + FL +Q + RG+ Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKYI 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H IIHRDLK SNV ++ D +I DFG+AR
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 21/161 (13%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY-----LH 589
+ AD + L+++Y + F +A +K + + G+ + +LY +H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIF 625
++HRDLK +N+L+ + P KI+D G AR+F
Sbjct: 123 YLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 30/173 (17%)
Query: 475 FASYNKLGEGGFGPV---YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + +G G G V Y L + +A+K+LS+ F+N+ A+ +R L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYREL 67
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF--------IFD----QARATFLDWQKRIHIVG 579
V L+ C + L+ + P KSL+ F + D Q LD ++ +++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+ GI +LH IIHRDLK SN+++ +D KI DFG+AR G + T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 39/172 (22%), Positives = 74/172 (43%), Gaps = 57/172 (33%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 531 LVKLLGCCI-----QADESMLIYEYM---------PNKSL-----DFFIFDQARATFLDW 571
++ + ++ ++YE M +++L +F++
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 39/170 (22%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D+ +LG G +G V K V G +AVKR+ T+ ++ Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------------RATVNSQEQKRLL 47
Query: 532 VKL-----LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD------WQKRIHI--- 577
+ L C ++ Y + + D +I + T LD + K + I
Sbjct: 48 MDLDISMRSVDCPY---TVTFYGALFREG-DVWICMEVMDTSLDKFYKKVYDKGLTIPED 103
Query: 578 -VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+G IA I+ YLH S++ +IHRD+K SNVL++ + K+ DFG++
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 467 SIAKATDNFASYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSK--GSGQGMEEFKNEVTLI 523
+I + D + ++G G +G V G ++A+K+L + S + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 524 ARLQHRNLVKLLGCCIQADESML----IYEYMP------NKSLDFFIFDQARATFLDWQK 573
++H N++ LL D S+ Y MP K + + R FL +Q
Sbjct: 69 KHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ- 126
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +G+ Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 127 -------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 497 GQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESML-IYEYMP 552
G E+A+K L + + + F+ E L ARL H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 553 NKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--- 608
++L + D A L + ++ + + H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 609 DNDMNPKISDFGMARIFGG----DEIQ-TNTHKVVGT 640
+ K+ DFG+ + G D T T +V+GT
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---EVTL 522
+I + + + + + +G G +G V + G +AVK+LS+ Q + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRL 69
Query: 523 IARLQHRNLVKLLGCCIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQK 573
+ ++H N++ LL A ++ L+ M N + FL +Q
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ- 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 129 -------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G+ AVK L K + +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
II+RDLK N+LLD+ + ++DFG+ + G E T GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/173 (29%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQ 527
NF LG+G FG V E+ A+K L K +E E ++A
Sbjct: 1 DFNFLMV--LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 528 HRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
+ L C Q D + EY+ L + I F + +A F I
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--------AAEI 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ G+ +LH R II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 27/158 (17%)
Query: 476 ASYNKLGE----GGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFK---NEVTLIA 524
+G+ + K TLV AVK+++ S E+ K E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLV-----AVKKINLDS-CSKEDLKLLQQEIITSR 54
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVGGI 581
+LQH N++ + I E ++ M S + + + F + + I+ +
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDV 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
+ Y+H IHR +KAS++LL D +S
Sbjct: 111 LNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V++ V G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+ + LI EY+ L F+ + F++ ++ I+ + +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQQG 120
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGT 640
II+RDLK N+LLD + K++DFG+ + I G T TH GT
Sbjct: 121 ---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGT 163
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 21/161 (13%)
Query: 480 KLGEGGFGPVYKGTLVEGQ---EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGG----IARGILYLH 589
+ +D + L+++Y + F +A +A Q +V I GI YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIF 625
+ ++HRDLK +N+L+ + P KI+D G AR+F
Sbjct: 126 AN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 34/165 (20%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
D+F S +G G FG V LV+ G A+K+L K Q + + E ++A
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILA 56
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSL-------DFFIFDQARATFLDWQKRIH 576
+ +VKL Q + + LI EY+P + D F ++ R F
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY------- 106
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
IA IL + ++ IHRD+K N+LLD + K+SDFG+
Sbjct: 107 ----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 34/207 (16%)
Query: 442 KLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQ--E 499
K K TK K M+ +F+F LG G FG V T
Sbjct: 11 KKKDSDSTKEPKRKNKMKYEDFNFI------------RTLGTGSFGRVILATYKNEDFPP 58
Query: 500 IAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
+A+KR K + ++ +E ++ + H V L G L+ E++
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG-- 116
Query: 557 DFFIFDQARATFLDWQKRI-HIVGGI--ARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613
+FF TFL KR + VG A+ +L + I++RDLK N+LLD D
Sbjct: 117 EFF-------TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 614 PKISDFGMARIFGGDEIQTNTHKVVGT 640
K++DFG A++ + T T+ + GT
Sbjct: 170 IKMTDFGFAKV-----VDTRTYTLCGT 191
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 23/153 (15%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRL--SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 538 CIQADESMLIYEYMPNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L++EY+ L+ ++ R+ K IH + H+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH----------WCHK 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ I+HRD+K N+L+ ++ K+ DFG AR
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 43/151 (28%), Positives = 63/151 (41%), Gaps = 21/151 (13%)
Query: 484 GGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL---------VK 533
G FG VY G A+K L K M KN+VT + + + + K
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD---MIA-KNQVTNV-KAERAIMMIQGESPYVAK 61
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L D L+ EY+ I DW K+ + + G+ LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
IIHRD+K N+L+D + K++DFG++R
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 479 NKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNL 531
LG G FG V +KGT G+ A+K L K M++ ++ E +++ L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL---YL 588
V ++ + + E++ L F +A D K H A +L YL
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H II+RDLK N+LLDN + K++DFG A+
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q + + LI +Y+ + F R F + + R + G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFY-SGEIILA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +LH ++ I++RD+K N+LLD++ + ++DFG+++ F +E + T+ GT
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 49/161 (30%), Positives = 70/161 (43%), Gaps = 40/161 (24%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHR--NLV 532
+G G G VYK G +AVK++ + + EE K +V L H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVL---KSHDCPYIV 77
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-WQKRI------HIVGGIARGI 585
K G I D FI + +T LD KRI I+G + I
Sbjct: 78 KCYGYFI--------------TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123
Query: 586 L----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+ YL + + +IHRD+K SN+LLD N K+ DFG++
Sbjct: 124 VKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 23/133 (17%)
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE---YMPNKSLDF- 558
KR+ GS + + +NE+ + RL H N++K+ E +L E YM + DF
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 559 ---FIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
F++D+A + L Q R I+ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 613 NPKISDFGMARIF 625
+ DFG A F
Sbjct: 305 KIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-05
Identities = 22/81 (27%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 328 DEFPKYVKLKLPDTSSSWFNASMN-LKECSELCSKN---CSCTAYANSDVERGGSGCLLW 383
DEF K L + N EC+ C KN SC A+ R CL +
Sbjct: 2 DEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFV-FAKARK--QCLWF 58
Query: 384 -FGDLMDMKEYNDGGQDLYIR 403
F + +++ G DLY
Sbjct: 59 PFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G AVK L K + +E + + L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
A++ + +Y+ L FF + R FL+ + R + +A I YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFY-AAEVASAIGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
II+RDLK N+LLD+ + ++DFG+ + G E + T GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 31/169 (18%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR----LQHRN-- 530
LG+G FG V KGT + A+K L K +++ E T++ + L +
Sbjct: 8 LGKGSFGKVMLAERKGT---DELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPF 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGI 585
L +L C D + EY+ L + I F + A F IA G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--------AAEIAIGL 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+LH II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYK-GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
F S +D + +G+G +G V+K G + AVK L EE + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 524 ARLQ-HRNLVKLLGC-----CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI-- 575
L H N+VK G D+ L+ E S + D + FL +R+
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS----VTDLVKG-FLKRGERMEE 123
Query: 576 ----HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+I+ G+ +LH + + IHRD+K +N+LL + K+ DFG++ ++
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 632 TNTHKVVGT 640
NT VGT
Sbjct: 181 RNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGM--EEFKNEVTLIARLQ-HRNLVK 533
+LG+G +G V E E +A+K+++ + + + E+ L+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 534 LLGCCIQADES---MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
L I + + +YE + L I T +Q I+ I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY---QILCGLKYIHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
+ ++HRDLK N+L++ D KI DFG+AR F
Sbjct: 124 AN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 481 LGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEF--KNEVTLIARLQHRNL 531
LG+G FG V+ LV GQ A+K L K + + + K E ++A + H +
Sbjct: 4 LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
VKL + LI +++ + D F F + + ++ +A + +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYL-AELALALDHLH-- 115
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ II+RDLK N+LLD + + K++DFG+++
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++ AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F Q FL+ + R + IA + YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMAR 623
I++RDLK N+LLD+ + ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 16/84 (19%)
Query: 546 LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
L+ EY+ KSL + FD+ A + +A + YLH+ IIHRD
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALALDYLHRHG---IIHRD 129
Query: 601 LKASNVLLDNDMNPKISDFGMARI 624
LK N+L+ N+ + K++DFG++++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 26/155 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVK 533
LG+G FG V K T G+ A+K L K +E + VT LQ H L
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H +++RD+K N++LD D + KI+DFG+ +
Sbjct: 112 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 14/122 (11%)
Query: 502 VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI 560
VK ++ G G E+ ++ + HR ++ L I A + MP D F
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFT 174
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ R+ L ++ I I + + YLH IIHRD+K N+ LD N + DFG
Sbjct: 175 YVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFG 230
Query: 621 MA 622
A
Sbjct: 231 AA 232
|
Length = 392 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 28/156 (17%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
L D + EY L FF +F + RA F + I + Y
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAE--------IVSALGY 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
LH +++RDLK N++LD D + KI+DFG+ +
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G G VYK + + I AVK + + + ++ +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA----RGILYLHQDSRM 594
+ + E+M SLD + + H++G IA +G+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+I+HRD+K SN+L++ K+ DFG++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 31/165 (18%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+F + +G G FG V K T G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHI 577
+ +L D L+ EY P N+ D FD+ A F
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY-------- 107
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
+A +L +H +M +HRD+K NVL+D + K++DFG A
Sbjct: 108 ---LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV--KLLGC 537
L G VY + ++ +K S + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
S L+ E++ ++LD + +++ I +A + LHQ + +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARI 624
H DL N+L+D+ I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 25/71 (35%), Positives = 41/71 (57%), Gaps = 10/71 (14%)
Query: 574 RIHIVGGIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I+G IA G+ YL+ + RI+HRD+K SN+L+++ K+ DFG++ G+
Sbjct: 101 PVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GEL 154
Query: 630 IQTNTHKVVGT 640
I + VGT
Sbjct: 155 INSIADTFVGT 165
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 21/98 (21%)
Query: 549 EYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIA----RGILYLHQDSRMRIIHRDLK 602
E+M SLD + +A RI +I+G I+ RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLDQ-VLKKAG--------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
SN+L+++ K+ DFG++ G I + + VGT
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 40/165 (24%)
Query: 481 LGEGGFGPVYKGTLV----EGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVK- 533
+G+G +G V +LV +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 534 -------------LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++G C D +Y + + +Q F+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPENQVVEWFVQ---------- 110
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
IA + YLH+ I+HRDLK NV L K+ D G+AR+
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 25/155 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
H S +++RDLK N++LD D + KI+DFG+ +
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V LV G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-IARGILYLHQDS 592
L D + EY+ L FF + R D R G I + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSED---RTRFYGAEIVSALDYLHSG- 114
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+I++RDLK N++LD D + KI+DFG+ +
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++G+ AVK L K +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
++ + +++ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYA-AEIASALGYLHS---IN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMAR 623
I++RDLK N+LLD+ + ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
R + Y+H + + HRDLK N+L + D KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 36/169 (21%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKRLSKGSGQGMEEFKN-EVTLIARLQHRNLVKLLG 536
N +G G FG VY+ ++ E +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 537 C----CIQADESML----IYEYMPNKSLDFFIF----DQARATFL----DWQKRIHIVGG 580
C + +E + + E++P + + A FL +Q
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR-IFGG 627
+ R + Y+H I HRDLK N+L+D N K+ DFG A+ + G
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIF--DQARATFLDWQKRIH 576
E ++ + H ++++L G + LI +P D + + + D +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
I + R I YLH++ RIIHRD+KA N+ +++ + + DFG A
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 20/156 (12%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F +G G FG V V+ + A+K L K K E ++A +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + IF++ A F + + I
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--------IAELTCAI 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
+H +M IHRD+K N+L+D D + K++DFG+
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE-----IAVKRL-SKGSGQ 511
E WEF DN LG G FG V + T G+E +AVK L +
Sbjct: 31 EKWEF-------PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEY 550
E +E+ +++ L QH+N+V LLG C ++I EY
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN--------EV 520
++F + +G+G FG V LV+ G+ A+K L K E FK E
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++A +V L A LI E++P L + TF + R ++
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYM--- 107
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
A +L + ++ IHRD+K N+L+D + K+SDFG++ F
Sbjct: 108 -AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 479 NKLGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHR-- 529
++LG+G +G VYK G + +EI RL ++E K N++ + + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 530 --NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
+V G + EYM SLD + I + +G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
L ++ IIHRD+K +NVL++ + K+ DFG++
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + E++ L F + Q + L + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNF 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQT 632
LH+ II+RDLK NVLLD + + K++D+GM + I GD T
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
D+F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + +I A +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
L + ++ IHRD+K N+LLD + K+SDFG+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
++F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + + +I A +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
L + ++ IHRD+K N+LLD+ + K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 9/110 (8%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A+ + ++ I + RG+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 20/160 (12%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + A+K L K + + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + +F + A F IA
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
L + +M IHRD+K N+L+D D + K++DFG+ F
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/104 (31%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LV L C L+ EY+ L +F R L + I + +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQT 632
II+RDLK NVLLD D + K++D+GM + + GD T
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 20/160 (12%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + + A+K L K + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V+L D + +Y+P + IF + A F IA
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
+ +M IHRD+K N+L+D D + K++DFG+ F
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 40/160 (25%)
Query: 480 KLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT-------LIARLQH 528
LG+G G V+ LV G+ A+K L K M + +N+V ++A L H
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKE---MIK-RNKVKRVLTEQEILATLDH 60
Query: 529 RNLVKLLGCCIQADE-SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR---- 583
L L Q + L+ +Y P + F Q + K + +AR
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGG--ELFRLLQRQPG-----KCLSEE--VARFYAA 110
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
+ YLH + I++RDLK N+LL + +SDF
Sbjct: 111 EVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKLLG 536
+G+G FG VY+ + + I A+K LSK +E + E ++ R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 537 C--CIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYL 588
Q D + L+ +YM L + + F + RA F IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY-----------IAELVLAL 109
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ I++RDLK N+LLD + + DFG+++ D TNT
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + EY+ L +F R L + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
LH+ II+RDLK NVLLD++ + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 26/114 (22%)
Query: 517 KNEVTLIARLQHRNLVKLLGCC------IQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ E ++A+ + G + D +++ EY+ + L +
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ R ++ + R + LH + I+H DL SN++L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 14/109 (12%)
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+E L+ RL H ++ LL + + L+ +P D + + AR L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
V +AR +L Y+H + IIHRD+K NVL++ + + DFG A
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 45/171 (26%), Positives = 69/171 (40%), Gaps = 33/171 (19%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKG-SGQGM--EEFKNEVTLIARLQHRNLVKLL 535
+G+GG G VY V + +A+K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD--WQKR---------------IHIV 578
C D +Y MP +I + L WQK + I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I I Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 481 LGEGGFGPVYKGTLV-----------EGQEIAV--KRLSKGSGQGMEEFKNEVTLIARLQ 527
LG G +Y G L +EI V K L F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H+++V L G C++ E++++ E++ LD F+ ++ W + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 588 LHQDSRMRIIHRDLKASNVLL-----DNDMNP--KISDFGM 621
L +D + +H ++ N+LL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 22/58 (37%), Positives = 35/58 (60%), Gaps = 8/58 (13%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+A+G+ +L + IHRDL A N+LL + KI DFG+AR +I+ +++ VV
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVV 272
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
LD + +A+G+ +L + IHRD+ A NVLL + KI DFG+AR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 38/180 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNE------VT 521
D+F KLGEG FG VYK +LV + +K+ + G +E + NE
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-------DF------FIF----DQA 564
A + L + + DE L++ Y +L +F ++ D
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 565 RATFLDWQKRIHIVGGIARGILY-LHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMA 622
+ L+ + + I+ I R IL+ L I+HRD+K N++ KI D G A
Sbjct: 248 KG--LERENK--IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRN 530
D+F ++LG G G V+K + I ++L + + E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A + Q + + +G+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 640 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.95 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.93 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.93 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.92 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.92 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.92 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.91 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.91 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.91 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.89 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.89 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.89 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.89 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.89 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.89 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.89 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.89 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.89 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.89 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.88 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.88 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.88 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.88 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.88 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.88 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.88 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.88 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.88 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.88 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.88 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.87 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.87 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.87 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.87 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.87 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.87 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.87 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.87 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.87 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.86 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.86 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.86 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.86 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.86 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.86 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.86 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.86 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.86 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.86 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.86 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.86 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.86 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.85 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.85 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.85 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.85 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.85 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.85 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.85 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.85 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.85 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.85 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.85 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.85 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.85 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.85 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.85 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.85 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.85 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.85 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.85 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.84 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.84 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.84 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.84 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.84 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.84 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.84 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.84 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.84 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.84 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.84 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.84 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.84 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.83 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.83 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.83 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.83 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.83 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.83 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.83 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.83 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.83 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.83 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.83 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.83 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.83 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.83 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.83 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.83 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.82 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.82 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.82 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.82 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.82 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.82 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.82 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.82 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.81 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.81 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.81 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.81 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.81 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.81 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.81 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.8 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.8 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.8 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.8 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.8 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.8 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.8 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.8 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.8 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.79 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.79 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.79 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.79 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.79 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.79 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.79 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.79 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.79 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.79 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.79 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.79 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.79 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.78 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.78 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.78 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.78 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.78 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.77 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.77 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.77 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.76 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.76 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.75 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.74 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.74 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.73 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.73 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.72 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.71 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.66 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.65 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.63 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.62 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.61 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.57 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.56 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.55 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.54 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.54 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.39 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.39 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.13 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.13 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.3 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.25 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.22 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.48 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.36 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.35 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.34 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.21 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.13 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.76 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.31 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 95.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.94 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 93.93 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.88 Aligned_cols=168 Identities=51% Similarity=0.885 Sum_probs=154.7
Q ss_pred cccccchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEE
Q 006563 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (640)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 538 (640)
....|++.++.++|++|+..+.||+|+||.||+|.+.++..||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998865443156799999999999999999999999
Q ss_pred EeCC-eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 539 IQAD-ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 539 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
.+.+ +++||||||++|+|+++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876544 78999999999999999999999998899999999999999999999999
Q ss_pred eeccceeccC
Q 006563 618 DFGMARIFGG 627 (640)
Q Consensus 618 DFGla~~~~~ 627 (640)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999977644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.87 Aligned_cols=152 Identities=32% Similarity=0.545 Sum_probs=136.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..+|...+.||+|+|++||+|++.+ +.+||||.+.+. .+...+.+..|+++|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4677777889999999999999876 789999999865 4556677889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC------CceEEeeeccc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND------MNPKISDFGMA 622 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kI~DFGla 622 (640)
|||++|+|..|++... .+++.+...++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999996643 5899999999999999999999998 9999999999999764 56899999999
Q ss_pred eeccCCc
Q 006563 623 RIFGGDE 629 (640)
Q Consensus 623 ~~~~~~~ 629 (640)
|.+....
T Consensus 163 R~L~~~~ 169 (429)
T KOG0595|consen 163 RFLQPGS 169 (429)
T ss_pred hhCCchh
Confidence 9986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=259.42 Aligned_cols=159 Identities=36% Similarity=0.653 Sum_probs=139.9
Q ss_pred ccccchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEE
Q 006563 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (640)
Q Consensus 460 ~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 539 (640)
.+.++.+++.. .+.||+|-||.|+.|.+.....||+|.++.. ....+.|.+|+++|.+|+|+|||+++|+|.
T Consensus 200 ~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 200 PWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred CeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 34455555443 3689999999999999988889999999865 334578999999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
.++.++||||||++|+|.++|+.. ....+.-.+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccc
Confidence 999999999999999999999773 3446888999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCcc
Q 006563 620 GMARIFGGDEI 630 (640)
Q Consensus 620 Gla~~~~~~~~ 630 (640)
||||.+..++.
T Consensus 348 GLAr~~~d~~Y 358 (468)
T KOG0197|consen 348 GLARLIGDDEY 358 (468)
T ss_pred ccccccCCCce
Confidence 99997766654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=258.26 Aligned_cols=146 Identities=38% Similarity=0.630 Sum_probs=130.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-eeEEEEEccCCCC
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEYMPNKS 555 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~gs 555 (640)
+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...||||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 46999999999999997655599999986432 22569999999999999999999999999987 7999999999999
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceeccC
Q 006563 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGG 627 (640)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~~ 627 (640)
|..++.+. ....+++..+++++.|||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++....
T Consensus 127 L~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 127 LSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred HHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999775 34569999999999999999999999864 99999999999999997 999999999998754
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=223.62 Aligned_cols=109 Identities=51% Similarity=0.805 Sum_probs=81.3
Q ss_pred CCeEEEEecCCCCCCCC--cceEEEecCC-eEEecCCCceEEee-ccccCC-CCceEEEeecccEEEEeCCCCceeeeec
Q 006563 64 PRTVAWVANRETPLTDQ--SGLLNVTSKG-IVLLDGRDRIFWSS-NTSITM-KNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (640)
Q Consensus 64 ~~t~VW~Anr~~Pv~~~--~~~l~~~~~G-L~l~d~~~~~vWst-~~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSF 138 (640)
++||||+|||+.|+... ...|.++.|| |+|.|..++++|++ ++.+.. .+..|+|+|+|||||++. .+.+|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence 47999999999999653 4789999999 99999999999999 555433 578999999999999996 688999999
Q ss_pred cCCCcccCCCCeecceeccCCceEEEeccCCCCCC
Q 006563 139 DHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173 (640)
Q Consensus 139 d~PTDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps 173 (640)
||||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus 80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999988888778899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=250.29 Aligned_cols=161 Identities=29% Similarity=0.473 Sum_probs=138.1
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (640)
.+.|..+++||+|.||.|||++. ..|+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35577778999999999999986 458999999987543 33344567999999999999999999999887 68999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+|||++ +|.-++.. ....++..++..++.|++.||+|+|..+ |+|||||.+|||||.++.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999998 77666643 2345899999999999999999999998 9999999999999999999999999999998
Q ss_pred CCccccccceee
Q 006563 627 GDEIQTNTHKVV 638 (640)
Q Consensus 627 ~~~~~~~~~~~~ 638 (640)
.+..+..|++++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 877766776664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=243.46 Aligned_cols=156 Identities=29% Similarity=0.396 Sum_probs=135.8
Q ss_pred cccccccccCceeEEEEEecC-CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-eeEEEEEccC
Q 006563 476 ASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEYMP 552 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 552 (640)
..++.||+|..|+|||+.++. ++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 344699999999999999976 778999999544 3455678999999999999999999999999998 5999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcccc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 632 (640)
+|||+.++... ..+++...-+|+.+|++||.|||++. .||||||||+||||+..+++||+|||.++.+...
T Consensus 162 gGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999654 34889999999999999999999732 4999999999999999999999999999998544
Q ss_pred ccceeeeC
Q 006563 633 NTHKVVGT 640 (640)
Q Consensus 633 ~~~~~~Gt 640 (640)
..++.+||
T Consensus 233 ~a~tfvGT 240 (364)
T KOG0581|consen 233 IANTFVGT 240 (364)
T ss_pred hccccccc
Confidence 34557776
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=244.28 Aligned_cols=159 Identities=29% Similarity=0.484 Sum_probs=132.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCch-------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
+.|...+.||+|+||.|-+|.-+. ++.||||++.+.... ......+|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 456667899999999999998654 999999999864211 122356999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEeeecc
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGM 621 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~DFGl 621 (640)
|||||||++|+|.+.+.... .+.+..-..++.|++.|+.|||+.+ |+||||||+|||+..+ ..+||+||||
T Consensus 252 YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999998886543 3566666788999999999999998 9999999999999655 7899999999
Q ss_pred ceeccCCccccccceeeeC
Q 006563 622 ARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 622 a~~~~~~~~~~~~~~~~Gt 640 (640)
||..++.. .+++.-||
T Consensus 326 AK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGT 341 (475)
T ss_pred hhccccce---ehhhhcCC
Confidence 99987433 23344444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=253.60 Aligned_cols=153 Identities=30% Similarity=0.432 Sum_probs=139.3
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..|...+.||+|+|+.||.++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||++++++++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688888999999999999998 66999999999863 3445678899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+|++++|..++. +++.+++.+...+..||+.||.|||+.+ |+|||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4456999999999999999999999987 999999999999999999999999999999866
Q ss_pred ccc
Q 006563 629 EIQ 631 (640)
Q Consensus 629 ~~~ 631 (640)
+.+
T Consensus 172 ~Er 174 (592)
T KOG0575|consen 172 GER 174 (592)
T ss_pred ccc
Confidence 433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=262.25 Aligned_cols=153 Identities=31% Similarity=0.552 Sum_probs=136.4
Q ss_pred ccccccccccCceeEEEEEecC----CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..+.++||.|.||.|++|+++. ...||||.|+.. ......+|+.|+.||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3556799999999999999865 346999999865 34567789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
||+||+|+.||+... ..+++.+...+.++||.||+||-+-+ +|||||.++||||+.+..+||+||||+|.+..+.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999997654 34899999999999999999999876 9999999999999999999999999999987665
Q ss_pred ccc
Q 006563 630 IQT 632 (640)
Q Consensus 630 ~~~ 632 (640)
...
T Consensus 786 ~~~ 788 (996)
T KOG0196|consen 786 EAA 788 (996)
T ss_pred Ccc
Confidence 333
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=248.92 Aligned_cols=159 Identities=33% Similarity=0.540 Sum_probs=136.1
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhh--CCCCceeeeEeEEEeCC----eeEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD----ESMLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV 547 (640)
.....++||+|+||.||||.+.+ +.||||++.. +..+.|.+|-++.+. ++|+||+++++.-..+. +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34445689999999999999954 9999999874 456778888887764 58999999999876655 78999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
+||.++|+|.+||.. ..++|.+..+|+..+++||+|||++ .+++|+|||||++||||.+|+++.|+||||
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999943 4689999999999999999999976 456899999999999999999999999999
Q ss_pred ceeccCCccccccceeeeC
Q 006563 622 ARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 622 a~~~~~~~~~~~~~~~~Gt 640 (640)
|.++.....+..+..-+||
T Consensus 363 Al~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eEEecCCCCCcchhhhhhh
Confidence 9999776666555556666
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=258.49 Aligned_cols=151 Identities=34% Similarity=0.589 Sum_probs=134.0
Q ss_pred hccccccccccccCceeEEEEEecC------CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
+.+....+.||+|+||+||+|+... .+.||||.++..... ..++|++|+++|+.++|+|||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455566799999999999998543 457999999877554 788999999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 545 MLIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
+||+|||.+|+|.+||+.... ...|+..+.+.||.|||.||+||-++. +|||||..||+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999975321 223889999999999999999999887 999999999999999999
Q ss_pred eEEeeeccceec
Q 006563 614 PKISDFGMARIF 625 (640)
Q Consensus 614 ~kI~DFGla~~~ 625 (640)
+||+||||+|-+
T Consensus 642 VKIsDfGLsRdi 653 (774)
T KOG1026|consen 642 VKISDFGLSRDI 653 (774)
T ss_pred EEecccccchhh
Confidence 999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=233.25 Aligned_cols=162 Identities=27% Similarity=0.429 Sum_probs=140.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|..+++||+|+||+||.++.++ ++.+|+|.+++.. ....+...+|..+|.+++||.||+++-.+.+++.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999998776 7889999998652 3346678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||+.+|.|..+|.++. .+++......+.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.-.
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999996543 3778877788889999999999998 9999999999999999999999999999764
Q ss_pred CCccccccceeeeC
Q 006563 627 GDEIQTNTHKVVGT 640 (640)
Q Consensus 627 ~~~~~~~~~~~~Gt 640 (640)
.+.. .++++.||
T Consensus 177 ~~~~--~t~tfcGT 188 (357)
T KOG0598|consen 177 KDGD--ATRTFCGT 188 (357)
T ss_pred cCCC--ccccccCC
Confidence 4432 34457776
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=202.74 Aligned_cols=109 Identities=40% Similarity=0.920 Sum_probs=102.9
Q ss_pred eecCCCCCCCccCCCCCCcCcceeeeEEEeeCCeEEEEEecCCC-ceEEEEEccCCCEEEEEEeCCCCcEEEEEEecCCC
Q 006563 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGP-AVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDR 277 (640)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~r~~l~~~G~l~~~~~~~~~~~w~~~w~~p~~~ 277 (640)
||+|+|+|..|++.|++. ....+.+.|+.+++|.+++|...+. .++|++||.+|+++++.|++..+.|...|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~-~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMS-SNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCccccc-ccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence 899999999999999998 6667889999999999999998777 89999999999999999999999999999999999
Q ss_pred CcccccCCCCccccCCCCCcCCCCCCCccCC
Q 006563 278 CDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308 (640)
Q Consensus 278 C~~~~~CG~~g~C~~~~~~~C~C~~GF~~~~ 308 (640)
||+|+.||+||+|+.+..+.|+|+|||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988888999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=200.41 Aligned_cols=114 Identities=47% Similarity=0.766 Sum_probs=100.9
Q ss_pred CCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCCCceEEe
Q 006563 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWS 103 (640)
Q Consensus 25 ~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWs 103 (640)
++|.+|++|+|+++.|++|||.+......+.+|||.+.+ +++||.||++.| ....+.|.++.+| |+|.|.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578899999999999999999987654489999999877 899999999999 4456789999999 9999999999999
Q ss_pred eccccCCCCceEEEeecccEEEEeCCCCceeeeeccCC
Q 006563 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (640)
Q Consensus 104 t~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~P 141 (640)
+++.+.....+|+|+|+|||||++. .+.+||||||||
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP 116 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence 9987434567899999999999997 478999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.20 Aligned_cols=147 Identities=33% Similarity=0.509 Sum_probs=131.4
Q ss_pred cccccccccccCceeEEEEEecCC----cE-EEEEEccc---CCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEG----QE-IAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g----~~-VavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
+....++||+|+||.||+|++... .. ||||.... .....+++|.+|+++|++++|||||+++|++....+++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 334447999999999999998653 23 89999874 24567889999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||||+|++|+|+++|.+... .++..+++.++.+.|.||+|||+++ +|||||.++|+|++.+..+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999976544 5899999999999999999999988 999999999999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=219.66 Aligned_cols=150 Identities=34% Similarity=0.619 Sum_probs=132.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hh-hHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|.||.||+|+... |+.||||+++.... ++ .....+|++.|+.++|+||+.|++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356667899999999999998654 89999999985422 22 3457899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+. +|+..+++. ...++..++..++.++++||+|||.+. |+||||||.|+|+++++.+||+|||||+.++..
T Consensus 82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 899888654 346899999999999999999999988 999999999999999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-27 Score=225.45 Aligned_cols=149 Identities=25% Similarity=0.423 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
+.|+.+.++|+|+||.|||++.++ |+.||||++.... +...+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 356667799999999999999987 9999999987543 2334567899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++.-|+.+- +. ...++.....+++.|+++|+.|+|.++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eLe-~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE-RY--PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH-hc--cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99986665543 22 234788889999999999999999988 99999999999999999999999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=235.67 Aligned_cols=154 Identities=32% Similarity=0.435 Sum_probs=135.5
Q ss_pred HHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.+..++|...+.||+|+|++|++++..+ ++++|||++.+. ..+..+....|-++|.+| .||.|++|+-.+.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445778888999999999999998765 889999999764 223345677889999999 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
+|+|+||+++|+|..++.+- ..+++.....++.+|+.||+|||..+ ||||||||+|||||+++++||+|||-|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999664 34788888889999999999999988 9999999999999999999999999999
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
++...
T Consensus 223 ~l~~~ 227 (604)
T KOG0592|consen 223 ILSPS 227 (604)
T ss_pred cCChh
Confidence 99653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=222.74 Aligned_cols=167 Identities=25% Similarity=0.472 Sum_probs=140.3
Q ss_pred hccccccccccccCceeEEEEE-ecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEe-EEEeCCe-eEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG-CCIQADE-SML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~-l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~l 546 (640)
..+|.+.++||+|.||.|||+. +.+|..||.|.+.-. +.+..+.+..|+.+|++|+|||||++++ -+.+.++ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3457778899999999999996 467899999988732 4556778999999999999999999999 4555555 899
Q ss_pred EEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 547 IYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDS-RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
||||+..|+|...+.+- ...+.++++.+++++.|++.||..+|..- +..|+||||||.||+|+.++.+|+.||||+|.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999988653 23456999999999999999999999842 12399999999999999999999999999999
Q ss_pred ccCCccccccceeeeC
Q 006563 625 FGGDEIQTNTHKVVGT 640 (640)
Q Consensus 625 ~~~~~~~~~~~~~~Gt 640 (640)
+..+.+ -.+..+||
T Consensus 178 l~s~~t--fA~S~VGT 191 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGT 191 (375)
T ss_pred hcchhH--HHHhhcCC
Confidence 976554 34567887
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=233.59 Aligned_cols=151 Identities=30% Similarity=0.479 Sum_probs=132.1
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHh--HHHHHHHHhhCC-CCceeeeEeEEEeCC-eeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--FKNEVTLIARLQ-HRNLVKLLGCCIQAD-ESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~--f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~ 545 (640)
..++|..+++||.|.||.||+|+-.+ ++.||||++++.-.. .++ =++|++.|++|. |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678888999999999999998644 889999999864222 333 358999999998 999999999999988 899
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|.++ +.|||+||+|||+.....+||+||||||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999976 898888665 567999999999999999999999998 999999999999999999999999999988
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 161 ~Sk 163 (538)
T KOG0661|consen 161 RSK 163 (538)
T ss_pred ccC
Confidence 543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=232.71 Aligned_cols=149 Identities=35% Similarity=0.578 Sum_probs=132.8
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+.....++||+|-||.|.++....+..||||+++.... ....+|..|+++|.+++|||||+|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 33455689999999999999998889999999987644 45689999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|+|.+++....... ++-....+|+.|||.||+||.+-. +|||||.++|||+|.++++||+|||++|-+
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999997653332 566667789999999999999876 999999999999999999999999999965
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=216.49 Aligned_cols=151 Identities=28% Similarity=0.464 Sum_probs=127.9
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hh-hHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QG-MEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (640)
.+.|..++.|++|.||.||+|+... ++.||+|+++.... .+ --.-++|+.+|.+++|||||.+-.+.... +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3567778999999999999998765 77899999975421 11 11347899999999999999999987654 56999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||||++ +|..++..-. ..+...+...+..|+++|++|||... |+||||||+|+|+++.|.+||+||||||.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999988 7888775433 45788888899999999999999987 9999999999999999999999999999997
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 229 sp 230 (419)
T KOG0663|consen 229 SP 230 (419)
T ss_pred CC
Confidence 55
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=221.24 Aligned_cols=150 Identities=31% Similarity=0.503 Sum_probs=131.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC--eeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 549 (640)
.++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 446666899999999999999866 8899999987653333677899999999999999999999855444 6899999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~~ 627 (640)
|+++|+|.+++.+... .+++..+.....||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999976543 5899999999999999999999988 999999999999999 79999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=250.41 Aligned_cols=150 Identities=35% Similarity=0.623 Sum_probs=133.9
Q ss_pred ccccccccccccCceeEEEEEecC--Cc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE--GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~--g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
.+....+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344556789999999999998765 33 4899999876 4567789999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 546 LIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
|++|||++|+|..||++... ...|...+.+.++.|||+||.||++++ .|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987522 346999999999999999999999987 99999999999999999999999999
Q ss_pred ceec
Q 006563 622 ARIF 625 (640)
Q Consensus 622 a~~~ 625 (640)
||.+
T Consensus 849 ArDi 852 (1025)
T KOG1095|consen 849 ARDI 852 (1025)
T ss_pred hHhh
Confidence 9944
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=223.43 Aligned_cols=150 Identities=26% Similarity=0.518 Sum_probs=134.6
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.+|...+.||+|.||+|-++.- ..|+.||||.+++. +.+..-.+.+|+++|..|+||||+.++.+|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3455667999999999999976 56999999999865 3455667899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||..+|.|.+|+.+. ..|++.+...+++||..|+.|+|.+. ++|||||.+|||||.++.+||+||||+-++..+
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999654 35899999999999999999999886 999999999999999999999999999987544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=223.89 Aligned_cols=165 Identities=30% Similarity=0.471 Sum_probs=133.9
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--------------hhhHhHHHHHHHHhhCCCCceee
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------------QGMEEFKNEVTLIARLQHRNLVK 533 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~ 533 (640)
.+..+.|.....||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445678888999999999999999864 488999999975321 11357889999999999999999
Q ss_pred eEeEEEeC--CeeEEEEEccCCCChhHHHhhccccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC
Q 006563 534 LLGCCIQA--DESMLIYEYMPNKSLDFFIFDQARATF-LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (640)
Q Consensus 534 l~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 610 (640)
|+.+..+. +..|||+|||..|.+... ..... +...+..++++++..||+|||.++ ||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99998765 468999999999987431 22233 889999999999999999999998 999999999999999
Q ss_pred CCceEEeeeccceeccCC---ccccccceeeeC
Q 006563 611 DMNPKISDFGMARIFGGD---EIQTNTHKVVGT 640 (640)
Q Consensus 611 ~~~~kI~DFGla~~~~~~---~~~~~~~~~~Gt 640 (640)
++++||+|||.+...... .....+.+.+||
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT 278 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGT 278 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCC
Confidence 999999999999977211 122234456666
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=190.37 Aligned_cols=112 Identities=49% Similarity=0.783 Sum_probs=99.3
Q ss_pred CCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCCCceEEe
Q 006563 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWS 103 (640)
Q Consensus 25 ~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWs 103 (640)
+.|..|++|+|+++.|++|||.+... ..+.+|||+..+ +++||+|||+.|+.++ ..|.++++| |+|.|.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence 56888999999999999999998754 578999999887 8999999999998764 789999999 9999999999999
Q ss_pred eccccCCCCceEEEeecccEEEEeCCCCceeeeeccC
Q 006563 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (640)
Q Consensus 104 t~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~ 140 (640)
+++.......+|+|+|+|||||++. .+.++||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence 9986335667899999999999987 46799999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=232.95 Aligned_cols=152 Identities=35% Similarity=0.633 Sum_probs=132.9
Q ss_pred cccccchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEe
Q 006563 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
+.|.+.++++ ...+.||+|.||+||+|.+.. .||||.+... ..+..+.|++|+..+++-+|.||+-+.|
T Consensus 385 ~~WeIp~~ev-------~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 385 EEWEIPPEEV-------LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccCHHHh-------hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 3444555444 344689999999999999854 7999999765 3456889999999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
+|..+.. .||+.+|++-+|..+|+..+ ..++..+.+.||.|||+||.|||.++ |||||||..||+|.+++++||
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence 9998877 99999999999999996644 45899999999999999999999998 999999999999999999999
Q ss_pred eeeccceec
Q 006563 617 SDFGMARIF 625 (640)
Q Consensus 617 ~DFGla~~~ 625 (640)
+||||+..-
T Consensus 530 gDFGLatvk 538 (678)
T KOG0193|consen 530 GDFGLATVK 538 (678)
T ss_pred ecccceeee
Confidence 999999764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=230.09 Aligned_cols=159 Identities=28% Similarity=0.489 Sum_probs=139.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||||+-+. .+.||+|.+.+.. ....+.+.+|++++++++|||||.+++.++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467777899999999999998765 7889999998653 3456778999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+.+ +|..+|..+. .+++.....|+.++..||.|||+.. |+|||+||+||||+..+.+|++|||+||.++.+.
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999996543 4899999999999999999999986 9999999999999999999999999999986544
Q ss_pred cccccceeeeC
Q 006563 630 IQTNTHKVVGT 640 (640)
Q Consensus 630 ~~~~~~~~~Gt 640 (640)
. ..+++.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 2 34567776
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=224.01 Aligned_cols=150 Identities=27% Similarity=0.391 Sum_probs=135.4
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|..+.+||+|+||.||+++-++ |+.+|+|+|++.. ..+.+..+.|-.+|...+++.||+|+..+.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998766 8899999998753 4456778999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|++..+|.... .|+.......+.+.+-|+.-||+.+ +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999996543 5777777888889999999999998 9999999999999999999999999997664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=207.31 Aligned_cols=151 Identities=30% Similarity=0.424 Sum_probs=134.3
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|..+..||.|+||.|.+.+.+. |.-+|+|.+++.. -.+.+...+|..+|+.+.||.+++|++.+.+....+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3567778899999999999999876 7789999998642 23455678999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||.++|.|..+|++.. .++......+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999996543 3788888999999999999999988 99999999999999999999999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 197 r 197 (355)
T KOG0616|consen 197 R 197 (355)
T ss_pred c
Confidence 3
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=213.20 Aligned_cols=150 Identities=29% Similarity=0.493 Sum_probs=128.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCch--hhHhHHHHHHHHhhCCCCc-eeeeEeEEEeCC------
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ--GMEEFKNEVTLIARLQHRN-LVKLLGCCIQAD------ 542 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~--~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 542 (640)
..|..+++||+|+||+||+|+... |+.||+|++.....+ .-....+|+.++.+++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 456666789999999999998754 889999998754331 2344678999999999999 999999999877
Q ss_pred eeEEEEEccCCCChhHHHhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
..+||+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||.||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999966 898888664432 34677888999999999999999988 99999999999999999999999999
Q ss_pred ceecc
Q 006563 622 ARIFG 626 (640)
Q Consensus 622 a~~~~ 626 (640)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=225.07 Aligned_cols=153 Identities=31% Similarity=0.483 Sum_probs=129.2
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC-
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD- 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~- 542 (640)
.++|...++||+|+||.||+|... .++.||+|++.... ....+.+.+|++++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467888889999999999999742 24679999987543 23456789999999999 8999999999987654
Q ss_pred eeEEEEEccCCCChhHHHhhccc---------------------------------------------------------
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (640)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864321
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 566 --ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 566 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 124788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=219.46 Aligned_cols=151 Identities=33% Similarity=0.558 Sum_probs=130.4
Q ss_pred ccccccccccccCceeEEEEEecC-----------------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-----------------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 534 (640)
++|...++||+|+||.||++...+ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567777899999999999997533 2369999987543 3345679999999999999999999
Q ss_pred EeEEEeCCeeEEEEEccCCCChhHHHhhcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006563 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQA----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598 (640)
Q Consensus 535 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 598 (640)
++++.+.+..++||||+++|+|.+++.... ....++|..+..++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134788899999999999999999987 999
Q ss_pred cccCCCCEEEcCCCceEEeeeccceecc
Q 006563 599 RDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 599 ~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||||+|||+++++.+||+|||+++.+.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=223.59 Aligned_cols=151 Identities=28% Similarity=0.456 Sum_probs=132.7
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC----Cc-hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCC
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG----SG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD 542 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 542 (640)
...++|...+.||+|+||+|+.|.... ++.||+|.+.+. .. ...+.+.+|+.+++.++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345678888999999999999997654 799999977653 11 23455678999999998 999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeecc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGM 621 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGl 621 (640)
..++||||+.+|+|.+++.+. ..+.+.....++.|++.|++|||..+ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999662 34777899999999999999999988 9999999999999999 9999999999
Q ss_pred ceecc
Q 006563 622 ARIFG 626 (640)
Q Consensus 622 a~~~~ 626 (640)
+....
T Consensus 168 s~~~~ 172 (370)
T KOG0583|consen 168 SAISP 172 (370)
T ss_pred ccccC
Confidence 99983
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=206.59 Aligned_cols=155 Identities=29% Similarity=0.425 Sum_probs=135.1
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+.++|...+.||+|.||.||.|+.+. +-.||+|++.+.. .+...++.+|+++-+.|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34678888999999999999999866 6689999987642 2334678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||.++|+|.+.|.+.. ...++......++.|+|.||.|+|..+ ||||||||+|+|++..+..||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999997543 345777888889999999999999987 9999999999999999999999999998754
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 176 ~~k 178 (281)
T KOG0580|consen 176 SNK 178 (281)
T ss_pred CCC
Confidence 333
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=216.60 Aligned_cols=149 Identities=32% Similarity=0.490 Sum_probs=121.2
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-----eEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-----SMLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV 547 (640)
.|...+++|.|+||.||+|.+.+ ++.||||+.....+ .--.|+++|++++|||||+|+-++....+ ..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45566899999999999999876 68999999865432 22469999999999999999998865432 3689
Q ss_pred EEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla~~~ 625 (640)
||||+. +|...+++-. .+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||+|||-||++
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 7877776421 1234566666778899999999999977 9999999999999976 99999999999999
Q ss_pred cCCcc
Q 006563 626 GGDEI 630 (640)
Q Consensus 626 ~~~~~ 630 (640)
...+.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 76554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=225.46 Aligned_cols=159 Identities=31% Similarity=0.519 Sum_probs=140.5
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
..|....+||+|+-|.||.+.-. .++.||||++........+-+.+|+.+|+..+|+|||+++..+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45666679999999999999754 48899999998765555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCccc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 631 (640)
++|+|.+.+.. ..+++.++..|.+++++||+|||.++ |+|||||.+||||+.++.+||+|||++..+..++..
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999888833 34899999999999999999999998 999999999999999999999999999999776653
Q ss_pred cccceeeeC
Q 006563 632 TNTHKVVGT 640 (640)
Q Consensus 632 ~~~~~~~Gt 640 (640)
-.+++||
T Consensus 426 --R~TmVGT 432 (550)
T KOG0578|consen 426 --RSTMVGT 432 (550)
T ss_pred --cccccCC
Confidence 3358887
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=215.82 Aligned_cols=160 Identities=26% Similarity=0.424 Sum_probs=133.6
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHh--hCCCCceeeeEeEEEeCC----eeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIA--RLQHRNLVKLLGCCIQAD----ESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l 546 (640)
......+.||+|.||.|++|.+ .|+.||||++...+ .+.+.+|.++.+ .|+|+||+.+++.-...+ .++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4566778999999999999999 47899999997543 345677777775 469999999999865443 4799
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
|.+|.++|||.+||.+ ..++-...+++++.+|.||++||.+ +++.|.|||||+.|||+.+++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999944 4689999999999999999999954 788899999999999999999999999999
Q ss_pred ceeccCC--ccccccceeeeC
Q 006563 622 ARIFGGD--EIQTNTHKVVGT 640 (640)
Q Consensus 622 a~~~~~~--~~~~~~~~~~Gt 640 (640)
|.....+ +.....+..+||
T Consensus 363 Av~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred eEEecccCCcccCCCCCccce
Confidence 9887654 334455566776
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=212.07 Aligned_cols=150 Identities=24% Similarity=0.381 Sum_probs=133.9
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...++||.|.-++||+|+. +.++.||||++.-.. ....+++.+|+..|+.++||||++++..|..+.++|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788888999999999999986 448899999987542 3347889999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||..||+.++++..-.. .+++..+..|.+++++||.|||.++ .||||||+.||||+++|.+||+|||.+--+
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999765433 3899999999999999999999998 999999999999999999999999977655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=216.00 Aligned_cols=154 Identities=32% Similarity=0.511 Sum_probs=133.2
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
+.||.|-||+||-|+++. |+.||||.+.+. ...+.+.+++|+.+|.+++||.||.|.-.|+..+..+.|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 689999999999999876 999999999865 34556789999999999999999999999999999999999997777
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEeeeccceeccCCcccc
Q 006563 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARIFGGDEIQT 632 (640)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~DFGla~~~~~~~~~~ 632 (640)
|+-+|..+.. .|+......++.||+.||.|||.++ |+||||||+||||.+. -.+||+|||+||++++...+.
T Consensus 650 LEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 650 LEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred HHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 7777765443 3788888888999999999999998 9999999999999643 569999999999998766443
Q ss_pred ccceeeeC
Q 006563 633 NTHKVVGT 640 (640)
Q Consensus 633 ~~~~~~Gt 640 (640)
.++||
T Consensus 725 ---sVVGT 729 (888)
T KOG4236|consen 725 ---SVVGT 729 (888)
T ss_pred ---hhcCC
Confidence 56776
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=224.90 Aligned_cols=153 Identities=31% Similarity=0.523 Sum_probs=137.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.+....++||-|-||.||.|.++. .-.||||.|+.. .-..++|+.|..+|+.++|||+|+|+|+|......|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 344556799999999999999977 668999999864 345789999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
..|+|.+||++-.+. .++--..+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+||||+|++.+|..
T Consensus 346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999876543 4677778899999999999999987 99999999999999999999999999999987753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=234.61 Aligned_cols=148 Identities=35% Similarity=0.575 Sum_probs=130.1
Q ss_pred cccccccCceeEEEEEec-CCc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 478 YNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-~g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++||+|+||+||||.+- +|+ +||||.+... ..+..+++++|+-+|++++||||+||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 368999999999999863 343 6899998755 3456789999999999999999999999998765 88999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCccc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 631 (640)
+.|.|.++++..+ ..+.-+..+.+..|||+||.|||++. ++||||.++||||.+-..+||.|||+|+++..++.+
T Consensus 780 P~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999997643 34788899999999999999999876 999999999999999999999999999999877644
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=221.80 Aligned_cols=152 Identities=22% Similarity=0.274 Sum_probs=133.1
Q ss_pred HHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
....++|...+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345789989999999999999999865 788999998642 223345688999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++|+|..++... .++......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999988432 3788888999999999999999987 99999999999999999999999999998
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 192 ~~~ 194 (370)
T cd05621 192 MDE 194 (370)
T ss_pred ccc
Confidence 743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=221.07 Aligned_cols=148 Identities=25% Similarity=0.382 Sum_probs=131.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|+..+.||+|+||+||++.... ++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 467888999999999999998754 7899999987531 233456888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|..++.+. ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998653 34889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=211.30 Aligned_cols=148 Identities=30% Similarity=0.456 Sum_probs=129.8
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
|...+.||+|+||.||++... +++.||+|.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 566789999999999999874 58899999986432 22345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999988875432 235889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=221.50 Aligned_cols=146 Identities=25% Similarity=0.386 Sum_probs=129.8
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.|..++.||+|+||+||+++... ++.||+|++... .....+.+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57778899999999999998755 789999998653 22345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+++|+|..++.+. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999988653 34788888899999999999999987 999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=226.12 Aligned_cols=160 Identities=31% Similarity=0.466 Sum_probs=136.4
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------eeEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESML 546 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 546 (640)
+...+.||+|+||.||+|+.+. |+.||||.+.+.. ....+.-.+|+++|++++|+|||++.+.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3444689999999999999655 9999999987643 334566789999999999999999999865443 4689
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc--CCC--ceEEeeeccc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDM--NPKISDFGMA 622 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kI~DFGla 622 (640)
|||||++|||...|.+......|++...+.+..++..||.|||+++ |+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988877778999999999999999999999987 99999999999982 333 4799999999
Q ss_pred eeccCCccccccceeeeC
Q 006563 623 RIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 623 ~~~~~~~~~~~~~~~~Gt 640 (640)
|.+..++ ..+.++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9987665 46678887
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=221.25 Aligned_cols=148 Identities=26% Similarity=0.397 Sum_probs=132.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||||++... .....+.+.+|++++..++|+||+++++++.++...+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468888999999999999998764 889999998743 1234556889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998653 34889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=221.21 Aligned_cols=147 Identities=26% Similarity=0.363 Sum_probs=129.9
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++... +++.||||++.+. .....+.+.+|++++++++|+||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36778899999999999999865 4889999998643 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++|+|..++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988543 34788888899999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=216.44 Aligned_cols=149 Identities=25% Similarity=0.362 Sum_probs=132.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|.+... .....+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 567888899999999999999865 789999998643 1234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++|+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988653 34788888899999999999999987 99999999999999999999999999997743
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=216.95 Aligned_cols=148 Identities=25% Similarity=0.405 Sum_probs=131.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|++.... ....+.+..|++++..++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 367888999999999999999865 7899999987531 234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999998543 34788899999999999999999987 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=220.07 Aligned_cols=153 Identities=31% Similarity=0.455 Sum_probs=131.3
Q ss_pred hccccccccccccCceeEEEEEe------cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l------~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++.. ..+..||||+++... ....+.+.+|++++..+ +||||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35677789999999999999964 225689999987542 33456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc----------------------------------------------------------
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (640)
.++||||+++|+|..++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988864221
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 566 --------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 566 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
...+++..++.++.||++||+|||+.+ |+||||||+|||++++..+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=213.85 Aligned_cols=141 Identities=26% Similarity=0.337 Sum_probs=125.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+.||+|+||.||++... +++.||+|++.+. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 4889999998753 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 998888543 35789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=224.11 Aligned_cols=152 Identities=18% Similarity=0.215 Sum_probs=132.3
Q ss_pred cccccccccccCceeEEEEEecC--CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~--g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.|...+.||+|+||.||++.... ++.|++|.+..........+..|+++++.++|||||++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 37778899999999999997543 5678888876554455567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 552 PNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 552 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++|+|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999888643 22345889999999999999999999987 999999999999999999999999999987543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=213.46 Aligned_cols=148 Identities=23% Similarity=0.352 Sum_probs=131.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36777889999999999999876 48899999986431 234566889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999988553 34788999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=216.01 Aligned_cols=150 Identities=25% Similarity=0.356 Sum_probs=131.8
Q ss_pred hccccccccccccCceeEEEEEecC--CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999998654 358999998643 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|..++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998653 34788999999999999999999987 9999999999999999999999999999864
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=220.38 Aligned_cols=146 Identities=24% Similarity=0.396 Sum_probs=129.2
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.|..++.||+|+||.||+++... ++.+|+|++.+.. ....+.+.+|++++++++|+||+++++.+.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999998754 7889999987532 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+++|+|..++.+. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999988553 34788888889999999999999987 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.74 Aligned_cols=151 Identities=23% Similarity=0.283 Sum_probs=132.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 467888999999999999998764 778999998642 1233456888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|..++.+.. ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999996532 34788889999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=212.51 Aligned_cols=140 Identities=22% Similarity=0.313 Sum_probs=125.0
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||.||++...+ ++.||+|++... .....+.+..|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999998765 788999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 9988653 34789999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.73 Aligned_cols=150 Identities=24% Similarity=0.308 Sum_probs=131.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 467788999999999999999765 889999998642 2233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++|+|..++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998542 234788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=218.85 Aligned_cols=147 Identities=24% Similarity=0.394 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368888999999999999998755 7899999986431 233466889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999999998553 34788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=214.15 Aligned_cols=151 Identities=24% Similarity=0.314 Sum_probs=133.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 467888999999999999998754 8899999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|..++.+.. ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999986542 35889999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=218.99 Aligned_cols=150 Identities=24% Similarity=0.290 Sum_probs=131.4
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+++++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45678888999999999999998765 789999998642 22334557889999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|..++... .++......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988542 3677788889999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=226.96 Aligned_cols=152 Identities=31% Similarity=0.459 Sum_probs=133.6
Q ss_pred hccccccccccccCceeEEEEEecCC-cEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEE-Ee------CC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEG-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC-IQ------AD 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g-~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~-~~------~~ 542 (640)
..++.+.+.|.+|||+.||.+....+ .++|+|++-..+....+.+.+|+++|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34566778999999999999999886 999999998778888999999999999997 99999999932 21 13
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
+.+|+||||++|.|-+++..+.... |++.++++|+.++++|+++||.. ++||||||||.+||||+.++..||||||-|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5799999999999999987654443 99999999999999999999987 588999999999999999999999999988
Q ss_pred eec
Q 006563 623 RIF 625 (640)
Q Consensus 623 ~~~ 625 (640)
.-.
T Consensus 194 tt~ 196 (738)
T KOG1989|consen 194 TTK 196 (738)
T ss_pred ccc
Confidence 643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.13 Aligned_cols=141 Identities=27% Similarity=0.355 Sum_probs=125.5
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+.||+|+||.||++.... ++.||+|++.+. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998754 889999998753 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 998887543 34889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=218.34 Aligned_cols=153 Identities=33% Similarity=0.505 Sum_probs=130.8
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++++ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888899999999999998742 24579999997543 33456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc----------------------------------------------------------
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (640)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 566 ---------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 566 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
...+++....+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 124788889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=217.38 Aligned_cols=154 Identities=22% Similarity=0.267 Sum_probs=133.9
Q ss_pred hHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 467 ~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
++....++|...+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 344456889999999999999999998865 778999998642 2233456789999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++||||+++|+|..++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999988542 3678888889999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+.+..
T Consensus 190 ~~~~~ 194 (371)
T cd05622 190 MKMNK 194 (371)
T ss_pred eEcCc
Confidence 88753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=212.18 Aligned_cols=150 Identities=32% Similarity=0.590 Sum_probs=129.5
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.+|+..+.||+|+||.||+|.+.. ++ .||+|.+.... ....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468888999999999999998643 33 38999987543 34467899999999999999999999999764 5689
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||+++|+|.+++.... ..+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986543 34789999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
.+
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=217.38 Aligned_cols=154 Identities=31% Similarity=0.436 Sum_probs=131.3
Q ss_pred hhccccccccccccCceeEEEEEecC------CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD 542 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 542 (640)
..++|...++||+|+||.||+|+... +..||||++..... ...+.|.+|+++++++. ||||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34677888899999999999998532 34699999975432 33567999999999996 999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccc---------------------------------------------------------
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (640)
..+|||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988864210
Q ss_pred ------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 566 ------------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 566 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
...+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceeccC
Q 006563 610 NDMNPKISDFGMARIFGG 627 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~ 627 (640)
+++.+||+|||+++.+..
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=212.72 Aligned_cols=141 Identities=26% Similarity=0.347 Sum_probs=125.0
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+.||+|+||.||++... +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 4889999998753 2234556788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 998887543 35889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=205.43 Aligned_cols=148 Identities=28% Similarity=0.451 Sum_probs=130.4
Q ss_pred ccccccccccccCceeEEEEEec----CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46777889999999999999764 25689999987653 23346789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||+++|+|+.++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999986532 35889999999999999999999987 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=207.45 Aligned_cols=148 Identities=27% Similarity=0.462 Sum_probs=128.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||+|.... ++.||+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 468888999999999999998764 7899999987432 23345678999999999999999999999988899999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++ +|..++.... ..+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 8888875432 34788899999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=215.43 Aligned_cols=150 Identities=25% Similarity=0.413 Sum_probs=133.6
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999876 4889999998753 1234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++++|..++.+. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 35889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=204.70 Aligned_cols=144 Identities=40% Similarity=0.677 Sum_probs=125.7
Q ss_pred cccccccCceeEEEEEec-----CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 478 YNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-----~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.+.||.|.||.||+|.+. .+..|+||.+.... ....++|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999987 25689999996543 345789999999999999999999999999888899999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|+|.++|.... ...+++..+..|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||+++..
T Consensus 84 ~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 84 PGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999997752 235899999999999999999999987 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=211.57 Aligned_cols=150 Identities=21% Similarity=0.274 Sum_probs=130.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 367788899999999999999865 678999998642 1223445888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999996532 34788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=209.89 Aligned_cols=141 Identities=26% Similarity=0.344 Sum_probs=124.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+.||+|+||.||++... .++.||+|.+.+. .......+..|++++..++|+||+++++++......+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 4889999998753 2234566788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 998887543 358899999999999999999997 55 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-23 Score=203.86 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=127.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe-----CCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-----ADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 543 (640)
...|...+.||+|+||.|.++.... |+.||||++... .....++-.+|+++|+.++|+||+.+.....- -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455556789999999999998755 889999999743 34556788999999999999999999998765 356
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.|+|+|+| ..+|.+.++.+ ..|+......++.|+++||+|+|+.+ |+||||||+|+|++.+...||+||||||
T Consensus 101 vYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 45888888543 23788888889999999999999988 9999999999999999999999999999
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
....
T Consensus 174 ~~~~ 177 (359)
T KOG0660|consen 174 YLDK 177 (359)
T ss_pred eccc
Confidence 9864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=205.01 Aligned_cols=143 Identities=19% Similarity=0.330 Sum_probs=124.6
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchh---hHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeEEEEEcc
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIYEYM 551 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 551 (640)
..|++|+++.||+|.. +++.||||++....... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4799999999999998 68899999997643322 5678899999999999999999999977 34679999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|+|..++... ..+++.....++.+++.||.|||... .++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999998653 35889999999999999999999742 278999999999999999999999999987543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=213.75 Aligned_cols=144 Identities=31% Similarity=0.457 Sum_probs=125.2
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34455678999999999999875 48899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|... ....+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999998542 23567778889999999999999987 9999999999999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.37 Aligned_cols=148 Identities=26% Similarity=0.389 Sum_probs=131.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++..++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 367788999999999999998765 889999998643 2334567888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|..++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999988543 34788999999999999999999987 9999999999999999999999999998663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-23 Score=185.64 Aligned_cols=148 Identities=28% Similarity=0.471 Sum_probs=127.3
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...++||+|.||+||||+..+ ++.||+|++... ....-...++|+.+++.++|.|||+++.+.......-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556799999999999998766 778999987643 223345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|.. +|.++...- ...++......++.|+++||.|+|+++ +.||||||.|.|++.+++.|++|||||+-++-
T Consensus 83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 965 677776443 335888889999999999999999988 99999999999999999999999999998763
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=204.26 Aligned_cols=151 Identities=34% Similarity=0.552 Sum_probs=130.6
Q ss_pred ccccccccccccCceeEEEEEe-----cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|+..+.||+|+||.||+|.. ..++.|++|.+.... .+..++|.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566778999999999999985 235789999987533 3445678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 547 IYEYMPNKSLDFFIFDQAR--------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
||||+++++|.+++..... ...+++...+.++.+++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999854321 235789999999999999999999987 99999999999999999
Q ss_pred ceEEeeeccceecc
Q 006563 613 NPKISDFGMARIFG 626 (640)
Q Consensus 613 ~~kI~DFGla~~~~ 626 (640)
.+||+|||+++.+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=215.79 Aligned_cols=150 Identities=30% Similarity=0.418 Sum_probs=132.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+-|+..+.||+|+-|.|-.|++.. |+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346667889999999999998765 9999999997642 223445778999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|-|.+++.+.+ .+.+++..+++.||+.|+.|+|..+ |+||||||+|+|||.++.+||+|||||.+-.++
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999996644 4888999999999999999999987 999999999999999999999999999986544
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=209.78 Aligned_cols=147 Identities=26% Similarity=0.388 Sum_probs=128.0
Q ss_pred cccccccccccCceeEEEEEec----CCcEEEEEEcccC----CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCee
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~----~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 544 (640)
+|...+.||+|+||.||+++.. .++.||+|++.+. .....+.+..|++++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4677789999999999998753 4789999998643 122345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++|+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999888543 34888999999999999999999987 99999999999999999999999999987
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
+.
T Consensus 155 ~~ 156 (332)
T cd05614 155 FL 156 (332)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=208.49 Aligned_cols=150 Identities=24% Similarity=0.316 Sum_probs=132.3
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3678888999999999999998764 7789999887542 2345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+++++|.+++... ..+++..+..++.+++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998553 34789999999999999999999853 39999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-23 Score=213.41 Aligned_cols=162 Identities=25% Similarity=0.439 Sum_probs=140.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-eEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-SMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 548 (640)
++|..++++|+|+||.++..+++. ++.+++|++... .....+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 567778899999999999887754 668889987643 33445578899999999999999999999999988 99999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+.+.+.+ ...+++..++.++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+||+++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999987654 456899999999999999999999776 999999999999999999999999999999877
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
.. ...+++||
T Consensus 160 ~~--~a~tvvGT 169 (426)
T KOG0589|consen 160 DS--LASTVVGT 169 (426)
T ss_pred hh--hhheecCC
Confidence 62 34457776
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=208.78 Aligned_cols=141 Identities=28% Similarity=0.431 Sum_probs=123.5
Q ss_pred ccccccCceeEEEEEec----CCcEEEEEEcccC----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+.||+|+||.||+++.. .++.||+|.+... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 58999999999999753 4788999998743 122345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+++++|..++.+. ..+.+.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999888543 34678888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=201.12 Aligned_cols=150 Identities=34% Similarity=0.551 Sum_probs=134.3
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|+..++||+|+||.||+|...+++.|++|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 568888999999999999999888889999998753 2345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++.... ...+++..+..++.++++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999986543 335788999999999999999999987 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=206.18 Aligned_cols=149 Identities=30% Similarity=0.457 Sum_probs=128.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888899999999999999976 488999999875432 233467889999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|++ ++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 5777766543 234788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=202.52 Aligned_cols=143 Identities=29% Similarity=0.457 Sum_probs=123.2
Q ss_pred cccccCceeEEEEEecC---CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 480 KLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
+||+|+||.||+|.... ...+++|.+.... ......|.+|+++++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997644 3468888876442 2345678899999999999999999999999999999999999999
Q ss_pred hhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 556 LDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 556 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999866432 233567888899999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=200.69 Aligned_cols=148 Identities=30% Similarity=0.512 Sum_probs=131.8
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457777899999999999999988889999988643 2334678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+|+|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 999999886432 24889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-23 Score=213.53 Aligned_cols=152 Identities=32% Similarity=0.531 Sum_probs=131.4
Q ss_pred ccccccccchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeE
Q 006563 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535 (640)
Q Consensus 456 ~~~~~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~ 535 (640)
...++|.+.+++|.+. +.||.|+-|.||+|++. ++.||||+++... ..+++-|++|+|+||+.+.
T Consensus 114 qq~e~WeiPFe~IsEL-------eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 114 QQEELWEIPFEEISEL-------EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hhhhhccCCHHHhhhh-------hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEe
Confidence 4456788888876543 68999999999999994 6899999876432 2478889999999999999
Q ss_pred eEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 536 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
|+|.+..-.+||||||+.|.|...|+.. ..++......+..+||.||.|||.+. |||||||.-||||..+..+|
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEE
Confidence 9999999999999999999999999653 34677777888999999999999987 99999999999999999999
Q ss_pred EeeeccceeccCC
Q 006563 616 ISDFGMARIFGGD 628 (640)
Q Consensus 616 I~DFGla~~~~~~ 628 (640)
|+|||-++.+..-
T Consensus 253 IsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 253 ISDFGTSKELSDK 265 (904)
T ss_pred eccccchHhhhhh
Confidence 9999999987543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=200.23 Aligned_cols=149 Identities=30% Similarity=0.538 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++...++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4566778999999999999988777789999987543 334679999999999999999999999999888999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 9999998865332 5899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=203.13 Aligned_cols=150 Identities=31% Similarity=0.577 Sum_probs=131.3
Q ss_pred ccccccccccccCceeEEEEEec-----CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-----~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 545 (640)
.+|...+.||+|+||.||++... .++.|++|++........+.|.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777789999999999999753 4778999998876666677899999999999999999999987643 4578
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|+||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235899999999999999999999987 999999999999999999999999999976
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=205.33 Aligned_cols=149 Identities=24% Similarity=0.414 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||+++... ++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 467888999999999999999865 7889999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999877655422 235888999999999999999999887 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=203.50 Aligned_cols=144 Identities=33% Similarity=0.447 Sum_probs=125.7
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 47899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 557 DFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 557 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 88875432 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=200.48 Aligned_cols=150 Identities=31% Similarity=0.525 Sum_probs=134.7
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|++|.||++...+++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45677788999999999999998778899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999986543 345899999999999999999999987 9999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=220.67 Aligned_cols=159 Identities=22% Similarity=0.292 Sum_probs=134.7
Q ss_pred HhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
.+.....++|...+.||+|+||+||+++.. +++.||||++... .......+.+|+..+..++|+|+++++..+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 444555678999999999999999999864 5899999998653 2344567889999999999999999988775432
Q ss_pred --------eeEEEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 543 --------ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 543 --------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
..++||||+++|+|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 2679999999999999886532 2346889999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceeccC
Q 006563 614 PKISDFGMARIFGG 627 (640)
Q Consensus 614 ~kI~DFGla~~~~~ 627 (640)
+||+|||+++.+..
T Consensus 182 vkL~DFGls~~~~~ 195 (496)
T PTZ00283 182 VKLGDFGFSKMYAA 195 (496)
T ss_pred EEEEecccCeeccc
Confidence 99999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=208.32 Aligned_cols=150 Identities=24% Similarity=0.329 Sum_probs=131.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|+..+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 3678888999999999999998864 7788999887542 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+++++|.+++... ..+++.....++.++++||.|||+.. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998543 34788999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=207.91 Aligned_cols=143 Identities=27% Similarity=0.338 Sum_probs=125.4
Q ss_pred ccccccCceeEEEEEe----cCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 479 NKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l----~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
+.||+|+||.||++.. ..++.+|+|++.... ......+..|++++++++|+||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 247899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+|+|..++.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999888543 34899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=208.06 Aligned_cols=141 Identities=27% Similarity=0.392 Sum_probs=123.9
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.+|+|++.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999998765 788999998753 223455678888888776 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9998887543 34889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=202.56 Aligned_cols=153 Identities=30% Similarity=0.521 Sum_probs=131.7
Q ss_pred hhccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
.+++|+..+.||+|+||.||+|... .+..||+|.+.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888899999999999998753 24579999986532 2345678999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
.++||||+++++|.+++.+... ...+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234688899999999999999999976 999999999999999999999
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=202.25 Aligned_cols=153 Identities=31% Similarity=0.538 Sum_probs=137.9
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
...+|...++||+|+||.||+|...+++.+++|.+........+++..|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888899999999999999988899999999876555567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++.+.. ...+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999996543 345899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=200.68 Aligned_cols=149 Identities=32% Similarity=0.559 Sum_probs=132.2
Q ss_pred ccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
++|+..+.||+|+||.||+|.+.. ...||||.+.... ....++|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998753 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999986533 25899999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=203.27 Aligned_cols=149 Identities=30% Similarity=0.458 Sum_probs=130.0
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667789999999999999875 48899999987532 1223457889999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999998886532 235899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=207.10 Aligned_cols=141 Identities=28% Similarity=0.431 Sum_probs=123.7
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998765 789999998753 223445677889988876 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9998888543 34788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=213.63 Aligned_cols=162 Identities=29% Similarity=0.452 Sum_probs=136.8
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCee
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 544 (640)
...++|..+.+||+|.||+|+++.+.. ++.+|||.+++.. ....+..+.|.+++... +||.++.|+.++..+++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345788999999999999999999876 7789999999863 34566778888888777 599999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+.+|++..+. ....++......++..|+.||+|||+++ ||+||||.+|||||.+|.+||+||||+|.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999953332 3345889999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccccccceeeeC
Q 006563 625 FGGDEIQTNTHKVVGT 640 (640)
Q Consensus 625 ~~~~~~~~~~~~~~Gt 640 (640)
-..... .|.++=||
T Consensus 518 ~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGT 531 (694)
T ss_pred cCCCCC--ccccccCC
Confidence 643332 24456665
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=206.98 Aligned_cols=146 Identities=29% Similarity=0.404 Sum_probs=126.6
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCC-CceeeeEeEEEeCCeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 548 (640)
+|...+.||+|+||.||+|.... ++.||+|++.+. .....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 46777899999999999998765 678999998753 23345678889999999965 56888999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999888543 34788999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=206.47 Aligned_cols=142 Identities=32% Similarity=0.425 Sum_probs=121.6
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.||+|.+... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998765 778999998753 123344566677777654 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9998888543 24788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=207.70 Aligned_cols=140 Identities=26% Similarity=0.392 Sum_probs=124.2
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.||+|++++. .....+.+..|..++.++ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999998764 789999999753 223455688999999988 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9998887543 35899999999999999999999987 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=206.49 Aligned_cols=147 Identities=29% Similarity=0.390 Sum_probs=126.7
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+|...+.||+|+||.||++.... ++.||+|.+.+.. ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 46677899999999999998765 6789999987532 22344567788888777 6899999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999998888543 34788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=212.08 Aligned_cols=152 Identities=30% Similarity=0.454 Sum_probs=129.7
Q ss_pred hccccccccccccCceeEEEEEecC------CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++++.. ++.||+|++..... ...+.+..|++++.++. |+||++++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3456667899999999999998642 45899999975432 33457889999999997 9999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc----------------------------------------------------------
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (640)
.++|+||+++|+|.+++.+...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864321
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 566 -------------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 566 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
...+++.....++.|++.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124678888999999999999999876 9999999999999
Q ss_pred cCCCceEEeeeccceecc
Q 006563 609 DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~ 626 (640)
++++.+||+|||+++.+.
T Consensus 273 ~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 273 CEGKLVKICDFGLARDIM 290 (401)
T ss_pred eCCCEEEEEecCcceecc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=199.76 Aligned_cols=145 Identities=30% Similarity=0.448 Sum_probs=124.9
Q ss_pred ccccccCceeEEEEEecC---CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+.||+|+||.||+|...+ +..+++|.+..... .....+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998654 35789998875432 34457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 555 SLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 555 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+|..++..... ....++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999865332 234677888899999999999999987 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=202.27 Aligned_cols=151 Identities=34% Similarity=0.610 Sum_probs=132.7
Q ss_pred ccccccccccccCceeEEEEEec------CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46777889999999999999752 245689999876655567789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
||||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1235899999999999999999999987 999999999999999999999
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=207.57 Aligned_cols=144 Identities=30% Similarity=0.488 Sum_probs=123.6
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHH---hhCCCCceeeeEeEEEeCCeeEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLI---ARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
|...+.||+|+||.||++.... ++.||||++.+.. ....+.+..|++++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4556799999999999998754 8899999987431 23345566666554 567899999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||+++++|..++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887743 35899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=224.21 Aligned_cols=150 Identities=24% Similarity=0.334 Sum_probs=131.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...++||+|+||.||+|.... ++.||+|++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 568888999999999999998764 8899999987532 233567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 549 EYMPNKSLDFFIFDQA--------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234667888999999999999999987 9999999999999999999999999
Q ss_pred cceec
Q 006563 621 MARIF 625 (640)
Q Consensus 621 la~~~ 625 (640)
+|+.+
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=212.10 Aligned_cols=140 Identities=21% Similarity=0.335 Sum_probs=124.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|...+.||+|+||.||++.... ++.||+|.... +.+.+|++++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 568888999999999999998754 78899996532 45678999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
. ++|..++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 6 6787777543 34789999999999999999999987 999999999999999999999999999764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=202.13 Aligned_cols=141 Identities=22% Similarity=0.368 Sum_probs=120.8
Q ss_pred cccccCceeEEEEEecC-------------------------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeee
Q 006563 480 KLGEGGFGPVYKGTLVE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~-------------------------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 534 (640)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 12588998876544455678999999999999999999
Q ss_pred EeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC--
Q 006563 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-- 612 (640)
Q Consensus 535 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 612 (640)
+++|.+....++||||+++|+|+.++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886532 35788999999999999999999887 99999999999997643
Q ss_pred -----ceEEeeeccceec
Q 006563 613 -----NPKISDFGMARIF 625 (640)
Q Consensus 613 -----~~kI~DFGla~~~ 625 (640)
.+|++|||++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-23 Score=202.18 Aligned_cols=159 Identities=29% Similarity=0.490 Sum_probs=139.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+-|.++.+||+|+||.|||+.+++ |+.||||.+.. ....+++..|+.+|.+.+.+++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 447777899999999999999876 89999999865 346788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCccc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 631 (640)
--|+..++++- ++++|.+.++..++...++||+|||.-. -||||||+.||||+.++.+|++|||.|..+...-
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999854 4567999999999999999999999864 8999999999999999999999999999885322
Q ss_pred cccceeeeC
Q 006563 632 TNTHKVVGT 640 (640)
Q Consensus 632 ~~~~~~~Gt 640 (640)
+.-+++.||
T Consensus 184 AKRNTVIGT 192 (502)
T KOG0574|consen 184 AKRNTVIGT 192 (502)
T ss_pred HhhCccccC
Confidence 223346666
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=202.39 Aligned_cols=153 Identities=28% Similarity=0.501 Sum_probs=130.9
Q ss_pred hhccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
..++|...+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678888999999999999997542 4579999886543 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
.++||||+++|+|..++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234577888999999999999999987 999999999999999999999
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=207.49 Aligned_cols=146 Identities=24% Similarity=0.437 Sum_probs=124.9
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----eeE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (640)
+|...+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3667789999999999999875 4889999998743 2234457889999999999999999999986432 479
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+. ++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 6888877543 34889999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=214.32 Aligned_cols=144 Identities=25% Similarity=0.331 Sum_probs=126.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
...|...+.||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578888999999999999999866 7889999643 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+. ++|..++.... ..++|..++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 95 68887775432 35899999999999999999999987 99999999999999999999999999998744
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=203.64 Aligned_cols=151 Identities=32% Similarity=0.505 Sum_probs=129.8
Q ss_pred ccccccccccccCceeEEEEEecC---------------CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE---------------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~---------------g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
++|...+.||+|+||.||++...+ ...||+|.+... .....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 567788899999999999987643 225899998754 2334567999999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEE
Q 006563 537 CCIQADESMLIYEYMPNKSLDFFIFDQAR---------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (640)
++...+..++||||+++++|..++..... ...+++..++.++.++++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854321 124788999999999999999999987 999999999999
Q ss_pred EcCCCceEEeeeccceecc
Q 006563 608 LDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 608 l~~~~~~kI~DFGla~~~~ 626 (640)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=200.65 Aligned_cols=149 Identities=31% Similarity=0.503 Sum_probs=126.1
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||+|.... ++ .+++|.+.... ....+++..|+..+++++|+||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 456677899999999999998743 44 47888876433 234567888888999999999999999875 455789
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986533 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=205.80 Aligned_cols=141 Identities=26% Similarity=0.377 Sum_probs=121.0
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHH-HHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++... +++.+|+|++.+. .....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999865 4889999998643 2233445556655 46778999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9998887543 34889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=207.03 Aligned_cols=160 Identities=29% Similarity=0.453 Sum_probs=139.2
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 545 (640)
....|...+.||+|.||.||+++... |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44567777899999999999999877 99999999976533 23468899999999998 999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC----CceEEeeecc
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGM 621 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kI~DFGl 621 (640)
+|||++.+|.|.+.+.+. . +++.....++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999888665 2 899999999999999999999987 9999999999999543 4799999999
Q ss_pred ceeccCCccccccceeeeC
Q 006563 622 ARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 622 a~~~~~~~~~~~~~~~~Gt 640 (640)
|+..... .....++||
T Consensus 186 a~~~~~~---~~~~~~~Gt 201 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGT 201 (382)
T ss_pred ceEccCC---ceEeeecCC
Confidence 9998762 235567776
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=198.04 Aligned_cols=148 Identities=30% Similarity=0.519 Sum_probs=131.1
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+|...+.||+|+||.||++....+..+|+|.+.+.. ...++|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466678999999999999998777789999986532 2345788999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999986533 25899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=205.28 Aligned_cols=141 Identities=28% Similarity=0.392 Sum_probs=120.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHH-HHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++... +++.||+|++.+.. ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999986 48899999987431 222344555554 56789999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999888543 34788889999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=198.73 Aligned_cols=156 Identities=28% Similarity=0.411 Sum_probs=134.3
Q ss_pred HHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++.+++++.....||+|+||.||+|...+ +..|++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34456667666799999999999998654 67899999887666667789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceec
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~ 625 (640)
|+||+++++|..++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++..+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999865432212378888899999999999999887 999999999999976 679999999999876
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
.
T Consensus 160 ~ 160 (268)
T cd06624 160 A 160 (268)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=205.52 Aligned_cols=141 Identities=28% Similarity=0.381 Sum_probs=120.0
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHH-HHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
++||+|+||.||+++... ++.||+|++.+.. ....+++..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998854 7899999986431 122344555554 57889999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|...+... ..+.......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9998877543 34778888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=205.48 Aligned_cols=141 Identities=32% Similarity=0.474 Sum_probs=123.6
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+++... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998765 789999998743 223456677888888876 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999888543 34889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=205.99 Aligned_cols=146 Identities=29% Similarity=0.405 Sum_probs=126.1
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 549 (640)
|...+.||+|+||.||++.... ++.||+|++.+. .....+.+..|.++++.+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 5666899999999999998754 889999998753 2234456788999998885 5778889999998899999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999888543 34889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.31 Aligned_cols=151 Identities=33% Similarity=0.600 Sum_probs=132.7
Q ss_pred ccccccccccccCceeEEEEEecC------CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|...+.||+|+||.||+|...+ ++.||+|.+...... ..+.|.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457777899999999999998743 468999998765443 4678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 546 LIYEYMPNKSLDFFIFDQA-----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
+||||+++++|..++.... ....+++.....++.+++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 1245789999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecc
Q 006563 615 KISDFGMARIFG 626 (640)
Q Consensus 615 kI~DFGla~~~~ 626 (640)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=199.83 Aligned_cols=151 Identities=36% Similarity=0.628 Sum_probs=130.9
Q ss_pred ccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|...+.||+|+||.||+|.... ...|++|.+.... ....++|.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 457777899999999999998644 2579999987543 334567899999999999999999999999988999
Q ss_pred EEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 546 LIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
++|||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145889999999999999999999987 99999999999999999
Q ss_pred ceEEeeeccceecc
Q 006563 613 NPKISDFGMARIFG 626 (640)
Q Consensus 613 ~~kI~DFGla~~~~ 626 (640)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=200.61 Aligned_cols=153 Identities=28% Similarity=0.505 Sum_probs=133.2
Q ss_pred hccccccccccccCceeEEEEEecC-----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 544 (640)
.++|...+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999866 6789999987543 3446678999999999999999999999877 4678
Q ss_pred EEEEEccCCCChhHHHhhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
++++||+++++|..++...... ..+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 46899999999999999999999887 999999999999999999999999
Q ss_pred ccceeccC
Q 006563 620 GMARIFGG 627 (640)
Q Consensus 620 Gla~~~~~ 627 (640)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (280)
T cd05043 162 ALSRDLFP 169 (280)
T ss_pred CCcccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=204.85 Aligned_cols=141 Identities=28% Similarity=0.380 Sum_probs=124.5
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.+|+|++.+.. ....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998765 7889999997532 23455688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9998887543 34899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=197.74 Aligned_cols=148 Identities=25% Similarity=0.445 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++|+||+++++.+..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 56788889999999999999874 57889999987554445567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999988543 34789999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=196.62 Aligned_cols=143 Identities=31% Similarity=0.511 Sum_probs=127.0
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
+.||+|+||.||++... +++.+|+|.+.... ......|.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 58899999876542 34456799999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9988543 235889999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.67 Aligned_cols=154 Identities=31% Similarity=0.515 Sum_probs=133.2
Q ss_pred hhccccccccccccCceeEEEEEecC------CcEEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
..++|+..+.||+|+||.||++.... ...+|+|.+... ......++.+|++++.++ +|+||+++++++.+++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44668888899999999999998643 357999998754 234456788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
..+++|||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12346899999999999999999999887 99999999999999
Q ss_pred CCCceEEeeeccceeccC
Q 006563 610 NDMNPKISDFGMARIFGG 627 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~ 627 (640)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=202.67 Aligned_cols=148 Identities=28% Similarity=0.473 Sum_probs=128.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||+|.... ++.||+|++.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 567888899999999999998754 7789999987542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++ +|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 7877775432 34788899999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.36 Aligned_cols=152 Identities=30% Similarity=0.474 Sum_probs=128.1
Q ss_pred hccccccccccccCceeEEEEEe------cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC-C
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-D 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l------~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 542 (640)
.++|...+.||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35688889999999999999973 346789999997543 23456788999999999 689999999988764 4
Q ss_pred eeEEEEEccCCCChhHHHhhccc---------------------------------------------------------
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (640)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998864210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 566 -------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 566 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123788889999999999999999987 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-23 Score=212.96 Aligned_cols=149 Identities=30% Similarity=0.491 Sum_probs=128.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..|+.++.||.|+||.||.++... .+.||||++.-..+ .....++.|+..|.+++|||+|.+.||+......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346777899999999999998755 67899999874433 34567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||- ||-.+++.- ..+++...++..|..+.+.||+|||+.+ .||||||+.||||++.+.+|++|||-|.+..+
T Consensus 106 EYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9995 466666633 2346888999999999999999999987 99999999999999999999999999998743
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=197.83 Aligned_cols=149 Identities=32% Similarity=0.586 Sum_probs=125.3
Q ss_pred cccccccccCceeEEEEEecCCc---EEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------Cee
Q 006563 476 ASYNKLGEGGFGPVYKGTLVEGQ---EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DES 544 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~g~---~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 544 (640)
...+.||+|+||.||+|...+.. .+|+|.+... .....+.+..|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 34578999999999999876532 5899988653 234567889999999999999999999988643 246
Q ss_pred EEEEEccCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 545 MLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
++++||+++|+|..++.... ....+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=200.51 Aligned_cols=152 Identities=32% Similarity=0.558 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEec------CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.+|...+.||+|+||.||+++.. +...+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45677789999999999999753 245689999876555556789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 547 IYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
||||+++++|.+++.... ....+++..++.++.+|+.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1234899999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceeccC
Q 006563 614 PKISDFGMARIFGG 627 (640)
Q Consensus 614 ~kI~DFGla~~~~~ 627 (640)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=197.25 Aligned_cols=150 Identities=30% Similarity=0.525 Sum_probs=132.9
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.+|...+.||+|+||.||++...+ ++.|++|++... ....+++.+|++++++++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 346677899999999999998765 788999998754 344678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999886533 345899999999999999999999887 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=202.89 Aligned_cols=141 Identities=30% Similarity=0.445 Sum_probs=122.4
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+|...+ ++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999765 7889999987531 23345566778888764 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999888543 34788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=196.93 Aligned_cols=149 Identities=32% Similarity=0.541 Sum_probs=127.6
Q ss_pred ccccccccccCceeEEEEEecC----CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-----
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 543 (640)
|...+.||+|+||.||+|.+.. +..||+|++... .....+++..|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3456789999999999998753 367999998753 23345689999999999999999999999876554
Q ss_pred -eEEEEEccCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 544 -SMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 544 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
.++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred ccceecc
Q 006563 620 GMARIFG 626 (640)
Q Consensus 620 Gla~~~~ 626 (640)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05035 158 GLSKKIY 164 (273)
T ss_pred cceeecc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=233.25 Aligned_cols=143 Identities=26% Similarity=0.495 Sum_probs=123.3
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
...+...+.||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||+++|+|.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34567778999999999999987 46889999998754321 23468899999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|++|+|.+++. .++|..+.+|+.|||+||+|||..+..+|+||||||+||+++.++.+++. ||++...
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999984 27999999999999999999997766779999999999999999998886 7766543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=197.28 Aligned_cols=150 Identities=30% Similarity=0.543 Sum_probs=131.2
Q ss_pred ccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.+|...+.||+|+||.||+|.... ...+|+|.+.... ....+.|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467778899999999999998642 3379999987542 23456889999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|..++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986543 35799999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=207.46 Aligned_cols=151 Identities=29% Similarity=0.481 Sum_probs=134.0
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
....|.....||+|.|++|.++++.. +.+||||.+++.. ......+.+|+++|..+.|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45678888999999999999998765 8899999998753 33445688999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||..+|.+.+++.+..+ ........++.|+.+|++|||.++ |+|||||++||||+.++.+||+|||++-.+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999977654 333677788999999999999998 99999999999999999999999999998853
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=199.91 Aligned_cols=152 Identities=32% Similarity=0.505 Sum_probs=132.3
Q ss_pred hccccccccccccCceeEEEEEecC-----------------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVK 533 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-----------------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~ 533 (640)
.++|...+.||+|+||.||++...+ +..||+|.+.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567888999999999999987643 2458999987543 345678999999999999999999
Q ss_pred eEeEEEeCCeeEEEEEccCCCChhHHHhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCC
Q 006563 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQA--------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (640)
Q Consensus 534 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (640)
+++++......++++||+++++|..++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 1235899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeeeccceecc
Q 006563 606 VLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 606 ILl~~~~~~kI~DFGla~~~~ 626 (640)
|++++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=198.38 Aligned_cols=153 Identities=28% Similarity=0.487 Sum_probs=132.3
Q ss_pred hccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||++.... +..||+|.+.... .....++.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567788899999999999998753 3689999987543 23456788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 545 MLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
++||||+++++|..++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 234789999999999999999999887 9999999999999999999999
Q ss_pred eeccceeccC
Q 006563 618 DFGMARIFGG 627 (640)
Q Consensus 618 DFGla~~~~~ 627 (640)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=206.35 Aligned_cols=153 Identities=31% Similarity=0.484 Sum_probs=128.7
Q ss_pred hccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC-C
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-D 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 542 (640)
.++|...+.||+|+||.||+|...+ ++.||+|++.... ....+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3568888999999999999996432 4689999987542 23345688899999999 899999999988754 5
Q ss_pred eeEEEEEccCCCChhHHHhhccc---------------------------------------------------------
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (640)
..++++||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988854221
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 566 -ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 566 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
...++|..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125899999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=201.29 Aligned_cols=153 Identities=30% Similarity=0.516 Sum_probs=131.9
Q ss_pred hccccccccccccCceeEEEEEec--------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~--------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 466777889999999999999742 24479999887542 34567789999999999 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
...++||||+++|+|..++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 235788999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccC
Q 006563 609 DNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~ 627 (640)
++++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=199.53 Aligned_cols=150 Identities=34% Similarity=0.513 Sum_probs=128.7
Q ss_pred cccccccccccCceeEEEEEecC------CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+|...+.||+|+||.||+|.... ...+++|.+..... ...+.+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 35667899999999999997532 35688988875432 345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCC
Q 006563 547 IYEYMPNKSLDFFIFDQA---------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (640)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1235889999999999999999999887 9999999999
Q ss_pred EEEcCCCceEEeeeccceecc
Q 006563 606 VLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 606 ILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=199.98 Aligned_cols=150 Identities=35% Similarity=0.539 Sum_probs=129.1
Q ss_pred cccccccccccCceeEEEEEecC------CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+|...++||+|+||.||+|.... ++.||+|++...... ..+.|.+|+.++.+++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35566799999999999998643 468999999754332 34678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 547 IYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
++||+++++|..++.... ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235888999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecc
Q 006563 614 PKISDFGMARIFG 626 (640)
Q Consensus 614 ~kI~DFGla~~~~ 626 (640)
+||+|||+++.+.
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=198.85 Aligned_cols=149 Identities=26% Similarity=0.480 Sum_probs=122.2
Q ss_pred cccccccccccCceeEEEEEec--CCcEEEEEEcccCC--chhhHhHHHHHHHHhhC---CCCceeeeEeEEEe-----C
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQ-----A 541 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~--~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~ 541 (640)
+|...+.||+|+||.||+++.. .++.||+|++.... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777889999999999999863 36789999886432 22234566777776655 69999999999863 3
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...++||||++ ++|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45899999997 58988886533 234889999999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++....
T Consensus 157 ~~~~~~ 162 (290)
T cd07862 157 ARIYSF 162 (290)
T ss_pred eEeccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=202.77 Aligned_cols=141 Identities=32% Similarity=0.447 Sum_probs=122.2
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+++... ++.||+|.+.... ....+.+..|.+++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999998865 7899999987531 23345667788887754 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999888543 34788899999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=203.24 Aligned_cols=141 Identities=26% Similarity=0.360 Sum_probs=118.9
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHH-HHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEV-TLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+++... ++.+|+|++.+.. .....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999998765 6789999987431 12233444444 456788999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++... ..+.......++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999888553 23677778889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=196.31 Aligned_cols=142 Identities=26% Similarity=0.492 Sum_probs=123.2
Q ss_pred ccccccCceeEEEEEecCCc-----------EEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 479 NKLGEGGFGPVYKGTLVEGQ-----------EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~-----------~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
+.||+|+||.||+|...+.. .|++|.+...... .+.|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999986533 4778877654332 6789999999999999999999999988 778999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-------ceEEeeec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-------NPKISDFG 620 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kI~DFG 620 (640)
+||+++|+|..++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5889999999999999999999887 99999999999999887 79999999
Q ss_pred cceeccC
Q 006563 621 MARIFGG 627 (640)
Q Consensus 621 la~~~~~ 627 (640)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=196.48 Aligned_cols=143 Identities=30% Similarity=0.441 Sum_probs=124.1
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||.||++.... ++.+|+|++.... ....+.+..|++++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998754 8899999986421 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 88875433 234889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=194.39 Aligned_cols=143 Identities=31% Similarity=0.553 Sum_probs=123.4
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
.||+|+||.||+|.+. .+..||+|.+.... ....++|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 24579999987553 234567999999999999999999999885 457899999999999
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 99988643 235899999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=199.59 Aligned_cols=151 Identities=32% Similarity=0.532 Sum_probs=130.3
Q ss_pred ccccccccccccCceeEEEEEec-----------------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-----------------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-----------------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 534 (640)
++|+..+.||+|+||.||++... +...||+|.+.... ....+.|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998532 13468999987542 3445689999999999999999999
Q ss_pred EeEEEeCCeeEEEEEccCCCChhHHHhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCE
Q 006563 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQAR--------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (640)
Q Consensus 535 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (640)
++++...+..++||||+++++|..++..... ...+++.....++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134788899999999999999999987 99999999999
Q ss_pred EEcCCCceEEeeeccceecc
Q 006563 607 LLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 607 Ll~~~~~~kI~DFGla~~~~ 626 (640)
|+++++.+||+|||+++.+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEcCCCCEEeccCccccccc
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=196.67 Aligned_cols=150 Identities=30% Similarity=0.552 Sum_probs=131.3
Q ss_pred ccccccccccccCceeEEEEEecC-C---cEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g---~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.+|...+.||+|+||.||+|.... + ..||+|.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346677899999999999998754 3 36999998754 334567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|+.++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999886532 35899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=194.77 Aligned_cols=148 Identities=32% Similarity=0.569 Sum_probs=132.9
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777789999999999999874 78999999976543 56789999999999999999999999998889999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999865432 35899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=197.63 Aligned_cols=151 Identities=30% Similarity=0.542 Sum_probs=131.9
Q ss_pred ccccccccccccCceeEEEEEec------CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+++...++||+|+||.||++... ++..+++|.+........+.|.+|+++++.++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34566689999999999999642 245789999887666667789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
++||+++++|..++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 135889999999999999999999887 9999999999999999999
Q ss_pred EEeeeccceecc
Q 006563 615 KISDFGMARIFG 626 (640)
Q Consensus 615 kI~DFGla~~~~ 626 (640)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=199.80 Aligned_cols=149 Identities=25% Similarity=0.310 Sum_probs=130.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||++.... +..+++|.+.... ....+++.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 367888999999999999998764 7788998886542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|..++... ..+++.....++.|+++||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999998653 34788999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=201.94 Aligned_cols=141 Identities=33% Similarity=0.457 Sum_probs=124.1
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.||+|++.+. .....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998865 778999998753 223456677888998888 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++.+. ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9998887543 24899999999999999999999987 999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=192.66 Aligned_cols=143 Identities=33% Similarity=0.519 Sum_probs=127.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876533 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
.++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 9885432 34789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=190.90 Aligned_cols=153 Identities=29% Similarity=0.447 Sum_probs=132.2
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC----c-h---hhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS----G-Q---GMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~----~-~---~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
.-++|...+.||.|..+.|-+..++. |++.|+|++.... . + -.++-..|+.+|+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567777899999999999888765 7899999986431 1 1 133456799999998 59999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
+...++|+|.|+.|.|.++|.. ...++++...+|+.|+.+|++|||... ||||||||+|||+|++..+||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999954 345899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCc
Q 006563 621 MARIFGGDE 629 (640)
Q Consensus 621 la~~~~~~~ 629 (640)
+|..+.+.+
T Consensus 169 Fa~~l~~Ge 177 (411)
T KOG0599|consen 169 FACQLEPGE 177 (411)
T ss_pred eeeccCCch
Confidence 999986544
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=197.49 Aligned_cols=148 Identities=29% Similarity=0.443 Sum_probs=128.9
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
|...+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++.+++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 555678999999999999875 48899999986532 12334578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886533 235899999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=197.26 Aligned_cols=142 Identities=25% Similarity=0.437 Sum_probs=121.5
Q ss_pred cccccCceeEEEEEecCCc---EEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 480 KLGEGGFGPVYKGTLVEGQ---EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~---~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
+||+|+||.||++...++. .+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999765433 46677766443 3446789999999999999999999999999999999999999999
Q ss_pred hhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 556 LDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 556 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|..++.+... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999865432 234677778899999999999999887 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=207.19 Aligned_cols=147 Identities=27% Similarity=0.418 Sum_probs=126.8
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----eeE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (640)
+|+..+.||+|+||.||++... +++.||+|++... .....+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3677789999999999999874 5889999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|+||+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 5777766432 35899999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=194.14 Aligned_cols=151 Identities=33% Similarity=0.566 Sum_probs=135.1
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|+||.||++...+++.+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788888999999999999998888899999987543 34577999999999999999999999999888999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999986543 235899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=196.32 Aligned_cols=147 Identities=29% Similarity=0.473 Sum_probs=131.0
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
|+..+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+|++++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999998865 678899998766556677899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++|..++.+. ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9998887542 235899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=195.24 Aligned_cols=143 Identities=22% Similarity=0.407 Sum_probs=122.8
Q ss_pred ccccccCceeEEEEEecC-------------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 479 NKLGEGGFGPVYKGTLVE-------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-------------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
+.||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998642 2258899887654455567899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc-------eEEee
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-------PKISD 618 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kI~D 618 (640)
+||||+++++|+.++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998875432 34889999999999999999999987 999999999999987654 89999
Q ss_pred eccceecc
Q 006563 619 FGMARIFG 626 (640)
Q Consensus 619 FGla~~~~ 626 (640)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=195.04 Aligned_cols=149 Identities=30% Similarity=0.556 Sum_probs=130.0
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...++||+|+||.||+|...+...||+|++.... ...++|.+|++++++++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5678888999999999999988777789999987532 33467899999999999999999999874 456799999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+|+|.+++.+.. ...+++..+..++.++++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999986532 335789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=196.60 Aligned_cols=149 Identities=34% Similarity=0.570 Sum_probs=130.2
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|++|.||+|+.. .++.||+|++.... ....+.+.+|+.++..++|+||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667789999999999999875 48899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++ ++|..++........+++..+..++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888765444456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=196.45 Aligned_cols=152 Identities=32% Similarity=0.519 Sum_probs=131.4
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC------
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA------ 541 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------ 541 (640)
.+++.|...+.||+|+||.||+|...+ ++.||+|++... ....+++..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456778888899999999999998765 788999998654 33456788999999998 799999999998753
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...+++|||+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 35799999999999999886532 345889999999999999999999987 99999999999999999999999999
Q ss_pred ceecc
Q 006563 622 ARIFG 626 (640)
Q Consensus 622 a~~~~ 626 (640)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=196.85 Aligned_cols=150 Identities=31% Similarity=0.550 Sum_probs=129.9
Q ss_pred ccccccccccccCceeEEEEEec-----CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-----~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
..|...+.||+|+||.||++... .++.||+|.+.... ....+.+.+|++++++++|+|++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677789999999999999742 36789999987543 34456799999999999999999999999875 567
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++++|.+++.+.. ..+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999985432 35899999999999999999999987 99999999999999999999999999987
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-22 Score=205.60 Aligned_cols=160 Identities=26% Similarity=0.447 Sum_probs=139.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..|...+.||+|.||.||||.... ++.||+|++... ....++++.+|+.+++.++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 345666799999999999998765 788999999854 345677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
|.+|++...|.. ...+++....-|+++++.||.|||.+. .+|||||+.|||+..++.+|++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999988843 334577777888999999999999987 99999999999999999999999999999876665
Q ss_pred ccccceeeeC
Q 006563 631 QTNTHKVVGT 640 (640)
Q Consensus 631 ~~~~~~~~Gt 640 (640)
.. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 54 568887
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=196.35 Aligned_cols=149 Identities=26% Similarity=0.328 Sum_probs=132.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|..++.||.|.-|+||++++.+ +...|+|++.+.. .+...+...|-+||+.++||-+.+|++.+......+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456666899999999999999977 5789999998753 344567788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||++|+|..+++++. .+.++...+..++.+|+-||+|||-.+ ||.|||||+||||-++|++-++||.|+...
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999988876654 456888888889999999999999987 999999999999999999999999999876
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=196.45 Aligned_cols=149 Identities=31% Similarity=0.540 Sum_probs=128.0
Q ss_pred ccccccccccccCceeEEEEEec-CCc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||+|... +++ .||+|.+... .....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56777789999999999999854 344 4899998754 33445678999999999999999999999875 45789
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999886532 35889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=197.47 Aligned_cols=150 Identities=27% Similarity=0.442 Sum_probs=134.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++... +++.+++|.+........+.|..|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 466888889999999999999875 4789999998766556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|..++.+.. ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999885532 35899999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=199.41 Aligned_cols=152 Identities=32% Similarity=0.493 Sum_probs=132.0
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++... .+..||+|++.... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888899999999999999742 24579999987543 33456789999999999 79999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||+++|+|..++.... ...+++..+..++.+++.||+|||+.+ |+|+||||+|||++++..+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986533 234899999999999999999999987 9999999999999999999999999998
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 190 ~~~~ 193 (302)
T cd05055 190 DIMN 193 (302)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=196.79 Aligned_cols=148 Identities=32% Similarity=0.489 Sum_probs=133.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+.|...++||+|+||.||+|.... ++.+++|.+........+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 567788899999999999998865 7899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++++|..++.+.. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999988775432 34899999999999999999999887 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=200.44 Aligned_cols=149 Identities=34% Similarity=0.601 Sum_probs=128.7
Q ss_pred ccccccccccccCceeEEEEEecC-Cc--EEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~--~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
++|+..+.||+|+||.||+|...+ +. .+++|.+... .....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 567777899999999999998754 43 4688877643 234556789999999999 899999999999999999999
Q ss_pred EEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
+||+++++|..++.... ....+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986532 1235889999999999999999999887 9999999999999999999
Q ss_pred EEeeecccee
Q 006563 615 KISDFGMARI 624 (640)
Q Consensus 615 kI~DFGla~~ 624 (640)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=193.92 Aligned_cols=149 Identities=32% Similarity=0.558 Sum_probs=130.7
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777789999999999999988888999999875432 3467999999999999999999999874 456899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999986532 234799999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=194.25 Aligned_cols=151 Identities=30% Similarity=0.604 Sum_probs=132.0
Q ss_pred hccccccccccccCceeEEEEEecC-C---cEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g---~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|+..+.||+|+||.||+|.... + ..+++|.+.... ....+++..|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567777899999999999998753 3 269999987542 3345679999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|..++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999986532 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=196.24 Aligned_cols=148 Identities=30% Similarity=0.458 Sum_probs=128.9
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
|+..+.||+|+||.||++.... ++.+|+|.+.... ....+.+..|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5566789999999999998764 7899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|..++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 999999988855332 34889999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=193.73 Aligned_cols=149 Identities=35% Similarity=0.567 Sum_probs=131.7
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...++||+|+||.||++...+++.||+|.+.... ...+.+.+|+.++++++|+|++++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 35677788999999999999998889999999987543 3356789999999999999999999986 456789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999886543 345899999999999999999999887 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=198.24 Aligned_cols=150 Identities=27% Similarity=0.484 Sum_probs=134.0
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367888899999999999999864 5889999998765555567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++|..++.+ ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..+
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999998843 24788999999999999999999987 999999999999999999999999999876433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=199.42 Aligned_cols=152 Identities=31% Similarity=0.512 Sum_probs=131.6
Q ss_pred hccccccccccccCceeEEEEEecC--------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||++.... ...+|+|.+.... ....+++..|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578888999999999999997532 3469999987542 34456788999999999 799999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965421 235899999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeeccceecc
Q 006563 609 DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~ 626 (640)
++++.+||+|||+++.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=198.02 Aligned_cols=151 Identities=23% Similarity=0.394 Sum_probs=132.0
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|+..+.||+|+||.||++... .++.+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677789999999999999886 5889999988653 2334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|..++........+++..+..++.++++||.|||+.. +|+|+||||+||+++.++.+||+|||++..+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999988865433346899999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=196.00 Aligned_cols=150 Identities=28% Similarity=0.459 Sum_probs=131.4
Q ss_pred ccccccccccccCceeEEEEEecC------CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|.....||+|+||.||+++... .+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 567778899999999999998642 457999988754433 4678999999999999999999999999888999
Q ss_pred EEEEccCCCChhHHHhhcccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 546 LIYEYMPNKSLDFFIFDQARA------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
+||||+++++|.+++...... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654422 25899999999999999999999987 999999999999999999999999
Q ss_pred ccceec
Q 006563 620 GMARIF 625 (640)
Q Consensus 620 Gla~~~ 625 (640)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=194.59 Aligned_cols=148 Identities=25% Similarity=0.471 Sum_probs=132.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|...+.||+|+||.||++.... ++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 467777899999999999998754 7899999987654455567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999988543 34889999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=193.60 Aligned_cols=152 Identities=23% Similarity=0.417 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 56788889999999999999875 5889999987542 2234457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++.... ....++......++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=191.76 Aligned_cols=150 Identities=27% Similarity=0.412 Sum_probs=132.7
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|++|.||++.... ++.|++|.+... .....+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 36667899999999999998754 789999988643 334567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|..++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 99999999986542 346899999999999999999999887 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=219.15 Aligned_cols=149 Identities=26% Similarity=0.426 Sum_probs=132.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...++||+|+||.||+|... .++.||||++.... ....+.+..|+.+++.++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999986 48899999987532 233467889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++... ..+++...+.|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999988543 24788889999999999999999987 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=198.91 Aligned_cols=152 Identities=32% Similarity=0.521 Sum_probs=130.9
Q ss_pred hccccccccccccCceeEEEEEec--------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~--------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||++... ....+|+|.+.... ....+++..|++++.++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356777889999999999999742 24568999987542 34466789999999999 699999999999998
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
...++++||+++|+|..++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999965321 235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceecc
Q 006563 609 DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~ 626 (640)
++++.+||+|||+++.+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 168 TEDNVMKIADFGLARGVH 185 (314)
T ss_pred cCCCcEEEcccccccccc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=201.68 Aligned_cols=139 Identities=24% Similarity=0.349 Sum_probs=118.8
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC---CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
||+|+||.||+++... ++.||+|++.+.. ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998754 8899999986431 12233455666666655 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+|..++.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9998888543 34789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-21 Score=194.29 Aligned_cols=144 Identities=23% Similarity=0.362 Sum_probs=126.6
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|...++||+|+||.||++... .++.||+|.+... .....+++.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 4666789999999999999864 4788999998654 2334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999996542 3678888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=197.69 Aligned_cols=148 Identities=27% Similarity=0.490 Sum_probs=132.6
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..+|...+.||+|+||.||++... .++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888889999999999999864 4889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++++|..++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+.
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999998843 24789999999999999999999987 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=192.22 Aligned_cols=152 Identities=24% Similarity=0.432 Sum_probs=134.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|+..+.||+|+||.||+|... +++.|++|.++.. .....+.+.+|++++++++|+|++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999987 6889999988632 2334668999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++.+. .....+++..+..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=198.24 Aligned_cols=150 Identities=31% Similarity=0.549 Sum_probs=128.9
Q ss_pred ccccccccccccCceeEEEEEecC-Cc--EEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~--~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
++|+..+.||+|+||.||+|...+ +. .+++|.++.. .....+.|..|+++++++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467778899999999999998765 33 4788888743 334456789999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1135889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceec
Q 006563 615 KISDFGMARIF 625 (640)
Q Consensus 615 kI~DFGla~~~ 625 (640)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=196.77 Aligned_cols=152 Identities=31% Similarity=0.549 Sum_probs=132.3
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888899999999999999864 35689999987543 34456799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCC
Q 006563 545 MLIYEYMPNKSLDFFIFDQAR-------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (640)
++|+||+++|+|..++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864321 124788999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeeeccceecc
Q 006563 606 VLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 606 ILl~~~~~~kI~DFGla~~~~ 626 (640)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=207.24 Aligned_cols=145 Identities=23% Similarity=0.364 Sum_probs=125.6
Q ss_pred hccccccccccccCceeEEEEEecC---CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..+|...+.||+|+||.||++...+ ++.|++|.+... +.+.+|++++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3568888999999999999997543 567999987643 34568999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|++. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 578777732 345899999999999999999999987 999999999999999999999999999876543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=191.87 Aligned_cols=149 Identities=31% Similarity=0.546 Sum_probs=129.5
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|++|.||++....+..+++|++.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4567778999999999999998777789999886542 33467899999999999999999999875 456899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999986532 335789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=193.29 Aligned_cols=145 Identities=34% Similarity=0.561 Sum_probs=127.9
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhh--HhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
|...+.||+|+||+||++.... ++.+|+|++........ .....|+.++..++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4556899999999999999876 56899999987643322 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++++|..++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2345799999999999999999999987 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=194.47 Aligned_cols=153 Identities=30% Similarity=0.515 Sum_probs=131.5
Q ss_pred hhccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
.+++|...+.||+|+||.||+|.... +..|++|.+.... ......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678888999999999999998754 4578999886543 3344579999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC---ceEE
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKI 616 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kI 616 (640)
.++||||+++++|..++..... ...+++..++.++.||++||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 235899999999999999999999987 99999999999998654 6999
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=194.71 Aligned_cols=149 Identities=27% Similarity=0.448 Sum_probs=130.5
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|+....||+|+||.||+++... ++.||+|++.... ....+.+.+|++++++++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 357777899999999999999864 8899999886432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|++++.|..++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999888776432 34899999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=200.43 Aligned_cols=151 Identities=30% Similarity=0.503 Sum_probs=130.3
Q ss_pred ccccccccccccCceeEEEEEecC--------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
.+|...+.||+|+||.||++.... ...||+|.+.... ....+++.+|++++.++ +|+||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457778899999999999997421 2368999887532 34467899999999999 7999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
..++++||+++|+|..++.+.. ....+++..++.++.|+++||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235889999999999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceecc
Q 006563 610 NDMNPKISDFGMARIFG 626 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~ 626 (640)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (334)
T cd05100 169 EDNVMKIADFGLARDVH 185 (334)
T ss_pred CCCcEEECCcccceecc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=194.69 Aligned_cols=149 Identities=32% Similarity=0.569 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.+|...+.||+|+||.||+|...+ ++ .+|+|.+.... ....+++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456777899999999999998754 32 58999887553 3345788999999999999999999999987 78899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||+++|+|.+++.... ..+++...+.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986543 24899999999999999999999976 9999999999999999999999999998765
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=204.90 Aligned_cols=149 Identities=27% Similarity=0.532 Sum_probs=130.1
Q ss_pred ccccccccccCceeEEEEEecC---Cc--EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE---GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~---g~--~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
....+.||+|-||.||+|...+ |+ .||||..+.+ .....+.|+.|..+|++++|||||+|+|+|.+ ...+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3445789999999999998643 33 5899998864 45668889999999999999999999999976 4789999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|.++-|.|..||..++. .|+..+...++.||..||+|||+.. .|||||.++|||+.+...+|++||||+|-+..+
T Consensus 470 EL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999976544 4888888999999999999999886 999999999999999999999999999988654
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 545 ~ 545 (974)
T KOG4257|consen 545 A 545 (974)
T ss_pred c
Confidence 3
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=194.42 Aligned_cols=145 Identities=38% Similarity=0.584 Sum_probs=125.7
Q ss_pred cccccccccCceeEEEEEe-----cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEE
Q 006563 476 ASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 547 (640)
...+.||+|+||+||++.. .+++.||+|.+.... ....+.|.+|++++++++|+||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 347789999987543 23467789999999999999999999998764 357899
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999988542 4899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=207.72 Aligned_cols=154 Identities=29% Similarity=0.475 Sum_probs=128.1
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEc--cc--CCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe--eEEEEEcc
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRL--SK--GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE--SMLIYEYM 551 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l--~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey~ 551 (640)
.+||+|+|-+||||.... |.+||--.+ .+ ..+...+.|..|+++|+.|+|+|||+++..+.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 589999999999998754 667763222 21 134556899999999999999999999999987665 78999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceeccCCcc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~~~~~ 630 (640)
..|+|..|+.+.+ .++.+....+++||++||.|||.+. +||||||||..||+|+. -|.+||+|+|||.++....
T Consensus 126 TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999996543 3678888999999999999999986 78999999999999975 4899999999999985443
Q ss_pred ccccceeeeC
Q 006563 631 QTNTHKVVGT 640 (640)
Q Consensus 631 ~~~~~~~~Gt 640 (640)
.+.++||
T Consensus 201 ---aksvIGT 207 (632)
T KOG0584|consen 201 ---AKSVIGT 207 (632)
T ss_pred ---cceeccC
Confidence 2347777
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=191.42 Aligned_cols=148 Identities=31% Similarity=0.503 Sum_probs=130.4
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|++|.||++... .++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888899999999999999875 48899999876432 1234578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||+++++|.+++... ..+++.....++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999888543 34788888999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=191.10 Aligned_cols=147 Identities=37% Similarity=0.613 Sum_probs=130.9
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++++..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998865 778999998765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQAR------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|..++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999866421 256899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=190.53 Aligned_cols=151 Identities=23% Similarity=0.397 Sum_probs=132.9
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|+||.||.++... ++.+++|++... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47778899999999999988654 788999987643 344567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++|.+++.+.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999886543 345899999999999999999999887 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=208.37 Aligned_cols=149 Identities=23% Similarity=0.396 Sum_probs=121.7
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-------- 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 541 (640)
..++|...+.||+|+||.||+|...+ ++.||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 34679999999999999999998754 7899999886432 2345799999999999999999886432
Q ss_pred CeeEEEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeee
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDF 619 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DF 619 (640)
...++||||+++ +|..++... .....+++.....++.||++||+|||+.+ |+||||||+||||+.+. .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135789999985 666655432 23346889999999999999999999987 99999999999998664 7999999
Q ss_pred ccceeccC
Q 006563 620 GMARIFGG 627 (640)
Q Consensus 620 Gla~~~~~ 627 (640)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987643
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=191.93 Aligned_cols=144 Identities=34% Similarity=0.495 Sum_probs=128.2
Q ss_pred ccccccCceeEEEEEecC--C--cEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--g--~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+..|++++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998754 2 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|..++.+... ..+++.....++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999876443 46899999999999999999999987 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=195.44 Aligned_cols=150 Identities=31% Similarity=0.420 Sum_probs=132.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367778899999999999998764 7899999986432 234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++++|.+++... ..++...+..++.|+++||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999988654 35889999999999999999999987 999999999999999999999999999886443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=191.26 Aligned_cols=142 Identities=32% Similarity=0.544 Sum_probs=123.5
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
+||+|+||.||+|.+. +++.+|+|++.... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 46789999986442 234678999999999999999999999875 45678999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999998543 34889999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=196.15 Aligned_cols=148 Identities=32% Similarity=0.507 Sum_probs=129.8
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCch-----hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
+|...+.||+|+||.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3666789999999999999875 4889999998754322 234567899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+ +++|..++.... ..+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986533 35899999999999999999999987 99999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=196.36 Aligned_cols=148 Identities=28% Similarity=0.475 Sum_probs=128.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 567888899999999999998754 7889999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++ ++|..++.... ..+++.....++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58888875432 34788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=193.51 Aligned_cols=152 Identities=23% Similarity=0.419 Sum_probs=132.5
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.. .+++.++||.+... .....+++.+|+++++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577778999999999999986 46889999987643 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++.... ....+++..+..++.+|++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=191.41 Aligned_cols=150 Identities=33% Similarity=0.528 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|+||.||++...++..+++|.+... ....+.|.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3567788899999999999999877888999988753 2345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999986543 345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=202.61 Aligned_cols=142 Identities=21% Similarity=0.336 Sum_probs=124.2
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..+|...+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++.++...++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4578889999999999999998765 678999975432 235689999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+. ++|..++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 139 ~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 139 YS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred cC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 95 5787777543 235899999999999999999999987 999999999999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=207.58 Aligned_cols=149 Identities=35% Similarity=0.551 Sum_probs=131.4
Q ss_pred ccccccccCceeEEEEEecC--Cc--EEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 477 SYNKLGEGGFGPVYKGTLVE--GQ--EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~--g~--~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
..++||+|.||.|++|.+.. |+ .||||.+..... ...+.|++|+.+|.+|+|+|+++|+|+..+ ...+||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34689999999999998855 44 589999987644 368899999999999999999999999887 6789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
+.|+|.+.|++ .....+-......++.|||.||.||..+. .|||||.++|+||-..-.+||+||||.|-++..+.
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999987 33445777888899999999999999887 99999999999999999999999999999976653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=188.57 Aligned_cols=143 Identities=36% Similarity=0.551 Sum_probs=128.6
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
++||+|+||.||++...+++.|++|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 379999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
.++.... ..+++..+..++.+++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9986532 24788999999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=190.35 Aligned_cols=147 Identities=31% Similarity=0.501 Sum_probs=130.3
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC-----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
|...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 555678999999999999886 68899999886432 234567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++.+. ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998543 24789999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=191.44 Aligned_cols=143 Identities=36% Similarity=0.625 Sum_probs=123.8
Q ss_pred ccccccCceeEEEEEecC-Cc--EEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~--~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||+|...+ +. .+++|.+... .....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865 33 4788888753 234456789999999999 899999999999999999999999999
Q ss_pred CChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 554 KSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 554 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999987 9999999999999999999999999
Q ss_pred ccee
Q 006563 621 MARI 624 (640)
Q Consensus 621 la~~ 624 (640)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=192.05 Aligned_cols=147 Identities=29% Similarity=0.466 Sum_probs=127.9
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCc----------hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG----------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+.++++++|+|++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3556679999999999999865 488999998753211 12346788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++|+||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 35888999999999999999999987 999999999999999999999999999
Q ss_pred eecc
Q 006563 623 RIFG 626 (640)
Q Consensus 623 ~~~~ 626 (640)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-22 Score=191.84 Aligned_cols=152 Identities=29% Similarity=0.491 Sum_probs=124.7
Q ss_pred hccccccccccccCceeEEEEEecC-----CcEEEEEEcccCCc-hh-hHhHHHHHHHHhhCCCCceeeeEeEEEe-CCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG-QG-MEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 543 (640)
...|+....||+|.||.|||+.-.+ ..++|+|+++.... .+ -....+|+.+++.++|+||++|..++.+ ...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3457777899999999999996543 23689999875421 11 2346789999999999999999999887 677
Q ss_pred eEEEEEccCCCChhHHHhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC----CceEEe
Q 006563 544 SMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKIS 617 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kI~ 617 (640)
.+|++||.++ +|..+++. ....+.++......|+.||+.|+.|||++- |+||||||.||||..+ +.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999988 66666543 223457888999999999999999999987 9999999999999877 999999
Q ss_pred eeccceeccC
Q 006563 618 DFGMARIFGG 627 (640)
Q Consensus 618 DFGla~~~~~ 627 (640)
|||+||++..
T Consensus 179 DlGlaR~~~~ 188 (438)
T KOG0666|consen 179 DLGLARLFNN 188 (438)
T ss_pred cccHHHHhhc
Confidence 9999999854
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=192.89 Aligned_cols=148 Identities=32% Similarity=0.566 Sum_probs=130.1
Q ss_pred cccccccccccCceeEEEEEec-----CCcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESM 545 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-----~g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 545 (640)
.|...+.||+|+||.||++.+. .++.+|||.+...... ..++|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556679999999999999864 2678999998765432 46789999999999999999999999887 55789
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|||+++++|..++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999986543 24899999999999999999999987 999999999999999999999999999987
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
.
T Consensus 160 ~ 160 (284)
T cd05038 160 P 160 (284)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.87 Aligned_cols=146 Identities=21% Similarity=0.359 Sum_probs=129.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367778899999999999998765 7889999987542 234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
||+++++|..++... ..+++.....++.++++||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998553 34789999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=194.20 Aligned_cols=159 Identities=27% Similarity=0.389 Sum_probs=134.4
Q ss_pred chHhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEe-
Q 006563 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ- 540 (640)
Q Consensus 464 ~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~- 540 (640)
.+..+..+.++|+..+.||+|+||.||++.... ++.+++|.+.... ...+++.+|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345556678899999999999999999998754 7889999876532 2345688899999999 69999999999853
Q ss_pred ----CCeeEEEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 541 ----ADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 541 ----~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
++..++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 35689999999999999887542 22345888999999999999999999887 99999999999999999999
Q ss_pred Eeeeccceecc
Q 006563 616 ISDFGMARIFG 626 (640)
Q Consensus 616 I~DFGla~~~~ 626 (640)
|+|||+++.+.
T Consensus 165 l~dfg~~~~~~ 175 (286)
T cd06638 165 LVDFGVSAQLT 175 (286)
T ss_pred EccCCceeecc
Confidence 99999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=189.17 Aligned_cols=147 Identities=29% Similarity=0.507 Sum_probs=127.9
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 551 (640)
++|...+.||+|+||.||++... +..|++|.+... ...+.|.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45777789999999999999764 778999988643 235678999999999999999999998654 45689999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++.... ...+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999986543 235889999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=192.83 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=126.3
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHH-HhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||++.... ++.||+|++.... .....++..|+.+ ++.++|+||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 467788899999999999998764 8899999987542 2334456666665 566789999999999999999999999
Q ss_pred ccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|++ |+|..++.+. .....+++..+..++.||+.||+|||++. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 6888877543 22346899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=190.83 Aligned_cols=148 Identities=29% Similarity=0.465 Sum_probs=127.5
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
.+|...+.||+|+||.||++...+ ++.|++|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 467788899999999999998755 8899999875321 22356788999999999999999999988764 457
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+++|||+++++|.+++... ..+++.....++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 23788888999999999999999987 99999999999999999999999999986
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=189.52 Aligned_cols=149 Identities=26% Similarity=0.498 Sum_probs=133.9
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|...+.||+|+||.||++.... ++.+++|.+........+.+.+|++++++++|+||+++++++..+...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 567888899999999999998754 7789999987655556788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|..++... ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999988553 235889999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=194.74 Aligned_cols=148 Identities=28% Similarity=0.507 Sum_probs=133.0
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.+|...+.||.|++|.||++.. .+++.|++|.+........+.+.+|+++++.++|+|++++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688888999999999999986 458899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|..++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999998843 24799999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=195.83 Aligned_cols=149 Identities=35% Similarity=0.648 Sum_probs=126.4
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||++.... ++ .||+|.+..... ....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 456677899999999999998643 43 478898875432 3345788999999999999999999998754 5679
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999886432 24789999999999999999999987 9999999999999999999999999999765
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=188.40 Aligned_cols=142 Identities=28% Similarity=0.416 Sum_probs=127.3
Q ss_pred ccccccCceeEEEEE-ecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~-l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
+.||+|+|+.|--++ +..+.++|||++.+..........+|++++...+ |+||+.|+.++++....|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 489999999998876 5669999999999987778889999999999885 99999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC---ceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kI~DFGla~~~~ 626 (640)
..++.++ +.+++.+..++..+||.||.|||.++ |.||||||+|||-.+.. -+||+||.|+.-+.
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 8888543 45889999999999999999999998 99999999999996544 47999999997663
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=191.80 Aligned_cols=149 Identities=26% Similarity=0.443 Sum_probs=128.7
Q ss_pred ccccccccccccCceeEEEEEecCC----cEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g----~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4566778999999999999986542 468999887654 3456789999999999999999999998865 567899
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999986532 24899999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=190.76 Aligned_cols=145 Identities=32% Similarity=0.532 Sum_probs=128.5
Q ss_pred ccccccccccCceeEEEEEecCCcEEEEEEcccCC------chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56678999999999999998889999999886432 122356889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+
T Consensus 82 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 82 EFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999998543 24788999999999999999999887 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=193.23 Aligned_cols=149 Identities=30% Similarity=0.451 Sum_probs=127.8
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++++|...+.||+|+||.||+|... +++.|++|++..... .....+.+|+++++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578888899999999999999875 488999999875432 22346788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||++ ++|..++.... ..+.+..+..++.||++||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 67766664432 34778888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=189.97 Aligned_cols=143 Identities=32% Similarity=0.549 Sum_probs=122.0
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCeeEEEEEccC
Q 006563 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESMLIYEYMP 552 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 552 (640)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.++++++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 347999998643 23456788899999999999999999998864 445789999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|.+++.+.. ..+.+..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999986532 23678888999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=200.67 Aligned_cols=147 Identities=30% Similarity=0.426 Sum_probs=124.6
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 542 (640)
..++|...+.||+|+||.||++.... ++.||+|++... .....+++.+|+.+++.++|+||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999998754 889999998643 2334567889999999999999999999986543
Q ss_pred -eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 543 -ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 543 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
..++||||+++ +|...+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 45554421 3778888899999999999999987 99999999999999999999999999
Q ss_pred ceecc
Q 006563 622 ARIFG 626 (640)
Q Consensus 622 a~~~~ 626 (640)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=189.68 Aligned_cols=146 Identities=34% Similarity=0.566 Sum_probs=128.0
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCch---------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ---------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
|.....||+|++|.||+|.... ++.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5556789999999999998754 789999988643221 235688999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|+||+++++|..++... ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999998543 34788899999999999999999987 99999999999999999999999999988
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
+.
T Consensus 156 ~~ 157 (267)
T cd06628 156 LE 157 (267)
T ss_pred cc
Confidence 75
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=187.98 Aligned_cols=149 Identities=29% Similarity=0.556 Sum_probs=131.6
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.+|...+.||+|+||.||++...+++.+++|.+.... ...++|.+|++++++++|+|++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4566778999999999999988778899999987542 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|..++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999886432 34789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=194.66 Aligned_cols=149 Identities=29% Similarity=0.458 Sum_probs=130.5
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|+..+.||+|+||.||++...+ ++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 357778899999999999999865 88999999865322 235678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|..+.... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998766432 23899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.69 Aligned_cols=142 Identities=20% Similarity=0.260 Sum_probs=114.0
Q ss_pred HhhccccccccccccCceeEEEEEec--CCcEEEEEEcccC-----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~--~g~~VavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
...++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|.+++|+|++..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34577988999999999999999875 4677899987533 12235568999999999999999853322 24
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCCEEEcCCCceEEeeecc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kI~DFGl 621 (640)
..+|||||+++++|.. + .. . . ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~-~~-~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A-RP-H----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHH-h-Cc-c----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 6799999999999962 2 11 0 1 1357789999999999987 999999 99999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=199.45 Aligned_cols=150 Identities=29% Similarity=0.445 Sum_probs=127.2
Q ss_pred HhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----- 541 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----- 541 (640)
...++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578888899999999999999865 47899999987532 23345678899999999999999999987543
Q ss_pred -CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 542 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
...++++|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 6788877632 34889999999999999999999987 9999999999999999999999999
Q ss_pred cceeccC
Q 006563 621 MARIFGG 627 (640)
Q Consensus 621 la~~~~~ 627 (640)
+++.+..
T Consensus 164 ~~~~~~~ 170 (343)
T cd07878 164 LARQADD 170 (343)
T ss_pred cceecCC
Confidence 9997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=193.24 Aligned_cols=143 Identities=27% Similarity=0.476 Sum_probs=123.5
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+.||+|+||.||+|.... ...|++|.+........+++.+|+.+++.++|+|++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997643 234888887665555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc--------eEEeeeccc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PKISDFGMA 622 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kI~DFGla 622 (640)
+++|+|..++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999865432 5889999999999999999999987 999999999999987765 699999998
Q ss_pred eecc
Q 006563 623 RIFG 626 (640)
Q Consensus 623 ~~~~ 626 (640)
....
T Consensus 156 ~~~~ 159 (258)
T cd05078 156 ITVL 159 (258)
T ss_pred cccC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=192.79 Aligned_cols=147 Identities=30% Similarity=0.480 Sum_probs=128.3
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56778889999999999999876 478999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+++ +|..++.+.. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 8988876543 25789999999999999999999987 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=192.81 Aligned_cols=160 Identities=31% Similarity=0.431 Sum_probs=136.2
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
+...++..++++|...+.||+|+||.||++... +++.+|+|.+.... ...+++.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999875 47899999986532 2345678899999999 89999999999876
Q ss_pred CC-----eeEEEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 541 AD-----ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 541 ~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
.+ ..++|+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 5799999999999998885422 2345899999999999999999999887 9999999999999999999
Q ss_pred EEeeeccceecc
Q 006563 615 KISDFGMARIFG 626 (640)
Q Consensus 615 kI~DFGla~~~~ 626 (640)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=186.48 Aligned_cols=150 Identities=25% Similarity=0.409 Sum_probs=131.1
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|...+.||+|+||.||++... .++.+++|.+... .....+.+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667789999999999999875 4789999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|..++... ....++......++.+++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998887543 2335788999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=191.00 Aligned_cols=149 Identities=32% Similarity=0.554 Sum_probs=130.5
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|+..+.||+|++|.||+|+... ++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 46778899999999999999864 88999999875432 23466788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++ +|..++........+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88887765444456899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=187.27 Aligned_cols=152 Identities=28% Similarity=0.457 Sum_probs=134.4
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|+..+.||+|+||.||++... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46778889999999999999865 47889999986532 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|..++........+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999866443346899999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=192.81 Aligned_cols=147 Identities=28% Similarity=0.476 Sum_probs=129.4
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 35566789999999999998754 7789999887442 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|..++.. ..+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999988743 34789999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-22 Score=188.28 Aligned_cols=149 Identities=28% Similarity=0.452 Sum_probs=127.2
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++.|+..++||+|.|+.||+..... |+.+|+|++... ...+.+++.+|+++.+.|+|||||+|+....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567777899999999999987644 888888877532 3446788999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGla~~~ 625 (640)
|+|.+++|-.-+..+ ...++...-..++||+++|.|+|..+ |||||+||.|+||.+ .--+|++|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999996555332 45777888899999999999999998 999999999999953 345899999999998
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
+
T Consensus 164 ~ 164 (355)
T KOG0033|consen 164 N 164 (355)
T ss_pred C
Confidence 7
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=194.53 Aligned_cols=143 Identities=28% Similarity=0.460 Sum_probs=118.1
Q ss_pred ccccccCceeEEEEEec---CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 553 (640)
++||+|+||.||+|... .++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 58999999999999865 35789999987532 23457889999999999999999998865 3457899999865
Q ss_pred CChhHHHhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE----cCCCceEEeeeccce
Q 006563 554 KSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (640)
Q Consensus 554 gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kI~DFGla~ 623 (640)
+|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 7777664321 1235888999999999999999999987 9999999999999 456789999999998
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07868 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=186.80 Aligned_cols=142 Identities=37% Similarity=0.594 Sum_probs=124.0
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997533 26899999876543 34567999999999999999999999875 5568999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+|||+++++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999996543 5899999999999999999999887 99999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=195.15 Aligned_cols=144 Identities=19% Similarity=0.271 Sum_probs=124.3
Q ss_pred ccccccc--CceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 478 YNKLGEG--GFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 478 ~~~lg~G--~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.++||+| +|++||++.... ++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 789999998754 8899999987542 2334567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..+
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999998865322 24889999999999999999999987 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=187.27 Aligned_cols=148 Identities=28% Similarity=0.488 Sum_probs=133.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|+..+.||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 567888899999999999999876 78999999875422 678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|.+++... ...+++.....++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999988543 245899999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=188.12 Aligned_cols=148 Identities=30% Similarity=0.492 Sum_probs=127.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
.+|...+.||+|+||.||++.... ++.|++|++.... .+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 467888999999999999998754 8899999886431 23345688999999999999999999988753 567
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++++||+++++|..++... ..+++.....++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988543 24788999999999999999999877 99999999999999999999999999986
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=195.39 Aligned_cols=142 Identities=29% Similarity=0.482 Sum_probs=127.3
Q ss_pred cccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
...||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 357999999999999875 4789999998765555567789999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
..++.. ..+++.....++.+|+.||+|||+.+ |+||||||+||++++++.+||+|||++..+.
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 988743 24789999999999999999999987 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=214.60 Aligned_cols=158 Identities=22% Similarity=0.354 Sum_probs=130.8
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
...++|...+.||+|+||.||++.... ++.+|+|.+... .......|..|+.++++++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999998765 668899988643 233456789999999999999999999988654 468
Q ss_pred EEEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecccCCCCEEEcC---------
Q 006563 545 MLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSR----MRIIHRDLKASNVLLDN--------- 610 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlkp~NILl~~--------- 610 (640)
+|||||+++|+|..+|.... ....+++..++.|+.||+.||+|||..+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999886532 23458999999999999999999998532 34999999999999964
Q ss_pred --------CCceEEeeeccceeccC
Q 006563 611 --------DMNPKISDFGMARIFGG 627 (640)
Q Consensus 611 --------~~~~kI~DFGla~~~~~ 627 (640)
...+||+|||+++.+..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc
Confidence 34589999999987743
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=188.37 Aligned_cols=149 Identities=32% Similarity=0.522 Sum_probs=125.0
Q ss_pred ccccccccccCceeEEEEEecC----CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
|...+.||+|+||.||+|.+.. ++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 3456789999999999998642 578999998754 2345677899999999999999999999886542
Q ss_pred eeEEEEEccCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 1234788999999999999999999987 999999999999999999999999
Q ss_pred ccceecc
Q 006563 620 GMARIFG 626 (640)
Q Consensus 620 Gla~~~~ 626 (640)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-20 Score=186.39 Aligned_cols=149 Identities=40% Similarity=0.627 Sum_probs=131.0
Q ss_pred cccccccccCceeEEEEEecC-----CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 476 ASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
...+.||+|+||.||++...+ +..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 345789999999999998865 378999999765433 56789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+++++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998653321 2899999999999999999999987 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=189.96 Aligned_cols=149 Identities=30% Similarity=0.489 Sum_probs=131.8
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667789999999999999875 48899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+ +++|..++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886543 45899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=187.68 Aligned_cols=146 Identities=31% Similarity=0.556 Sum_probs=127.2
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++|+|++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577778999999999999975 67789999986432 346789999999999999999999998654 5799999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999986543 235889999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=192.63 Aligned_cols=150 Identities=25% Similarity=0.335 Sum_probs=132.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++...+ ++.+|+|.+..... ...+.+..|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 357778899999999999998865 88999999875432 24567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++++|.+++... ....+++.....++.|+++||+|||..+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988643 2345899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=187.96 Aligned_cols=148 Identities=29% Similarity=0.497 Sum_probs=131.9
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++... +++.|++|.+..... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999875 578999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++... ..+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 9999999988543 24788899999999999999999987 99999999999999999999999999988743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=188.50 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=131.8
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|...+.||.|++|.||+|.... ++.|++|.+.... ....+.+.+|++++++++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 56777899999999999998764 7899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|..++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999988543 5899999999999999999999987 99999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=198.00 Aligned_cols=148 Identities=28% Similarity=0.420 Sum_probs=125.4
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 541 (640)
..++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999998654 788999998753 233456788999999999999999999987543
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...++||||+++ +|...+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 347999999976 66665532 3788889999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=188.59 Aligned_cols=148 Identities=28% Similarity=0.502 Sum_probs=128.9
Q ss_pred cccccccccccCceeEEEEEe-cCCcEEEEEEcccCC------chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366778999999999999986 448899999986432 1135678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceec
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~ 625 (640)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999988543 34789999999999999999999987 99999999999998775 5999999999877
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-21 Score=181.20 Aligned_cols=153 Identities=27% Similarity=0.363 Sum_probs=135.1
Q ss_pred hccccccccccccCceeEEEEE-ecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----eeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~-l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (640)
.++|.+.++||+|||+.||.++ +.+++.+|+|++.-...++.++.++|++..++++|||+++++.++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678888999999999999998 4557889999998766778889999999999999999999998875433 489
Q ss_pred EEEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 546 LIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|++.|...|+|.+.+..... ...+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999988865433 447999999999999999999999986 5899999999999999999999999998876
Q ss_pred c
Q 006563 625 F 625 (640)
Q Consensus 625 ~ 625 (640)
.
T Consensus 179 a 179 (302)
T KOG2345|consen 179 A 179 (302)
T ss_pred c
Confidence 5
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=198.56 Aligned_cols=148 Identities=29% Similarity=0.429 Sum_probs=125.1
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 541 (640)
..++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999998654 789999998753 223456788999999999999999999988643
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...++||||+++ +|...+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999976 56555522 3788888999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=190.63 Aligned_cols=148 Identities=24% Similarity=0.373 Sum_probs=129.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|+..+.||+|+||+||++...+ ++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 457777899999999999998754 7889999876543 34467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+++++|..++... ..+++.....++.+++.||.|||+.. .++|+||||+||++++++.++|+|||++..+
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999887543 34889999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=189.82 Aligned_cols=149 Identities=28% Similarity=0.507 Sum_probs=121.9
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhC---CCCceeeeEeEEEeC-----C
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA-----D 542 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 542 (640)
+|...+.||+|+||.||++...+ ++.||+|.+..... .....+.+|++++..+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 36777899999999999998764 88999999875321 1223456677766655 699999999988642 3
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++||||+++ +|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47999999985 8888775433 234899999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=188.00 Aligned_cols=148 Identities=26% Similarity=0.502 Sum_probs=130.4
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 548 (640)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|+.++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4666789999999999999974 4889999998654 3345567889999999986 999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++++|..++... .+++.....++.++++||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999888432 5889999999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=193.63 Aligned_cols=143 Identities=29% Similarity=0.464 Sum_probs=127.3
Q ss_pred cccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
...||+|+||.||++... +++.|++|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999875 4889999998755445566788999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 887743 34789999999999999999999987 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-20 Score=185.20 Aligned_cols=150 Identities=24% Similarity=0.424 Sum_probs=131.2
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|+||.+|++... +++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677789999999999999875 4789999998643 233456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|..++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999998885432 234789999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=187.52 Aligned_cols=146 Identities=29% Similarity=0.484 Sum_probs=128.9
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556678999999999999864 47899999876432 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|..++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999988843 24789999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=191.73 Aligned_cols=143 Identities=29% Similarity=0.460 Sum_probs=117.9
Q ss_pred ccccccCceeEEEEEecC---CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 553 (640)
.+||+|+||.||+++..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998754 4689999987532 23467889999999999999999999864 4567999999876
Q ss_pred CChhHHHhhc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE----cCCCceEEeeeccce
Q 006563 554 KSLDFFIFDQ------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (640)
Q Consensus 554 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kI~DFGla~ 623 (640)
+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235888999999999999999999987 9999999999999 566789999999999
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-20 Score=185.59 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=134.8
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|++|.||++.... ++.|++|++..... ...+++.+|++.+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 357777899999999999999876 88999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++|..++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998654 458999999999999999999998 77 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=190.88 Aligned_cols=149 Identities=28% Similarity=0.495 Sum_probs=132.4
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888889999999999999864 5789999998755445567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|..++.+ ..+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999998853 24788999999999999999999987 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=189.22 Aligned_cols=148 Identities=24% Similarity=0.376 Sum_probs=132.0
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
+|...+.||+|+||.||++.... ++.+++|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 46777899999999999998864 8899999987532 2456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|..++... ..+++.....++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988553 35889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=192.35 Aligned_cols=148 Identities=27% Similarity=0.443 Sum_probs=125.6
Q ss_pred ccccccccccCceeEEEEEecC---CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (640)
|...+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++.+++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 6667899999999999998754 7899999987632 33346678899999999999999999999988 77999
Q ss_pred EEEccCCCChhHHHhhcc-c-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC----CCceEEeeec
Q 006563 547 IYEYMPNKSLDFFIFDQA-R-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISDFG 620 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kI~DFG 620 (640)
||||+++ +|..++.... . ...++......++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 5655553322 1 235888999999999999999999987 999999999999999 9999999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
+++.+.
T Consensus 158 ~~~~~~ 163 (316)
T cd07842 158 LARLFN 163 (316)
T ss_pred cccccC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=187.85 Aligned_cols=147 Identities=28% Similarity=0.471 Sum_probs=130.3
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 46666799999999999998754 7889999987543 345678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++++|.+++.. ..+++.....++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999988843 24788889999999999999999887 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=189.99 Aligned_cols=150 Identities=29% Similarity=0.459 Sum_probs=129.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 547 (640)
++|...+.||+|+||.||+|.... ++.+++|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 467777899999999999999864 78899999874322 2234567899999999999999999999877 789999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++ +|..++.... ..+++.....++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8888875433 35899999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=189.90 Aligned_cols=148 Identities=28% Similarity=0.377 Sum_probs=128.6
Q ss_pred cccccccccccCceeEEEEEec----CCcEEEEEEcccCC----chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCee
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 544 (640)
+|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3666789999999999999863 57899999987532 23346788999999999 599999999999988899
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|+||+++++|.+++... ..+++.....++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999988653 34788888899999999999999987 99999999999999999999999999987
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.3e-20 Score=189.50 Aligned_cols=150 Identities=27% Similarity=0.441 Sum_probs=127.0
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCe-----
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE----- 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 543 (640)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36778889999999999999875 48899999876432 223457888999999995 6999999999987665
Q ss_pred eEEEEEccCCCChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeec
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFG 620 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFG 620 (640)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78887754332 346899999999999999999999987 999999999999998 8999999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=188.73 Aligned_cols=145 Identities=39% Similarity=0.609 Sum_probs=125.2
Q ss_pred ccccccCceeEEEEEecC-------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+.||+|+||.||+|...+ ++.+++|.+.... .....++.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998653 2578999886543 24467889999999999999999999999998999999999
Q ss_pred cCCCChhHHHhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-----ceEEeeecc
Q 006563 551 MPNKSLDFFIFDQA----RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-----NPKISDFGM 621 (640)
Q Consensus 551 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kI~DFGl 621 (640)
+++++|.+++.+.. ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999877 99999999999999877 899999999
Q ss_pred ceecc
Q 006563 622 ARIFG 626 (640)
Q Consensus 622 a~~~~ 626 (640)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=189.53 Aligned_cols=150 Identities=25% Similarity=0.420 Sum_probs=130.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|+..+.||+|+||.||++...+ ++.|++|++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 357778899999999999998865 789999988753 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|++++.+..+.... ..+++..+..++.+|++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655332 34789999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=198.20 Aligned_cols=147 Identities=24% Similarity=0.384 Sum_probs=127.8
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-C-----CceeeeEeEEEeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-----RNLVKLLGCCIQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 546 (640)
+|.+.+.||+|.||.|-|+.... ++.||||++++. +.-..+...|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78888999999999999998755 889999999864 444566788999999886 4 579999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC--CceEEeeecccee
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARI 624 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kI~DFGla~~ 624 (640)
|+|.++. +|.++|....- ..++...+..|+.||+.||.+||+.+ ||||||||+||||.+- ..+||+|||.|..
T Consensus 266 VfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999865 89999976544 45889999999999999999999887 9999999999999643 4799999999987
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 54
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=189.81 Aligned_cols=148 Identities=29% Similarity=0.522 Sum_probs=128.7
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|++|.||+++.. +++.|+||++.... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4677789999999999999875 48899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++ ++|..++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 58888875533 345899999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=190.70 Aligned_cols=147 Identities=27% Similarity=0.495 Sum_probs=127.0
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++.... |+.+++|++.... ....+.+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36677899999999999998864 8899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++ +|..++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 974 777776543 234899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=202.18 Aligned_cols=153 Identities=23% Similarity=0.356 Sum_probs=121.1
Q ss_pred hhccccccccccccCceeEEEEEe-----------------cCCcEEEEEEcccCCchhhHh--------------HHHH
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTL-----------------VEGQEIAVKRLSKGSGQGMEE--------------FKNE 519 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l-----------------~~g~~VavK~l~~~~~~~~~~--------------f~~E 519 (640)
..++|...++||+|+||.||+|.+ .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235679999987543322233 3446
Q ss_pred HHHHhhCCCCce-----eeeEeEEEe--------CCeeEEEEEccCCCChhHHHhhccc---------------------
Q 006563 520 VTLIARLQHRNL-----VKLLGCCIQ--------ADESMLIYEYMPNKSLDFFIFDQAR--------------------- 565 (640)
Q Consensus 520 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 565 (640)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 678888754 3568999999999999998864210
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 566 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123577888999999999999999987 9999999999999999999999999997653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-20 Score=189.53 Aligned_cols=148 Identities=29% Similarity=0.498 Sum_probs=127.6
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..|...+.||+|+||.||+|... +++.|++|.+.... ....+++.+|+++++.++|+||++++++|..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777789999999999999875 48899999886432 233457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||++ |+|..++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 5666665432 234899999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.4e-20 Score=188.08 Aligned_cols=151 Identities=26% Similarity=0.382 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 548 (640)
++|...+.||.|++|.||++...+ ++.+|+|.+.... ....+++.+|++++++++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 357777899999999999999854 7889999987542 24567799999999999999999999998654 3689999
Q ss_pred EccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++++|.+++.... ....++......++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999998875422 2345788999999999999999999987 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=185.17 Aligned_cols=148 Identities=30% Similarity=0.494 Sum_probs=127.9
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC-----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
.+|...+.||+|+||.||++.... ++.|++|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 467888999999999999998754 889999987532 233456788999999999999999999998764 457
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++++||+++++|..++... ..+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999888543 24788889999999999999999887 99999999999999999999999999987
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=185.10 Aligned_cols=153 Identities=25% Similarity=0.454 Sum_probs=128.2
Q ss_pred cccccccccccCceeEEEEEecC--CcEEEEEEcccC----------CchhhHhHHHHHHHHhh-CCCCceeeeEeEEEe
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG----------SGQGMEEFKNEVTLIAR-LQHRNLVKLLGCCIQ 540 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~--g~~VavK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~ 540 (640)
+|+..+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36667899999999999999866 678999987532 12234567788888875 799999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
.+..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+.. .++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887542 22345889999999999999999999632 3999999999999999999999999
Q ss_pred ccceeccCC
Q 006563 620 GMARIFGGD 628 (640)
Q Consensus 620 Gla~~~~~~ 628 (640)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=198.41 Aligned_cols=144 Identities=28% Similarity=0.461 Sum_probs=126.6
Q ss_pred cccccCceeEEEEEecCC-cEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhH
Q 006563 480 KLGEGGFGPVYKGTLVEG-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g-~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 558 (640)
+||+|.||+||-|+..+. ..+|||.+.....+..+.+.+|+.+.+.++|.|||+++|.|.+++..-|.||-+++|+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999998774 4799999987767777889999999999999999999999999999999999999999999
Q ss_pred HHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEEeeeccceecc
Q 006563 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFG 626 (640)
Q Consensus 559 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~~~ 626 (640)
+|+..=..-.-.+.+.-...+||++||.|||+.. |||||||-.|||++ -.|.+||+|||-+|.+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc
Confidence 9965322111266777788899999999999987 99999999999995 57899999999999874
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=183.11 Aligned_cols=150 Identities=24% Similarity=0.375 Sum_probs=129.1
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-CeeEEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYE 549 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 549 (640)
+|...+.||+|++|.||++.... ++.+++|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 36777899999999999998754 678999998643 234456788999999999999999999987643 45789999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|.+++.... ...+++.++..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999886532 345899999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=188.01 Aligned_cols=159 Identities=30% Similarity=0.491 Sum_probs=134.9
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
.++.++..+.+.|+..+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4556666677889999999999999999998754 788999988654 23446788899999998 79999999999863
Q ss_pred ------CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 541 ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 541 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
....+++|||+++|+|..++.... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 356799999999999999886533 234788888999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecc
Q 006563 615 KISDFGMARIFG 626 (640)
Q Consensus 615 kI~DFGla~~~~ 626 (640)
||+|||+++.+.
T Consensus 161 ~l~dfg~~~~~~ 172 (282)
T cd06636 161 KLVDFGVSAQLD 172 (282)
T ss_pred EEeeCcchhhhh
Confidence 999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=187.58 Aligned_cols=151 Identities=30% Similarity=0.500 Sum_probs=135.3
Q ss_pred HhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..++.|...+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888889999999999999987 488999999876543 5677899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++++|.+++.... ..+++..+..++.++++||+|||..+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999996643 36899999999999999999999977 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=181.51 Aligned_cols=148 Identities=33% Similarity=0.516 Sum_probs=132.5
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|++|.||++.... ++.+++|.+..... ...+.+.+|++++++++|+|++++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36667899999999999998764 78999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 9999999988543 45899999999999999999999887 99999999999999999999999999998754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=190.71 Aligned_cols=153 Identities=29% Similarity=0.421 Sum_probs=126.5
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccCC-c------hhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-G------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~-~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 543 (640)
++|-.+++||+|+|+.|||+.. .+.+-||||+-..+. . .-.+...+|-++.+.|+||.||++++++.- ...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566678999999999999974 446788998754321 1 112345678899999999999999999865 466
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeec
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFG 620 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFG 620 (640)
.+-|+||+++.+|+.||... +.+++++...|+.||+.||.||.+. ++||||-||||.||||- ..+.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 89999999999999999553 4588999999999999999999987 58999999999999994 45789999999
Q ss_pred cceeccCCc
Q 006563 621 MARIFGGDE 629 (640)
Q Consensus 621 la~~~~~~~ 629 (640)
|++++..+.
T Consensus 619 LSKIMdddS 627 (775)
T KOG1151|consen 619 LSKIMDDDS 627 (775)
T ss_pred hhhhccCCc
Confidence 999997653
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=189.17 Aligned_cols=152 Identities=28% Similarity=0.500 Sum_probs=129.2
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC----
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD---- 542 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 542 (640)
...++|+..+.||+|+||.||+|.... ++.|++|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356788888999999999999999865 7899999987532 223356778999999999999999999987655
Q ss_pred ------eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 543 ------ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 543 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68999999986 666666432 235899999999999999999999987 999999999999999999999
Q ss_pred eeeccceeccC
Q 006563 617 SDFGMARIFGG 627 (640)
Q Consensus 617 ~DFGla~~~~~ 627 (640)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=186.51 Aligned_cols=142 Identities=32% Similarity=0.456 Sum_probs=124.5
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||+||++... +++.+++|.+.... ....+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 48899999986432 22345677899999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 998865433 35889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=179.86 Aligned_cols=150 Identities=32% Similarity=0.558 Sum_probs=134.3
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3566789999999999999986 578999999986654566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++|.+++.... ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999886542 45899999999999999999999977 999999999999999999999999999887544
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=185.74 Aligned_cols=140 Identities=26% Similarity=0.437 Sum_probs=125.9
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 88999999875432 4566789999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
..++.+.. .+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 99986533 5899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=182.56 Aligned_cols=150 Identities=26% Similarity=0.457 Sum_probs=130.3
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++... .++.+++|++... .....+.+.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677789999999999999875 4788999998653 234467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++.... ...+++..+..++.++++||+|||+.+ ++|+||+|+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999986533 345899999999999999999999987 9999999999999854 5689999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-20 Score=185.60 Aligned_cols=148 Identities=25% Similarity=0.365 Sum_probs=131.1
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+|...+.||+|+||.||++.... ++.+++|++.... ....+++.+|++++++++|+||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 46667899999999999998864 8899999987653 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|..++.... ..++......++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999886532 458889999999999999999998 65 9999999999999999999999999987663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=185.43 Aligned_cols=153 Identities=28% Similarity=0.467 Sum_probs=132.6
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC-----
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD----- 542 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~----- 542 (640)
.++++|...+.||+|++|.||++.... ++.+++|.+.... ...+.+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999854 7789999887543 3456799999999999 7999999999997654
Q ss_pred -eeEEEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 543 -ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 543 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3899999999999998886532 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
++..+.
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 998653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=180.71 Aligned_cols=150 Identities=30% Similarity=0.491 Sum_probs=133.6
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 548 (640)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3566789999999999999987 588999999875532 4567899999999999999999999999988 8899999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++++|.+++.... .+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 6899999999999999999999977 999999999999999999999999999987554
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=183.07 Aligned_cols=155 Identities=26% Similarity=0.475 Sum_probs=129.8
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 548 (640)
+|...+.||+|+||.||++... +++.+++|.+... .....+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3667789999999999999865 4788999988643 23445678899999999999999999998764 34579999
Q ss_pred EccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++++|..++.... ....+++.....++.++++||+|||..+ ..+++|+||+|+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2346899999999999999999999332 334999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 161 ~~~ 163 (265)
T cd08217 161 GHD 163 (265)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=191.75 Aligned_cols=149 Identities=30% Similarity=0.520 Sum_probs=127.2
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC--Cee
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 544 (640)
..++|...+.||+|+||.||+|.... ++.+++|++... .......+..|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 34678888899999999999998764 788999988642 233445678899999999 999999999998654 357
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888877432 5789999999999999999999987 99999999999999999999999999987
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-21 Score=201.29 Aligned_cols=148 Identities=28% Similarity=0.463 Sum_probs=131.9
Q ss_pred ccccccccccccCceeEEEEEecCCc-EEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~-~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+.|.++..||.|+||.||++..++.. ..|.|.|...+....+.|+-|+++|+..+||+||+|++.+...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45666778999999999999887644 45678887777788899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
.+|-.+.++..-. ..|+...+..++++++.||.|||++. |||||||+.|||++-+|.++++|||.+...
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 9999998886543 45899999999999999999999987 999999999999999999999999988654
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=185.16 Aligned_cols=148 Identities=28% Similarity=0.489 Sum_probs=128.7
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIYE 549 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 549 (640)
|...+.||+|+||.||++...+ ++.+++|++.... ....+.+.+|++++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4556789999999999998765 7899999997652 23345788999999999999999999999988 78999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+++ +|..++.... ..+++..+..++.+|++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 8887775432 35899999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=184.06 Aligned_cols=141 Identities=27% Similarity=0.376 Sum_probs=117.6
Q ss_pred cccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHH---hhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLI---ARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.||+|+||.||++...+ ++.+|+|.+.+.. ......+.+|..++ ...+|+|++++++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998754 7899999886532 12223344454433 34479999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|..++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999888543 34899999999999999999999987 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=203.17 Aligned_cols=153 Identities=24% Similarity=0.387 Sum_probs=119.0
Q ss_pred hhccccccccccccCceeEEEEEecC--CcEEEEE------------------EcccCCchhhHhHHHHHHHHhhCCCCc
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVK------------------RLSKGSGQGMEEFKNEVTLIARLQHRN 530 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~--g~~VavK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~n 530 (640)
..++|...+.||+|+||+||++.+.. +...++| .+. ........+.+|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987643 1111111 111 11223456889999999999999
Q ss_pred eeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 531 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
|+++++++...+..++|+|++.. +|..++..... ...........|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 66666543221 112334566789999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCC
Q 006563 609 DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~ 628 (640)
+.++.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=184.80 Aligned_cols=146 Identities=27% Similarity=0.464 Sum_probs=129.0
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 334469999999999999864 5789999998755445566788999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|.+++.. ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.+||+|||++..+..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999998855 24788999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=186.53 Aligned_cols=146 Identities=30% Similarity=0.530 Sum_probs=126.1
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
|...+.||+|+||.||++... +++.||+|++.... ....+.+..|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999875 47899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++....
T Consensus 107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 974 776666433 234899999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=182.14 Aligned_cols=141 Identities=28% Similarity=0.370 Sum_probs=125.9
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||.||+++... ++.+++|.+.... ....+.+.+|++++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999865 8899999987532 23456799999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9998553 24788999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=176.81 Aligned_cols=141 Identities=17% Similarity=0.148 Sum_probs=108.4
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCch--h-------hHhH-----------------HHHHHHHhhCCCCcee
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--G-------MEEF-----------------KNEVTLIARLQHRNLV 532 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~niv 532 (640)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999888999999998754211 1 1122 3489999999877764
Q ss_pred eeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCCEEEcCC
Q 006563 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 533 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILl~~~ 611 (640)
....+. ....+|||||++++++...... ...++......++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~- 153 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD- 153 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-
Confidence 433221 2234899999999877544322 23478889999999999999999 5766 999999999999984
Q ss_pred CceEEeeeccceeccCC
Q 006563 612 MNPKISDFGMARIFGGD 628 (640)
Q Consensus 612 ~~~kI~DFGla~~~~~~ 628 (640)
+.++|+|||+|.....+
T Consensus 154 ~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CcEEEEEccccccCCCc
Confidence 78999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=184.39 Aligned_cols=149 Identities=30% Similarity=0.486 Sum_probs=125.8
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46778889999999999999876 48899999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~ 626 (640)
|++ ++|..++.... ...+++.....++.||+.||+|||+.+ ++|+||+|+||++++ +..+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 47777764432 223678888899999999999999987 999999999999985 5679999999998754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=189.96 Aligned_cols=156 Identities=29% Similarity=0.419 Sum_probs=136.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.+.|..-++||+|+||.||-+.... |+-+|.|++.+. .+++..-.++|-.+|.+++.+.||.|-..+..++.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567777899999999999998765 888888888654 234455678899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+..|.+|+|..+|..... ..+++......+.+|+.||++||... ||.|||||+|||||+.++++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998876544 45899999999999999999999887 99999999999999999999999999999876
Q ss_pred Cccc
Q 006563 628 DEIQ 631 (640)
Q Consensus 628 ~~~~ 631 (640)
.+..
T Consensus 340 g~~~ 343 (591)
T KOG0986|consen 340 GKPI 343 (591)
T ss_pred CCcc
Confidence 6643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=182.72 Aligned_cols=150 Identities=25% Similarity=0.445 Sum_probs=130.3
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++.... +..+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46677899999999999998865 788999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~~ 627 (640)
+++++|..++.+.. ...+++..+..++.++++||+|||+.+ ++|+||||+||+++++. .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999886533 235799999999999999999999987 99999999999998875 579999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=185.52 Aligned_cols=142 Identities=28% Similarity=0.447 Sum_probs=126.9
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
.+||+|+||.||++... +++.||+|++........+.+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999875 58899999987554455677899999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 87743 24789999999999999999999987 99999999999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=184.41 Aligned_cols=147 Identities=31% Similarity=0.521 Sum_probs=127.8
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455678999999999999875 58899999987542 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+ ++|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 689888855432 35899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=186.45 Aligned_cols=150 Identities=33% Similarity=0.515 Sum_probs=127.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (640)
.++|...+.||+|+||.||+|.... ++.||+|.+..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4678888999999999999998754 88999999864322 2233567899999999999999999998765 45899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++ +|..++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 7877775432 45899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=189.80 Aligned_cols=151 Identities=26% Similarity=0.442 Sum_probs=128.2
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC---
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--- 542 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--- 542 (640)
....++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999864 5889999998643 2233456889999999999999999999987543
Q ss_pred ---eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 543 ---ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 543 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 6788877743 34889999999999999999999987 999999999999999999999999
Q ss_pred ccceeccC
Q 006563 620 GMARIFGG 627 (640)
Q Consensus 620 Gla~~~~~ 627 (640)
|+++....
T Consensus 163 g~~~~~~~ 170 (343)
T cd07880 163 GLARQTDS 170 (343)
T ss_pred cccccccc
Confidence 99987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=186.17 Aligned_cols=150 Identities=26% Similarity=0.493 Sum_probs=126.1
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe----
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 543 (640)
..++|...+.||+|+||.||++.... ++.||||++.... ......+.+|++++++++||||++++++|...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34578888999999999999998754 8899999886432 2223456789999999999999999999876543
Q ss_pred ----eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 544 ----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 544 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
.++||||+.+ +|..++... ...+++.....++.||++||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4999999975 777777443 235899999999999999999999987 999999999999999999999999
Q ss_pred ccceecc
Q 006563 620 GMARIFG 626 (640)
Q Consensus 620 Gla~~~~ 626 (640)
|++..+.
T Consensus 164 g~~~~~~ 170 (310)
T cd07865 164 GLARAFS 170 (310)
T ss_pred CCccccc
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=209.18 Aligned_cols=168 Identities=24% Similarity=0.277 Sum_probs=142.0
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEccc---CCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
.++.-..++|.++++||+|+||.|...++.. ++.+|.|++.+ .......-|.+|-.+|..-+.+-|+.++..+.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4445556889999999999999999999876 67889999986 2234456789999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
.++|||||||+||+|-.++.+.. .++..-...++..|.-||.-||+-+ +|||||||.|||||..|++|++|||-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999996543 3666666677889999999999877 99999999999999999999999999
Q ss_pred ceeccCCccccccceeeeC
Q 006563 622 ARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 622 a~~~~~~~~~~~~~~~~Gt 640 (640)
+-.+..+..-. ....|||
T Consensus 222 Clkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 222 CLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred HHhcCCCCcEE-eccccCC
Confidence 98887665432 3456777
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-19 Score=182.21 Aligned_cols=141 Identities=28% Similarity=0.368 Sum_probs=118.1
Q ss_pred cccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHH---HHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVT---LIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.||+|+||.||++.... ++.||+|.+.+... .....+..|.. .++...|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 78999999875321 22223444444 3444579999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999888543 35899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=169.53 Aligned_cols=156 Identities=26% Similarity=0.411 Sum_probs=130.1
Q ss_pred HHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCee
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 544 (640)
++...++......||+|++|.|-+-++.. |+.+|+|++... ..+..++.+.|+.+..+. ..|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34444555566789999999998887754 889999999754 456667888899876554 799999999999999999
Q ss_pred EEEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 545 MLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
++.||.|+- ||+.+..+- .....+++...-+||..|.+||.|||++ ..+||||+||+|||++.++.+||+|||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999965 787776442 3345688888999999999999999995 579999999999999999999999999998
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
.+.
T Consensus 198 ~L~ 200 (282)
T KOG0984|consen 198 YLV 200 (282)
T ss_pred eeh
Confidence 874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=185.05 Aligned_cols=149 Identities=34% Similarity=0.486 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||.||++... +++.|++|.+... .....+.+..|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36777889999999999999876 4889999998652 2233567889999999998 99999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999986532 5899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-19 Score=177.66 Aligned_cols=152 Identities=23% Similarity=0.414 Sum_probs=134.0
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++.... ++.+++|++..... ...+++.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 46677899999999999999864 78999999875432 4567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++|..++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999886542 1356899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=181.63 Aligned_cols=145 Identities=25% Similarity=0.363 Sum_probs=122.2
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCC-CCceeeeEeEEEeC--CeeEEEEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLIYE 549 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 549 (640)
|...+.||+|+||.||++... +++.+|+|++.... .........|+.++.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 455678999999999999865 48899999987542 222234457888898885 99999999999987 78999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|++ ++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 997 57777775432 35899999999999999999999987 999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=194.56 Aligned_cols=171 Identities=29% Similarity=0.484 Sum_probs=144.0
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
+++..+...++.|.+.+.||+|.+|.||+++..+ ++.+|+|++.... ...+++..|.++++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4556666678889999999999999999998755 8889999887653 3446778888898888 69999999999875
Q ss_pred -----CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 541 -----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 541 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
++.++||||||.+||..+++.... ...+.|..+..|++.++.||.+||... ++|||||=.||||+.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 456899999999999999987665 556999999999999999999999886 99999999999999999999
Q ss_pred EeeeccceeccCCccccccceeeeC
Q 006563 616 ISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 616 I~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+.|||++..+.....+ .++.+||
T Consensus 164 LvDFGvSaQldsT~gr--RnT~iGt 186 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR--RNTFIGT 186 (953)
T ss_pred Eeeeeeeeeeeccccc--ccCcCCC
Confidence 9999999998544333 3345665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=170.98 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=111.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCch--h------------------------hHhHHHHHHHHhhCCCCcee
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--G------------------------MEEFKNEVTLIARLQHRNLV 532 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~--~------------------------~~~f~~E~~~l~~l~H~niv 532 (640)
..||+|+||.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 589999999999999888999999998754211 0 11235788999999999875
Q ss_pred eeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCC
Q 006563 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 533 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~ 611 (640)
....+... ..+|||||++++++....... ..++......++.+++.+|.+||+ .+ |+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 54444332 348999999988654332221 236778888999999999999999 77 99999999999999 7
Q ss_pred CceEEeeeccceeccCC
Q 006563 612 MNPKISDFGMARIFGGD 628 (640)
Q Consensus 612 ~~~kI~DFGla~~~~~~ 628 (640)
+.++|+|||+|+.+..+
T Consensus 154 ~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 154 GKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCEEEEEcccceecCCC
Confidence 89999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=188.51 Aligned_cols=148 Identities=30% Similarity=0.441 Sum_probs=126.1
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 541 (640)
..++|...+.||+|+||.||++... +++.||+|++... .....+++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578988899999999999999875 4889999998643 233456778899999999999999999988643
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...++||||+.+ +|...+.. .++...+..++.|++.||+|||..+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999965 77776632 2788889999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-20 Score=206.29 Aligned_cols=152 Identities=31% Similarity=0.492 Sum_probs=123.0
Q ss_pred HHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC----
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA---- 541 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---- 541 (640)
..+...+|.++..||+||||.|||++.+ ||+.+|||+|... +......+.+|+.++++|+|||||+++..+.+.
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3456788999999999999999999864 6999999999755 334456788999999999999999887422100
Q ss_pred --------------------------------------------------------------------------------
Q 006563 542 -------------------------------------------------------------------------------- 541 (640)
Q Consensus 542 -------------------------------------------------------------------------------- 541 (640)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHH
Q 006563 542 -----------------------------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586 (640)
Q Consensus 542 -----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~ 586 (640)
.-+||=||||+...|..++.++.... .-....+++.+|++||+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 11367788888877777775543321 34566789999999999
Q ss_pred HHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 587 yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|+|+.+ ||||||||.||+||++..+||.|||||..
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 999988 99999999999999999999999999998
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=188.45 Aligned_cols=148 Identities=28% Similarity=0.471 Sum_probs=126.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----ee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 544 (640)
.++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467888899999999999999865 48899999986432 234567889999999999999999999876543 57
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|+||+++ +|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 77666632 34889999999999999999999987 99999999999999999999999999987
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=196.88 Aligned_cols=152 Identities=20% Similarity=0.277 Sum_probs=121.0
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCC------CceeeeEeEE
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH------RNLVKLLGCC 538 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~ 538 (640)
+++...+++|...++||+|+||+||++.... ++.||||++.... ...+++..|++++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3344557889999999999999999998755 7789999986532 233456667777776654 4588999988
Q ss_pred EeC-CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCC----
Q 006563 539 IQA-DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM---- 612 (640)
Q Consensus 539 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~---- 612 (640)
... ...++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4688999988 66787777543 3488999999999999999999974 5 99999999999998765
Q ss_pred ------------ceEEeeeccceec
Q 006563 613 ------------NPKISDFGMARIF 625 (640)
Q Consensus 613 ------------~~kI~DFGla~~~ 625 (640)
.+||+|||++...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-19 Score=178.78 Aligned_cols=142 Identities=27% Similarity=0.357 Sum_probs=119.9
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHH-hhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
+.||+|+||.||++.... ++.||+|.+.+.. ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 479999999999998754 8899999987542 12233445555544 455899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999988543 34788899999999999999999987 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=203.18 Aligned_cols=154 Identities=32% Similarity=0.467 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEecC--------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++....+.||+|.||.|++|.+.. ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|.++
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3444444689999999999997542 3479999998653 35677899999999998 699999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhcc---------c--c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQA---------R--A--TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
+..++|+||+++|+|..+|++.+ . . ..+...+.+.++.|||.||+||++.. +|||||.+||||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999998765 0 1 23889999999999999999999886 9999999999999
Q ss_pred cCCCceEEeeeccceeccCC
Q 006563 609 DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~ 628 (640)
.++..+||+||||||....+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred cCCCEEEEccccceeccCCC
Confidence 99999999999999976443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=187.51 Aligned_cols=154 Identities=29% Similarity=0.436 Sum_probs=130.0
Q ss_pred hHhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 465 ~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
..++...+++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4556677899999999999999999999864 58899999987532 22346788999999999999999999988643
Q ss_pred ------CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 542 ------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 542 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
...++++|++ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367888876 7788877743 24889999999999999999999987 99999999999999999999
Q ss_pred Eeeeccceecc
Q 006563 616 ISDFGMARIFG 626 (640)
Q Consensus 616 I~DFGla~~~~ 626 (640)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=189.34 Aligned_cols=149 Identities=23% Similarity=0.447 Sum_probs=127.5
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 544 (640)
.++|+..+.||+|+||.||++.... ++.|++|++.... ....+.+.+|+.++.+++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888899999999999998754 8899999987542 2345677889999999999999999998753 3467
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|+||+. ++|..++... ..+++.....++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 5888887432 34899999999999999999999987 99999999999999999999999999987
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=183.22 Aligned_cols=147 Identities=26% Similarity=0.367 Sum_probs=127.0
Q ss_pred ccccccccccCceeEEEEEec----CCcEEEEEEcccCC----chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeE
Q 006563 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (640)
|...+.||+|++|.||++... +++.||||.+.+.. ....+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 566789999999999998753 46789999886431 22345688999999999 5999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++++|..++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+
T Consensus 82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999888543 34788999999999999999999887 999999999999999999999999999876
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 156 ~~ 157 (288)
T cd05583 156 LA 157 (288)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=185.70 Aligned_cols=152 Identities=27% Similarity=0.341 Sum_probs=131.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.+-|...+.||+|.|+.|-++++. .|..||||++.+.. .-....+..|++.|+.++|||||+|+.+...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 355666679999999999999875 48999999998652 334556889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE-cCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kI~DFGla~~~~~ 627 (640)
|.=.+|+|.+|+.+... .+.+....+++.||+.|+.|+|+.+ +|||||||+||.+ .+-+.+|+.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976544 3788888899999999999999887 9999999999887 5568899999999977754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 172 G 172 (864)
T KOG4717|consen 172 G 172 (864)
T ss_pred c
Confidence 3
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-18 Score=176.81 Aligned_cols=150 Identities=22% Similarity=0.298 Sum_probs=121.8
Q ss_pred HHHhhccccccccc--cccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 468 IAKATDNFASYNKL--GEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 468 l~~~~~~f~~~~~l--g~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.....++|...+.+ |+|+||.||++.... ++.+++|.+........ |+.....+ +|+|++++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445666666666 999999999998754 77889998764321111 22222222 79999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccc
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMA 622 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla 622 (640)
.++||||+++++|..++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999985532 6899999999999999999999987 99999999999999988 9999999999
Q ss_pred eeccCC
Q 006563 623 RIFGGD 628 (640)
Q Consensus 623 ~~~~~~ 628 (640)
+.+...
T Consensus 158 ~~~~~~ 163 (267)
T PHA03390 158 KIIGTP 163 (267)
T ss_pred eecCCC
Confidence 876543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=178.87 Aligned_cols=152 Identities=29% Similarity=0.497 Sum_probs=132.2
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|+..+.||+|+||.||++... +++.+++|.+.... .....++.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4667789999999999999765 47889999987532 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++|..++.+... ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999998865322 346899999999999999999999887 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=182.69 Aligned_cols=149 Identities=24% Similarity=0.408 Sum_probs=125.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||++.... ++.||||++.... .....++..|++++.+.. |+||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567777899999999999999876 8899999987542 234456777888777775 9999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+++ +|..++.... ..+++..+..++.++++||+|||+.. +|+||||+|+||++++++.+||+|||++..+.
T Consensus 95 ~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 95 LMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9854 6776664422 36899999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=181.63 Aligned_cols=148 Identities=30% Similarity=0.444 Sum_probs=127.1
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEcc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
|...+.||+|++|.||+|...+ ++.|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4556789999999999999865 78899999875422 22234567899999999 999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+|+|..++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889988875543 235899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-20 Score=178.44 Aligned_cols=158 Identities=27% Similarity=0.383 Sum_probs=127.5
Q ss_pred cccccchHhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-hhhHhHHHHHHHHhhC-CCCceeeeE
Q 006563 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLL 535 (640)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~ 535 (640)
.+..|+...|+. +..||.|+||+|+|-.++. |+.+|||++..... ...++++.|.+...+- +.||||+++
T Consensus 57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344555544443 3589999999999998866 89999999986543 5567888998876555 689999999
Q ss_pred eEEEeCCeeEEEEEccCCCChhHHHhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 536 GCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 536 g~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
|.+..++..++.||.|.- ||+++... ......+++...-.|......||.||-++- .|||||+||+|||||..+.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCC
Confidence 999999999999999965 77665432 112334778877888888999999998754 6999999999999999999
Q ss_pred eEEeeeccceecc
Q 006563 614 PKISDFGMARIFG 626 (640)
Q Consensus 614 ~kI~DFGla~~~~ 626 (640)
+|++|||++..+.
T Consensus 207 vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 207 VKLCDFGICGQLV 219 (361)
T ss_pred EeeecccchHhHH
Confidence 9999999998774
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=182.53 Aligned_cols=149 Identities=30% Similarity=0.509 Sum_probs=127.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+.|+..+.||+|+||.||+|.... ++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 346667899999999999999754 788999988642 2233457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+. |+|..++.... ..+++..+..++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 57777664332 34789999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=185.31 Aligned_cols=147 Identities=25% Similarity=0.382 Sum_probs=125.1
Q ss_pred ccccc-cccccccCceeEEEEEec-CCcEEEEEEcccCCchh--------------hHhHHHHHHHHhhCCCCceeeeEe
Q 006563 473 DNFAS-YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG--------------MEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 473 ~~f~~-~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
++|.. .+.||+|+||.||++... .++.||||.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 357999999999999865 48899999886432211 124778999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
++..++..++||||++ |+|.+++... ..+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5888887542 34788999999999999999999987 999999999999999999999
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=180.79 Aligned_cols=145 Identities=30% Similarity=0.513 Sum_probs=124.6
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
|...+.||+|+||.||+|+... ++.|++|++.... ....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5555789999999999998754 7889999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+. ++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 5776666443 235899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=181.00 Aligned_cols=150 Identities=27% Similarity=0.407 Sum_probs=123.5
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+|...+.||+|+||.||++.... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 44455789999999999998754 7899999987542 234567889999999996 99999999999998899999999
Q ss_pred cCCCChhHHHhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+.. ++..+... ......+++.....++.++++||+|||+.. .++||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 874 55443321 112245899999999999999999999752 39999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-19 Score=184.43 Aligned_cols=150 Identities=29% Similarity=0.473 Sum_probs=127.7
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCee
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 544 (640)
...+++|+..+.||+|+||.||++... +++.||+|++.+. .....+.+..|++++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 5889999987643 22345678899999999999999999999876 4578
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++++||+ +++|..++.. ..+++.....++.|+++||+|||+.+ |+||||+|+|||+++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 4588877743 24678888899999999999999987 99999999999999999999999999986
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=186.61 Aligned_cols=149 Identities=26% Similarity=0.478 Sum_probs=127.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Ce
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 543 (640)
.++|...+.||+|+||.||++.... ++.||||.+... .....+.+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578888999999999999998754 889999998753 233345678899999999999999999988654 34
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++|+||+. ++|..++... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6888777442 35899999999999999999999987 9999999999999999999999999998
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=183.05 Aligned_cols=141 Identities=20% Similarity=0.230 Sum_probs=120.5
Q ss_pred cccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
.+|.|+++.||++.. +++.||+|++... .....+.+..|+++++.++|+||+++++++.+.+..+++|||+++++|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555556666554 5889999998754 3445678999999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
.++..... ..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+
T Consensus 88 ~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 88 DLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred HHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence 99865422 34788889999999999999999987 999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-20 Score=178.86 Aligned_cols=148 Identities=27% Similarity=0.344 Sum_probs=127.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCch---hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ---GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|..+++||+|.||+|.+++-+. ++.+|+|++++...- ....-+.|-++|...+||.+..|-..+...+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678888999999999999997654 888999999876333 333456788999999999999999889999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||..+|.|..+|.+. ..+++.........|..||.|||+.+ ||.||||.+|.|||.++++||+||||++.-
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999998888543 34666666677889999999999987 999999999999999999999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-19 Score=184.12 Aligned_cols=142 Identities=23% Similarity=0.291 Sum_probs=122.6
Q ss_pred cccccc--CceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G--~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
..||+| +|++||++... .++.||+|++.... ....+.+.+|+.+++.++|+||+++++++..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 89999999875 58999999987432 23456788999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|.+++..... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999998865432 34888999999999999999999887 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=179.62 Aligned_cols=148 Identities=30% Similarity=0.490 Sum_probs=128.5
Q ss_pred ccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
|...+.||+|++|.||++... +++.+++|++..... ...+.+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999875 488899999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++ +|..++.... ..+++..+..++.++++||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 8877775532 35899999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.6e-19 Score=185.06 Aligned_cols=146 Identities=31% Similarity=0.484 Sum_probs=123.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378888899999999999999865 58899999986532 223456889999999999999999999987543
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 665554 224788999999999999999999987 999999999999999999999999999
Q ss_pred eecc
Q 006563 623 RIFG 626 (640)
Q Consensus 623 ~~~~ 626 (640)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-18 Score=177.17 Aligned_cols=148 Identities=30% Similarity=0.524 Sum_probs=123.9
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhC---CCCceeeeEeEEEeCCe-----
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADE----- 543 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 543 (640)
|+..+.||+|+||.||+++... ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4566799999999999999875 88999999874322 2234566787776655 69999999999988776
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.+++|||+++ +|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 78887755332 35899999999999999999999987 9999999999999999999999999998
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 156 ~~~~ 159 (287)
T cd07838 156 IYSF 159 (287)
T ss_pred eccC
Confidence 8743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-20 Score=207.22 Aligned_cols=165 Identities=27% Similarity=0.425 Sum_probs=136.2
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..+-++...+.||.|.||.||.+...+ |+..|+|.+.-. .....+...+|+.++..|+|||+|+.+|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344566777899999999999998655 888899987643 23456678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
.||||++|+|.+.+.+. ..+++.....+-.|++.|++|||+++ ||||||||.||+|+.++.+|.+|||-|+.+.
T Consensus 1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999998553 23566666677889999999999998 9999999999999999999999999999886
Q ss_pred CCc--cccccceeeeC
Q 006563 627 GDE--IQTNTHKVVGT 640 (640)
Q Consensus 627 ~~~--~~~~~~~~~Gt 640 (640)
... .......+.||
T Consensus 1386 ~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGT 1401 (1509)
T ss_pred CchhcCCHHHHhhcCC
Confidence 542 12233445555
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=185.53 Aligned_cols=148 Identities=29% Similarity=0.461 Sum_probs=129.0
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-----eeE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (640)
+|...+.||+|+||.||++.... ++.+++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46677899999999999999765 8899999987643 344567899999999999999999999988775 789
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++ +|..++.+. ..+++..+..++.++++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 787777443 26899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.8e-19 Score=186.28 Aligned_cols=156 Identities=23% Similarity=0.409 Sum_probs=131.7
Q ss_pred chHhHHHh---hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEe
Q 006563 464 DFASIAKA---TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 464 ~~~~l~~~---~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
.|..|+++ ..-|..++.||-|+||.|.++.-.| ...+|.|.|.+.+ ++.....++|..||+..+.+-||+|+.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 44455554 3457778899999999999998666 4567999887652 345566789999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
-+.+++.+|+||||+++|++..+|.+.. .+.+.....++.+++.|+++.|.-+ +|||||||.|||||.++++||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence 9999999999999999999999996643 3666666677779999999999876 999999999999999999999
Q ss_pred eeeccceec
Q 006563 617 SDFGMARIF 625 (640)
Q Consensus 617 ~DFGla~~~ 625 (640)
+||||+.-+
T Consensus 771 TDFGLCTGf 779 (1034)
T KOG0608|consen 771 TDFGLCTGF 779 (1034)
T ss_pred eeccccccc
Confidence 999999765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=182.53 Aligned_cols=146 Identities=28% Similarity=0.414 Sum_probs=121.9
Q ss_pred cccccccccccCceeEEEEEecC---CcEEEEEEcccCC--chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC----Ce
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS--GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA----DE 543 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 543 (640)
+|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 36667899999999999998753 6789999987432 22345688899999999 599999999986543 34
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++++||+. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688889886 588888743 235889999999999999999999987 9999999999999999999999999998
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-19 Score=179.23 Aligned_cols=147 Identities=33% Similarity=0.521 Sum_probs=128.8
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
|+..+.||+|++|.||+|+..+ ++.+++|.+.... ....+.+..|++++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 3455789999999999999865 8899999987643 333467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+ ++|.+++.... ..+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58998886542 35899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-21 Score=179.30 Aligned_cols=149 Identities=28% Similarity=0.572 Sum_probs=121.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEccc-CCchh-hHhHHHHHHHHhhCCCCceeeeEeEEEeC--------
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK-GSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQA-------- 541 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~-~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 541 (640)
+.|....+||+|.||.||+++..+ ++.||+|++-- +.+.+ -...++|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345555799999999999998766 67788887542 22221 23457899999999999999999988543
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...+||++++++ +|.-+|.... ..++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 237999999988 7777774432 34788899999999999999999876 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
||.+..
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 988743
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=180.99 Aligned_cols=149 Identities=30% Similarity=0.507 Sum_probs=125.2
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
.++|...+.||+|+||.||++.... ++.+++|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4788888999999999999998754 78999998864322 22346788999999999999999999875543
Q ss_pred --eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 543 --ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 543 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
..++|+||+.. +|...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 36999999975 566665432 235899999999999999999999987 9999999999999999999999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
+++...
T Consensus 161 ~~~~~~ 166 (311)
T cd07866 161 LARPYD 166 (311)
T ss_pred cchhcc
Confidence 998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=173.60 Aligned_cols=141 Identities=30% Similarity=0.428 Sum_probs=125.9
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
||+|+||.||++.... ++.+++|.+..... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999998764 88999999875422 2456889999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
.+++.... .+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99885432 4899999999999999999999977 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.3e-19 Score=184.67 Aligned_cols=151 Identities=28% Similarity=0.375 Sum_probs=127.6
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--------hhhHhHHHHHHHHhhCC---CCceeeeEeEEEe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQ 540 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--------~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~ 540 (640)
.+|..+..+|+|+||.|..+.++. ..+|+||.+.+... ...-....|+.+|+.++ |+||+|++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888999999999999999876 56899999876421 11223567999999997 9999999999999
Q ss_pred CCeeEEEEEccC-CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 541 ADESMLIYEYMP-NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 541 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
.+..||+||-.. +-+|.+++... ..+++.+..-|+.||+.|+++||+++ |||||||-+|+.++.++.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 45677777432 34889999999999999999999998 999999999999999999999999
Q ss_pred ccceeccCCc
Q 006563 620 GMARIFGGDE 629 (640)
Q Consensus 620 Gla~~~~~~~ 629 (640)
|-|.......
T Consensus 715 gsaa~~ksgp 724 (772)
T KOG1152|consen 715 GSAAYTKSGP 724 (772)
T ss_pred cchhhhcCCC
Confidence 9998876544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=183.55 Aligned_cols=146 Identities=29% Similarity=0.487 Sum_probs=124.9
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC----------
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA---------- 541 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------- 541 (640)
.+|...+.||+|+||.||+|.... ++.|++|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 678888999999999999998754 889999998765555667889999999999999999999876543
Q ss_pred ----CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEE
Q 006563 542 ----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKI 616 (640)
Q Consensus 542 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI 616 (640)
...++|+||++ ++|..++.+ ..+++.....++.||++||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588777743 24788999999999999999999987 99999999999997 4567899
Q ss_pred eeeccceecc
Q 006563 617 SDFGMARIFG 626 (640)
Q Consensus 617 ~DFGla~~~~ 626 (640)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=176.12 Aligned_cols=150 Identities=29% Similarity=0.437 Sum_probs=123.5
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccC-----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
+|...+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36667899999999999998754 344555554421 122334577899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++ ..+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 22346899999999999999999999987 999999999999976 469999999998764
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=175.63 Aligned_cols=147 Identities=19% Similarity=0.269 Sum_probs=109.0
Q ss_pred ccccccccccccCceeEEEEEecCC----cEEEEEEcccCCchhh-----------HhHHHHHHHHhhCCCCceeeeEeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQGM-----------EEFKNEVTLIARLQHRNLVKLLGC 537 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g----~~VavK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g~ 537 (640)
+.|...++||+|+||.||+|...+. ..+++|.......... .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788889999999999999987654 3456664332211110 112233345567789999999998
Q ss_pred EEeCC----eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 538 CIQAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 538 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
+.... ..++++|++.. ++...+... ...++..+..|+.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 76543 34677787644 555555332 22567888899999999999999987 999999999999999999
Q ss_pred eEEeeeccceecc
Q 006563 614 PKISDFGMARIFG 626 (640)
Q Consensus 614 ~kI~DFGla~~~~ 626 (640)
+||+|||+|+.+.
T Consensus 165 ~~l~DFGla~~~~ 177 (294)
T PHA02882 165 GYIIDYGIASHFI 177 (294)
T ss_pred EEEEEcCCceeec
Confidence 9999999998774
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=183.16 Aligned_cols=149 Identities=30% Similarity=0.482 Sum_probs=127.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe----
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 543 (640)
..++|...+.||+|++|.||+|.... ++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45788888999999999999998865 788999998643 22334667889999999999999999998766554
Q ss_pred --eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 544 --SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 544 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
.++|+||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888743 34899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
+..+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-20 Score=176.20 Aligned_cols=149 Identities=28% Similarity=0.430 Sum_probs=121.5
Q ss_pred cccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----CeeEEEEE
Q 006563 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DESMLIYE 549 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E 549 (640)
.+.||-|+||.||....+ +|+.||.|++...- -...+.+.+|++++.-++|.|++..++...-. .++|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 368999999999998874 48999999987542 23457788999999999999999998875433 24678888
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
.|.. +|.+++.... .|+-..+.-+..||++||+|||+.+ |.||||||.|.|++++...||+||||||.-..++
T Consensus 138 LmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8854 7877775433 3666677778999999999999987 9999999999999999999999999999876665
Q ss_pred cccc
Q 006563 630 IQTN 633 (640)
Q Consensus 630 ~~~~ 633 (640)
....
T Consensus 211 ~~hM 214 (449)
T KOG0664|consen 211 RLNM 214 (449)
T ss_pred hhhh
Confidence 4433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=164.06 Aligned_cols=149 Identities=35% Similarity=0.515 Sum_probs=132.2
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3455789999999999999876 889999999865444 57789999999999999999999999999899999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++|.+++..... .+++.....++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999998855332 1789999999999999999999986 999999999999999999999999999988544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=162.18 Aligned_cols=137 Identities=19% Similarity=0.304 Sum_probs=106.1
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-----CCCceeeeEeEEEeCC---e-eEEE
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-----QHRNLVKLLGCCIQAD---E-SMLI 547 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV 547 (640)
..+.||+|+|+.||. +++....+||++........+.+.+|+.+++.+ +||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 446899999999996 544333478888765444567899999999999 5799999999998863 3 3378
Q ss_pred EEc--cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecccCCCCEEEcC----CCceEEee-e
Q 006563 548 YEY--MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI-LYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISD-F 619 (640)
Q Consensus 548 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kI~D-F 619 (640)
+|| ++.++|.+++.+. .++.. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+| |
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5689999999542 24444 35577888777 9999988 999999999999973 34899999 5
Q ss_pred cccee
Q 006563 620 GMARI 624 (640)
Q Consensus 620 Gla~~ 624 (640)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-18 Score=167.97 Aligned_cols=132 Identities=21% Similarity=0.179 Sum_probs=114.3
Q ss_pred cCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhHHHhh
Q 006563 484 GGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (640)
Q Consensus 484 G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 562 (640)
|.+|.||++.... ++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999998754 7899999987542 234455556666799999999999999999999999999999998855
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
.. .+++.....++.|+++||+|||+.+ |+||||||+||++++++.++++|||++..+.
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 32 4899999999999999999999987 9999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=176.37 Aligned_cols=161 Identities=24% Similarity=0.377 Sum_probs=135.1
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEccc--CCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 549 (640)
..|+.+++||+||-+.||++...+.+.+|+|++.. .+.+..+-|.+|+.+|.+|+ |.+||.|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45777789999999999999998888899887653 35567888999999999995 9999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|= ..+|.++|..... ...+| .+..+..|++.++.++|+++ |||.||||.|+|+-+ |.+||+|||+|+.+..+.
T Consensus 441 ~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 85 4489999966443 33456 66788999999999999998 999999999999965 589999999999998887
Q ss_pred cccccceeeeC
Q 006563 630 IQTNTHKVVGT 640 (640)
Q Consensus 630 ~~~~~~~~~Gt 640 (640)
+...--.-+||
T Consensus 514 TsI~kdsQvGT 524 (677)
T KOG0596|consen 514 TSIVKDSQVGT 524 (677)
T ss_pred cceeeccccCc
Confidence 66544445555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=187.22 Aligned_cols=149 Identities=26% Similarity=0.350 Sum_probs=105.9
Q ss_pred hhccccccccccccCceeEEEEEecC-----CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeE------EE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC------CI 539 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~ 539 (640)
..++|...+.||+|+||.||+|.+.+ +..||+|++..... .+....| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999999855 57899998764321 1111111 1122222222222211 24
Q ss_pred eCCeeEEEEEccCCCChhHHHhhcccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 540 QADESMLIYEYMPNKSLDFFIFDQARA-----------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
...+.+|||||+++++|.+++...... .......+..++.||++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888643210 01122345578999999999999987 9999999
Q ss_pred CCCEEEcC-CCceEEeeeccceecc
Q 006563 603 ASNVLLDN-DMNPKISDFGMARIFG 626 (640)
Q Consensus 603 p~NILl~~-~~~~kI~DFGla~~~~ 626 (640)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5799999999998663
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-18 Score=162.88 Aligned_cols=146 Identities=23% Similarity=0.382 Sum_probs=124.1
Q ss_pred ccccccccCceeEEEEEecC-CcEEEEEEcccC-CchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 477 SYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
.+..||.|.-|.|++.+... |..+|||.+.+. +....++++..++++.+-+ .|.||+-+|++.......+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 33579999999999999876 889999999865 3456678888888888775 89999999999999999999999954
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
-++++|.+.. ..+++...-++...+.+||.||.+++ .|+|||+||+|||+|+.+.+|++|||++..+..
T Consensus 176 -C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 176 -CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred -HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 4666665433 34778888888999999999999876 599999999999999999999999999987743
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-18 Score=173.71 Aligned_cols=161 Identities=30% Similarity=0.392 Sum_probs=129.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc---hhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (640)
..+|..+.+||+|+||+|.++.-+. .+.+|||++++... ...+--..|-++|+.. +-|.++.|+.++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3467778899999999999998765 45689999987532 2233345677778776 57889999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+.+|+|...+.+-.+ +.+......|.+||-||-|||+++ ||.||||..|||||.++++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888855433 566777888999999999999998 9999999999999999999999999998642
Q ss_pred CCccccccceeeeC
Q 006563 627 GDEIQTNTHKVVGT 640 (640)
Q Consensus 627 ~~~~~~~~~~~~Gt 640 (640)
-+ ...|++.-||
T Consensus 502 ~~--~~TTkTFCGT 513 (683)
T KOG0696|consen 502 FD--GVTTKTFCGT 513 (683)
T ss_pred cC--CcceeeecCC
Confidence 22 2235555565
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-18 Score=165.88 Aligned_cols=147 Identities=25% Similarity=0.341 Sum_probs=120.7
Q ss_pred hhccccc-cccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC----Ce
Q 006563 471 ATDNFAS-YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA----DE 543 (640)
Q Consensus 471 ~~~~f~~-~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 543 (640)
.+++|++ .++||-|-.|+|-.+..+. ++.+|+|.|... ...++|+++.-.. .|+|||.+++++.+. .-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566654 3589999999999998765 778999988643 3446788876555 699999999998653 34
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeec
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFG 620 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFG 620 (640)
+++|||.|++|.|...+.++. ...+++++.-.|+.||+.|+.|||..+ |.||||||+|+|.. .+-.+|++|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 689999999999988886654 345899999999999999999999887 99999999999995 45679999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
+||.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=154.08 Aligned_cols=143 Identities=36% Similarity=0.620 Sum_probs=127.0
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEcccCCch-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhH
Q 006563 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 558 (640)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999866 889999998765332 35779999999999999999999999999999999999999999999
Q ss_pred HHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceeccCC
Q 006563 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGD 628 (640)
Q Consensus 559 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~~~ 628 (640)
++.... ..+++..+..++.+++++|+|||+.+ ++|+||+|.||+++. +..++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 885432 35889999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.7e-17 Score=160.27 Aligned_cols=138 Identities=32% Similarity=0.502 Sum_probs=124.0
Q ss_pred CceeEEEEEecC-CcEEEEEEcccCCchh-hHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhHHHhh
Q 006563 485 GFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (640)
Q Consensus 485 ~fg~Vy~g~l~~-g~~VavK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 562 (640)
+||.||++...+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999998654444 68899999999999999999999999999999999999999999998855
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
... +++..+..++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 332 789999999999999999999987 999999999999999999999999999987543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7e-18 Score=157.95 Aligned_cols=144 Identities=24% Similarity=0.454 Sum_probs=123.0
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCe--eEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE--SMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~--~~lV 547 (640)
.++|+..+++|+|.++.||.|.. .+.+.++||+++.. ..+.+.+|+.+|..|. ||||++|++...++.. ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788889999999999999974 45778999999854 3467889999999997 9999999999887654 6899
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla~~~~ 626 (640)
+||+++.+...+. ..|+..++...+.++++||.|+|+.+ |.|||+||.|+++|.. -..+|+|+|||...-
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876544 24677778888999999999999988 9999999999999865 569999999999874
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
+
T Consensus 185 p 185 (338)
T KOG0668|consen 185 P 185 (338)
T ss_pred C
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=157.26 Aligned_cols=135 Identities=21% Similarity=0.315 Sum_probs=113.8
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCc--h------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--Q------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+.||+|++|.||+|.. .+..|++|+...... . ....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677888997653221 1 124578899999999999998888887778888999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999888432 12 77899999999999999987 99999999999999 789999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-17 Score=179.35 Aligned_cols=149 Identities=30% Similarity=0.450 Sum_probs=117.8
Q ss_pred ccccccccccCcee-EEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 475 FASYNKLGEGGFGP-VYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 475 f~~~~~lg~G~fg~-Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
|...+.+|.|+.|+ ||+|.. ++++||||++-.. ..+-..+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45567889999875 689987 6789999998642 334567899999888 59999999988777888999999995
Q ss_pred CCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-----CCceEEeeeccceecc
Q 006563 553 NKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kI~DFGla~~~~ 626 (640)
.+|++++... .......--....+..|+++||++||.-+ ||||||||.||||+. ...++|+|||++|.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4999999663 11111111344677889999999999976 999999999999965 3579999999999997
Q ss_pred CCccc
Q 006563 627 GDEIQ 631 (640)
Q Consensus 627 ~~~~~ 631 (640)
.++..
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 76543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=179.97 Aligned_cols=140 Identities=20% Similarity=0.324 Sum_probs=113.2
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccC-C------chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG-S------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~-~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
...|...++||+|+||.||+|.+.....++.+++.+. . ....+.+.+|++++.+++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4445667899999999999998765443332222221 1 11235688999999999999999888888887888
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988773 34678999999999999987 9999999999999 677999999999997
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=154.40 Aligned_cols=147 Identities=20% Similarity=0.199 Sum_probs=112.6
Q ss_pred hHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCch----------------------hhHhHHHHHHHHh
Q 006563 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVTLIA 524 (640)
Q Consensus 467 ~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~----------------------~~~~f~~E~~~l~ 524 (640)
++......|...+.||+|+||.||++...+++.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 334444447777899999999999999888999999986542200 1123567888899
Q ss_pred hCCCCc--eeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 525 RLQHRN--LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 525 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
++.|++ +.+.++ ....++||||+++++|..+... .....++.++++++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 888774 444443 2455899999999998765421 234578889999999999987 9999999
Q ss_pred CCCEEEcCCCceEEeeeccceeccCCc
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+||++++++.++|+|||++..+..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=153.50 Aligned_cols=132 Identities=23% Similarity=0.358 Sum_probs=108.0
Q ss_pred cccccCceeEEEEEecCCcEEEEEEcccCCc--------hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.||+|+||.||+|.. ++..|++|....... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 567899998553211 11356778999999999887766666666777789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++++|.+++..... .++.+++++|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999887743211 78899999999999987 99999999999999 7899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.8e-17 Score=162.45 Aligned_cols=158 Identities=24% Similarity=0.364 Sum_probs=133.5
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC------CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEE
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 538 (640)
+++.....++....++.+|.||.||+|.+.+ .++|.+|.++.. ++-+...++.|.-++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445667777789999999999997654 346788888755 334567789999999999999999999999
Q ss_pred EeC-CeeEEEEEccCCCChhHHHh-----hccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 539 IQA-DESMLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 539 ~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
.+. ...+.+|.++.-|+|..+|. +......++..+...++.|++.||+|||.++ |||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 876 45789999999999999997 4444556888888999999999999999988 99999999999999999
Q ss_pred ceEEeeeccceecc
Q 006563 613 NPKISDFGMARIFG 626 (640)
Q Consensus 613 ~~kI~DFGla~~~~ 626 (640)
.+||+|=.|+|-+-
T Consensus 434 qVkltDsaLSRDLF 447 (563)
T KOG1024|consen 434 QVKLTDSALSRDLF 447 (563)
T ss_pred eEEeccchhccccC
Confidence 99999999999763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=156.93 Aligned_cols=149 Identities=18% Similarity=0.152 Sum_probs=112.9
Q ss_pred hhccccccccccccCceeEEEEE--ecCCcEEEEEEcccCCch------------------------hhHhHHHHHHHHh
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGT--LVEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVTLIA 524 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~--l~~g~~VavK~l~~~~~~------------------------~~~~f~~E~~~l~ 524 (640)
....|...+.||+|+||.||+|. ..+|+.||+|++...... ....+..|++.+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33457778899999999999998 567999999998743210 0123568999999
Q ss_pred hCCCC--ceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 525 RLQHR--NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 525 ~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
++.+. .+.++++. ...+|||||+++.+|....... ..+.......++.+++.+|+|||+.+ .|+|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 99753 33444443 2358999999998886554221 22455566789999999999999875 39999999
Q ss_pred CCCEEEcCCCceEEeeeccceeccCCc
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+||+++ ++.++|+|||+|...+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 9999999 8899999999999775544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.5e-17 Score=158.85 Aligned_cols=148 Identities=26% Similarity=0.371 Sum_probs=127.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (640)
.++|..+.+||+|+|++|..+++.. .+.+|+|++++. ....++-...|-.++... +||.+|.|+.++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4678888999999999999999876 677899988754 334455667777777666 69999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|.||+++|+|..++.++ ..|++.........|.-||.|||+.+ ||.||||..|+|||.++++|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999998777443 34777777778889999999999998 999999999999999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=153.49 Aligned_cols=141 Identities=15% Similarity=0.154 Sum_probs=114.3
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhh---Hh------HHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM---EE------FKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~---~~------f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
..++|...+++|+|+||.||.... +++.+++|.+........ .. +.+|++.+.++.|++|..+..+....
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999655 577899999975432221 22 67899999999999999998886543
Q ss_pred --------CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 542 --------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 542 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
...+|||||+++.+|.++.. ++. ....+++.+|..+|+.+ ++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24558999999999988 99999999999999888
Q ss_pred eEEeeeccceeccC
Q 006563 614 PKISDFGMARIFGG 627 (640)
Q Consensus 614 ~kI~DFGla~~~~~ 627 (640)
++|+|||..+....
T Consensus 173 i~liDfg~~~~~~e 186 (232)
T PRK10359 173 LRIIDLSGKRCTAQ 186 (232)
T ss_pred EEEEECCCcccccc
Confidence 99999999987643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=8e-16 Score=147.12 Aligned_cols=132 Identities=20% Similarity=0.176 Sum_probs=104.7
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCch----hhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEcc
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----GMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~----~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+...|++|+||+||.+.- ++..++.+.+.....- ....|.+|+++|++++ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999997655 5777887777654321 1225789999999995 5889999886 4569999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++.+|...+.. ....++.+++++|+++|..+ |+|||| ||.|||+++++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99988643311 11346788999999999998 999999 7999999999999999999999654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-17 Score=172.47 Aligned_cols=159 Identities=27% Similarity=0.349 Sum_probs=132.5
Q ss_pred ccccccccccccCceeEEEEEecCCc-EEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQ-EIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~-~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++..+..||-|+||.|-+....... ..|+|++++. .....+....|-.+|...+.+.||+|+-.+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34444568999999999988775533 3788877654 3345567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|-|-+|.|...|+++. .++..+...++..+++|++|||.++ ||.|||||+|++||.++-+||.|||+||.++..
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999997654 3677777788889999999999998 999999999999999999999999999998755
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
+ .|-++-||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 4 24445554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-17 Score=175.88 Aligned_cols=151 Identities=26% Similarity=0.454 Sum_probs=132.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|.....+|.|.||.|||++... ++..|+|.++........-...|+-+++..+|+|||.++|-+......++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34677777899999999999998754 88899999887666667778889999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+.+|+|+++.+-. ..+.+.++....+..++||+|||..+ -+|||||=.|||+++.+.+|++|||.+..++.
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence 99999998876433 24777888888899999999999988 79999999999999999999999999988753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=145.97 Aligned_cols=148 Identities=23% Similarity=0.364 Sum_probs=122.6
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC-CceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|..+++||.|+||.+|.|.. .+|++||||.-..... .-.+.-|.++...|+| ..|..+.-+..++..-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 47899999999999999999975 5599999998654332 2456778899999975 777788888888888999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGla~~~~ 626 (640)
.+ +.+|++++.--.+ .++.++.+-++-|++.-++|+|.++ .|||||||+|+|..- ...+.++||||||.+-
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 6688887743333 3788999999999999999999998 999999999999853 3568999999999874
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 166 d 166 (341)
T KOG1163|consen 166 D 166 (341)
T ss_pred c
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.3e-16 Score=166.24 Aligned_cols=146 Identities=25% Similarity=0.369 Sum_probs=120.2
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 549 (640)
+..|.....+|.|+|+.|-++.+.. ++..++|++.+.. .+-.+|+.++... +|+||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4556666679999999999988755 7889999998652 2234566665555 79999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE-cCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kI~DFGla~~~~~~ 628 (640)
.+.++-|...+..... .. ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...++
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887666544322 22 677789999999999999988 9999999999999 68999999999999988655
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.6e-16 Score=149.35 Aligned_cols=146 Identities=23% Similarity=0.409 Sum_probs=118.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeE-EEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC-CIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 549 (640)
+.|.+.+.||+|.||.+.+++++. .+.+++|-+... ....++|.+|..---.| .|.||+.-+++ +...+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 567778899999999999999987 567888877643 33467899988754445 59999987765 444566789999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE--cCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kI~DFGla~~~~ 626 (640)
|++.|+|..-+.. ..+.+.....++.|++.||.|+|++. +||||||.+|||| .+...+|++|||+.+..+
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999776633 34677778899999999999999998 9999999999999 344689999999998654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.7e-16 Score=157.15 Aligned_cols=147 Identities=28% Similarity=0.501 Sum_probs=126.6
Q ss_pred HHHhhccccccccccccCceeEEEEEecC----CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+...+ ....+.+|+++|..+ -+.||+++.++...++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34455678888999999999999998644 5689999987653 335688999999999 4999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeecc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGM 621 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGl 621 (640)
...+|+||+++....+++++ ++...+...++.+..||+++|..+ ||||||||+|+|.+.. +.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999998888744 567788888999999999999998 9999999999999754 6689999999
Q ss_pred ceec
Q 006563 622 ARIF 625 (640)
Q Consensus 622 a~~~ 625 (640)
|...
T Consensus 180 A~~~ 183 (418)
T KOG1167|consen 180 AQRY 183 (418)
T ss_pred HHHH
Confidence 9853
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.4e-16 Score=121.40 Aligned_cols=66 Identities=52% Similarity=1.111 Sum_probs=58.2
Q ss_pred ccCCCccceeeeccCCCCCcceecccCChhHHHHHhhcCCCceeeecccCCCCCceeeecccccccc
Q 006563 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDM 390 (640)
Q Consensus 324 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~ 390 (640)
|+.+++|.++.+|++|+++...+..+.++++|+..|++||||+||+|.++. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999877766679999999999999999999997554 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=154.08 Aligned_cols=145 Identities=26% Similarity=0.357 Sum_probs=119.2
Q ss_pred cccccccccccCceeEEEEEecCC--cEEEEEEcccCCchhhHhHHHHHHHHhhCCC----CceeeeEeEE-EeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEG--QEIAVKRLSKGSGQGMEEFKNEVTLIARLQH----RNLVKLLGCC-IQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g--~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 546 (640)
+|...++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..++... ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999987664 4788887665433322367889999988863 5788888887 46667899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-----CceEEeeecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-----MNPKISDFGM 621 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kI~DFGl 621 (640)
||+.+ +.+|.++..... ...++-.+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99876 668988775544 456899999999999999999999988 9999999999999754 4699999999
Q ss_pred ce
Q 006563 622 AR 623 (640)
Q Consensus 622 a~ 623 (640)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.9e-15 Score=134.52 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=114.4
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC--CceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
.+.|++|.++.||++...+ ..+++|....... ...+..|+.++..++| .++.+++++...++..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4689999999999999855 7899998865432 4678999999999976 589999988887788999999999877
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||+++..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7432 45666788999999999999865456999999999999999899999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.4e-15 Score=141.69 Aligned_cols=139 Identities=21% Similarity=0.276 Sum_probs=98.9
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCch--hhHhH----------------------HHHHHHHhhCCCCc--ee
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--GMEEF----------------------KNEVTLIARLQHRN--LV 532 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--iv 532 (640)
+.||+|+||.||++...+++.||||++...... ....+ ..|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999888999999988653211 11111 34555555554332 34
Q ss_pred eeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCC
Q 006563 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 533 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~ 611 (640)
+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++ +
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 44443 246899999999654321111100 11 4566889999999999998 65 99999999999999 8
Q ss_pred CceEEeeeccceeccCCc
Q 006563 612 MNPKISDFGMARIFGGDE 629 (640)
Q Consensus 612 ~~~kI~DFGla~~~~~~~ 629 (640)
+.++|+|||.+.....+.
T Consensus 151 ~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 151 GKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CcEEEEECcccccccCcc
Confidence 999999999998776544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-15 Score=147.61 Aligned_cols=146 Identities=32% Similarity=0.448 Sum_probs=116.1
Q ss_pred ccccccccccccCceeEEEEE-ecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------Ce
Q 006563 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~-l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 543 (640)
.+|..+..++.|.- .|-.+. ...+++||+|++... ..+..+...+|..++..+.|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666667887776 444332 234789999987643 344567788999999999999999999998643 34
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.|+|||||.. +|...+.- .++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 6999999965 77666642 3677888899999999999999987 9999999999999999999999999999
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 75433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-14 Score=141.34 Aligned_cols=149 Identities=21% Similarity=0.335 Sum_probs=121.1
Q ss_pred ccccccccccccCceeEEEEE-ecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~-l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
-+|.+.++||+|+||.++.|+ +-+++.||||.=... ...-++..|-+..+.| ..++|...+.|-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468888999999999999997 456899999974432 2233566677777777 468999888888888888999998
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-----CCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kI~DFGla~~~ 625 (640)
+ +-||+++..=-. ..++.++...||.|++.-++|+|++. +|-|||||+|+||.. ...+.|.||||||..
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 668888763322 34889999999999999999999998 999999999999953 456899999999998
Q ss_pred cCCc
Q 006563 626 GGDE 629 (640)
Q Consensus 626 ~~~~ 629 (640)
...+
T Consensus 180 rDp~ 183 (449)
T KOG1165|consen 180 RDPK 183 (449)
T ss_pred cCcc
Confidence 6544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-14 Score=145.80 Aligned_cols=152 Identities=20% Similarity=0.261 Sum_probs=124.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-C-C----ceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-R----NLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~ 544 (640)
+++|.+...+|+|.||.|-...... +..||||+++.. ..-.+..+-|++++.++. + | -+|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6788889999999999999987655 678999999765 344566788999999993 2 2 278888889999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--------------
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------------- 610 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------------- 610 (640)
+||+|.| +-|+.++|..+. ...++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 338888886543 345888999999999999999999987 999999999999832
Q ss_pred ------CCceEEeeeccceeccCCc
Q 006563 611 ------DMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 611 ------~~~~kI~DFGla~~~~~~~ 629 (640)
+..+||+|||-|..-.+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc
Confidence 3458999999999765444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=147.04 Aligned_cols=134 Identities=25% Similarity=0.331 Sum_probs=109.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-----C---CceeeeEeEEEe---
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----H---RNLVKLLGCCIQ--- 540 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~--- 540 (640)
.+|...++||=|.|++||++.... .+-||+|+.+.. ..-.+..+.|+++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678888999999999999998655 668999988643 344567789999999884 2 459999999875
Q ss_pred -CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC
Q 006563 541 -ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 541 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 611 (640)
+.+.+||+|++- .+|..++..... +-++...+.+|+.||+.||.|||.++ .|||-||||+||||-..
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 457899999994 467677655433 34888999999999999999999987 69999999999999543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-14 Score=150.45 Aligned_cols=156 Identities=19% Similarity=0.279 Sum_probs=131.7
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC------CCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ------HRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~ 543 (640)
..+.|.+.-..|+|-|++|.+|.... |++||||+|..+. --.+.=+.|+++|.+|. --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 44677777789999999999998755 8899999998753 22345578999999996 4678999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccc
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMA 622 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla 622 (640)
++||+|-+. .+|...|..-.....|....+..++.|+.-||..|-..+ |+|+||||.|||+++. ..+||||||-|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999774 488999987777777888889999999999999999876 9999999999999865 56899999999
Q ss_pred eeccCCccc
Q 006563 623 RIFGGDEIQ 631 (640)
Q Consensus 623 ~~~~~~~~~ 631 (640)
...+.++..
T Consensus 585 ~~~~eneit 593 (752)
T KOG0670|consen 585 SFASENEIT 593 (752)
T ss_pred ccccccccc
Confidence 988776653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.6e-13 Score=140.23 Aligned_cols=150 Identities=34% Similarity=0.525 Sum_probs=126.6
Q ss_pred ccccccccccCceeEEEEEecCCcEEEEEEcccCCch---hhHhHHHHHHHHhhCCCC-ceeeeEeEEEeCCeeEEEEEc
Q 006563 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ---GMEEFKNEVTLIARLQHR-NLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 550 (640)
|.....||.|+|+.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++...+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999887 78899988765322 367899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceeccCCc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~~~~ 629 (640)
+.++++..++........+.......++.+++.++.|+|..+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321125788899999999999999999987 99999999999999988 79999999999765443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=137.76 Aligned_cols=136 Identities=21% Similarity=0.271 Sum_probs=105.2
Q ss_pred cccc-ccCceeEEEEEecCCcEEEEEEcccCC-------------chhhHhHHHHHHHHhhCCCCce--eeeEeEEEeCC
Q 006563 479 NKLG-EGGFGPVYKGTLVEGQEIAVKRLSKGS-------------GQGMEEFKNEVTLIARLQHRNL--VKLLGCCIQAD 542 (640)
Q Consensus 479 ~~lg-~G~fg~Vy~g~l~~g~~VavK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~ 542 (640)
..|| .|+.|+||+.... +..+++|++.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998874 6788898875311 1223467889999999998775 67777754432
Q ss_pred e----eEEEEEccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 543 E----SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 543 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
. .++|+||+++ .+|..++... .++.. .+.+|+++|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 6898887432 23332 3568999999999988 9999999999999998899999
Q ss_pred eeccceecc
Q 006563 618 DFGMARIFG 626 (640)
Q Consensus 618 DFGla~~~~ 626 (640)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-13 Score=145.47 Aligned_cols=142 Identities=22% Similarity=0.311 Sum_probs=101.3
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhh----------------------------------------HhHHH
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM----------------------------------------EEFKN 518 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~----------------------------------------~~f~~ 518 (640)
+.||.|++|.||+|++.+|+.||||+.+....... -.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421110 02344
Q ss_pred HHHHHhhC----CCCceeeeEeEEE-eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 006563 519 EVTLIARL----QHRNLVKLLGCCI-QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR-GILYLHQDS 592 (640)
Q Consensus 519 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 592 (640)
|.+.+.++ +|.+-+.+-.++. .....+|||||+++++|.++....... . .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 55544444 2333333333332 234579999999999998776432111 2 23456666666 467889877
Q ss_pred CCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++|+|++|.||++++++.+++.|||++..+.++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.3e-13 Score=108.38 Aligned_cols=72 Identities=24% Similarity=0.415 Sum_probs=62.0
Q ss_pred ccCCCccceeeeccCCCCCcceecccCChhHHHHHhhc---CCCceeeecccCCCCCceeeeccccc-ccceeecCCCcc
Q 006563 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK---NCSCTAYANSDVERGGSGCLLWFGDL-MDMKEYNDGGQD 399 (640)
Q Consensus 324 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~ 399 (640)
|...+.|.++.++++|++.. .++++|+++|++ ||||+||+|.+. +.+|.+|.++| ++++.+.+.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44567899999999998754 689999999999 999999999642 46899999999 999888888899
Q ss_pred eeEEe
Q 006563 400 LYIRI 404 (640)
Q Consensus 400 lyirv 404 (640)
+|+|.
T Consensus 76 Ly~r~ 80 (80)
T cd00129 76 LYENK 80 (80)
T ss_pred eEeEC
Confidence 99983
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.9e-13 Score=150.15 Aligned_cols=149 Identities=25% Similarity=0.345 Sum_probs=114.6
Q ss_pred HHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeE
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESM 545 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 545 (640)
+.....|.+.++||+|+||+||+|...+|+.||+|.=+....- +|.-=.+++.+|+ -+.|..+..+..-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3345678888999999999999999989999999986654332 1222222333333 233444444455567789
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-------CCCceEEee
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-------NDMNPKISD 618 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kI~D 618 (640)
||+||.+-|+|.+++. ..+.++|...+.++.++++-++.||..+ |||+||||+|+||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999985 4556899999999999999999999987 99999999999994 235589999
Q ss_pred eccceecc
Q 006563 619 FGMARIFG 626 (640)
Q Consensus 619 FGla~~~~ 626 (640)
||-+--+.
T Consensus 845 fG~siDm~ 852 (974)
T KOG1166|consen 845 FGRSIDMK 852 (974)
T ss_pred cccceeee
Confidence 99986553
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=108.41 Aligned_cols=80 Identities=46% Similarity=0.950 Sum_probs=65.3
Q ss_pred cccccCC---CccceeeeccCCCCCcceecccCChhHHHHHhhcCCCceeeecccCCCCCceeeecccccccceeecCCC
Q 006563 321 ELKCRNG---DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG 397 (640)
Q Consensus 321 ~~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~ 397 (640)
+++|..+ +.|.++.++++|+..... ...++++|++.|++||+|+||+|.+ ++++|++|.+++.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567544 689999999999876543 6789999999999999999999864 3578999999999987655556
Q ss_pred cceeEEee
Q 006563 398 QDLYIRIA 405 (640)
Q Consensus 398 ~~lyirv~ 405 (640)
.++|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 89999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-11 Score=113.73 Aligned_cols=131 Identities=21% Similarity=0.180 Sum_probs=97.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCcee-eeEeEEEeCCeeEEEEEccCCCChh
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
+.|+.|.++.||+.... ++.+++|....... ....+..|++++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57889999999999865 77899998765422 223567899999888655544 444442 33468999999998875
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.+++.||+.+..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 0 11245678999999999876 23469999999999999 668999999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.2e-11 Score=131.54 Aligned_cols=147 Identities=17% Similarity=0.240 Sum_probs=94.3
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchh------------------------------h----H---
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG------------------------------M----E--- 514 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~------------------------------~----~--- 514 (640)
..|+. +.||+|++|.||+|++.+ |++||||++++..... . +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 689999999999999988 9999999997542110 0 1
Q ss_pred ---hHHHHHHHHhhCC----CCceeeeEeEEEe-CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHH-HH
Q 006563 515 ---EFKNEVTLIARLQ----HRNLVKLLGCCIQ-ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR-GI 585 (640)
Q Consensus 515 ---~f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL 585 (640)
+|..|+..+.+++ +.+.+.+-.++.+ ....+|||||++++.+.++-.-.... .+.. .++...++ -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence 1334444444442 4444444444333 45678999999999997642111111 1111 12221111 12
Q ss_pred HHHHhCCCCceEecccCCCCEEEcCCC----ceEEeeeccceeccCC
Q 006563 586 LYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGMARIFGGD 628 (640)
Q Consensus 586 ~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DFGla~~~~~~ 628 (640)
.-++..+ ++|+|+||.||+++.++ .+++.|||++..+.++
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2233445 99999999999999888 9999999999988644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.8e-11 Score=117.88 Aligned_cols=135 Identities=27% Similarity=0.462 Sum_probs=111.9
Q ss_pred cccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
+|.+...|..|+|+++. ..+++|++... .....+.|.+|.-.|+.+.||||+.++|.|..+.+..++..||+.|+|.
T Consensus 197 kl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 67888899999999965 44555666532 2333467999999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
..|.+. .....+..+..+++.+||+||+|||+..+ -|..--|.++.+++|++.+++|+
T Consensus 276 nvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 276 NVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 999654 34467888899999999999999999863 24445789999999999998885
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.6e-11 Score=141.27 Aligned_cols=94 Identities=20% Similarity=0.290 Sum_probs=72.9
Q ss_pred hCCC-CceeeeEeEE-------EeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006563 525 RLQH-RNLVKLLGCC-------IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596 (640)
Q Consensus 525 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 596 (640)
.++| .||+++++.+ .+....++++||+ .++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5788888877 2234567888987 55999999643 235899999999999999999999987 9
Q ss_pred EecccCCCCEEEcC-------------------CCceEEeeecccee
Q 006563 597 IHRDLKASNVLLDN-------------------DMNPKISDFGMARI 624 (640)
Q Consensus 597 vH~Dlkp~NILl~~-------------------~~~~kI~DFGla~~ 624 (640)
+||||||+||||+. +..+||+|||+++.
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 99999999999954 44566666666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.9e-11 Score=131.13 Aligned_cols=143 Identities=26% Similarity=0.330 Sum_probs=108.9
Q ss_pred cccccccCceeEEEEEecC-CcEEEEEEcc----cC-C-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 478 YNKLGEGGFGPVYKGTLVE-GQEIAVKRLS----KG-S-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~----~~-~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.+.+|.|++|.|+...... .+..+.|... .. . .+....+..|..+-..++|+|++..+..+.+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 4689999999777765433 2223333221 11 1 11122356777778889999998887777766666666999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++. +|..++.+. ..+...++..++.|+..|+.|||..+ |.|||+|++|++++.++.+||+|||.+..+.-
T Consensus 403 ~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 998888554 24777888899999999999999988 99999999999999999999999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=107.59 Aligned_cols=143 Identities=19% Similarity=0.262 Sum_probs=108.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCC--CceeeeEeEEEeCC---eeEEEEEccC
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH--RNLVKLLGCCIQAD---ESMLIYEYMP 552 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 552 (640)
+.|+.|..+.+|+....+|+.+++|....... .....+..|.+++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 47899999999999987778899998765322 235678899999999975 44677787766542 5689999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS---------------------------------------- 592 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 592 (640)
+.++...+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9887654311 23566667777788888888887421
Q ss_pred -------------CCceEecccCCCCEEEcC--CCceEEeeeccceec
Q 006563 593 -------------RMRIIHRDLKASNVLLDN--DMNPKISDFGMARIF 625 (640)
Q Consensus 593 -------------~~~ivH~Dlkp~NILl~~--~~~~kI~DFGla~~~ 625 (640)
+..++|+|+.|.|||++. +..+.|.||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=100.33 Aligned_cols=135 Identities=19% Similarity=0.313 Sum_probs=102.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEE-cccC--Cc-----hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKR-LSKG--SG-----QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~-l~~~--~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..+++|+-+.+|.+.+.+ ..+.+|. +.+. .+ -..+.-.+|+++|++++--.|..-+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 368899999999997644 3355553 4332 11 1123467899999998766666555566788888999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
.++..|.+.+... +..++..|-+-+.-||..+ |+|+||.++||++..+. +.++||||++.-...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999988888443 2466778888899999988 99999999999998875 999999999975443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-09 Score=102.35 Aligned_cols=138 Identities=13% Similarity=0.093 Sum_probs=98.4
Q ss_pred ccccccCceeEEEEEecC-------CcEEEEEEcccCC------------c----------hhhHhHH----HHHHHHhh
Q 006563 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS------------G----------QGMEEFK----NEVTLIAR 525 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-------g~~VavK~l~~~~------------~----------~~~~~f~----~E~~~l~~ 525 (640)
..||.|.-+.||.|.-.+ +..+|||+.+... . ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4789999775311 0 0012233 78888888
Q ss_pred CC--CCceeeeEeEEEeCCeeEEEEEccCCCChhH-HHhhccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeccc
Q 006563 526 LQ--HRNLVKLLGCCIQADESMLIYEYMPNKSLDF-FIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDL 601 (640)
Q Consensus 526 l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl 601 (640)
+. ..++.+++++ ...+|||||+.+..+.. .+.+ ..++......+..+++.+|.+| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 85 3556666654 46789999998754422 2211 1244445567788999999999 6666 999999
Q ss_pred CCCCEEEcCCCceEEeeeccceeccCC
Q 006563 602 KASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 602 kp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++.|||+++ +.+.|+|||.|.....+
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCCC
Confidence 999999974 68999999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=9e-10 Score=118.19 Aligned_cols=100 Identities=30% Similarity=0.523 Sum_probs=90.7
Q ss_pred HhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 523 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....++++|++||+|||... ...|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 45789999999999999999999999999999999999763 345899999999999999999999853 23999999
Q ss_pred CCCEEEcCCCceEEeeeccceecc
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++|+++|..+.+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.1e-09 Score=94.83 Aligned_cols=147 Identities=24% Similarity=0.319 Sum_probs=106.1
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEE-cccC-------CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKR-LSKG-------SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~-l~~~-------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
....+.+|+-+.|+++... |+...||. ..+. ..-..+..++|++++++++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4468899999999999874 55555553 3322 1123456789999999987656655555566777788999
Q ss_pred EccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC---ceEEeeecccee
Q 006563 549 EYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARI 624 (640)
Q Consensus 549 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kI~DFGla~~ 624 (640)
||.++ .++.+++...-.....+ .....++..|-+.+.-||... |||+||..+||+|..++ .+.+.||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46777776543332222 222578889999999999988 99999999999996554 358999999987
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
-..+
T Consensus 166 s~~~ 169 (229)
T KOG3087|consen 166 SRLP 169 (229)
T ss_pred ccCc
Confidence 5433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.6e-08 Score=100.71 Aligned_cols=149 Identities=26% Similarity=0.331 Sum_probs=97.9
Q ss_pred ccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCC----------CceeeeEeEEE-
Q 006563 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH----------RNLVKLLGCCI- 539 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H----------~niv~l~g~~~- 539 (640)
+...+.||.|+++.||.++..+ ++++|+|..... .....+++++|.-.+..+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3445689999999999999977 889999986532 23456778888766655432 12222222211
Q ss_pred --------eCC--------eeEEEEEccCCCChhHHHh---hccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006563 540 --------QAD--------ESMLIYEYMPNKSLDFFIF---DQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (640)
Q Consensus 540 --------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (640)
... +.+++|+-+ .++|..++. .... ...+....++.+..|+.+.+++||..+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 235677766 568877653 2211 223556667778899999999999998 9999
Q ss_pred ccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 600 DLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 600 Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+|+|++++.+|.++++||+-....+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 9999999999999999999998877643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.9e-09 Score=104.99 Aligned_cols=89 Identities=25% Similarity=0.482 Sum_probs=68.0
Q ss_pred CCCceeeeEeEEEe---------------------------CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHH
Q 006563 527 QHRNLVKLLGCCIQ---------------------------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579 (640)
Q Consensus 527 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 579 (640)
+|||||++.+++.+ +...|+||.-.+. +|..++..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 58888888776542 2346888876654 788888543 245566667888
Q ss_pred HHHHHHHHHHhCCCCceEecccCCCCEEE--cCCC--ceEEeeeccce
Q 006563 580 GIARGILYLHQDSRMRIIHRDLKASNVLL--DNDM--NPKISDFGMAR 623 (640)
Q Consensus 580 ~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kI~DFGla~ 623 (640)
|+++|+.|||.++ |.|||+|++|||| |++. ...|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999998 9999999999998 4443 46899999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-09 Score=117.71 Aligned_cols=144 Identities=25% Similarity=0.281 Sum_probs=113.7
Q ss_pred cccccCceeEEEEEe----cCCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccC
Q 006563 480 KLGEGGFGPVYKGTL----VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l----~~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.+|+|.||.|+...- ..+...|.|.+.+... ........|..+++.++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987542 2355677777664321 11124567888889997 9999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
+|.|...+.+. ...+..........+|-+++.+|+.+ |+|||+|++||+++.+|++|+.|||+++.+-..+
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99997766433 33555555666778999999999887 9999999999999999999999999999875444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.7e-10 Score=124.35 Aligned_cols=143 Identities=19% Similarity=0.242 Sum_probs=112.9
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCC-chhhHhHHHHHHH--HhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-GQGMEEFKNEVTL--IARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++...+.||.+.|=+|.+++.++|. |+||.+-+.. .-..+.|.++++- ++.++|||.+.+.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4555678999999999999998887 8888876543 3445566655544 4456899999887765555556788888
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..+ +|.+.| ..+..|...+..=|+.|++.||.-+|..+ |+|+|||.+||||+.-.=+.|+||.--|.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 866 666555 34556777888889999999999999988 99999999999999999999999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.6e-08 Score=91.86 Aligned_cols=128 Identities=27% Similarity=0.344 Sum_probs=83.3
Q ss_pred eEEEEEecCCcEEEEEEcccCC--------------c-------h-----hhHhHHHHHHHHhhCCCC--ceeeeEeEEE
Q 006563 488 PVYKGTLVEGQEIAVKRLSKGS--------------G-------Q-----GMEEFKNEVTLIARLQHR--NLVKLLGCCI 539 (640)
Q Consensus 488 ~Vy~g~l~~g~~VavK~l~~~~--------------~-------~-----~~~~f~~E~~~l~~l~H~--niv~l~g~~~ 539 (640)
.||.|.-.++..+|+|...... . . ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999875321 0 0 012356899999999755 45666654
Q ss_pred eCCeeEEEEEccC--CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 540 QADESMLIYEYMP--NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 540 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
....|||||++ +..+..+. ... ++......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 55554433 211 11234456777888866665 5665 9999999999999988 9999
Q ss_pred eeeccceeccCC
Q 006563 617 SDFGMARIFGGD 628 (640)
Q Consensus 617 ~DFGla~~~~~~ 628 (640)
+|||.|.....+
T Consensus 148 IDf~qav~~~~p 159 (188)
T PF01163_consen 148 IDFGQAVDSSHP 159 (188)
T ss_dssp --GTTEEETTST
T ss_pred EecCcceecCCc
Confidence 999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.8e-07 Score=93.21 Aligned_cols=139 Identities=20% Similarity=0.142 Sum_probs=98.3
Q ss_pred ccccCceeEEEEEecCCcEEEEEEcccCCch-hh----------HhHHHHHHHHhhCCC--CceeeeEeEEEe-----CC
Q 006563 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GM----------EEFKNEVTLIARLQH--RNLVKLLGCCIQ-----AD 542 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~-~~----------~~f~~E~~~l~~l~H--~niv~l~g~~~~-----~~ 542 (640)
+-+..-..|++..+ +|+.+.||+....... .. ..+.+|.+.+.++.. -....++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667655 5778999976432211 11 137789998888853 334455666543 23
Q ss_pred eeEEEEEccCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-------CCce
Q 006563 543 ESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------DMNP 614 (640)
Q Consensus 543 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~ 614 (640)
..+||+|++++- +|.+++.+... ...+...+..++.++++.+.-||..+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 468999999986 88888743211 22445666789999999999999998 999999999999975 5789
Q ss_pred EEeeecccee
Q 006563 615 KISDFGMARI 624 (640)
Q Consensus 615 kI~DFGla~~ 624 (640)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999999965
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.5e-07 Score=95.73 Aligned_cols=140 Identities=20% Similarity=0.314 Sum_probs=111.8
Q ss_pred eeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeEEEEEccCC-CChhHHH
Q 006563 487 GPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIYEYMPN-KSLDFFI 560 (640)
Q Consensus 487 g~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 560 (640)
.+.||+.. .+|..++.||++....+.....-.-++.++++.|+|+|++..++.. ...++|||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788865 5689999999954433333334456788999999999999998863 3468999999987 6776655
Q ss_pred hhcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 561 FDQA------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 561 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+... .....++...+.++.|++.||.++|+.+ +..+-|.|++||++.+.+++|+..|+-.++..|
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4322 1234778899999999999999999988 888999999999999999999999999998776
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 6
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.2e-07 Score=98.98 Aligned_cols=122 Identities=16% Similarity=0.236 Sum_probs=99.0
Q ss_pred ecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHH
Q 006563 494 LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573 (640)
Q Consensus 494 l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 573 (640)
..++.+|.|..++.......+...+.++.|+.++||||++++.........|||+|-+ ..|..++.+.. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHH
Confidence 3457888888887655433455678889999999999999999999999999999988 45666664432 333
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 574 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
..-.+.||+.||.|||+.+ .++|++|.-..|++++.++.||.+|.++...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 4455789999999999876 5999999999999999999999999988654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-08 Score=113.24 Aligned_cols=162 Identities=23% Similarity=0.321 Sum_probs=119.5
Q ss_pred ccccccccccccCceeEEEEEecC--CcEEEEEEcccCC--chhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~--g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 547 (640)
..|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345556679999999998776644 3456666665432 222334445777767776 99999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecccCCCCEEEcCCC-ceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~ 625 (640)
.||..++++...+.... ....+....-....|+..++.|+| +.+ +.|+|+||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999876663211 112344455577889999999999 766 99999999999999999 9999999999988
Q ss_pred cC-Cccccccceee
Q 006563 626 GG-DEIQTNTHKVV 638 (640)
Q Consensus 626 ~~-~~~~~~~~~~~ 638 (640)
.. +..........
T Consensus 176 ~~~~g~~~~~~~~~ 189 (601)
T KOG0590|consen 176 RNKNGAERSLKDRC 189 (601)
T ss_pred cccCCcceeeeccc
Confidence 66 44333333333
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-06 Score=95.22 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=92.3
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhh------------------------------Hh----------HHH
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM------------------------------EE----------FKN 518 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~------------------------------~~----------f~~ 518 (640)
+.|+.++-|.||+|++++|++||||+.++.-.... ++ +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999999999999999876421111 11 223
Q ss_pred HHHHHhhC----CCCceeeeEeEEE-eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 006563 519 EVTLIARL----QHRNLVKLLGCCI-QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI-LYLHQDS 592 (640)
Q Consensus 519 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~ 592 (640)
|..-+.++ ++..-+++=.++. -..+..|+|||++|-.+.++..-+.. ..+-+ .|+..++++. .-+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence 33333332 2222233333333 34677999999999888877432222 23422 3333333322 2222234
Q ss_pred CCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++|.|..|.||+++.++.+-+-|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999988654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=82.78 Aligned_cols=108 Identities=27% Similarity=0.288 Sum_probs=84.9
Q ss_pred hHhHHHHHHHHhhCC--CCceeeeEeEEEeCC----eeEEEEEccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHH
Q 006563 513 MEEFKNEVTLIARLQ--HRNLVKLLGCCIQAD----ESMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585 (640)
Q Consensus 513 ~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 585 (640)
.....+|...+..+. .-...+.+++..... ..+||+|++++ -+|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 345778888877774 444566777766532 35899999998 479888855222 45556778999999999
Q ss_pred HHHHhCCCCceEecccCCCCEEEcCCC---ceEEeeeccceecc
Q 006563 586 LYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFG 626 (640)
Q Consensus 586 ~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kI~DFGla~~~~ 626 (640)
+-||+.+ |+|+|++++|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999998887 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.4e-06 Score=84.09 Aligned_cols=136 Identities=22% Similarity=0.247 Sum_probs=94.2
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCc----------------------hhhHhHHHHHHHHhhCCCC--cee
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG----------------------QGMEEFKNEVTLIARLQHR--NLV 532 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~--niv 532 (640)
..+.||.|.-+.||.|..++|.+++||.=..... -......+|.+.|.+|.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4468999999999999999999999995322100 0122356788899988644 666
Q ss_pred eeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 533 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
+.+++ +...+||||.++-.|...- ++-...-.|+..|++-+.-+-..+ |||+|+.+-||++++++
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 66654 4568999999986653211 112222234444555444444555 99999999999999999
Q ss_pred ceEEeeeccceeccC
Q 006563 613 NPKISDFGMARIFGG 627 (640)
Q Consensus 613 ~~kI~DFGla~~~~~ 627 (640)
.+.|+||=-+-....
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999987766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-05 Score=77.93 Aligned_cols=140 Identities=16% Similarity=0.125 Sum_probs=103.2
Q ss_pred ccccCceeEEEEEecCCcEEEEEEcccC------CchhhHhHHHHHHHHhhCC--CCceeeeEeEEEeC----CeeEEEE
Q 006563 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKG------SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQA----DESMLIY 548 (640)
Q Consensus 481 lg~G~fg~Vy~g~l~~g~~VavK~l~~~------~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~----~~~~lV~ 548 (640)
-++||.+-|++-.+. |+.+-+|+-... .+.+...|.+|...|.++. ...+.+.+.+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 466899999997764 446888876522 1345678999999999885 33355555322222 2358999
Q ss_pred EccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc--eEEeeeccceec
Q 006563 549 EYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kI~DFGla~~~ 625 (640)
|-+++ -+|++++.+.. ....+...+..++.+|++.+.-||..+ +.|+|+.+.|||++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97764 68888875432 224567777899999999999999988 999999999999986666 999999987754
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.30 E-value=3e-06 Score=74.30 Aligned_cols=85 Identities=22% Similarity=0.389 Sum_probs=58.8
Q ss_pred EEEecCC-eEEecCC-CceEEeeccccC-CCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCc
Q 006563 84 LNVTSKG-IVLLDGR-DRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (640)
Q Consensus 84 l~~~~~G-L~l~d~~-~~~vWst~~~~~-~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~ 160 (640)
+....+| +++.+.. +.++|++++... .....+.|.++|||||++. .+.++|+| +|-
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S-----~t~--------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS-----NTT--------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe-----ccc---------------
Confidence 3345688 8888765 579999998643 2236789999999999986 36789997 110
Q ss_pred eEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeec
Q 006563 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRA 201 (640)
Q Consensus 161 ~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~ 201 (640)
...|.|.+.|+.+|+..++-. .....|.+
T Consensus 83 -----------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S 111 (114)
T smart00108 83 -----------GANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111 (114)
T ss_pred -----------CCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence 124568899999998655422 23466765
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.6e-06 Score=70.19 Aligned_cols=72 Identities=38% Similarity=0.756 Sum_probs=54.9
Q ss_pred CccceeeeccCCCCCcceecccCChhHHHHHhhc-CCCceeeecccCCCCCceeeecc-cccccceeecCCCcceeEE
Q 006563 328 DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLWF-GDLMDMKEYNDGGQDLYIR 403 (640)
Q Consensus 328 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~lyir 403 (640)
..|..+.++.+++..... ....++++|++.|+. +|+|.||.|.. ++.+|.+|. +.+.+.+..+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 458888888888654432 346799999999999 99999999853 456899999 7777776455556666665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.5e-07 Score=97.10 Aligned_cols=149 Identities=25% Similarity=0.311 Sum_probs=117.5
Q ss_pred hhccccccccccccCceeEEEEEec--CCcEEEEEEcccCCchhhHh--HHHHHHHHhhC-CCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGSGQGMEE--FKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~--~g~~VavK~l~~~~~~~~~~--f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (640)
.+.+|..+..||.+.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+.+....+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888889999999999987654 36678888876553322222 24566666666 5899999888888888888
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeecccee
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARI 624 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla~~ 624 (640)
+-.||++++++...+ .....++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987655 22334778888899999999999999876 9999999999999876 8899999999964
Q ss_pred c
Q 006563 625 F 625 (640)
Q Consensus 625 ~ 625 (640)
+
T Consensus 417 ~ 417 (524)
T KOG0601|consen 417 L 417 (524)
T ss_pred c
Confidence 3
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.2e-06 Score=73.04 Aligned_cols=81 Identities=21% Similarity=0.364 Sum_probs=57.6
Q ss_pred CC-eEEecCC-CceEEeeccccC-CCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCceEEEe
Q 006563 89 KG-IVLLDGR-DRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSS 165 (640)
Q Consensus 89 ~G-L~l~d~~-~~~vWst~~~~~-~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~~~l~S 165 (640)
+| |++.+.. ++++|++|+... .....+.|.++|||||.+. .+.++|||=-
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~~-------------------------- 82 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSSNT-------------------------- 82 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEecc--------------------------
Confidence 78 8888754 579999998642 3456789999999999986 4678999721
Q ss_pred ccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecC
Q 006563 166 WKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (640)
Q Consensus 166 ~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~ 202 (640)
..+.+.+.+.|+.+|+..++-. .....|.+.
T Consensus 83 -----~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 113 (116)
T cd00028 83 -----TRVNGNYVLVLLDDGNLVLYDS-DGNFLWQSF 113 (116)
T ss_pred -----cCCCCceEEEEeCCCCEEEECC-CCCEEEcCC
Confidence 0124668899999998655422 245567654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.2e-06 Score=80.00 Aligned_cols=61 Identities=21% Similarity=0.109 Sum_probs=53.3
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+|.+++... ...+++..+..++.||++||+|||+.+ ||+|||+++++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 6888888643 235899999999999999999999864 999999999999999 999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-05 Score=77.76 Aligned_cols=140 Identities=17% Similarity=0.209 Sum_probs=85.0
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc--eeeeEeEEEeCCeeEEEEEccCCCC-
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYEYMPNKS- 555 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 555 (640)
..|++|..+.||+. .+...++|...... ......+|.+++..+..-. +.+.+++....+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999983 24566778766432 3345688999998886433 4667777777777889999999863
Q ss_pred hhHHHh--------------------hccccCCCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCceEecccC
Q 006563 556 LDFFIF--------------------DQARATFLDWQKRIH-IVG----------GIAR-GILYLHQ-DSRMRIIHRDLK 602 (640)
Q Consensus 556 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivH~Dlk 602 (640)
+...+. +...........+.. +.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 000000011111000 000 0111 1222221 123457899999
Q ss_pred CCCEEEcCCCceEEeeecccee
Q 006563 603 ASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~ 624 (640)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-06 Score=86.38 Aligned_cols=96 Identities=25% Similarity=0.310 Sum_probs=79.4
Q ss_pred HHHhhCCCCceeeeEeEEEeC-----CeeEEEEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006563 521 TLIARLQHRNLVKLLGCCIQA-----DESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRM 594 (640)
Q Consensus 521 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 594 (640)
.-|-.+.|.|||+++.++.+. .+..++.|||+-|+|..+|++... ...+......++.-||+.||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345556799999999998654 347899999999999999976543 23455666668899999999999996 58
Q ss_pred ceEecccCCCCEEEcCCCceEEe
Q 006563 595 RIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 595 ~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
+|+|+++..+.|++..++.+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999998885
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.1e-06 Score=77.89 Aligned_cols=106 Identities=22% Similarity=0.206 Sum_probs=84.0
Q ss_pred HHHHHHHhhCCC-CceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006563 517 KNEVTLIARLQH-RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (640)
Q Consensus 517 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (640)
.+|..+|..+++ +++.+++|.|- .++|.||...+++......-..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 69999999993 3689999988766321000011123689999999999999999999876566
Q ss_pred eEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+..+|++|+|+-+++++++|+.|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999887653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.6e-05 Score=85.29 Aligned_cols=142 Identities=15% Similarity=0.221 Sum_probs=90.6
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhh---------------------------H----------hHHHHHH
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM---------------------------E----------EFKNEVT 521 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~---------------------------~----------~f~~E~~ 521 (640)
+.|+..+.|.||+|++++|+.||||.-++.-+... + +|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57999999999999999999999998765421110 0 1334443
Q ss_pred HHh----hCCCCce---eeeEeEEE-eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006563 522 LIA----RLQHRNL---VKLLGCCI-QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593 (640)
Q Consensus 522 ~l~----~l~H~ni---v~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 593 (640)
-.. .+.|-++ |++=.++. -...+.|+||||+|..+.+...-... .++-.....-+.++.--+-+-| +
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~--G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT--G- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc--C-
Confidence 332 2335551 11222222 23468999999999888665432222 2444444333333333333333 2
Q ss_pred CceEecccCCCCEEEcC----CCceEEeeeccceeccC
Q 006563 594 MRIIHRDLKASNVLLDN----DMNPKISDFGMARIFGG 627 (640)
Q Consensus 594 ~~ivH~Dlkp~NILl~~----~~~~kI~DFGla~~~~~ 627 (640)
.+|+|-.|.||++.. +..+.+-||||.+.+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999983 67899999999988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.5e-06 Score=97.07 Aligned_cols=111 Identities=24% Similarity=0.373 Sum_probs=74.3
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|..+++|..|+||.||..+++. .+.+|.|+-+++. ..++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence 3677788899999999999998876 5667774332210 0011 22222233333
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+-...+.... .++- +.+.+++|||..+ |+|||+||.|.||+.-+++|+.||||.+..
T Consensus 136 ---gDc~tllk~~g---~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcccCC---CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 33333332211 1211 2277899999987 999999999999999999999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.6e-06 Score=89.46 Aligned_cols=149 Identities=21% Similarity=0.272 Sum_probs=113.7
Q ss_pred ccccccccc--cCceeEEEEEe---cCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEE
Q 006563 475 FASYNKLGE--GGFGPVYKGTL---VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESML 546 (640)
Q Consensus 475 f~~~~~lg~--G~fg~Vy~g~l---~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 546 (640)
|.....+|. |.+|.+|.+.. .++..+|+|+-+.. .++....=.+|+...++++ |+|.++....+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 444467898 99999999987 34778898873322 2233333356777777774 9999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR----GILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGM 621 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGl 621 (640)
-+|++. .+|..+.... ...++......+..+..+ ||..+|... ++|-|+||.||++.++ ...++.|||+
T Consensus 196 qtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999886 5666665332 223555556666667777 999999987 9999999999999998 8999999999
Q ss_pred ceeccCCc
Q 006563 622 ARIFGGDE 629 (640)
Q Consensus 622 a~~~~~~~ 629 (640)
...++...
T Consensus 270 v~~i~~~~ 277 (524)
T KOG0601|consen 270 VSKISDGN 277 (524)
T ss_pred eEEccCCc
Confidence 99987554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.1e-05 Score=74.64 Aligned_cols=141 Identities=14% Similarity=0.164 Sum_probs=85.9
Q ss_pred cccccCc-eeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccCCCChh
Q 006563 480 KLGEGGF-GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (640)
Q Consensus 480 ~lg~G~f-g~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 557 (640)
.|..|.. ..||+.... +..+.+|+..... ...+..|++++..+. +.-+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 788998764 4677888765432 345678888888874 444567787776666789999999998775
Q ss_pred HHHh-------------------hccc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 006563 558 FFIF-------------------DQAR-ATFLD--WQKRIHIVG--------------------GIARGILYLHQ----D 591 (640)
Q Consensus 558 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 591 (640)
.... .... ..... ...++.-.. .+.+.+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 3310 0000 00010 001110000 01111222211 1
Q ss_pred CCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 592 ~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..+.++|+|+.|.|||++++....|.||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999988889999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.2e-06 Score=91.00 Aligned_cols=81 Identities=26% Similarity=0.381 Sum_probs=72.7
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++.|+++...+|.++|.++......++...+.++.|++.|++| ++ .+|+|+||.||....+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877776778899999999999999999 54 899999999999999999999999999
Q ss_pred eeccCCc
Q 006563 623 RIFGGDE 629 (640)
Q Consensus 623 ~~~~~~~ 629 (640)
..+...+
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8876555
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00019 Score=70.84 Aligned_cols=144 Identities=20% Similarity=0.206 Sum_probs=85.1
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCC--ceeeeEeEEEeC---CeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGCCIQA---DESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~Ey~~~ 553 (640)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++...... ...+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578899999999999877 68899986543 4556778888888887532 356677655433 346899999999
Q ss_pred CChhH----------------HHh---hc-cccCCCCHHHH---------HHH------------HHHHHH-HHHHHHh-
Q 006563 554 KSLDF----------------FIF---DQ-ARATFLDWQKR---------IHI------------VGGIAR-GILYLHQ- 590 (640)
Q Consensus 554 gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~- 590 (640)
..+.. .+. .. .......+... ... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88766 111 01 00011111110 000 111222 2333332
Q ss_pred ---CCCCceEecccCCCCEEEc-CCCceEEeeeccceec
Q 006563 591 ---DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIF 625 (640)
Q Consensus 591 ---~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~~ 625 (640)
..+..++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00024 Score=68.76 Aligned_cols=138 Identities=15% Similarity=0.194 Sum_probs=87.0
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHh---------HHHHHHHHhhCC---CCceeeeEeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE---------FKNEVTLIARLQ---HRNLVKLLGCCI 539 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~---------f~~E~~~l~~l~---H~niv~l~g~~~ 539 (640)
.++|...+++.......|.+-.. +++...+|..........+. ..+++..+.+++ -...+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45666666666666666666555 45677778765432221111 223444444443 233333333332
Q ss_pred e-----CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 540 Q-----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 540 ~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
. ....+|+|||+++-.|.++.. ++. .++..++++|.-||+.+ +.|+|..|+|++++++ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2 234568999999987754431 221 24556788899999998 9999999999999865 49
Q ss_pred EEeeeccceec
Q 006563 615 KISDFGMARIF 625 (640)
Q Consensus 615 kI~DFGla~~~ 625 (640)
++.||+..+..
T Consensus 174 ~iID~~~k~~~ 184 (229)
T PF06176_consen 174 RIIDTQGKRMS 184 (229)
T ss_pred EEEECcccccc
Confidence 99999988754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00017 Score=70.65 Aligned_cols=155 Identities=15% Similarity=0.189 Sum_probs=97.4
Q ss_pred cchHhHHHhhccccccc---cccccCceeEEEEEecCCcEEEEEEcccCCchhh---------Hh---------------
Q 006563 463 FDFASIAKATDNFASYN---KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM---------EE--------------- 515 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~---~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~---------~~--------------- 515 (640)
.+...+....+...... .|.+|.-+.||+|.-.++..+|||+......... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444544444443333 4567888999999888899999999864321110 01
Q ss_pred HHHHHHHHhhCC--CCceeeeEeEEEeCCeeEEEEEccCCCCh-hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006563 516 FKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592 (640)
Q Consensus 516 f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 592 (640)
...|..-|.++. +-.+.+-+++. +-.|||||+...-. .-.|. ...+...+...+..++++.|.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 124455555542 33444444432 34799999965421 11111 111222245566778888888887733
Q ss_pred CCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
.+||+||+.-|||+. ++.+.|+|||-|..+..+
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 399999999999999 889999999999877543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00063 Score=65.59 Aligned_cols=134 Identities=15% Similarity=0.238 Sum_probs=89.2
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCC----------------chhhHhHHHHHHHHhhCC------CCceeeeE
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------------GQGMEEFKNEVTLIARLQ------HRNLVKLL 535 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv~l~ 535 (640)
...||+|+.-.||. +++....+||++.... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35899999999994 5666677888877554 122455666666554444 89999999
Q ss_pred eEEEeCCeeEEEEEccCC--C----ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 536 GCCIQADESMLIYEYMPN--K----SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 536 g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
|+.....-.-+|+|...+ | +|.+++.+. .++. .. ...+-+=..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999988888899997643 3 466666332 2444 22 223334445666665 99999999999994
Q ss_pred CC---C-ceEEee-ecccee
Q 006563 610 ND---M-NPKISD-FGMARI 624 (640)
Q Consensus 610 ~~---~-~~kI~D-FGla~~ 624 (640)
.. . .+.|.| ||-...
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ecCCCceEEEEEeCCCCccc
Confidence 32 2 466665 444443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00065 Score=80.28 Aligned_cols=78 Identities=19% Similarity=0.397 Sum_probs=56.4
Q ss_pred cccccccCceeEEEEEecCC---cEEEEEEcccCC-chhhHhHHHHHHHHhhCC-CCce--eeeEeEEEeC---CeeEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVEG---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNL--VKLLGCCIQA---DESMLI 547 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g---~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 547 (640)
...++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788899999999877654 356777654322 123356889999999995 6654 7888888764 357899
Q ss_pred EEccCCCC
Q 006563 548 YEYMPNKS 555 (640)
Q Consensus 548 ~Ey~~~gs 555 (640)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00076 Score=67.21 Aligned_cols=140 Identities=17% Similarity=0.200 Sum_probs=75.8
Q ss_pred ccccccCce-eEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCC---ceeeeEeEEEeC---CeeEEEEEcc
Q 006563 479 NKLGEGGFG-PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCIQA---DESMLIYEYM 551 (640)
Q Consensus 479 ~~lg~G~fg-~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 551 (640)
+.|+.|+.. .||+. +..+.+|.... ......+..|.+++..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467766665 58864 23566676443 22345788899998877521 233444443322 1348899999
Q ss_pred CCCChhHH---------------H---hhccccC--C-----------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 006563 552 PNKSLDFF---------------I---FDQARAT--F-----------L-DWQKRI--HIV-------GGIARG-ILY-L 588 (640)
Q Consensus 552 ~~gsL~~~---------------l---~~~~~~~--~-----------l-~~~~~~--~i~-------~~ia~g-L~y-L 588 (640)
++.++... + +.-.... . + .|.... .+. .+.+.. ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776321 1 1000000 0 0 121110 000 011111 111 1
Q ss_pred Hh--CCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 589 HQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 589 H~--~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+. ..+..++|+|+.+.|||++++...-|.||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1233489999999999999876678999998865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.002 Score=66.59 Aligned_cols=77 Identities=10% Similarity=0.070 Sum_probs=55.9
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC---CceeeeEeEEEeC---CeeEEEEEc
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH---RNLVKLLGCCIQA---DESMLIYEY 550 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~Ey 550 (640)
..+.|+.|..+.||+-...+++ +.+|..+.. .....|..|.+.|+.+.- ..+.+++++|..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3457999999999998766664 555664321 123578899999988853 4678888887543 568999999
Q ss_pred cCCCCh
Q 006563 551 MPNKSL 556 (640)
Q Consensus 551 ~~~gsL 556 (640)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0021 Score=63.87 Aligned_cols=142 Identities=18% Similarity=0.243 Sum_probs=80.2
Q ss_pred ccccccCceeEEEEEecC--CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEEccCCCC
Q 006563 479 NKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
+.|..|-...+|+....+ ++.+.+|+....... .-.-..|+.++..+...++ .++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456777778999987764 567888876543221 1223468888888753333 34444332 248999999877
Q ss_pred hhHH--------------Hh---hcccc--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 006563 556 LDFF--------------IF---DQARA--------TFLD-WQKRIHIVG----------------------GIARGILY 587 (640)
Q Consensus 556 L~~~--------------l~---~~~~~--------~~l~-~~~~~~i~~----------------------~ia~gL~y 587 (640)
+... +. ..... .... |.....+.. .+.+-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 10 00000 0111 111111110 11111112
Q ss_pred H----HhC-CCCceEecccCCCCEEEcC-CCceEEeeeccceec
Q 006563 588 L----HQD-SRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (640)
Q Consensus 588 L----H~~-~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~ 625 (640)
| ... .+..++|+|+.+.|||+++ +..+.|.||..|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 2 111 2345999999999999998 578999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0026 Score=68.00 Aligned_cols=75 Identities=13% Similarity=0.229 Sum_probs=53.7
Q ss_pred ccccccCceeEEEEEecCC-cEEEEEEcccC-----C--chhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeEEE
Q 006563 479 NKLGEGGFGPVYKGTLVEG-QEIAVKRLSKG-----S--GQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g-~~VavK~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 547 (640)
+.||.|.+..||+....+| +.|.||.-... . +...+.+..|.+.|..+. ...+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999999877 58999974321 1 123456777888877752 3456677776 44557899
Q ss_pred EEccCCCC
Q 006563 548 YEYMPNKS 555 (640)
Q Consensus 548 ~Ey~~~gs 555 (640)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0023 Score=61.37 Aligned_cols=125 Identities=26% Similarity=0.432 Sum_probs=90.0
Q ss_pred ccccccccccccCc-eeEEEEEecCCcEEEEEEccc---CC---------c---------hhhHhHHHHHHHHhhCC---
Q 006563 473 DNFASYNKLGEGGF-GPVYKGTLVEGQEIAVKRLSK---GS---------G---------QGMEEFKNEVTLIARLQ--- 527 (640)
Q Consensus 473 ~~f~~~~~lg~G~f-g~Vy~g~l~~g~~VavK~l~~---~~---------~---------~~~~~f~~E~~~l~~l~--- 527 (640)
.+++.++.||.|.- |.|+|.++ +|+.+|+|.... .. . ...+.|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999998 567999998221 00 0 12346889999988886
Q ss_pred CCce--eeeEeEEEeCC------------------eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHH
Q 006563 528 HRNL--VKLLGCCIQAD------------------ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587 (640)
Q Consensus 528 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 587 (640)
+.++ |+-+|+..-.. ...||.||.+... .+. .+-+.++.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 88999874321 1357778776532 111 2235577888899
Q ss_pred HHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 588 LH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 4588999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.003 Score=55.20 Aligned_cols=99 Identities=23% Similarity=0.412 Sum_probs=64.1
Q ss_pred CEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEe-cCCCCCCCCcceEEEecCC-eEEecCCCceEEeecccc
Q 006563 31 ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVA-NRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSI 108 (640)
Q Consensus 31 ~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~A-nr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~ 108 (640)
+.+.+.+|.+.|-|-.-++ | +.|+. ..++||.. +...+.. ....+.|.++| |+|.|..+.++|++...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----L-vl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----L-VLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----E-EEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred cccccccccccceECCCCe-----E-EEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence 3455545888888866542 2 22332 35779999 4333332 45789999999 99999999999999532
Q ss_pred CCCCceEEEee--cccEEEEeCCCCceeeeeccCCC
Q 006563 109 TMKNPVVQLMD--SGNLVLTDGNYNSLLWQSFDHPC 142 (640)
Q Consensus 109 ~~~~~~a~Lld--sGNlVl~~~~~~~~lWQSFd~PT 142 (640)
...+.+..++ .||++ ... ...+.|.|=+.|+
T Consensus 82 -ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 -PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS 114 (114)
T ss_dssp -SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred -CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence 4567777887 89998 543 3568898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0025 Score=64.41 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=77.2
Q ss_pred cccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEEccCCCChhH
Q 006563 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKSLDF 558 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 558 (640)
.+..|-...+|+.. .+++.+++|..........-...+|.++++.+....+ .++++.. ...+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 34557777889887 3566788887554322211235778888888854333 3344432 2368999999866532
Q ss_pred H--------------Hh---hcc-ccCCCCHHHHH-HHHHH---------HHHHHHHHHhC-----CCCceEecccCCCC
Q 006563 559 F--------------IF---DQA-RATFLDWQKRI-HIVGG---------IARGILYLHQD-----SRMRIIHRDLKASN 605 (640)
Q Consensus 559 ~--------------l~---~~~-~~~~l~~~~~~-~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlkp~N 605 (640)
. +. ... ....++...++ ....+ +.+-+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11 110 01112222111 11101 11112222111 12358999999999
Q ss_pred EEEcCCCceEEeeecccee
Q 006563 606 VLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 606 ILl~~~~~~kI~DFGla~~ 624 (640)
|++++++ ++|.||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0042 Score=57.83 Aligned_cols=128 Identities=21% Similarity=0.248 Sum_probs=83.1
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceee-eEeEEEeCCeeEEEEEccCCCCh
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK-LLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
.+.|++|.+|.||+|.+.. .++|+|.-...+ ....+..|++++..+.-.++.. ++.+- +..+.|||..+-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 3589999999999998854 588888765433 3467889999999988666543 33332 23455999999888
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC-CCCEEEcCCCceEEeeeccceec
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK-ASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kI~DFGla~~~ 625 (640)
.+.-... +-+. ...+++.---|...+ |-|..|. |...+|-.+..+.|+||.-|..-
T Consensus 100 ~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 6654221 2222 223444422233333 7777775 34444444459999999999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0093 Score=61.55 Aligned_cols=143 Identities=20% Similarity=0.202 Sum_probs=85.8
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCC--ceeeeEeE------EEeCCeeEEEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGC------CIQADESMLIYE 549 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 549 (640)
.+.|..|....+|+....+ ..+++|+... ...++...|++++..+.+. .+.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999887644 4677887754 2234566778877777433 24444432 123445689999
Q ss_pred ccCCCChhH----HH----------hhc----c----ccCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 006563 550 YMPNKSLDF----FI----------FDQ----A----RATFLDWQKRIH----------IVGGIARGILYLHQ----DSR 593 (640)
Q Consensus 550 y~~~gsL~~----~l----------~~~----~----~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 593 (640)
|+++..+.. .. +.. . ......|..... ....+...+.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876531 10 000 0 001123332211 11123445555553 122
Q ss_pred CceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 594 ~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0081 Score=62.25 Aligned_cols=141 Identities=25% Similarity=0.317 Sum_probs=81.1
Q ss_pred cccccCceeEEEEEecC-------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEEcc
Q 006563 480 KLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~-------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~ 551 (640)
.+..|--..+|+....+ ++.+++|+..... ........|.+++..+....+ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 44555556888887654 4778888865432 223445678888877753333 345555432 3689999
Q ss_pred CCCChhHH-------H----------hhcccc--------CCCCHHHHHH--------------------------HHHH
Q 006563 552 PNKSLDFF-------I----------FDQARA--------TFLDWQKRIH--------------------------IVGG 580 (640)
Q Consensus 552 ~~gsL~~~-------l----------~~~~~~--------~~l~~~~~~~--------------------------i~~~ 580 (640)
++..+... + ++.... ...-|..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766321 0 000000 0000111100 1112
Q ss_pred HHHHHHHHHh------CCCCceEecccCCCCEEEcCC----CceEEeeeccceec
Q 006563 581 IARGILYLHQ------DSRMRIIHRDLKASNVLLDND----MNPKISDFGMARIF 625 (640)
Q Consensus 581 ia~gL~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kI~DFGla~~~ 625 (640)
+.+-+.+|.. ..+..++|+|+.|.|||++++ ..++++||..|..-
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 2223334432 234568999999999999884 78999999999753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.022 Score=59.48 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=75.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC--CceeeeEe------EEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLG------CCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 550 (640)
+.|..|....+|+....+| .+++|+..... .+....|+.++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566677778998876555 57788765222 2333344455544421 12333332 11224567899999
Q ss_pred cCCCChhH-----H------H---hhcc--------ccCCCCH-HHHHHH------------H-HHHHHHHHHHHhC---
Q 006563 551 MPNKSLDF-----F------I---FDQA--------RATFLDW-QKRIHI------------V-GGIARGILYLHQD--- 591 (640)
Q Consensus 551 ~~~gsL~~-----~------l---~~~~--------~~~~l~~-~~~~~i------------~-~~ia~gL~yLH~~--- 591 (640)
+++..+.. . | +... ....+.| .....- . ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 1 0000 0011222 221111 1 1111222333211
Q ss_pred -CCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 592 -~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
-+..+||+|+.|.|||++++...-|.||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776678999998863
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0017 Score=51.80 Aligned_cols=49 Identities=14% Similarity=0.352 Sum_probs=35.2
Q ss_pred eeccCCCCCcceecccCChhHHHHHhhcCCCceeeecccCCCCCceeeecccc
Q 006563 334 VKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGD 386 (640)
Q Consensus 334 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~ 386 (640)
.+++++..+..... ..+.++|+..|+.+|+|.||.|.. +...|+++...
T Consensus 10 ~~~~~~g~d~~~~~-~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTVF-ASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCcceee-cCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 45555554444332 568999999999999999999853 34579987653
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.028 Score=59.42 Aligned_cols=141 Identities=17% Similarity=0.253 Sum_probs=78.7
Q ss_pred cccccCceeEEEEEecC-----CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCcee-eeEeEEEeCCeeEEEEEccCC
Q 006563 480 KLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
.+..|-.-.+|+....+ ++.+.+|+.........+ -..|.+++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34445566788876533 357888877654333333 26788888877544443 455654322 58999987
Q ss_pred CChhHH-------H----------hhcc-c-cC-CCCHHHHHHHHH-----------------HHHHHHHHH----Hh-C
Q 006563 554 KSLDFF-------I----------FDQA-R-AT-FLDWQKRIHIVG-----------------GIARGILYL----HQ-D 591 (640)
Q Consensus 554 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~-----------------~ia~gL~yL----H~-~ 591 (640)
.+|... + +... . .. ...|.+...... .+...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776321 0 0000 0 00 111222212111 111112222 21 2
Q ss_pred CCCceEecccCCCCEEEcC-CCceEEeeeccceec
Q 006563 592 SRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (640)
Q Consensus 592 ~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~ 625 (640)
.+..++|+|+++.|||+++ +..+++.||..|..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2346899999999999986 468999999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.074 Score=55.22 Aligned_cols=144 Identities=21% Similarity=0.235 Sum_probs=81.5
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC--CceeeeEeEE------EeCCeeEEEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCC------IQADESMLIYE 549 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~------~~~~~~~lV~E 549 (640)
...++.|.-..+|+....++ ...+|+..... ..++...|.+++..|.. -.+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34667777788998876555 46678765421 12345566666666632 2234444321 12345789999
Q ss_pred ccCCCChh----H-------HH---hhccc------c---CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 006563 550 YMPNKSLD----F-------FI---FDQAR------A---TFLDWQKRIH------------IVGGIARGILYLHQ---- 590 (640)
Q Consensus 550 y~~~gsL~----~-------~l---~~~~~------~---~~l~~~~~~~------------i~~~ia~gL~yLH~---- 590 (640)
|+++..+. . .+ +.... . ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885532 0 01 10000 0 0112221111 11123445555543
Q ss_pred CCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 591 ~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..+..++|+|+.+.||+++++....|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2235699999999999999887779999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.04 Score=56.46 Aligned_cols=74 Identities=20% Similarity=0.302 Sum_probs=47.6
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
..+.++-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+.+.+++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34578888889999877 567889999865 233456788888777773 55677888888777778999999987
Q ss_pred C
Q 006563 554 K 554 (640)
Q Consensus 554 g 554 (640)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.035 Score=56.70 Aligned_cols=32 Identities=25% Similarity=0.496 Sum_probs=26.8
Q ss_pred CceEecccCCCCEEEcCCCc-eEEeeeccceec
Q 006563 594 MRIIHRDLKASNVLLDNDMN-PKISDFGMARIF 625 (640)
Q Consensus 594 ~~ivH~Dlkp~NILl~~~~~-~kI~DFGla~~~ 625 (640)
..++|+|+.|.|||+++++. .-|.||+.+.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997554 579999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.084 Score=54.63 Aligned_cols=128 Identities=16% Similarity=0.302 Sum_probs=76.1
Q ss_pred CcEEEEEEccc--CCchhhHhHHHHHHHHhhCC--CCceeeeEeEEEeCC--eeEEEEEccCCCCh---------h-HHH
Q 006563 497 GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQAD--ESMLIYEYMPNKSL---------D-FFI 560 (640)
Q Consensus 497 g~~VavK~l~~--~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~--~~~lV~Ey~~~gsL---------~-~~l 560 (640)
++...++ ... ..........+|.++|+.+. -.-+.+.++.|.++. ..+.||||.++..+ . .+.
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 5666666 321 12233445667888888774 344556778887766 67999999987322 1 111
Q ss_pred h--------h---c--------------cccCCCCHHHHHHHHH--------HHHHHHHHHHhC-----CCCceEecccC
Q 006563 561 F--------D---Q--------------ARATFLDWQKRIHIVG--------GIARGILYLHQD-----SRMRIIHRDLK 602 (640)
Q Consensus 561 ~--------~---~--------------~~~~~l~~~~~~~i~~--------~ia~gL~yLH~~-----~~~~ivH~Dlk 602 (640)
. . - ..+..-.|......+. ....-..+|++. .++.++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 1 0 0 0011122222221111 122334555543 34569999999
Q ss_pred CCCEEEcCCCceEEeeeccceec
Q 006563 603 ASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~ 625 (640)
+.|++++.+...-|.||+++.+=
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999988999999999863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.02 Score=58.39 Aligned_cols=143 Identities=17% Similarity=0.199 Sum_probs=92.0
Q ss_pred cchHhHHHhhc---cccccccccccCceeEEEEEecCCcEEEEEEcccC--------------------Cch--hhHhHH
Q 006563 463 FDFASIAKATD---NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--------------------SGQ--GMEEFK 517 (640)
Q Consensus 463 ~~~~~l~~~~~---~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--------------------~~~--~~~~f~ 517 (640)
++|-.|+...+ -++..+.||-|.-+.||.+...+|++.++|.-... +.. ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 55555554433 35667899999999999999988998887732110 000 011245
Q ss_pred HHHHHHhhCC-C-CceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006563 518 NEVTLIARLQ-H-RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (640)
Q Consensus 518 ~E~~~l~~l~-H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (640)
+|...|..|. | --+.+.+.+ +..++|||++.+-.|...- ...+..+.+.-+ ..-+.-|..++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~l---m~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDL---MGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHH---HHHHHHHHHcC---
Confidence 6777787774 2 223333433 4567899999887764322 122333333333 33344455566
Q ss_pred eEecccCCCCEEEcCCCceEEeeecc
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
+||+|..--||+++++..++++||=-
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ceecccchheeEEecCCCEEEeechH
Confidence 99999999999999999999999963
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.17 Score=53.28 Aligned_cols=72 Identities=15% Similarity=0.222 Sum_probs=46.9
Q ss_pred cccccCceeEEEEEecCC-cEEEEEEcccC------C-chhhHhHHHHHHHHhhCC--CC-ceeeeEeEEEeCCeeEEEE
Q 006563 480 KLGEGGFGPVYKGTLVEG-QEIAVKRLSKG------S-GQGMEEFKNEVTLIARLQ--HR-NLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g-~~VavK~l~~~------~-~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 548 (640)
.||.|....||++..+++ +.|+||.-... + +-..++..-|.+.|.... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998664 58999964321 1 223445556777776552 23 34445544 455667999
Q ss_pred EccCC
Q 006563 549 EYMPN 553 (640)
Q Consensus 549 Ey~~~ 553 (640)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.0034 Score=72.36 Aligned_cols=148 Identities=16% Similarity=0.177 Sum_probs=95.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEccc---CCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.+.+...+-+.++.++.++...-.. |...++|.... ...+..+....+-.+....+||-+++..--+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 4556666777888888888764322 32223322221 1122233333333333334566666655555566778999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|..+++|...|+... ..+..-....+..+.++++|||... +.|+|++|.|+|...++..+++|||+.+..
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999988775433 1222222234456788999999865 899999999999999999999999965543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.0037 Score=68.49 Aligned_cols=142 Identities=15% Similarity=0.108 Sum_probs=95.2
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc-eeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 549 (640)
.+..+...+..+++++++++|.+-...+....+.+... .+..-++++|.+++||| .+..++-+..+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34444445678899999999886544444444444321 45567889999999999 7777777766777899999
Q ss_pred ccCCC-C-hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNK-S-LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~g-s-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++..+ + ..... .....+.......+.+.-+++++|||+.. -+|+| |||..+ ...|..||+.+..+.+
T Consensus 315 i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence 99877 2 11100 11112333344455566788999999864 58998 777766 5889999999887754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 384 ~ 384 (829)
T KOG0576|consen 384 T 384 (829)
T ss_pred c
Confidence 3
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.36 Score=51.75 Aligned_cols=73 Identities=14% Similarity=0.137 Sum_probs=48.2
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCC---c----hhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS---G----QGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~---~----~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 547 (640)
.+.||.|.--.||+... +++.+.||+-.... . ...+.-..|.+.|..+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 35789999999999776 45578898754211 1 12333344556555443 357788888876 456789
Q ss_pred EEccCC
Q 006563 548 YEYMPN 553 (640)
Q Consensus 548 ~Ey~~~ 553 (640)
|||++.
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.21 Score=52.21 Aligned_cols=137 Identities=23% Similarity=0.334 Sum_probs=80.0
Q ss_pred CceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc------eeeeEeEEE--eCC--eeEEEEEccCCC
Q 006563 485 GFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCI--QAD--ESMLIYEYMPNK 554 (640)
Q Consensus 485 ~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~--~~~--~~~lV~Ey~~~g 554 (640)
.--.+|+....+|+. ++|..... ....++..|+..|..+.-.. +..+-|-.. -.. ..+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888877776 77777654 33456666777776663111 222222211 123 678899999988
Q ss_pred ChhH-H----Hh-------------------hccccCCCCHHH---H----------HHHHHHHHHHHHHHHhC------
Q 006563 555 SLDF-F----IF-------------------DQARATFLDWQK---R----------IHIVGGIARGILYLHQD------ 591 (640)
Q Consensus 555 sL~~-~----l~-------------------~~~~~~~l~~~~---~----------~~i~~~ia~gL~yLH~~------ 591 (640)
.+.. . ++ +........|.. + .....++...+..+++.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8762 1 10 011112344541 0 11223344444444433
Q ss_pred -CCCceEecccCCCCEEEcCCCc-eEEeeecccee
Q 006563 592 -SRMRIIHRDLKASNVLLDNDMN-PKISDFGMARI 624 (640)
Q Consensus 592 -~~~~ivH~Dlkp~NILl~~~~~-~kI~DFGla~~ 624 (640)
....+||+|+.|.||+++++.. +.+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1123999999999999999884 99999998763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.054 Score=52.89 Aligned_cols=30 Identities=33% Similarity=0.523 Sum_probs=21.8
Q ss_pred ceEecccCCCCEEE-cCCCceEEeeecccee
Q 006563 595 RIIHRDLKASNVLL-DNDMNPKISDFGMARI 624 (640)
Q Consensus 595 ~ivH~Dlkp~NILl-~~~~~~kI~DFGla~~ 624 (640)
-++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.16 Score=52.87 Aligned_cols=140 Identities=19% Similarity=0.205 Sum_probs=91.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCC-------c--hh-------------hH----hHHHHHHHHhhCCCCcee
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-------G--QG-------------ME----EFKNEVTLIARLQHRNLV 532 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~-------~--~~-------------~~----~f~~E~~~l~~l~H~niv 532 (640)
.-|..|.-+.||.+.-.+|..+|||+++... . .+ .+ -...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577899999999999999999999875320 0 00 00 123456666666543332
Q ss_pred eeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 533 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
.---.. -....|||+|+....- -........+.......+-.+++.-|.-|.+.| ++||.||.--|+|+.+ +
T Consensus 230 ~PePIl--Lk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 230 CPEPIL--LKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCcee--eecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 110000 0123699999863221 111112234666677788889999999999887 5999999999999965 5
Q ss_pred ceEEeeeccceecc
Q 006563 613 NPKISDFGMARIFG 626 (640)
Q Consensus 613 ~~kI~DFGla~~~~ 626 (640)
.+.|+|.+-+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 89999998877653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.23 Score=52.13 Aligned_cols=141 Identities=16% Similarity=0.213 Sum_probs=75.5
Q ss_pred cccccCceeEEEEEecC----CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCcee-eeEeEEEeCCeeEEEEEccCCC
Q 006563 480 KLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
.|..|=--.+|+....+ +..+.+|+........ -.-.+|..++..+...++. +++++...+ +|.||+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 34334455677776543 2378888766543322 2235788888887655543 556655322 589999776
Q ss_pred ChhH-------HH----------hhcc-c--cCCCCHHHHHHHHH----------------------HHHHHHH----HH
Q 006563 555 SLDF-------FI----------FDQA-R--ATFLDWQKRIHIVG----------------------GIARGIL----YL 588 (640)
Q Consensus 555 sL~~-------~l----------~~~~-~--~~~l~~~~~~~i~~----------------------~ia~gL~----yL 588 (640)
.|.. .+ +... . ...--|....+... .+.+-+. ++
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6521 11 0100 0 00111222211111 1111122 22
Q ss_pred Hh-CCCCceEecccCCCCEEEcC-CCceEEeeeccceec
Q 006563 589 HQ-DSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (640)
Q Consensus 589 H~-~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~ 625 (640)
.. ..+.-.+|+|+.+.|||+++ +..++++||..|..-
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11 12234789999999999974 578999999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.18 Score=53.69 Aligned_cols=74 Identities=11% Similarity=0.141 Sum_probs=48.8
Q ss_pred cccccccCceeEEEEEecC-CcEEEEEEcccC-----C-chhhHhHHHHHHHHhhCC--CC-ceeeeEeEEEeCCeeEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----S-GQGMEEFKNEVTLIARLQ--HR-NLVKLLGCCIQADESMLI 547 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-----~-~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV 547 (640)
.+.||.|.-..||++.... ++.|+||.-... + +-..++..-|.+.|+... -| .+.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3588999999999999853 568999864321 1 223455666777776553 23 35556554 45556789
Q ss_pred EEccCC
Q 006563 548 YEYMPN 553 (640)
Q Consensus 548 ~Ey~~~ 553 (640)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.66 Score=48.03 Aligned_cols=30 Identities=27% Similarity=0.403 Sum_probs=25.8
Q ss_pred CceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 594 ~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..++|+|+.+.||+++. ..+.|.||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 46899999999999988 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.31 Score=51.46 Aligned_cols=135 Identities=14% Similarity=0.177 Sum_probs=83.3
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEE-------EeCCeeEEEE
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC-------IQADESMLIY 548 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~ 548 (640)
....||+|+-+.+|----. +.. +.|++..-......+ .++.|.+. .||-+..-+.+= ..+...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3468999999999953211 122 346665443322222 23344444 465544312111 1112245666
Q ss_pred EccCCCC-hhHHHh---hccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 549 EYMPNKS-LDFFIF---DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 549 Ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
..+++.. ...++. ++......+|...++.++.+|.+.+-||+.+ .+-+|+.++|+|+.++..+.+.|=
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 6665532 222322 1223446899999999999999999999998 888999999999998888777653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 640 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 9e-92
Identities = 72/188 (38%), Positives = 101/188 (53%), Gaps = 14/188 (7%)
Query: 463 FDFASIAKATDNF------ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQG 512
F F + T+NF NK+GEGGFG VYKG + +AVK+L+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
++F E+ ++A+ QH NLV+LLG D+ L+Y YMPN SL + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I G A GI +LH++ IHRD+K++N+LLD KISDFG+AR
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 633 NTHKVVGT 640
T ++VGT
Sbjct: 191 MTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 4e-89
Identities = 77/183 (42%), Positives = 109/183 (59%), Gaps = 9/183 (4%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVT 521
F + A+DNF++ N LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGG 580
+I+ HRNL++L G C+ E +L+Y YM N S+ + ++ + LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KV 637
ARG+ YLH +IIHRD+KA+N+LLD + + DFG+A++ +TH V
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK----DTHVTTAV 195
Query: 638 VGT 640
GT
Sbjct: 196 RGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 7e-82
Identities = 70/182 (38%), Positives = 109/182 (59%), Gaps = 10/182 (5%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
+ +AT+NF +G G FG VYKG L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-LDWQKRIHIVGGI 581
++ +H +LV L+G C + +E +LIY+YM N +L ++ T + W++R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KVV 638
ARG+ YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + TH V
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD---QTHLSTVVK 202
Query: 639 GT 640
GT
Sbjct: 203 GT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-62
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ 511
H + ++ + G FG V+K + + +AVK Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ 61
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIYEYMPNKSLDFFIFDQARAT 567
+ + EV + ++H N+++ +G + + LI + SL F+ +A
Sbjct: 62 SWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KAN 116
Query: 568 FLDWQKRIHIVGGIARGILYLHQD-------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ W + HI +ARG+ YLH+D + I HRD+K+ NVLL N++ I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 621 MARIFGGDEIQTNTHKVVGT 640
+A F + +TH VGT
Sbjct: 177 LALKFEAGKSAGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-54
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 23/196 (11%)
Query: 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT 521
E + + DN +G G +G VYKG+L + + +AVK S + Q K +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIY 59
Query: 522 LIARLQHRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
+ ++H N+ + + + +L+ EY PN SL ++ DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115
Query: 577 IVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--- 627
+ + RG+ YLH + + I HRDL + NVL+ ND ISDFG++ G
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 628 ---DEIQTNTHKVVGT 640
E VGT
Sbjct: 176 VRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-49
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGME 514
D + + + + K+G G FG V++ G ++AVK L + + +
Sbjct: 28 DGDDMDIPWCDLNIK-------EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN 79
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF EV ++ RL+H N+V +G Q ++ EY+ SL + LD ++R
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ + +A+G+ YLH I+HR+LK+ N+L+D K+ DFG++R+ + + +
Sbjct: 140 LSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 635 HKVVGT 640
GT
Sbjct: 199 --AAGT 202
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNE 519
F + + LG+G FG K T G+ + +K L + + F E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
V ++ L+H N++K +G + I EY+ +L I W +R+
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAK 115
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
IA G+ YLH M IIHRDL + N L+ + N ++DFG+AR+ ++ Q +
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+G G FG V K +++A+K++ S + F E+ ++R+ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + + ++G+ YLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 599 RDLKASNVLLDNDMN-PKISDFGMARIFGGDEIQTNTHKVVGT 640
RDLK N+LL KI DFG A +IQT+ G+
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQGMEE 515
L E DFA + +G GGFG VY+ G E+AVK Q +E
Sbjct: 1 LLEIDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIEN 52
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
+ E L A L+H N++ L G C++ L+ E+ L+ + + +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILV 108
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMARIFGG 627
+ IARG+ YLH ++ + IIHRDLK+SN+L+ + KI+DFG+AR +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 628 DEIQTNT 634
+
Sbjct: 169 TTKMSAA 175
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 30/195 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG----- 512
L I ++G+GGFG V+KG LV+ +A+K L G +G
Sbjct: 12 RLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 513 --MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+EF+ EV +++ L H N+VKL G ++ E++P L + D+A +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IK 120
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIF 625
W ++ ++ IA GI Y+ I+HRDL++ N+ L + + K++DFG+++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 626 GGDEIQTNTHKVVGT 640
+ + ++G
Sbjct: 178 ---QSVHSVSGLLGN 189
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 7/151 (4%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KL E G ++KG +G +I VK L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 537 CCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C LI +MP SL + + +D + + +ARG+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
I L + +V++D DM +IS + F
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAV 502
+KK ++ + WE I ++G G FG VYKG ++AV
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKW--HGDVAV 51
Query: 503 KRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI 560
K L+ + Q ++ FKNEV ++ + +H N++ +G + ++ ++ SL +
Sbjct: 52 KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL 110
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
A T + +K I I ARG+ YLH IIHRDLK++N+ L D KI DFG
Sbjct: 111 --HASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 621 MARIFGGDEIQTNTHKVVGT 640
+A ++ G+
Sbjct: 166 LATEKSRWSGSHQFEQLSGS 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 20/197 (10%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
K S ++ W+ F + +G+G FG VY G E+A++ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRW--HGEVAIRLIDIE 66
Query: 509 --SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ ++ FK EV + +H N+V +G C+ +I ++L + +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAK 124
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
LD K I I +G+ YLH I+H+DLK+ NV DN I+DFG+ I G
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGLFSISG 180
Query: 627 GDEIQTNTHK---VVGT 640
+ K G
Sbjct: 181 VLQAGRREDKLRIQNGW 197
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G +G V++G+ +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + S LI Y SL +D + T LD + IV IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGT 640
+ I HRDLK+ N+L+ + I+D G+A + +++ + VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 21/175 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
++G+G +G V+ G G+++AVK + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
I+ S LI +Y N SL +D ++T LD + + + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGT 640
+ I HRDLK+ N+L+ + I+D G+A F +E+ + VGT
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVK 503
M ED + +F+ + +LG+G FG V G+ +AVK
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 504 RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIF 561
+L + + + +F+ E+ ++ LQH N+VK G C A LI EY+P SL ++
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL- 135
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
Q +D K + I +G+ YL R IHRDL N+L++N+ KI DFG+
Sbjct: 136 -QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 622 ARIFGGDE 629
++ D+
Sbjct: 192 TKVLPQDK 199
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G FG V++G G+E+AVK S + + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + + L+ +Y + SL FD + + I + A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGT 640
+ I HRDLK+ N+L+ + I+D G+A D I + VGT
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
+F+ + +LG+G FG V G+ +AVK+L + + + +
Sbjct: 5 TQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ LQH N+VK G C A LI EY+P SL ++ Q +D K
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIK 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I +G+ YL R IHRDL N+L++N+ KI DFG+ ++ D+
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
F+ + ++LG+G FG V G +AVK+L +
Sbjct: 18 TIFEERHLKYI-------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ L +VK G L+ EY+P+ L F+ Q LD +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASR 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I +G+ YL R +HRDL A N+L++++ + KI+DFG+A++ D+
Sbjct: 129 LLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 20/177 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F+ + + LGEG FG V G+++AVK L SG +
Sbjct: 16 THFEKRFLKRI-------RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ K E+ ++ L H N+VK G C + + LI E++P+ SL ++ ++ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLK 126
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+++ I +G+ YL + +HRDL A NVL++++ KI DFG+ + D+
Sbjct: 127 QQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 55/177 (31%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F + K LGEG FG V G+ +AVK L +G Q
Sbjct: 26 TVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS 78
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+K E+ ++ L H +++K GCC A + L+ EY+P SL ++ +
Sbjct: 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLA 134
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ + I G+ YLH IHRDL A NVLLDND KI DFG+A+
Sbjct: 135 QLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 59/185 (31%), Positives = 87/185 (47%), Gaps = 30/185 (16%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +++ +LGE FG VYKG L + Q +A+K L G
Sbjct: 2 KLKEISLSAVRFM-------EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF------------ 559
EEF++E L ARLQH N+V LLG + +I+ Y + L F
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D+ + L+ +H+V IA G+ YL S ++H+DL NVL+ + +N KISD
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISD 171
Query: 619 FGMAR 623
G+ R
Sbjct: 172 LGLFR 176
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 29/189 (15%)
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSK 507
M + + I +LGEG FG V+ + +AVK L
Sbjct: 3 MHSGIHVQHIKRRDIVLK-------RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD 55
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------- 559
+ ++F+ E L+ LQH ++VK G C D ++++EYM + L+ F
Sbjct: 56 PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 560 -----IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ L + +HI IA G++YL + +HRDL N L+ ++
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLV 172
Query: 615 KISDFGMAR 623
KI DFGM+R
Sbjct: 173 KIGDFGMSR 181
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D + I +LGEG FG V+ + +AVK L + S
Sbjct: 32 DACVHHIKRRDIVLK-------WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF----------- 559
++F+ E L+ LQH+++V+ G C + ++++EYM + L+ F
Sbjct: 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
+ L + + + +A G++YL + + +HRDL N L+ + KI D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGD 201
Query: 619 FGMAR 623
FGM+R
Sbjct: 202 FGMSR 206
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV---EGQEI--AVKRLSKGSG-QGME 514
F + K LG G FG V+KG + E +I +K + SG Q +
Sbjct: 8 RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+ + I L H ++V+LLG C L+ +Y+P SL + + L Q
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLL 117
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
++ IA+G+ YL ++HR+L A NVLL + +++DFG+A + D+ Q
Sbjct: 118 LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 635 HK 636
+
Sbjct: 175 SE 176
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 14/171 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKN 518
W + + ++G G FG V+ G L + +AVK + +F
Sbjct: 109 WVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ 161
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ + H N+V+L+G C Q ++ E + F+ + L + + +V
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMV 219
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
G A G+ YL IHRDL A N L+ KISDFGM+R
Sbjct: 220 GDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W D + + ++G G FG V+ G + ++A+K + +G+ E+F E
Sbjct: 3 WVIDPSELTFV-------QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L H LV+L G C++ L+ E+M + L ++ + + + + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ G+ YL +IHRDL A N L+ + K+SDFGM R D+
Sbjct: 113 VCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEI--AVKRLSKGSGQGMEEFKN 518
WE + I +KLG G +G VY+G + + AVK L + + + +EEF
Sbjct: 8 WEMERTDITMK-------HKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLK 58
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMA 117
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
E I +LG G FG V G ++AVK + +GS +EF E
Sbjct: 3 MELKREEITLL-------KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
+ +L H LVK G C + ++ EY+ N L ++ ++ L+ + + +
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ G+ +L + IHRDL A N L+D D+ K+SDFGM R D+
Sbjct: 113 VCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D + +LG G FG V G ++A+K + +GS +EF E
Sbjct: 19 WEIDPKDLTFL-------KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEA 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ L H LV+L G C + +I EYM N L ++ + Q+ + +
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKD 128
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ + YL + +HRDL A N L+++ K+SDFG++R DE
Sbjct: 129 VCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 38/187 (20%), Positives = 80/187 (42%), Gaps = 28/187 (14%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--------VEGQEIAVKRLSKGSGQ 511
+ + LG+G F ++KG + E+ +K L K
Sbjct: 2 FHKIRNEDLIFN-------ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDW 571
E F +++++L H++LV G C+ DE++L+ E++ SLD ++ + ++
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINI 112
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMAR 623
++ + +A + +L +IH ++ A N+LL + + K+SD G++
Sbjct: 113 LWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 624 IFGGDEI 630
+I
Sbjct: 170 TVLPKDI 176
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 16 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 65
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 124
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ + YL +HRDL A NVL+ D K+SDFG+ +
Sbjct: 125 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G +AVK L + + + +EEF E
Sbjct: 215 WEMERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 325
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I+ + YL + IHR+L A N L+ + K++DFG++R+ GD
Sbjct: 326 QISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 188 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 237
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 296
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ + YL +HRDL A NVL+ D K+SDFG+ +
Sbjct: 297 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + +F E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +HRDL A N +LD K++DFG+AR
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+ WE I + +LG+G FG VY+G +A+K +++ S +
Sbjct: 18 DEWEVAREKITMS-------RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------IFDQA 564
EF NE +++ ++V+LLG Q +++I E M L + + +
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR- 623
K I + G IA G+ YL + + +HRDL A N ++ D KI DFGM R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 624 IFGGD 628
I+ D
Sbjct: 188 IYETD 192
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
++ +E D + LGEG FG V +G L ++AVK +
Sbjct: 20 EELQNKLEDVVIDRNLLILG-------KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL 72
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESMLIYEYMPNKSLDFFI 560
S + +EEF +E + H N+++LLG CI+ + M+I +M L ++
Sbjct: 73 DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 561 ---FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ + Q + + IA G+ YL S +HRDL A N +L +DM ++
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVA 189
Query: 618 DFGMAR-IFGGD 628
DFG+++ I+ GD
Sbjct: 190 DFGLSKKIYSGD 201
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
E + + I +G G G V G L +A+K L G + +
Sbjct: 44 REIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD 96
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E +++ + H N+++L G + +M++ EYM N SLD F+ + + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLV 154
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
++ G+ G+ YL S + +HRDL A NVL+D+++ K+SDFG++R+ D
Sbjct: 155 GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE S+ KLG G FG V+ T + ++AVK + GS +E F E
Sbjct: 183 WEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEA 234
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ LQH LVKL + + +I E+M SL F+ + K I
Sbjct: 235 NVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQ 292
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
IA G+ ++ + IHRDL+A+N+L+ + KI+DFG+AR+ +E
Sbjct: 293 IAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G ++ +A+K L +G+ EE E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HRDL A NVLL N KISDFG+++ G D+
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 13/169 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ +LG G FG V+ G ++AVK L +GS + F E
Sbjct: 8 WEVPRETLKLV-------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEA 59
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
L+ +LQH+ LV+L Q + +I EYM N SL F+ + L K + +
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQ 117
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
IA G+ ++ IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E
Sbjct: 118 IAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G+G FG VY G ++ + A+K LS+ + +E F E L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+G + + ++ YM + L FI ++ + I +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +HRDL A N +LD K++DFG+AR
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 26/193 (13%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
+KE +E LG+G FG V + L ++AVK L
Sbjct: 9 DELKEKLEDVLIPEQQFTLG-------RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES------MLIYEYMPNKSLDFF 559
+ +EEF E + H ++ KL+G +++ M+I +M + L F
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 560 IFD---QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
+ L Q + + IA G+ YL S IHRDL A N +L DM +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178
Query: 617 SDFGMAR-IFGGD 628
+DFG++R I+ GD
Sbjct: 179 ADFGLSRKIYSGD 191
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 28/183 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE---IAVKRLSKG-SGQGME 514
D+ I + +GEG FG V K + + A+KR+ + S
Sbjct: 18 IYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------------I 560
+F E+ ++ +L H N++ LLG C L EY P+ +L F
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ A+ L Q+ +H +ARG+ YL S+ + IHRDL A N+L+ + KI+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 621 MAR 623
++R
Sbjct: 188 LSR 190
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ +HRDL A N +LD K++DFG+AR
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 50/175 (28%), Positives = 88/175 (50%), Gaps = 18/175 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGME 514
E + + + +G G FG VYKG L +A+K L G + +
Sbjct: 39 TEIHPSCVTRQ-------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV 91
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+F E ++ + H N+++L G + M+I EYM N +LD F+ + + +
Sbjct: 92 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQL 149
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ ++ GIA G+ YL + M +HRDL A N+L+++++ K+SDFG++R+ D
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 17/174 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSG-QGMEE 515
E D +I+ +G G FG V G L + +A+K L G + +
Sbjct: 40 KELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E +++ + H N+++L G ++ M++ EYM N SLD F+ + + +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLV 150
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
++ GIA G+ YL S M +HRDL A N+L+++++ K+SDFG+ R+ D
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 23 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMAR 623
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 18/174 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 10 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLI 119
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R
Sbjct: 120 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 48/176 (27%), Positives = 70/176 (39%), Gaps = 20/176 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--VEGQEI--AVKRLSKG---SGQGM 513
+ KLG+G FG V +G G+ + AVK L + M
Sbjct: 13 CLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++F EV + L HRNL++L G + ++ E P SL + +
Sbjct: 66 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGT 122
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+A G+ YL R IHRDL A N+LL KI DFG+ R ++
Sbjct: 123 LSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-S 509
D WEF + LG G FG V + + +AVK L +G +
Sbjct: 18 DASKWEFPRDRLKLG-------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 70
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSL-DF-------- 558
+E+ ++ + H N+V LLG C + M+I E+ +L +
Sbjct: 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 559 ----FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ FL + I +A+G+ +L + + IHRDL A N+LL
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 615 KISDFGMAR 623
KI DFG+AR
Sbjct: 188 KICDFGLAR 196
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 18/174 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+ + LGEG FG VY+G +G++I AVK K + E+
Sbjct: 7 YGIAREDVVLN-------RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 59
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E ++ L H ++VKL+G + + + +I E P L ++ + L +
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLV 116
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I + + YL + +HRD+ N+L+ + K+ DFG++R ++
Sbjct: 117 LYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG ++ AVK L +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EES 136
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HRDL A NVLL KISDFG+++ DE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 64 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 116
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMAR 623
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 34/193 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 30 WEFPRDKLTLG-------KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 618 DFGMAR-IFGGDE 629
DFG+AR I D
Sbjct: 200 DFGLARDINNIDY 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-32
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G + ++I A+K L +G+ + EE E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+HR+L A NVLL N KISDFG+++ G D+
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-32
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 177 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 228
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 286
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 287 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 479 NKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNL 531
+GEG FG V++ +AVK L + S +F+ E L+A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF---------------------IFDQARATFLD 570
VKLLG C L++EYM L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD 628
+++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 260 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 311
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 369
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 370 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 39/198 (19%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LGEG FG V K T +AVK L + S +
Sbjct: 18 WEFPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF-------------- 558
+ +E ++ ++ H +++KL G C Q +LI EY SL F
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
D L I I++G+ YL + M+++HRDL A N+L+
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGR 187
Query: 613 NPKISDFGMAR-IFGGDE 629
KISDFG++R ++ D
Sbjct: 188 KMKISDFGLSRDVYEEDS 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 34/193 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 76 WEFPRDKLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 618 DFGMAR-IFGGDE 629
DFG+AR I D
Sbjct: 246 DFGLARDINNIDY 258
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 18/174 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 385 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLI 494
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 52/191 (27%), Positives = 76/191 (39%), Gaps = 30/191 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
E WEF ++ LG G FG V + T ++AVK L
Sbjct: 39 EKWEFPRNNLQFG-------KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-----------DFF 559
E +E+ +++ L QH N+V LLG C ++I EY L +
Sbjct: 92 EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 560 IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
+ + +H +A+G+ +L + IHRD+ A NVLL N KI DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 620 GMAR-IFGGDE 629
G+AR I
Sbjct: 209 GLARDIMNDSN 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 49/186 (26%), Positives = 73/186 (39%), Gaps = 33/186 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V + T +AVK L
Sbjct: 18 WEFPRNRLSFG-------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL---------------D 557
E +E+ +++ L H N+V LLG C +++I EY L
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ LD + + +A+G+ +L + IHRDL A N+LL + KI
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKIC 187
Query: 618 DFGMAR 623
DFG+AR
Sbjct: 188 DFGLAR 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WE + LGEG FG V + ++AVK L + +
Sbjct: 64 WELPRDRLVLG-------KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 116
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ L + + +ARG+ YL + + IHRDL A NVL+ D KI+
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 618 DFGMAR 623
DFG+AR
Sbjct: 234 DFGLAR 239
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 28/185 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+F +G GGFG V+K ++G+ +KR+ + E+ + EV +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 532 VKLLGCCIQADESM----------------LIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
V GC D + E+ +L+ +I ++ R LD +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ D +T
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 636 KVVGT 640
+ GT
Sbjct: 180 RSKGT 184
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 38/191 (19%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V T ++AVK L +
Sbjct: 40 WEFPRENLEFG-------KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF------------- 558
E +E+ ++ +L H N+V LLG C + LI+EY L ++
Sbjct: 93 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
+ ++ L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGK 209
Query: 613 NPKISDFGMAR 623
KI DFG+AR
Sbjct: 210 VVKICDFGLAR 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
+F LG GGFG V++ V+ A+KR+ E+ EV +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 531 LVKLLGCCI---------QADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V+ + + + +Y + ++L ++ + + +HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
IA + +LH ++HRDLK SN+ D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 23/178 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDW--QKRIHIVGGIA 582
N+V+ + ++ +Y L I Q F LDW Q I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--------IC 135
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ ++H +I+HRD+K+ N+ L D ++ DFG+AR+ +GT
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 9/151 (5%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEGGF V L +G A+KR+ Q EE + E + H N+++L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 539 IQADESM----LIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++ + L+ + +L + + + FL + + ++ GI RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
HRDLK +N+LL ++ P + D G
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY G L IA+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRMR 595
+ + E +P S + R+ + + +G + IL YLH +
Sbjct: 90 ENGFIKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 596 IIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HRD+K NVL++ KISDFG ++ G T T GT
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 25/177 (14%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+NF K+GEG +G VYK + G+ +A+K++ ++ E++L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIHIVGGI 581
L H N+VKLL ++ L++E++ K D + T + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+G+ + H R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 10/173 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
NF K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILY 587
N++K I+ +E ++ E L I + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+H R++HRD+K +NV + K+ D G+ R F ++ +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 31/179 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK +G+ +A+KR+ ++ E++L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L H N+V L+ L++E+M K LD ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ RG+ + H + RI+HRDLK N+L+++D K++DFG+AR F G +++ TH+VV
Sbjct: 128 -LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 12/166 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+H DLK +N L+ + K+ DFG+A D VGT
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 28/193 (14%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+F LG+G FG V K ++ + A+K++ + + +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI---------FD--QARATFLDWQKRIHIVG 579
+V+ ++ + + KS F +D + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF------------GG 627
I + Y+H IIHRDLK N+ +D N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 628 DEIQTNTHKVVGT 640
N +GT
Sbjct: 181 PGSSDNLTSAIGT 193
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 12/166 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+H DLK +N L+ + K+ DFG+A D VGT
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH++
Sbjct: 109 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN- 160
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
R+IHRDLK N+ L+ D+ KI DFG+A D
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 41/180 (22%), Positives = 81/180 (45%), Gaps = 32/180 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ K+GEG +G V+K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIV 578
L+H+N+V+L + L++E+ K D D +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ +G+ + H ++HRDLK N+L++ + K+++FG+AR F G ++ + +VV
Sbjct: 110 --LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 31/179 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK G+ A+K++ +E+ E++++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L+H N+VKL +L++E++ K LD + A Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ GI Y H R++HRDLK N+L++ + KI+DFG+AR F G ++ TH++V
Sbjct: 109 -LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 18/150 (12%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH
Sbjct: 83 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH--- 132
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
R R+IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K +G+ + K L G + + +EV L+ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
H+ D ++HRDLK +NV LD N K+ DFG+ARI D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 12/202 (5%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQ 498
+ ++H + L SY K+GEG G V G+
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMV--VDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 499 EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
++AVK + Q E NEV ++ QH N+V++ + +E ++ E++ +L
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT- 130
Query: 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D L+ ++ + + + + YLH +IHRD+K+ ++LL D K+SD
Sbjct: 131 ---DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 619 FGMARIFGGDEIQTNTHKVVGT 640
FG D + + +VGT
Sbjct: 185 FGFCAQISKDVPKRKS--LVGT 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 16/169 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
++G G F VYKG E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 537 CCIQADESM----LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+ L+ E M + +L ++ R + + I +G+ +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 593 RMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRDLK N+ + + KI D G+A + + V+GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGT 193
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 12/166 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+H DLK +N L+ + K+ DFG+A D VG
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+G+G G VY V GQE+A+++++ E NE+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V L + DE ++ EY+ SL D T +D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 29/180 (16%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSL---DFFIFDQARATFLDWQKRIHIV 578
L H N++ LL L++++M + + + + +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM------ 120
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+G+ YLHQ I+HRDLK +N+LLD + K++DFG+A+ F G + TH+VV
Sbjct: 121 --TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 36/186 (19%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIA 524
++ F KLG G + VYKG G +A+K + S +G E++L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA-- 582
L+H N+V+L ++ L++E+M D ++D + + G+
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM----------DNDLKKYMDSRTVGNTPRGLELN 108
Query: 583 ----------RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+G+ + H +I+HRDLK N+L++ K+ DFG+AR F G + T
Sbjct: 109 LVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT 164
Query: 633 NTHKVV 638
+ +VV
Sbjct: 165 FSSEVV 170
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 8/170 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLLG + ++ E+ P ++D I + + Q ++ + + + +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G F VY+ + G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D + L+ E N + + R + H + I G+LYLH
Sbjct: 79 YF--EDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
I+HRDL SN+LL +MN KI+DFG+A
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 40/186 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
D + KLGEG +G VYK V + +A+KR+ +E + EV+L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH------I 577
LQHRN+++L LI+EY + ++D +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQT 632
+ + G+ + H R +HRDLK N+LL KI DFG+AR F G I+
Sbjct: 138 LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 633 NTHKVV 638
TH+++
Sbjct: 194 FTHEII 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 28/173 (16%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNLVKLLG 536
++G G FG V++ G + AVK++ +E F+ E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 537 CCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + E + SL + RA ++ +G G+ YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT- 168
Query: 592 SRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHK---VVGT 640
RI+H D+KA NVLL +D + + DFG A D + + + GT
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 10/155 (6%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
L EGGF VY+ + G+E A+KRL + EV + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 538 CIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
E L+ + L F+ L + I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
+ IIHRDLK N+LL N K+ DFG A
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-25
Identities = 45/182 (24%), Positives = 75/182 (41%), Gaps = 17/182 (9%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQ 527
+ + +LG GGFG V + + G+++A+K+ + E + E+ ++ +L
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 528 HRNLVKLL------GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
H N+V D +L EY L ++ L ++ I
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + YLH+ RIIHRDLK N++L + KI D G A+ E + V
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184
Query: 639 GT 640
GT
Sbjct: 185 GT 186
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARL 526
+ + +KLGEG + VYKG +A+K + +G EV+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVGGI 581
+H N+V L L++EY+ + LD I + +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
RG+ Y H R +++HRDLK N+L++ K++DFG+AR +T ++VV
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 32/180 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL + L++EY + LD + + + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + + H+ IHRD+K N+L+ K+ DFG AR+ +V
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 32/180 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL C + L++E++ + L+ F D +Q
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ------ 132
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I GI + H IIHRD+K N+L+ K+ DFG AR + +V
Sbjct: 133 --IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 42/210 (20%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS 509
M+ + +E D + K+G+G FG V+K + + A+K++
Sbjct: 1 MAKQYDSVECPFCDEV------SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--- 51
Query: 510 GQGMEEFKN--------EVTLIARLQHRNLVKLLGCCIQADESM--------LIYEYMPN 553
ME K E+ ++ L+H N+V L+ C L++++ +
Sbjct: 52 ---MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108
Query: 554 --KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L F + + ++ + G+ Y+H R +I+HRD+KA+NVL+ D
Sbjct: 109 DLAGL----LSNVLVKFTLSEIK-RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRD 160
Query: 612 MNPKISDFGMARIFG---GDEIQTNTHKVV 638
K++DFG+AR F + T++VV
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 33/179 (18%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLSK----------------GSGQGMEE-FKNEV 520
L +G F + L E + A+K+ K S + + FKNE+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 521 TLIARLQHRNLVKLLGCCIQADESM--LIYEYMPNKSL-----DFFIFDQARATFLDWQK 573
+I +++ + G I + +IYEYM N S+ FF+ D+ F+ Q
Sbjct: 95 QIITDIKNEYCLTCEG--IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
I+ + Y+H + I HRD+K SN+L+D + K+SDFG + +I+
Sbjct: 153 IKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 52/170 (30%), Positives = 87/170 (51%), Gaps = 10/170 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ F KLGEG +G VYK E GQ +A+K++ ++E E++++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + ++ EY S+ I + R L + I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
MR IHRD+KA N+LL+ + + K++DFG+A + NT V+GT
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHRN 530
+ + +G G FG V++ LVE E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 531 LVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+V L + L+ EY+P ++ + + L + ++ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY---QL 150
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVV 638
R + Y+H + I HRD+K N+LLD K+ DFG A+I + N +
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC 203
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS 509
M+ L E D +++ F +G G +G VYKG V+ GQ A+K + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVT 60
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGC------CIQADESMLIYEYMPNKSL-DFFIF 561
G EE K E+ ++ + HRN+ G D+ L+ E+ S+ D +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LI 118
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
+ L + +I I RG+ +LHQ ++IHRD+K NVLL + K+ DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 622 ARIFGGDEIQTNTHKVVGT 640
+ + NT +GT
Sbjct: 176 SAQLDRTVGRRNT--FIGT 192
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 35/189 (18%)
Query: 470 KATDNFASYNKLGEGGFGPVYKG--TLVEGQEIAVKRLSKGSGQGMEEFKN--------E 519
+A + ++GEG +G V+K G+ +A+KR+ ++ + E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61
Query: 520 VTLIARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPN--KSLDFFIFDQARATFL 569
V ++ L+ H N+V+L C + L++E++ + D+ +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGV 117
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ ++ + RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173
Query: 630 IQTNTHKVV 638
T VV
Sbjct: 174 -MALTSVVV 181
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 41/197 (20%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++D E + K +F + LG G G + + + +++AVKR+ +
Sbjct: 6 SLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---EC 60
Query: 513 MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARATFL 569
EV L+ +H N+++ C + D + E +L ++ + +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624
+ I ++ G+ +LH + I+HRDLK N+L+ + ISDFG+ +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 625 FGGDEIQTNTHK-VVGT 640
+ V GT
Sbjct: 173 LAVGRHSFSRRSGVPGT 189
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S K S + ++ EV + +L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + + + + + + G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH +IHRD+KA N+LL K+ DFG A N+ VGT
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGT 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHR 529
+ F K+G+G FG V+KG + +A+K + + +E+ + E+T++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+ K G ++ + +I EY+ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ IHRD+KA+NVLL K++DFG+A +I+ NT VGT
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 37/191 (19%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQ-GMEEFKN----EVTLI 523
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 524 ARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
RL+ H N+V+L+ C + L++E++ DQ T+LD
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPP 115
Query: 576 HIVGG--------IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ RG+ +LH + I+HRDLK N+L+ + K++DFG+ARI+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 628 DEIQTNTHKVV 638
T VV
Sbjct: 173 Q--MALTPVVV 181
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 29/189 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNL 531
+ S LG G G V +G+ +AVKR+ + E+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
++ C D + + E N +L + I ++ IA G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDN-------------DMNPKISDFGMARIFGGDE--IQ 631
+LH ++IIHRDLK N+L+ ++ ISDFG+ + + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 632 TNTHKVVGT 640
TN + GT
Sbjct: 187 TNLNNPSGT 195
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 24/161 (14%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 529 RNLVKLLGCCIQADES--MLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
N+++L G D + LI EY P ++ + FD+ R + +
Sbjct: 69 PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE--------L 118
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
A + Y H R+IHRD+K N+LL + KI+DFG +
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 12/167 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ G E +K ++K Q E + E+ ++ L H N++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
++ E L + + QAR L ++ + + Y H +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 597 IHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+H+DLK N+L + KI DFG+A +F DE T GT
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---NAAGT 189
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 21/189 (11%)
Query: 463 FDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE 515
FD + S+ LG G FG V+K G ++A K + + EE
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQK 573
KNE++++ +L H NL++L ++ +L+ EY+ L FD+ + L
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQ 631
I + I GI ++HQ M I+H DLK N+L N KI DFG+AR + E
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 632 TNTHKVVGT 640
GT
Sbjct: 246 K---VNFGT 251
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 35/179 (19%), Positives = 60/179 (33%), Gaps = 27/179 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QH 528
+F ++LG G +G V+K +G+ AVKR + EV ++ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 529 RNLVKLLGCCIQADESMLIY-EYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGI 581
V+L + + + E SL +A+
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD--------T 166
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +LH ++H D+K +N+ L K+ DFG+ G G
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGD 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG GG VY + ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ D L+ EY+ +L +I L I+ I GI + H MR
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HRD+K N+L+D++ KI DFG+A+ + T T+ V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGT 175
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWE-FDFASIAKATDNFASY----NKLGEGGFGPVYKGTL 494
+ + K G + K ++W+ + + + Y +LG G FG V++
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 495 VE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553
G+ K ++ KNE++++ +L H L+ L E +LI E++
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 554 KSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L FD+ A + + I+ + G+ ++H+ I+H D+K N++ +
Sbjct: 133 GEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 612 MNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
KI DFG+A DEI T
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKV---TTAT 213
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
D++ +G G V +++A+KR++ + M+E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + DE L+ + + S+ + ++ LD I+ + G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHK--VVGT 640
YLH + IHRD+KA N+LL D + +I+DFG+ A + G +I N + VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 19/188 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFK 517
+ + + LG+G FG V K QE AVK ++K +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRI 575
EV L+ +L H N++KL + ++ E L FD+ R F +
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA- 124
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQT 632
I+ + GI Y+H+ I+HRDLK N+LL + D + KI DFG++ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 633 NTHKVVGT 640
+GT
Sbjct: 182 ---DRIGT 186
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 5e-22
Identities = 25/194 (12%), Positives = 53/194 (27%), Gaps = 38/194 (19%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-------- 528
LG+ + T G+ V +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 529 --------RNLVKLLGCC-----IQADESMLIYEY---MPNKSLDFF-----IFDQARAT 567
+LVK + M + P + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 568 -FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 627 GDEIQTNTHKVVGT 640
G + +
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 36/191 (18%), Positives = 58/191 (30%), Gaps = 28/191 (14%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
+ ++ LGEG F VY+ T Q+ +K + EF L+ R
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120
Query: 526 LQ---HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF--LDWQKRIHIVGG 580
L+ +K + + S+L+ E +L I + I
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----------KISDFGMARIFGGDE 629
+ I +H IIH D+K N +L N + D G +
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 630 IQTNTHKVVGT 640
T T
Sbjct: 238 KGTIFTAKCET 248
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 42/160 (26%), Positives = 65/160 (40%), Gaps = 28/160 (17%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG +G V + AVK L K G K E+ L+ RL+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 536 GCCIQADESM--LIYEYMPNKSLDFFIF--------DQARATFLDWQKRIHIVGGIARGI 585
++ ++ EY + QA F Q ++ G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--CQ----LIDGLE--- 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
YLH I+H+D+K N+LL KIS G+A
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 9e-22
Identities = 22/179 (12%), Positives = 39/179 (21%), Gaps = 36/179 (20%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
L G V+ VE ++ A+K + S +E ARL + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 537 CC--------------------------IQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+L+ F F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 569 -LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
+ + R L ++H N+ + D + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 41/182 (22%), Positives = 71/182 (39%), Gaps = 21/182 (11%)
Query: 469 AKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ Y N +G G +G V A K++ K + ++ FK E+ ++
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGI 581
L H N+++L + L+ E L F++ + F + I+ +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA-RIMKDV 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ Y H+ + + HRDLK N L D K+ DFG+A F ++ V
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKV 169
Query: 639 GT 640
GT
Sbjct: 170 GT 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 19/196 (9%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--S 509
H + + + LG+G FG V K QE AVK ++K
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EV L+ +L H N++KL + ++ E L FD R
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKR 117
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + I+ + GI Y+H+ I+HRDLK N+LL++ D + KI DFG++
Sbjct: 118 FSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 625 FGGDEIQTNTHKVVGT 640
F + +GT
Sbjct: 174 FQQNTKM---KDRIGT 186
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 25/179 (13%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N+V+L + E L+ +Y+P + + + + + ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---Q 164
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVV 638
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ E N +
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 23/175 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVK-----RLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+G+G F V + E GQ+ AVK + + G E+ K E ++ L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDW---QKRIHIVGGIARGILYL 588
LL +++E+M L + RA H + I + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 589 HQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
H IIHRD+K VLL +N K+ FG+A G VGT
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGT 196
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 24/151 (15%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G FG VY + +A+K L K +G+E + E+ + + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 537 CCIQADESM--LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLH 589
D L+ E+ P L + FD+ R+ + +A + Y H
Sbjct: 82 YF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH 131
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
++IHRD+K N+L+ KI+DFG
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYL 588
LV L +E ++IYE+M L F++ + + + + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
H+ +H DLK N++ + K+ DFG+ + + GT
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 39/184 (21%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 537 CCIQADES--MLIYEYM-------------PNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ + L+++Y + + L +Q I
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------I 137
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTH-- 635
GI YLH ++HRDLK +N+L+ + KI+D G AR+F ++
Sbjct: 138 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLD 193
Query: 636 -KVV 638
VV
Sbjct: 194 PVVV 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 444 KKQGLTKMSHMKEDMELWEFDFASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQ 498
++ L ++ ++ I + + KLG G +G V
Sbjct: 10 GRENLYFQGDLQATPGMF------ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 499 EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
E A+K + K S + EV ++ L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 557 DFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---D 611
FD R F + I+ + G+ YLH+ I+HRDLK N+LL++ D
Sbjct: 124 ----FDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGT 640
KI DFG++ +F + + +GT
Sbjct: 176 ALIKIVDFGLSAVFENQKKM---KERLGT 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 19/177 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
+DN+ +LG+G F V + G E A K ++ S + ++ + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + L+++ + L F+ AR + + H + I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
Y H I+HR+LK N+LL K++DFG+A E H GT
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 3e-21
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 24/206 (11%)
Query: 451 MSHMK--EDMELWEFDFASIAKATDNFASYNKLGEG--GFGPVYKGTLVE-GQEIAVKR- 504
M+H L+ +S + +G+G V G+ + V+R
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 505 -LSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
L S + + + E+ + H N+V I +E ++ +M S D
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDL 116
Query: 564 ARATFLDWQKRIHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
F+D + I I +G+L Y+H M +HR +KAS++L+ D +S
Sbjct: 117 ICTHFMDGMNELAI-AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 620 GMARIFGGDEIQTNT-----HKVVGT 640
+ V
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKV 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 33/166 (19%), Positives = 68/166 (40%), Gaps = 16/166 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G FG V++ + K + G K E++++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+E ++I+E++ + F++ A L+ ++ + V + + +LH I
Sbjct: 71 ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 597 IHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
H D++ N++ + KI +FG AR + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 23/185 (12%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEV 520
+ A+ F+ +LG+G F V + G E A K ++ S + ++ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIV 578
+ +LQH N+V+L + L+++ + L F+ AR + + H +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCI 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTH 635
I I Y H I+HR+LK N+LL K++DFG+A E H
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188
Query: 636 KVVGT 640
GT
Sbjct: 189 GFAGT 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGIL 586
LI EY + FD +AR+ F Q I +
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKF--RQ--------IVSAVQ 128
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
Y H + RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-21
Identities = 55/186 (29%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNE 519
+ +T F+ LG+G FG V GQE AVK +SK E E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHI 577
V L+ +L H N++KL L+ E L FD +R F + I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RI 131
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNT 634
+ + GI Y+H+ +I+HRDLK N+LL++ D N +I DFG++ F +
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--- 185
Query: 635 HKVVGT 640
+GT
Sbjct: 186 KDKIGT 191
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 22/173 (12%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G E A K + K G EE + EV+++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A+ L ++ + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGT 640
+I H DLK N++L + P K+ DFG+A N + GT
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
D+ +LG G +G V K V GQ +AVKR+ + + Q + ++ + R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
V G + + + E M + SLD F +D + I I+G IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LH S++ +IHRD+K SNVL++ K+ DFG++ D++ + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGC 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 46/194 (23%), Positives = 73/194 (37%), Gaps = 35/194 (18%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARL-Q 527
T F K+G G FG V+K ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 528 HRNLVKLLGCCIQADESMLIY-EYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGI 585
H ++V+ + D+ MLI EY SL I + R ++ + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARIFG 626
Y+H M ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 627 GDEIQTNTHKVVGT 640
++ G
Sbjct: 185 -----SSPQVEEGD 193
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 15/170 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 536 GCCIQADESMLIY----EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + EY+ +L + + + ++ I ++ + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGT 640
+ IIHRD+K +N+++ K+ DFG+AR T T V+GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 28/188 (14%)
Query: 470 KATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EE 515
+T F LG G V + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 516 FKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQ 572
EV ++ ++ H N+++L L+++ M L FD + T + +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ + I LH+ + I+HRDLK N+LLD+DMN K++DFG + E
Sbjct: 126 TR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 633 NTHKVVGT 640
+V GT
Sbjct: 180 -LREVCGT 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 38/177 (21%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G F V+ G+ A+K + K +NE+ ++ +++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
L+ + + L FD RI ++ + +
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FD-----------RILERGVYTEKDASLVIQQVLSAVK 120
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH+ I+HRDLK N+L + + I+DFG++++ + T GT
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGT 170
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--------MEEFKNEVTLIARL-QHR 529
+G G V + G E AVK + + + E + E ++ ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILY 587
+++ L+ + L+++ M L FD + + + R I+ + + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLLEAVSF 215
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH I+HRDLK N+LLD++M ++SDFG + E ++ GT
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 45/192 (23%), Positives = 73/192 (38%), Gaps = 44/192 (22%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--------FKNEVTL 522
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDW 571
+ +L H ++K+ A++ ++ E M L FD + F
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ- 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGD 628
+ + YLH IIHRDLK NVLL + D KI+DFG ++I G
Sbjct: 123 ---------MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 629 EIQTNTHKVVGT 640
+ + GT
Sbjct: 171 SL---MRTLCGT 179
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 19/177 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
++ ++G G +G V K GQ +AVKR+ S + ++ ++ ++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
+V+ G + + + E M + S D F + + I I+G I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+L ++IIHRD+K SN+LLD N K+ DFG++ +T G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGC 188
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 50/173 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + + F + FD +AR F Q
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF--QQ---- 119
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I+ + Y H R ++HRDLK NVLLD MN KI+DFG++ + E
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 49/181 (27%), Positives = 75/181 (41%), Gaps = 22/181 (12%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIA 524
D + +LG G F V K G E A K + K G EE + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIAR 583
++ H N++ L + +LI E + L FD A+ L ++ + I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVG 639
G+ YLH +I H DLK N++L + P K+ DFG+A N + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 640 T 640
T
Sbjct: 181 T 181
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 36/179 (20%), Positives = 62/179 (34%), Gaps = 56/179 (31%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRNL 531
LG G FG V+ E +E+ VK + K + + E+ +++R++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFI----------FD-----------QARATFLD 570
+K+ + N+ + F A F
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF-- 136
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
Q + + YL IIHRD+K N+++ D K+ DFG A +
Sbjct: 137 RQ--------LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 24/180 (13%), Positives = 53/180 (29%), Gaps = 37/180 (20%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ--------- 527
LG+ + T E G+ V +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 528 ----------------HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFF--IFDQARA- 566
+ ++++ +Y M + F + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRN 530
LG G G V + +++A++ +SK + E+ ++ +L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
++K+ A++ ++ E M L FD+ L + + YLH
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 590 QDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ IIHRDLK NVLL + D KI+DFG ++I G + + GT
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 304
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 49/172 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LGEG FG V T Q++A+K +S+ M + E++ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 537 CCIQADESMLIYEYMPNKSLDFFI--------FD-----------QARATFLDWQKRIHI 577
Y+ + + + FD + R F Q
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ----- 116
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I I Y H R +I+HRDLK N+LLD+++N KI+DFG++ I
Sbjct: 117 ---IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 6e-20
Identities = 49/173 (28%), Positives = 71/173 (41%), Gaps = 22/173 (12%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G+E A K + K G EE + EV ++ ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A L + + I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGT 640
RI H DLK N++L + P K+ DFG+A N + GT
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGT 174
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 50/173 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + S F + FD ++R F Q
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF--QQ---- 124
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
I+ G+ Y H R ++HRDLK NVLLD MN KI+DFG++ + E
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-20
Identities = 34/169 (20%), Positives = 65/169 (38%), Gaps = 23/169 (13%)
Query: 480 KLGEGGFGPVYKG--TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
+ GG G +Y V G+ + +K L G + E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 536 -GCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ Y EY+ +SL +++ L + I + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +++ DLK N++L + K+ D G + + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGT 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 20/172 (11%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538
LGEG V L+ QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ D L++E M S+ R F + + +V +A + +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 597 IHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNT-----HKVVGT 640
HRDLK N+L + KI DF + + + G+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-20
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 441 KKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE 499
KKL++ L + + + L + K D F ++LG G G V+K + G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 500 IAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
+A K + + + E+ ++ +V G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD- 119
Query: 559 FIFDQARATFLDWQKRI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDM 612
L RI I+G ++ ++ YL + +I+HRD+K SN+L+++
Sbjct: 120 --------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGT 640
K+ DFG++ G I + + VGT
Sbjct: 170 EIKLCDFGVS----GQLIDSMANSFVGT 193
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 27/185 (14%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN----EVTLIA 524
K D F G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 525 RLQHRNLVKLLGCCIQADES-------MLIYEYMP---NKSLDFFIFDQARATFLDWQKR 574
L H N+V+L E ++ EY+P ++ + Q + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + R I LH S + HRD+K NVL++ K+ DFG A+ E N
Sbjct: 135 LF---QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PN 188
Query: 634 THKVV 638
+
Sbjct: 189 VAYIC 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 27/191 (14%)
Query: 466 ASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGME 514
++ + +N Y +LG G F V K G + A K + K G E
Sbjct: 1 GTVFR-QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQK 573
+ + EV+++ +QH N++ L + +LI E + L FD A L ++
Sbjct: 60 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEE 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDE 629
+ I G+ YLH ++I H DLK N++L + P KI DFG+A
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 630 IQTNTHKVVGT 640
N + GT
Sbjct: 173 EFKN---IFGT 180
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 41/235 (17%), Positives = 72/235 (30%), Gaps = 50/235 (21%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVK-----RLS 506
H E F S+ + + +G+G +G V + A+K ++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 507 KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ + + +E K EV L+ +L H N+ +L L+ E L +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 567 TFLDWQKRI-------------------------------------HIVGGIARGILYLH 589
+ + +I+ I + YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 590 QDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDEIQTNT--HKVVGT 640
I HRD+K N L + K+ DFG+++ F GT
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 53/196 (27%), Positives = 78/196 (39%), Gaps = 34/196 (17%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK-------------GS 509
+ K KLG G +G V E A+K + K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EE NE++L+ L H N++KL L+ E+ L F+ R
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + +I+ I GI YLH+ I+HRD+K N+LL+N +N KI DFG++
Sbjct: 143 FDE-CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 625 FGGDEIQTNTHKVVGT 640
F D +GT
Sbjct: 199 FSKDYKL---RDRLGT 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
T+ + + +LG+G F V + V GQE A ++ S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + LI++ + L F+ AR + + H + I +L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HCIQQILEAVL 124
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ HQ M ++HR+LK N+LL K++DFG+A G+ Q GT
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGT 176
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 33/171 (19%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHR--NL 531
LG GGFG VY G + + +A+K + K G EV L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIVGGIA 582
++LL + D +LI E P D F F + AR+ F WQ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFF--WQ--------VL 159
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQT 632
+ + H ++HRD+K N+L+D N K+ DFG +
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD 207
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 17/168 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKL- 534
+G GG G VY+ V + +A+K +S + E RLQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 535 -LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G + D + + + L + Q L + + IV I + H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH--- 151
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
HRD+K N+L+ D + DFG+A DE T VGT
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGT 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 52/170 (30%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LGEG F V + A+K L K + E +++RL H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 537 CCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q DE + Y N L +I FD+ F + I + YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLHG 148
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VGT
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 39/175 (22%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARL----QHR 529
LG+GGFG V+ G L + ++A+K + + EV L+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 530 NLVKLLGCCIQADESM--LIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIV 578
+++LL + L+ E P + D F + +R F Q
Sbjct: 99 GVIRLLD--WFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFF--GQ------ 147
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQT 632
+ I + H ++HRD+K N+L+D K+ DFG + +
Sbjct: 148 --VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 50/190 (26%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK-------------------------GSGQGME 514
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 515 EF-KNEVTLIARLQHRNLVKLLGCCIQADESML--IYEYMPNKSLDFFIF-------DQA 564
E E+ ++ +L H N+VKL+ +E L ++E + + + DQA
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQA 139
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
R F D + +GI YLH +IIHRD+K SN+L+ D + KI+DFG++
Sbjct: 140 RFYFQD----------LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 625 FGGDEIQTNT 634
F G + +
Sbjct: 187 FKGSDALLSN 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 468 IAKATDNFASY-----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNE 519
++ +NF ++ +LG G F V + GQE A K L K E +E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 520 VTLIARLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRI 575
+ ++ + ++ L E +LI EY + F A + I
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVI 134
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQT 632
++ I G+ YLHQ I+H DLK N+LL + + KI DFGM+R G
Sbjct: 135 RLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189
Query: 633 NTHKVVGT 640
+++GT
Sbjct: 190 -LREIMGT 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 22/177 (12%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
TD + +G G + + E AVK + K + E+ ++ R QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLRYGQHP 76
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILY 587
N++ L ++ E M L D + F + + ++ I + + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEY 131
Query: 588 LHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 6e-18
Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
D F + LG GGFG V+ K T G+ A K+L+K +G + E ++A+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRI 575
+ R +V L + + L+ M + + I F + RA F Q
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ--- 297
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I G+ +LHQ II+RDLK NVLLD+D N +ISD G+A + +T
Sbjct: 298 -----IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG- 348
Query: 636 KVVGT 640
GT
Sbjct: 349 -YAGT 352
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 25/175 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGME 514
+ + ++ + ++G G G V+K + G IAVK++ G+ + +
Sbjct: 14 TIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++ ++ + +V+ G I + + E M + Q
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------KRMQG 119
Query: 574 RI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
I I+G + I+ YL + +IHRD+K SN+LLD K+ DFG++
Sbjct: 120 PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 41/164 (25%), Positives = 66/164 (40%), Gaps = 34/164 (20%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
+G G FG + + +AVK + +G ++E + E+ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 539 IQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGILY 587
+ +I EY L ++ +AR F Q ++ G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFF--QQ----LLSGVS----Y 131
Query: 588 LHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGDE 629
H M+I HRDLK N LLD KI DFG ++
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LGEG F K Q AVK +SK + + E+T + + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ L+ E + L F+ + + F + + +I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 596 IIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
++HRDLK N+L ++++ KI DFG AR+ D T T
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 26/172 (15%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + GQ+ A+K L + + EV + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 538 CIQADESM----LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+I E M L F I ++ F + + I+ I I +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS- 146
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I HRD+K N+L + D K++DFG A+ + +QT T
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYT 192
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 47/177 (26%), Positives = 70/177 (39%), Gaps = 39/177 (22%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG G VY+ + A+K L K + + + E+ ++ RL H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
E L+ E + L FD RI V I +
Sbjct: 118 ETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAVKQILEAVA 162
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH+ I+HRDLK N+L D KI+DFG+++I + V GT
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
+ F Y LG+GGFG V + T G+ A K+L K +G NE ++ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ R +V L + +++ L+ M L F I+ +A F + + + I G
Sbjct: 241 VNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA-AEICCG 298
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ LH R RI++RDLK N+LLD+ + +ISD G+A + VGT
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 39/216 (18%), Positives = 72/216 (33%), Gaps = 19/216 (8%)
Query: 435 LFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL 494
+ I R +L + L + M+E L + + I + +N E +
Sbjct: 33 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR------YFNAWLETPPEKWQEEMD 86
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
+ S M+ ++ + +N V L + + +
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146
Query: 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+L ++ + + +HI IA + +LH ++HRDLK SN+ D
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV 203
Query: 615 KISDFGMARIFGGDEIQTNT----------HKVVGT 640
K+ DFG+ DE + VGT
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-17
Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 41/179 (22%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
D + + +G G +G V + +E + +A+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 522 LIARLQHRNLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLD 570
++ RL H ++VK+L I D ++ E + ++ + + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLL- 162
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 35/184 (19%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNE---VTL 522
++F+ + +G GGFG VY T G+ A+K L K QG NE ++L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 523 IARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIH 576
++ +V + + + I + M L + + F +A F +
Sbjct: 246 VSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE---- 300
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I G+ ++H +++RDLK +N+LLD + +ISD G+A F + H
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 637 VVGT 640
VGT
Sbjct: 350 SVGT 353
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 39/184 (21%), Positives = 67/184 (36%), Gaps = 34/184 (18%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE--FKN---------EV 520
+ + G +G V G EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 521 TLIARLQHRNLVKLLGCCI-QADESM----LIYEYMPN------KSLDFFIFDQARATFL 569
L+ H N++ L + + +M L+ E M I Q +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-HIQYF 139
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I G+ LH+ ++HRDL N+LL ++ + I DF +AR D
Sbjct: 140 MYH--------ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 630 IQTN 633
+T+
Sbjct: 189 NKTH 192
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 36/175 (20%), Positives = 74/175 (42%), Gaps = 25/175 (14%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR 529
D++ KLG G + V++ + +++ VK L ++ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 530 NLVKLLGCCIQADESM---LIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARG 584
N++ L ++ S L++E++ N F ++ I +
Sbjct: 92 NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKA 142
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVV 638
+ Y H M I+HRD+K NV++D++ ++ D+G+A Q +V
Sbjct: 143 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA 192
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 38/172 (22%), Positives = 65/172 (37%), Gaps = 25/172 (14%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 538 C---IQADESM-LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + ++ E + L F I D+ F + + I+ I I YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS- 179
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ I HRD+K N+L + K++DFG A+ T
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYT 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 42/212 (19%), Positives = 77/212 (36%), Gaps = 59/212 (27%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
+ ++ LG G FG V + +E G+ A+K++ + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 530 NLVKLLGCCIQADESM---------------------------------------LIYEY 550
N++KL+ +I EY
Sbjct: 61 NIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 551 MP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607
+P +K L FI I+ + R + ++H + I HRD+K N+L
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIY---QLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 608 LD-NDMNPKISDFGMARIFGGDEIQTNTHKVV 638
++ D K+ DFG A+ + + +
Sbjct: 174 VNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 37/217 (17%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L + ++ + ++ E + + D+F +G G F V K T
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-- 85
Query: 496 EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
GQ A+K ++K + F+ E ++ R + +L Q + + L+ EY
Sbjct: 86 -GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYY 143
Query: 552 PNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604
L A F + I I +H+ + +HRD+K
Sbjct: 144 VGGDL-LTLLSKFGERIPAEMARFY--------LAEIVMAIDSVHR---LGYVHRDIKPD 191
Query: 605 NVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGT 640
N+LLD + +++DFG ++ +++ VGT
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGT 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 40/181 (22%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V + + +A+K+LS+ F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +S+ ++ E M +L I D R ++L +
Sbjct: 77 LMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY 134
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 135 Q--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 632 T 632
T
Sbjct: 184 T 184
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 36/161 (22%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 538 C---IQADESM-LIYEYMP---------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ + ++ E + ++ F +A I+ I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEA 129
Query: 585 ILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMA 622
I YLH + I HRD+K N+L + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 41/209 (19%), Positives = 82/209 (39%), Gaps = 21/209 (10%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L + ++ E +E + + + + ++F +G G FG V K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA-- 98
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K L+K E F+ E ++ + + L Q D ++ L+ +Y
Sbjct: 99 -DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L + + + R ++ + I +HQ + +HRD+K N+L+D +
Sbjct: 157 VGGDL-LTLLSKFEDRLPEEMARFYL-AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMN 211
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +++DFG D + VGT
Sbjct: 212 GHIRLADFGSCLKLMEDGTVQ-SSVAVGT 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L K ++ + ++ I +++ +G G FG V K T
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST-- 93
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K LSK + F E ++A +V+L Q D + ++ EYM
Sbjct: 94 -RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 552 PNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606
P L + + A F + + + +H M IHRD+K N+
Sbjct: 152 PGGDL-VNLMSNYDVPEKWARFYTAE--------VVLALDAIHS---MGFIHRDVKPDNM 199
Query: 607 LLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGT 640
LLD + K++DFG ++ ++ +T VGT
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGT 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 40/181 (22%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V V + +A+K+LS+ F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +++ L+ E M L I D R ++L +
Sbjct: 114 LMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYLLY 171
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH S IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 172 Q--------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 632 T 632
T
Sbjct: 221 T 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 41/176 (23%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
+G G +G VY + +A+K++++ F++ E+T++ RL+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREITILNRLKSD 85
Query: 530 NLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLDWQKRIHIV 578
+++L I D ++ E + K+ F + + + +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--TILYN------ 137
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ G ++H IIHRDLK +N LL+ D + K+ DFG+AR ++
Sbjct: 138 --LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 33/174 (18%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVK 533
+G+G FG V +V+ + A+K ++K E +N E+ ++ L+H LV
Sbjct: 23 IGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q +E M ++ + + L + F + + + +
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLF--------ICELVMALD 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YL RIIHRD+K N+LLD + I+DF +A + + Q T + GT
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MAGT 177
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 39/187 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 522 LIARLQHRNLVKLLGCCI-QADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ R +H N++ + E M ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I RG+ Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D T
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 634 --THKVV 638
T V
Sbjct: 187 FLTEYVA 193
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVK 533
LG+G FG V LV+ G+ A+K L K +E E ++ +H L
Sbjct: 156 LGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q + + + EY L FF +F + RA F I +
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFY--------GAEIVSALD 262
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
YLH S +++RDLK N++LD D + KI+DFG+ + D T
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 16/148 (10%), Positives = 45/148 (30%), Gaps = 12/148 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLL 535
G ++ +++A+ + ++E + ++R+ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+++ E++ SL + T I + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ S V + D + ++
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ S +G G +G V G+++A+K+LS+ F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKR 574
L+ +QH N++ LL S+ L+ +M L + F + + +
Sbjct: 76 LLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQ 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
++V + +G+ Y+H ++HRDLK N+ ++ D KI DFG+AR +
Sbjct: 130 -YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 43/165 (26%), Positives = 65/165 (39%), Gaps = 24/165 (14%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + + EY L FF +F + RA F I + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFY--------GAEIVSALEYLH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+++RD+K N++LD D + KI+DFG+ + D T
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 33/165 (20%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G ++A+K+L + F++ E+ L+ ++H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMRHEN 85
Query: 531 LVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LL DE++ L+ +M L + + L + +V + +
Sbjct: 86 VIGLLDV-FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLK 139
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
G+ Y+H IIHRDLK N+ ++ D KI DFG+AR +
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 4e-13
Identities = 34/199 (17%), Positives = 56/199 (28%), Gaps = 46/199 (23%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRL--------SKGSGQGMEEFKNEVTL 522
T+ K+GEG FG V++ + +A+K + + + EE E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 523 IARLQ---------HRNLVKLLGCCI----------QADESMLIYEYMPNKSLDFFIFDQ 563
L + L +A + + N DFF DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 564 A----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607
R I+ + + +R HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 608 LDNDMNPKISDFGMARIFG 626
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 41/190 (21%), Positives = 73/190 (38%), Gaps = 48/190 (25%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ LG GG G V+ + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 522 LIARLQHRNLVKLL----------GCCIQADESM----LIYEYMP---NKSLDFFIFDQA 564
+I RL H N+VK+ + + + ++ EYM L+ +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR 623
A +Q + RG+ Y+H + ++HRDLK +N+ ++ D+ KI DFG+AR
Sbjct: 121 HARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 624 IFGGDEIQTN 633
I
Sbjct: 170 IMDPHYSHKG 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 39/172 (22%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMP---NKSLDFFIFDQARATFLDW 571
L+ ++H N++ LL S+ L+ M N + FL +
Sbjct: 81 LLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 140 Q--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 42/167 (25%), Positives = 79/167 (47%), Gaps = 26/167 (15%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V+ K + + +++ A+K L K + + K E ++ + H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
Q + + LI +++ L F +F + F + +A + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFY--------LAELALALDH 141
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
LH + II+RDLK N+LLD + + K++DFG+++ E + +
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 27/178 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQH 528
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIA 582
LVKL ++ EY+ + F F + A F I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YLH + +I+RDLK N+L+D +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 28/169 (16%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V+ K T +I A+K L K + K E ++ ++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L+ Q + LI EY+ L F IF + A F + I+ +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFY--------LAEISMAL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+LHQ II+RDLK N++L++ + K++DFG+ + D T+T
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 31/169 (18%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
LG+G FG V +K T Q A+K L K ++ + + L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
+ C Q E++ + EY+ L + FD +RATF I G+
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATF--------YAAEIILGL 131
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+LH I++RDLK N+LLD D + KI+DFGM + + +TNT
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG G FG V+ A+K L K +++ +E +++ + H ++++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + +I +Y+ L F F A F + + + YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAE--------VCLALEYLH 123
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
II+RDLK N+LLD + + KI+DFG A+ + T+ + GT
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V + E ++ AVK L K ++ + +T L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
CC Q + + + E++ L F FD+ARA F I +++L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
H II+RDLK NVLLD++ + K++DFGM + + + T T
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 39/165 (23%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
LGEG +G V T G+ +A+K++ F E+ ++ +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N++ + + D +I E M ++ + + + +Q
Sbjct: 70 NIITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-------- 120
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
R + LH + +IHRDLK SN+L++++ + K+ DFG+ARI
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 25/166 (15%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V E+ AVK L K ++ + + L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
C Q + + + EY+ L + F + A F IA G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 38/181 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ KLG+G +G V+K G+ +AVK++ F+N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 522 LIARLQ-HRNLVKLLGCCIQADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ L H N+V LL + ++ L+++YM + + I + ++ +Q
Sbjct: 61 ILTELSGHENIVNLLN--VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ- 117
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ + I YLH S ++HRD+K SN+LL+ + + K++DFG++R F TN
Sbjct: 118 -------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 634 T 634
Sbjct: 168 N 168
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 31/177 (17%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIA 524
+F LG+G FG V KGT + AVK L K ++ + + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHI 577
+ L +L C Q + + + EY+ L + F + A F
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVFY-------- 447
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
IA G+ +L II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 31/169 (18%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A+K + K E+ T H LV
Sbjct: 17 IGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V + AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
Q + + + +Y+ L F+ F + RA F IA + YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
H + I++RDLK N+LLD+ + ++DFG+ + T+T
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 38/176 (21%), Positives = 62/176 (35%), Gaps = 26/176 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 13 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 511 QG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARAT 567
+E+ ++ + H N+V LLG C + M+I E+ +L ++
Sbjct: 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------- 118
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
KR V +G + + I DLK + + + S F +
Sbjct: 119 ---RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+A+G+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 31/169 (18%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A++ + K E+ T H LV
Sbjct: 60 IGRGSYAKVL---LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 166
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 30/176 (17%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRN-L 531
LG G +G V+ K + + ++ A+K L K + + E + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARG 584
V L Q + + LI +Y+ L F F + VG I
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +LH+ + II+RD+K N+LLD++ + ++DFG+++ F DE + + GT
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 15/122 (12%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
+ +T + + G++L + + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCNL------VLYDH---STSVWASNTGILGK 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
+ + V+ D R W+S++ N V+ L + GN+V+ Y S +W +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTG 106
Query: 139 DH 140
+
Sbjct: 107 TY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-10
Identities = 22/120 (18%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
++++ S+ G +L V ++ L + Y W +N T
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASN--TGGL 49
Query: 79 DQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L + + G +V+ D +R+ W + T+ + V+ L N+V+ Y ++W +
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI----YGPVVWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-09
Identities = 21/125 (16%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
+D + + G +L G + + L ++ W + T
Sbjct: 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDC-----NLVLYDNN----RAVWASG--TNG 47
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
+L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 48 KASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWAT 106
Query: 138 FDHPC 142
+
Sbjct: 107 HTNVG 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-09
Identities = 21/121 (17%), Positives = 39/121 (32%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + Q++ +L G + L + + Y+ W +N T
Sbjct: 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQN---GRQIWASN--TDR 48
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
L + S G +V+ D + W S + L G V+ Y +LW
Sbjct: 49 RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI----YGPVLWS 104
Query: 137 S 137
Sbjct: 105 L 105
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.1 bits (131), Expect = 2e-08
Identities = 40/262 (15%), Positives = 72/262 (27%), Gaps = 35/262 (13%)
Query: 14 ASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSA--KRYLGIWYKRVSPRTVAWVA 71
+ Q++ G+ L+S N F+L G +W + +
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIP 69
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSI-----TMKNPVVQLMDSGNLVLT 126
R ++ L G L D R W ++ S + L D GN+V
Sbjct: 70 LR----NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV-L 124
Query: 127 DGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGF 186
+ + + L + + G L G
Sbjct: 125 VDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---------GASKLVFQGDGN 175
Query: 187 PQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVI--NENEVYYECDAKGPAV 244
G+ +WN T V D V+ N V + G A
Sbjct: 176 LVAYGPNGAA------TWN--AGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS 227
Query: 245 SRLWVNQSG-LVL---RSIWSS 262
+ L + +G + + + +W+
Sbjct: 228 AVLRLQANGSIAILDEKPVWAR 249
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-08
Identities = 26/121 (21%), Positives = 45/121 (37%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L NG + + Y W N T
Sbjct: 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCNL------VLYDV---DKPIWATN--TGG 47
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
D+ L++ S G +V+ R+ W+SNT N V L N+V+ Y + W
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI----YGTARWA 103
Query: 137 S 137
+
Sbjct: 104 T 104
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 6e-08
Identities = 47/396 (11%), Positives = 113/396 (28%), Gaps = 101/396 (25%)
Query: 25 QSIRDGETLVSVNGTFELGFFSPGTS-----AKRYLGIWYKRVSPRTVAW--VANRETPL 77
+R + ++ ++G LG G + + + + W + N +P
Sbjct: 145 LELRPAKNVL-IDGV--LGS---GKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNSPE 196
Query: 78 TD----QSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN--LVLTDGNYN 131
T Q L + D I ++ +++ N LVL N
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQN 255
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK----SINDPAPG----E----FSL 179
+ W +F+ C LL R K D LS+ S++ + E
Sbjct: 256 AKAWNAFNLSCKILL----TTRF-KQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 180 WIDT----------HGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLC------- 222
++D P+ + ++ +W+ L +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 223 DYKFVINENEVYYEC-----DAKGPA--VSRLWVNQSGLVLRSIWSS-------QQDVWF 268
+Y+ +++ A P +S +W + + + + ++
Sbjct: 370 EYR------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 269 LAYYAP---LD-RCDLYSVCGANARCTTN-SSRRCDCLEGFVPKSPNNWS--------EG 315
P L+ + L + + + + + + +P + + +
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 316 CVRERELKCRNGDEFPK------YVKLKLPDTSSSW 345
+ F +++ K+ S++W
Sbjct: 484 IEHPERM-----TLFRMVFLDFRFLEQKIRHDSTAW 514
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 6e-04
Identities = 49/303 (16%), Positives = 80/303 (26%), Gaps = 101/303 (33%)
Query: 94 LDGRDRIFW---SSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMK 150
+ G R+FW S + V + ++ VL NY L P M
Sbjct: 61 VSGTLRLFWTLLSKQEEM-----VQKFVEE---VLRI-NYK-FLMSPIKTEQRQ--PSMM 108
Query: 151 LGRNFKTGMDR-----------HLSSWKSIN---------DPAPGEFSLWIDTHGFP--- 187
R + DR ++S + PA + G
Sbjct: 109 T-RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK-----NVLIDGVLGSG 162
Query: 188 -----QLVLRKGSVLQYRAGS--WNGLGFTGTPP--LKENVPLCDYKFVINENE------ 232
V V W L +P L+ L Y+ N
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTSRSDHSS 221
Query: 233 -VYYECDAKGPAVSRLWVNQSG----LVLRSIWSSQQDVW--FLAYYAPLDRCDLYSVCG 285
+ + + RL ++ LVL ++ +++ W F
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK--AWNAF----------------- 262
Query: 286 ANARC----TTNSSRRCDCLEGFVPKSP--NNWSEGCVRERELKCRNGDEFPKYVKLK-- 337
N C TT + D L ++ S + E+K KY+ +
Sbjct: 263 -NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT-LTPDEVK----SLLLKYLDCRPQ 316
Query: 338 -LP 339
LP
Sbjct: 317 DLP 319
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 7e-04
Identities = 43/359 (11%), Positives = 103/359 (28%), Gaps = 87/359 (24%)
Query: 306 PKSPNNWSEGCVRERELKCRNGDEFPKY--------VKLKLPDTSSSWFNASMNLKECSE 357
+ P+ + + +R+ + F KY +KL+ A + L+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---------QALLELRPAKN 152
Query: 358 L-------CSKNC-SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG------QDLYIR 403
+ K + + V+ + W +++K N Q L +
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW----LNLKNCNSPETVLEMLQKLLYQ 208
Query: 404 IASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWE- 462
I +++ L I A L + + K + L + +++ + + W
Sbjct: 209 IDPN------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-NAKAWNA 261
Query: 463 FDF----------ASIAKATDNFASYNKLGE---GGFGPVYKGTLVEGQEIAVKRLSKGS 509
F+ + + + + T E + + L K
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL------TPDEVKSL----LLKYL 311
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY--EYMPNK-------SLDFFI 560
++ EV + ++ I+ + +K SL+
Sbjct: 312 DCRPQDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 561 FDQARATFLD---WQKRIHIVGGIARGILYLHQDSR--MRIIHRDLKASNVLLDNDMNP 614
+ R F + HI + +++ M ++++ K S L++
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHKYS--LVEKQPKE 423
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-07
Identities = 24/133 (18%), Positives = 42/133 (31%), Gaps = 26/133 (19%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + Q++ L NG F+L + Y G W ++ R+
Sbjct: 2 GTNYLLSGQTLDTEGHLK--NGDFDLVMQDDC-NLVLYNGNW------QSNTANNGRDCK 52
Query: 77 LTDQS-GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
LT G L V+ +G W S N + G LV+ + ++
Sbjct: 53 LTLTDYGEL-------VIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV----FGPSVF 101
Query: 136 QSFDHPCDTLLPG 148
+ D + G
Sbjct: 102 KI-----DPWVRG 109
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 28/185 (15%), Positives = 58/185 (31%), Gaps = 41/185 (22%)
Query: 479 NKLGEGGFGPVYKGT---------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR 529
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 530 NLVKLLGC---CI---------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
KL I Q L+ + +SL + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL-----SERS 160
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIFGGDEIQ 631
V +A +L +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY----CP 213
Query: 632 TNTHK 636
+ H
Sbjct: 214 SGKHV 218
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
K+G G FG +Y GT + G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
+ D ++++ E + SL+ +F+ F + + + + I Y+H + I
Sbjct: 74 GAEGDYNVMVMELL-GPSLE-DLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 598 HRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH 635
HRD+K N L+ I DFG+A+ + + +T+ H
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQH 166
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 21/122 (17%), Positives = 41/122 (33%), Gaps = 19/122 (15%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
N+ + Q + L + +L + W +N T
Sbjct: 5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNLV----------LYGGKYGWQSN--TH 50
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
+ L + KG +++ D + WSS +S V+ L D G V+ Y ++
Sbjct: 51 GNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI----YGPAIF 106
Query: 136 QS 137
++
Sbjct: 107 ET 108
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 43/192 (22%), Positives = 67/192 (34%), Gaps = 58/192 (30%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG G F V+ +V +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 536 GCCIQADESMLIYEYMPN--KSLDFFIFDQARATFL------------DWQKR------- 574
AD + + K LD F + K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 575 IHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNP------KISDFGMARI 624
+ V I++ +L Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186
Query: 625 FGGDE----IQT 632
+ + IQT
Sbjct: 187 WYDEHYTNSIQT 198
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 7/73 (9%)
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLV 124
W N T + G +V++ + W S + + V+ L N+V
Sbjct: 49 NPIWATN--TGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 125 LTDGNYNSLLWQS 137
+ Y LW +
Sbjct: 107 I----YGDALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 38.7 bits (90), Expect = 8e-04
Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 1/77 (1%)
Query: 61 RVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
P+ + + E + + ++L + W++NT L
Sbjct: 11 DNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPD 70
Query: 121 GNLVLTDGNYNSLLWQS 137
G LV+ N +WQS
Sbjct: 71 GVLVVITNE-NVTVWQS 86
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 35/170 (20%), Positives = 62/170 (36%), Gaps = 31/170 (18%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG + G L + +A+K S + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFG 74
Query: 539 IQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKR---IHIVGGIARGIL----YLHQ 590
+ ++ E + SL D F D R + V IA ++ Y+H
Sbjct: 75 PCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH 635
+ +I+RD+K N L+ N I DF +A+ + + +T H
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKH 168
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 35/165 (21%), Positives = 70/165 (42%), Gaps = 23/165 (13%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGC 537
K+G G FG +Y GT + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
++ D ++L+ + + SL+ +F+ + V +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL-----SLKTVLMLADQMINRVEFVHS--- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH 635
+HRD+K N L+ I DFG+A+ + + T+ H
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQH 164
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 37/186 (19%), Positives = 65/186 (34%), Gaps = 45/186 (24%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI------AVKRLSKGSGQGMEEFK-----NEVTLIARLQH 528
+G+GGFG +Y + + + VK +G E K + I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 529 RNLVKLLG-----CCIQADESMLIYEYMP----NKSLDFFIFDQARATFLDWQKR---IH 576
+K LG D++ Y +M L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ---------KIYEANAKRFSRK 152
Query: 577 IVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIFGGDEI 630
V ++ IL Y+H+ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY----C 205
Query: 631 QTNTHK 636
HK
Sbjct: 206 PEGVHK 211
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-06
Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 16/122 (13%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + SQ + D L + + L + K S + W + T
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESG--TS 53
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
Q + + G + + D R + SNT + V+ L +G V+ Y +W
Sbjct: 54 GRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV----YGPAVW 109
Query: 136 QS 137
+
Sbjct: 110 ST 111
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 34/167 (20%), Positives = 70/167 (41%), Gaps = 25/167 (14%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
++GEG FG +++GT L+ Q++A+K + S ++E L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
+ ++L+ + + SL+ + D F + V A+ +L +H
Sbjct: 75 GQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-----SVKTVAMAAKQMLARVQSIH---E 124
Query: 594 MRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH 635
+++RD+K N L+ + + DFGM + + + T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY--RDPVTKQH 169
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 41/176 (23%), Positives = 62/176 (35%), Gaps = 38/176 (21%)
Query: 478 YNKLGEGGFGPVYKGT-LVEGQEIAVK---RLSKGSGQGMEEFKNEVTLIARLQHR---- 529
+ +G+G FG V K VE + +A+K Q EV L+ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEM 114
Query: 530 --NLVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V L C+ E S +Y+ + N + + R
Sbjct: 115 KYYIVHLKRHFMFRNHLCL-VFEMLSYNLYDLLRNTNFRGVSLNLTR----------KFA 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQT 632
+ +L+L + IIH DLK N+LL N KI DFG + G I
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 33/178 (18%), Positives = 66/178 (37%), Gaps = 32/178 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIA---VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
K+G GGFG +Y + ++ A VK + +G +E+ R+ ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKW 99
Query: 536 GCCIQADES---MLIY---EYMPNKSLDFFIFD---QARATFLDWQKR--IHIVGGIARG 584
Q D + +S F + + V +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 585 IL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIFGGDEIQTNTHK 636
+L Y+H++ +H D+KA+N+LL ++ +D+G++ + HK
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY----CPNGNHK 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 40/163 (24%), Positives = 63/163 (38%), Gaps = 39/163 (23%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR------N 530
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 531 LVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++ +L C+ E SM +YE + F R I
Sbjct: 161 VIHMLENFTFRNHICM-TFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSI 209
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMA 622
+ + LH + RIIH DLK N+LL K+ DFG +
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
V + T + G + +L ++ W+S S + V L NL +
Sbjct: 170 RVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAI-- 227
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 228 --YGGALWTT 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 640 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.98 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.95 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.92 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.92 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.92 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.92 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.92 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.92 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.91 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.91 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.91 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.91 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.91 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.91 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.91 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.91 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.91 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.91 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.91 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.91 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.91 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.91 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.91 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.91 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.91 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.91 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.9 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.9 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.9 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.9 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.9 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.9 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.9 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.9 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.9 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.9 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.9 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.9 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.9 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.9 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.9 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.9 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.9 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.9 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.9 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.9 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.9 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.9 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.9 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.9 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.9 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.9 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.89 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.89 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.89 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.89 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.89 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.89 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.89 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.89 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.89 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.89 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.89 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.89 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.89 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.89 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.89 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.89 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.89 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.89 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.89 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.89 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.89 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.89 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.89 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.89 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.89 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.89 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.89 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.89 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.89 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.89 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.89 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.89 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.89 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.89 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.89 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.89 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.89 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.88 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.88 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.88 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.88 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.88 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.88 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.88 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.88 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.88 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.88 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.88 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.88 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.88 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.88 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.87 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.87 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.87 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.87 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.87 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.87 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.87 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.87 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.86 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.86 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.86 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.86 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.86 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.86 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.85 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.85 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.84 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.61 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.55 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.53 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.26 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.2 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.02 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.02 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.42 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.8 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.16 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 85.9 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.1 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=367.54 Aligned_cols=231 Identities=20% Similarity=0.246 Sum_probs=178.6
Q ss_pred hcccccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCC----cceEEEecC
Q 006563 14 ASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQ----SGLLNVTSK 89 (640)
Q Consensus 14 ~~~~~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~----~~~l~~~~~ 89 (640)
++++.|+|++|++|++|++|+||+|+|+||||+++ ++|| |+ +++ +||+|||++|+.++ ++.|+|+.+
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 45678999999999999999999999999999543 5677 76 777 99999999999875 788999999
Q ss_pred C-eEE--ecCCCceEEeeccccC-----CCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCce
Q 006563 90 G-IVL--LDGRDRIFWSSNTSIT-----MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (640)
Q Consensus 90 G-L~l--~d~~~~~vWst~~~~~-----~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~~ 161 (640)
| |+| .|++|++||+++++.. .++++|+|+|+|||||++ +.+|||| ||||||||||++|.++++|+.
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~- 154 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE- 154 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE-
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc-
Confidence 9 999 7888999999997641 235789999999999998 5799999 999999999999999988864
Q ss_pred EEEeccCCCCCCCCceEEeecCCCCceEEEEeC-CEEEeecCCCCCCCccCCCCCCcCcceeeeEEEeeCC-eEEEEEec
Q 006563 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKG-SVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN-EVYYECDA 239 (640)
Q Consensus 162 ~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (640)
| ++.+||++|.|+++|+++|. ++++++ ...||++++|++..... .+. ....+.+.++++ ..++++..
T Consensus 155 -L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l--~l~---~dGnLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 155 -L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA--VFQ---GDGNLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp -E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE--EEC---TTSCEEEECTTSCEEEECSCT
T ss_pred -c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE--EEc---CCCeEEEEeCCCcEEEEecCC
Confidence 6 57899999999999999995 455654 58999999997632111 111 111233333333 33332222
Q ss_pred CCCceEEEEEccCCCEEEEEEeCCCCcEEEEEEec
Q 006563 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAP 274 (640)
Q Consensus 240 ~~~~~~r~~l~~~G~l~~~~~~~~~~~w~~~w~~p 274 (640)
....+|++|+.||++++|.| ...|..+|..|
T Consensus 224 -~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P 254 (276)
T 3m7h_A 224 -GHASAVLRLQANGSIAILDE---KPVWARFGFQP 254 (276)
T ss_dssp -TCTTCEEEECTTSCEEEEEE---EEEEESSSCCT
T ss_pred -CCCCEEEEEcCCccEEEEcC---CCeEEccCccC
Confidence 22458999999999999998 23455444444
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=305.69 Aligned_cols=216 Identities=15% Similarity=0.178 Sum_probs=164.5
Q ss_pred ccccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEe
Q 006563 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLL 94 (640)
Q Consensus 16 ~~~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~ 94 (640)
++.|+|.+|++|++|++| ++|.|+|||+++++ + ++|.. +|+||+|||+.| .++.|.++++| |+|.
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l-~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----L-VLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----E-EEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----E-EEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 667999999999999999 59999999987653 2 23443 799999999998 56789999999 9999
Q ss_pred cCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCccc-CCCCeeccee-ccCC-----ceEEEecc
Q 006563 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTL-LPGMKLGRNF-KTGM-----DRHLSSWK 167 (640)
Q Consensus 95 d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTl-Lpg~~l~~~~-~tg~-----~~~l~S~~ 167 (640)
|++|.+||++++.......+|+|+|+|||||++. ++||||||||||+ ||+| |.+. .+|+ ++.|+
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~--- 142 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH--- 142 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC---
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE---
Confidence 9999999999986433456899999999999952 8999999999877 6665 5554 5554 56787
Q ss_pred CCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCCCCCCccCCCCCCcCcceeeeEEEeeCCeEEEEEecCCCceEEE
Q 006563 168 SINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRL 247 (640)
Q Consensus 168 s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 247 (640)
+..||++|.|+|+|+++| +++++++...||++++|++. +...+.+.....+ +.+..++++.+.++.......+|+
T Consensus 143 s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl--~ly~~~~~~vw~s~~~~~~~~~rl 217 (236)
T 1dlp_A 143 ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM--DVLTNQNIAVWTSGNSRSAGRYVF 217 (236)
T ss_dssp SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE--EEEETTTEEEEECCCCCSSSCCEE
T ss_pred cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE--EEEeCCCcEEEEeCCCCCCCCEEE
Confidence 478999999999999999 57788888899999999753 4444444311111 111123334444444333356899
Q ss_pred EEccCCCEEEEE
Q 006563 248 WVNQSGLVLRSI 259 (640)
Q Consensus 248 ~l~~~G~l~~~~ 259 (640)
+|+++|++++|.
T Consensus 218 ~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 218 VLQPDRNLAIYG 229 (236)
T ss_dssp EECSSSCEEEEC
T ss_pred EEcCCCcEEEeC
Confidence 999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.79 Aligned_cols=165 Identities=31% Similarity=0.539 Sum_probs=141.5
Q ss_pred ccccccccccccCceeEEEEEec------CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...++||+|+||+||+|++. +++.||||+++....+..++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56777789999999999999874 367899999987766777899999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
|||||++|+|.++|.... ....++|..++.|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2346999999999999999999999987 999999999999999999999
Q ss_pred eeeccceeccCCccccccceeeeC
Q 006563 617 SDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 617 ~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+|||+|+.+.............||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred CCcccceecCCCCceeecCceecC
Confidence 999999987554433333344554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=297.01 Aligned_cols=165 Identities=27% Similarity=0.482 Sum_probs=133.7
Q ss_pred ccccccccccccCceeEEEEEec------CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 367899999987777778899999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
|||||++|+|.+++..... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975422 245999999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceeccCCccccccceeeeC
Q 006563 615 KISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 615 kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
||+|||+|+.+..........+..||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EECCCC----------------CCCC
T ss_pred EEcccccceeccCCCcceecCccccc
Confidence 99999999987554433333344554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=292.37 Aligned_cols=164 Identities=34% Similarity=0.508 Sum_probs=138.0
Q ss_pred cccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++...++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455679999999999999873 36789999997543 3456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 547 IYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
|||||++|+|.++|..... ...++|..+++|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965321 245999999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceeccCCccccccceeeeC
Q 006563 614 PKISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 614 ~kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+||+|||+|+.+........+....||
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EEECCcccceeccCCCceeEecccccC
Confidence 999999999987554433334444554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=285.69 Aligned_cols=160 Identities=29% Similarity=0.491 Sum_probs=130.8
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
+++...++||+|+||+||+|++.. .||||+++.. ..+..++|.+|+++|++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456667899999999999998754 6999998743 34556789999999999999999999999864 568999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
|++|+|.++|.... ..++|..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.+.....
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999996543 35999999999999999999999987 99999999999999999999999999998765444
Q ss_pred ccccceeeeC
Q 006563 631 QTNTHKVVGT 640 (640)
Q Consensus 631 ~~~~~~~~Gt 640 (640)
...+.+..||
T Consensus 188 ~~~~~~~~GT 197 (307)
T 3omv_A 188 SQQVEQPTGS 197 (307)
T ss_dssp ------CCCC
T ss_pred ceeecccccC
Confidence 3344556676
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=281.43 Aligned_cols=162 Identities=30% Similarity=0.420 Sum_probs=144.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||+||+++... ++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999998754 889999999753 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+++.+. ..+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 35899999999999999999999988 999999999999999999999999999998766
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
.....+.+++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555556667887
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=282.44 Aligned_cols=159 Identities=27% Similarity=0.441 Sum_probs=141.4
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
..|...++||+|+||.||+|+... |+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 568888999999999999999864 8999999997655556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCccc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 631 (640)
++|+|.+++.+ ..+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999998854 24899999999999999999999998 999999999999999999999999999988654332
Q ss_pred cccceeeeC
Q 006563 632 TNTHKVVGT 640 (640)
Q Consensus 632 ~~~~~~~Gt 640 (640)
.++++||
T Consensus 227 --~~~~~GT 233 (346)
T 4fih_A 227 --RKSLVGT 233 (346)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 3346676
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=283.90 Aligned_cols=151 Identities=25% Similarity=0.436 Sum_probs=130.5
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|..++.||+|+||+||+++... ++.||||++... .....+.|.+|+++|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 679999999999999999998754 899999999754 23456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||++|+|.+++.... ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999996543 345789999999999999999999988 99999999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=284.26 Aligned_cols=160 Identities=26% Similarity=0.430 Sum_probs=142.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.+.|...++||+|+||.||+|+... |+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3568888999999999999999765 899999999876566677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
|++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999988542 4899999999999999999999998 99999999999999999999999999998865433
Q ss_pred ccccceeeeC
Q 006563 631 QTNTHKVVGT 640 (640)
Q Consensus 631 ~~~~~~~~Gt 640 (640)
...+++||
T Consensus 303 --~~~~~~GT 310 (423)
T 4fie_A 303 --RRKSLVGT 310 (423)
T ss_dssp --CBCCCEEC
T ss_pred --cccccccC
Confidence 23456776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=282.76 Aligned_cols=175 Identities=27% Similarity=0.411 Sum_probs=145.6
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecC------CcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCC-Cceeee
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH-RNLVKL 534 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H-~niv~l 534 (640)
++..+.+...++|...+.||+|+||.||+|.+.. ++.||||++..... ...++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444444556789999999999999999998653 35799999976533 346789999999999965 999999
Q ss_pred EeEEEeC-CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 006563 535 LGCCIQA-DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600 (640)
Q Consensus 535 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 600 (640)
+|+|.+. +..+||||||++|+|.++|+.... ...++|..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999775 568999999999999999975432 245899999999999999999999987 99999
Q ss_pred cCCCCEEEcCCCceEEeeeccceeccCCccccccceeeeC
Q 006563 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 601 lkp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
|||+||||++++.+||+|||+|+.+..+.....+....||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999999999988666544444456665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.35 Aligned_cols=154 Identities=25% Similarity=0.444 Sum_probs=128.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-------
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------- 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------- 543 (640)
++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 56888999999999999999875 488999999975433 345679999999999999999999999876543
Q ss_pred -----eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEee
Q 006563 544 -----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (640)
Q Consensus 544 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~D 618 (640)
.+||||||++|+|.+++.........++.....++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976655455677888899999999999999988 99999999999999999999999
Q ss_pred eccceeccCCc
Q 006563 619 FGMARIFGGDE 629 (640)
Q Consensus 619 FGla~~~~~~~ 629 (640)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.12 Aligned_cols=162 Identities=25% Similarity=0.360 Sum_probs=129.2
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC----eeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 548 (640)
+++...++||+|+||+||+|++ .|+.||||++.... .....+..|+..+.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4566778999999999999998 58999999997532 11222345666677899999999999998764 579999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
|||++|+|.++|... .++|..+++++.|+|+||+|||++ ..++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999543 489999999999999999999986 23469999999999999999999999999999
Q ss_pred eccCCccc--cccceeeeC
Q 006563 624 IFGGDEIQ--TNTHKVVGT 640 (640)
Q Consensus 624 ~~~~~~~~--~~~~~~~Gt 640 (640)
........ ......+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 88554322 223345665
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=269.70 Aligned_cols=157 Identities=27% Similarity=0.413 Sum_probs=132.0
Q ss_pred cccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeEEEE
Q 006563 476 ASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIY 548 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 548 (640)
...++||+|+||.||+|.... ++.||+|++... .....+.|.+|+++|++++|||||++++++.. +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 445679999999999998765 889999998643 33456789999999999999999999999875 24579999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~~ 627 (640)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||||+||||++ ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 35899999999999999999999875 46999999999999984 78999999999987543
Q ss_pred CccccccceeeeC
Q 006563 628 DEIQTNTHKVVGT 640 (640)
Q Consensus 628 ~~~~~~~~~~~Gt 640 (640)
.. +.+++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 22 3345676
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=273.97 Aligned_cols=158 Identities=27% Similarity=0.352 Sum_probs=132.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.+.|...++||+|+||.||+|+... |+.||||+++... .+.+|++++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4567778899999999999999755 8999999997532 224699999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceeccCCc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~~~~ 629 (640)
|++|+|.+++.+. ..+++.....++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999653 35899999999999999999999987 99999999999999887 69999999999986543
Q ss_pred ccc---ccceeeeC
Q 006563 630 IQT---NTHKVVGT 640 (640)
Q Consensus 630 ~~~---~~~~~~Gt 640 (640)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 321 22345676
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=263.77 Aligned_cols=158 Identities=29% Similarity=0.496 Sum_probs=125.3
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||+||++.... ++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999998754 8999999997542 234567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+ +|+|.+++.+. ..+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67998888653 35899999999999999999999988 999999999999999999999999999987543
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
.. ..+..||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2245565
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=270.60 Aligned_cols=160 Identities=26% Similarity=0.330 Sum_probs=130.5
Q ss_pred ccccccccccccCceeEEEEEec----CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||+||+++.. .++.||||++.+.. ......+.+|+++|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999997542 2334568899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||||++|+|.+++.+. ..+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35899999999999999999999988 9999999999999999999999999999764
Q ss_pred CCccccccceeeeC
Q 006563 627 GDEIQTNTHKVVGT 640 (640)
Q Consensus 627 ~~~~~~~~~~~~Gt 640 (640)
.... ...+..||
T Consensus 178 ~~~~--~~~~~~GT 189 (304)
T 3ubd_A 178 DHEK--KAYSFCGT 189 (304)
T ss_dssp ---C--CCCSCCCC
T ss_pred CCCc--cccccccC
Confidence 4332 23345666
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=261.05 Aligned_cols=161 Identities=25% Similarity=0.421 Sum_probs=134.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------Ce
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 543 (640)
++|...+.||+|+||.||+|+.. .|+.||||++.+.. ....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 48999999997542 23456788999999999999999999997643 56
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.+||||||+ |+|..++... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 6798888543 35899999999999999999999988 9999999999999999999999999999
Q ss_pred eccCCc--cccccceeeeC
Q 006563 624 IFGGDE--IQTNTHKVVGT 640 (640)
Q Consensus 624 ~~~~~~--~~~~~~~~~Gt 640 (640)
.+.... ......+.+||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 875432 12233456666
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=252.16 Aligned_cols=148 Identities=24% Similarity=0.348 Sum_probs=131.1
Q ss_pred HHhhccccccccccccCceeEEEEEec----CCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
....++|...++||+|+||+||+|+.+ .++.||||++.+.. ....+.+|+++|..+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999753 36789999987543 345688999999998 69999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccc
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMA 622 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla 622 (640)
.+|||||+++|+|.+++. .+++.....++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999882 3789999999999999999999988 9999999999999877 79999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 166 ~~~~~ 170 (361)
T 4f9c_A 166 QGTHD 170 (361)
T ss_dssp EECTT
T ss_pred cccCC
Confidence 97643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=265.95 Aligned_cols=159 Identities=26% Similarity=0.379 Sum_probs=134.9
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhH---HHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEF---KNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f---~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...++||+|+||.||+++... |+.||||++.+.. ......+ ..++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999999865 8999999996431 1222223 3446677788999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|||||||++|+|..+|.+. ..+++.....++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999653 34899999999999999999999988 99999999999999999999999999998
Q ss_pred ccCCccccccceeeeC
Q 006563 625 FGGDEIQTNTHKVVGT 640 (640)
Q Consensus 625 ~~~~~~~~~~~~~~Gt 640 (640)
+..... .+.+||
T Consensus 342 ~~~~~~----~t~~GT 353 (689)
T 3v5w_A 342 FSKKKP----HASVGT 353 (689)
T ss_dssp CSSCCC----CSCCSC
T ss_pred cCCCCC----CCccCC
Confidence 865442 345666
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=265.71 Aligned_cols=161 Identities=24% Similarity=0.404 Sum_probs=140.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++.... |+.||+|++........+.+.+|+++|++++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3678899999999999999998765 899999999876555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC--CceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kI~DFGla~~~~~~ 628 (640)
|++|+|.+++... ...+++.....++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988543 235899999999999999999999988 9999999999999854 89999999999998654
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
.. .....||
T Consensus 311 ~~---~~~~~GT 319 (573)
T 3uto_A 311 QS---VKVTTGT 319 (573)
T ss_dssp SE---EEEECSS
T ss_pred Cc---eeeeEEC
Confidence 42 2344565
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=242.87 Aligned_cols=162 Identities=40% Similarity=0.724 Sum_probs=145.5
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
+.+.++...+++|...+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44555667889999999999999999999998889999999988776667788999999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999998865432 235899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++....
T Consensus 186 ~~~~~~ 191 (321)
T 2qkw_B 186 SKKGTE 191 (321)
T ss_dssp CEECSS
T ss_pred cccccc
Confidence 997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=254.77 Aligned_cols=161 Identities=20% Similarity=0.263 Sum_probs=141.1
Q ss_pred chHhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEE
Q 006563 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (640)
Q Consensus 464 ~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 539 (640)
.+.++....++|...++||+|+||.||+++... ++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445556667899999999999999999999876 7889999987521 223345899999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
+.+..+||||||++|+|..++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999653 235899999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCc
Q 006563 620 GMARIFGGDE 629 (640)
Q Consensus 620 Gla~~~~~~~ 629 (640)
|+|+.+..+.
T Consensus 220 Gla~~~~~~~ 229 (437)
T 4aw2_A 220 GSCLKLMEDG 229 (437)
T ss_dssp TTCEECCTTS
T ss_pred hhhhhcccCC
Confidence 9998875544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-26 Score=233.26 Aligned_cols=166 Identities=41% Similarity=0.665 Sum_probs=148.8
Q ss_pred cccccchHhHHHhhcccccc------ccccccCceeEEEEEecCCcEEEEEEcccCC----chhhHhHHHHHHHHhhCCC
Q 006563 459 ELWEFDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQH 528 (640)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~------~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l~H 528 (640)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999876 8899999999999987 67899999987532 2345779999999999999
Q ss_pred CceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 529 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCC
Q 006563 609 DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~ 628 (640)
++++.+||+|||+++.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp CTTCCEEECCCTTCEECCSC
T ss_pred cCCCcEEEeecccccccccc
Confidence 99999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=237.85 Aligned_cols=169 Identities=42% Similarity=0.747 Sum_probs=148.7
Q ss_pred ccccchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEE
Q 006563 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (640)
Q Consensus 460 ~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~ 538 (640)
...+++.++....++|...+.||+|+||.||++...+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976432 2344789999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 539 IQADESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 539 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
......++||||+++|+|..++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976432 3459999999999999999999999833349999999999999999999999
Q ss_pred eeccceeccCC
Q 006563 618 DFGMARIFGGD 628 (640)
Q Consensus 618 DFGla~~~~~~ 628 (640)
|||+++.+...
T Consensus 177 Dfg~~~~~~~~ 187 (326)
T 3uim_A 177 DFGLAKLMDYK 187 (326)
T ss_dssp CCSSCEECCSS
T ss_pred cCccccccCcc
Confidence 99999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.10 Aligned_cols=152 Identities=30% Similarity=0.511 Sum_probs=137.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++.... ++.||+|++........+.|.+|++++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3678888999999999999999865 889999998776667778899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999653 235899999999999999999999987 999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.63 Aligned_cols=161 Identities=27% Similarity=0.403 Sum_probs=143.0
Q ss_pred cccchHhHHHhhcc----------ccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCC
Q 006563 461 WEFDFASIAKATDN----------FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR 529 (640)
Q Consensus 461 ~~~~~~~l~~~~~~----------f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ 529 (640)
..+++++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777777654 666779999999999999986 5899999999876666678899999999999999
Q ss_pred ceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 530 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998843 24899999999999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceeccCC
Q 006563 610 NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~~ 628 (640)
.++.+||+|||+++.+..+
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TTCCEEECCCTTCEECCSS
T ss_pred CCCcEEEeeeeeeeecccC
Confidence 9999999999999987544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=232.99 Aligned_cols=154 Identities=24% Similarity=0.422 Sum_probs=135.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------ 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 543 (640)
.++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467888899999999999999986 58999999987543 3456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEEccCCCChhHHHhhccccCCCCHH
Q 006563 544 ---------------------------------------------------SMLIYEYMPNKSLDFFIFDQARATFLDWQ 572 (640)
Q Consensus 544 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 572 (640)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999876655667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 573 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
.+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999987 999999999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=228.33 Aligned_cols=151 Identities=26% Similarity=0.481 Sum_probs=136.6
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 467888899999999999999864 5889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
+++|+|.+++.+. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999998543 4889999999999999999999987 9999999999999999999999999999876443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=242.52 Aligned_cols=161 Identities=21% Similarity=0.277 Sum_probs=141.0
Q ss_pred chHhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEE
Q 006563 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (640)
Q Consensus 464 ~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 539 (640)
.++++....++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++.+++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999986 48999999997531 223456889999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
+.+..+|||||+++|+|..++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCc
Q 006563 620 GMARIFGGDE 629 (640)
Q Consensus 620 Gla~~~~~~~ 629 (640)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=237.01 Aligned_cols=154 Identities=31% Similarity=0.509 Sum_probs=135.4
Q ss_pred hccccccccccccCceeEEEEEec--------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~--------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||+++.. ++..||||++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999863 24579999997653 34567899999999999 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCC
Q 006563 609 DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~ 628 (640)
+.++.+||+|||+|+.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNI 256 (370)
T ss_dssp CTTCCEEECCCSSCEETTCC
T ss_pred CCCCCEEEccccCCcccCcc
Confidence 99999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=241.63 Aligned_cols=157 Identities=22% Similarity=0.265 Sum_probs=138.0
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
.++....++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3445567899999999999999999999865 789999998652 122345688999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
...+|||||+++|+|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999988542 3789999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCCc
Q 006563 622 ARIFGGDE 629 (640)
Q Consensus 622 a~~~~~~~ 629 (640)
|+.+....
T Consensus 215 a~~~~~~~ 222 (410)
T 3v8s_A 215 CMKMNKEG 222 (410)
T ss_dssp CEECCTTS
T ss_pred eEeeccCC
Confidence 99876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=232.78 Aligned_cols=151 Identities=30% Similarity=0.475 Sum_probs=135.6
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788899999999999999997 45899999998753 3345667899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+++... ..+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998654 24889999999999999999999987 999999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=237.12 Aligned_cols=151 Identities=29% Similarity=0.491 Sum_probs=135.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||+|... +++.||||.+.... ....++|.+|+++|++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999986 58899999987543 3345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++|+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999996543 34899999999999999999999987 99999999999999999999999999997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=231.20 Aligned_cols=153 Identities=29% Similarity=0.486 Sum_probs=131.3
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe----eEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----SMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV 547 (640)
.++|...+.||+|+||.||+|+.. ++.||||++... ......+..|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888999999999999999875 789999999754 2334456679999999999999999999987543 6999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
|||+++|+|.+++... .+++..+..++.|+++||+|||+. ...+|+||||||+|||+++++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999542 389999999999999999999987 01139999999999999999999999999
Q ss_pred cceeccCCcc
Q 006563 621 MARIFGGDEI 630 (640)
Q Consensus 621 la~~~~~~~~ 630 (640)
+|+.+.....
T Consensus 177 ~a~~~~~~~~ 186 (322)
T 3soc_A 177 LALKFEAGKS 186 (322)
T ss_dssp TCEEECTTSC
T ss_pred cccccccccC
Confidence 9998765443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=236.56 Aligned_cols=165 Identities=29% Similarity=0.464 Sum_probs=140.6
Q ss_pred ccchHhHHHhhccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceee
Q 006563 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVK 533 (640)
Q Consensus 462 ~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~ 533 (640)
.++..+.....++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4555666667889999999999999999999742 35789999997643 33456799999999999 7999999
Q ss_pred eEeEEEeCCe-eEEEEEccCCCChhHHHhhccc-----------------------------------------------
Q 006563 534 LLGCCIQADE-SMLIYEYMPNKSLDFFIFDQAR----------------------------------------------- 565 (640)
Q Consensus 534 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 565 (640)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8999999999999999975432
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 566 ----------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 566 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999987 9999999999999999999999999999875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=230.91 Aligned_cols=151 Identities=30% Similarity=0.404 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999876 58899999986542 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999888843 234899999999999999999999987 999999999999999999999999999987533
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=231.02 Aligned_cols=149 Identities=25% Similarity=0.338 Sum_probs=133.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3678888999999999999998764 889999999753 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999888643 34889999999999999999999987 9999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=229.12 Aligned_cols=152 Identities=30% Similarity=0.543 Sum_probs=134.0
Q ss_pred hccccccccccccCceeEEEEEec----CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+|... .+..||||++... .....+.|.+|++++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356778899999999999999985 3456999999764 33456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999995432 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
.+
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 44
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=236.10 Aligned_cols=152 Identities=31% Similarity=0.581 Sum_probs=128.1
Q ss_pred hccccccccccccCceeEEEEEec----CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+|+.. .+..||||++... .....++|.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888899999999999999875 4678999999754 33456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999653 235899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
.+
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 44
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=229.14 Aligned_cols=156 Identities=30% Similarity=0.544 Sum_probs=132.7
Q ss_pred HhhccccccccccccCceeEEEEEecCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
...++|...+.||+|+||.||+++. .++.||||++.... ....++|.+|++++++++||||+++++++.+....++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457888889999999999999987 67899999987543 34456899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999976544445899999999999999999999875 3599999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=234.50 Aligned_cols=151 Identities=23% Similarity=0.229 Sum_probs=131.7
Q ss_pred HhhccccccccccccCceeEEEEE------ecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC---CCceeeeEeEEEe
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQ 540 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~------l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~ 540 (640)
...++|...+.||+|+||.||+|. ...++.||||++... ...++..|++++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345778889999999999999994 445789999999754 3456788888888887 9999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--------
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------- 610 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------- 610 (640)
.+..+|||||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999996532 2346999999999999999999999987 999999999999998
Q ss_pred ---CCceEEeeeccceecc
Q 006563 611 ---DMNPKISDFGMARIFG 626 (640)
Q Consensus 611 ---~~~~kI~DFGla~~~~ 626 (640)
++.+||+|||+|+.+.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ---CTTEEECCCTTCEEGG
T ss_pred ccccCCEEEeeCchhhhhh
Confidence 8999999999998765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=231.73 Aligned_cols=150 Identities=31% Similarity=0.457 Sum_probs=132.7
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999998765 889999998753 223456688999999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998653 34899999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-25 Score=224.30 Aligned_cols=151 Identities=28% Similarity=0.459 Sum_probs=133.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... .++.||+|++.... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888899999999999999875 48899999985432 23456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998653 35899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.52 Aligned_cols=155 Identities=26% Similarity=0.403 Sum_probs=136.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC--eeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 547 (640)
.++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3678888999999999999999865 8899999987542 234577889999999999999999999998765 67999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE----cCCCceEEeeeccce
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kI~DFGla~ 623 (640)
|||+++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655555999999999999999999999987 9999999999999 888889999999999
Q ss_pred eccCCc
Q 006563 624 IFGGDE 629 (640)
Q Consensus 624 ~~~~~~ 629 (640)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 875543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=232.96 Aligned_cols=151 Identities=22% Similarity=0.388 Sum_probs=135.1
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+++++.++|||||++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3678888999999999999998765 789999998643 223456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998643 34899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=228.08 Aligned_cols=152 Identities=28% Similarity=0.391 Sum_probs=134.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCch------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
..+.|...+.||+|+||.||++.... ++.||+|.+.+.... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34678888999999999999998764 889999998764321 34679999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC----ceEEeee
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDF 619 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DF 619 (640)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999998543 35899999999999999999999987 99999999999998876 7999999
Q ss_pred ccceeccCC
Q 006563 620 GMARIFGGD 628 (640)
Q Consensus 620 Gla~~~~~~ 628 (640)
|+++.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=233.59 Aligned_cols=148 Identities=26% Similarity=0.388 Sum_probs=130.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...++||+|+||.||+++... ++.||+|++.+. .....+.+..|..++.++ +||||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4678889999999999999999865 778999998754 223445688999999887 89999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999988653 34899999999999999999999987 999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=218.15 Aligned_cols=152 Identities=31% Similarity=0.520 Sum_probs=136.9
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|+||.||++...++..||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788889999999999999999888899999997643 34577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....+.
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999996543 34899999999999999999999987 9999999999999999999999999999875443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-24 Score=223.56 Aligned_cols=151 Identities=22% Similarity=0.339 Sum_probs=134.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++.... ++.+|+|.+... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4678888999999999999998765 788999998754 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--CCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kI~DFGla~~~~~~ 628 (640)
+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999988543 235899999999999999999999987 999999999999987 789999999999987544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-25 Score=240.75 Aligned_cols=153 Identities=29% Similarity=0.521 Sum_probs=137.5
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||+|.+.. ++.||||++.... ...++|.+|+++|++++||||++++++|.+....+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34668888999999999999999876 7899999997643 346789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999997543 245899999999999999999999987 999999999999999999999999999987544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=226.00 Aligned_cols=152 Identities=32% Similarity=0.589 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEe-----cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
.++|...+.||+|+||.||++++ .+++.||||++........+.|.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788889999999999999984 24789999999876666678899999999999999999999998654 458
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999966432 4899999999999999999999987 99999999999999999999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+..+
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=225.50 Aligned_cols=150 Identities=26% Similarity=0.387 Sum_probs=134.0
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367888899999999999999876 48899999987531 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999653 34889999999999999999999987 99999999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=229.54 Aligned_cols=156 Identities=30% Similarity=0.523 Sum_probs=137.4
Q ss_pred HHhhccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
....++|...+.||+|+||.||++.... ++.||||++.... ....+.|.+|++++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3456789999999999999999998753 4789999997653 33467799999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 600 (640)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976321 146899999999999999999999987 99999
Q ss_pred cCCCCEEEcCCCceEEeeeccceeccC
Q 006563 601 LKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 601 lkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+|||+++++.+||+|||+++.+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CCcceEEECCCCeEEEeecCCCccccc
Confidence 999999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=224.17 Aligned_cols=155 Identities=31% Similarity=0.485 Sum_probs=136.1
Q ss_pred hhccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
..++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3577888899999999999999862 34789999997543 3456789999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
.++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 234889999999999999999999987 9999999
Q ss_pred CCCEEEcCCCceEEeeeccceeccCC
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+|||+++++.+||+|||+++.+...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred hheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999987544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.94 Aligned_cols=149 Identities=28% Similarity=0.546 Sum_probs=135.2
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788889999999999999999888999999997643 345679999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999986533 35899999999999999999999987 99999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=227.54 Aligned_cols=147 Identities=27% Similarity=0.395 Sum_probs=132.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 578888999999999999999865 789999999754 223456688999999988 899999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999988653 34899999999999999999999987 999999999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=228.41 Aligned_cols=151 Identities=27% Similarity=0.415 Sum_probs=133.0
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCee
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 544 (640)
...++|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 345789999999999999999999865 8899999997531 23456678899999877 899999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 34899999999999999999999987 99999999999999999999999999987
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=227.27 Aligned_cols=150 Identities=27% Similarity=0.335 Sum_probs=134.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3678888999999999999999864 8899999986531 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998653 24899999999999999999999987 99999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=229.02 Aligned_cols=149 Identities=32% Similarity=0.445 Sum_probs=127.5
Q ss_pred cccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCC
Q 006563 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 554 (640)
...+.||+|+||.||++... +++.||+|++........+++.+|++++++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33568999999999999875 48899999998765566788999999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE--cCCCceEEeeeccceeccCCc
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kI~DFGla~~~~~~~ 629 (640)
+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9988886543 34899999999999999999999987 9999999999999 667899999999999875443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=237.79 Aligned_cols=152 Identities=33% Similarity=0.513 Sum_probs=135.6
Q ss_pred HhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
...++|...+.||+|+||.||+|...++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3457788889999999999999999888999999998643 45678999999999999999999999986 667899999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999965422 24789999999999999999999987 99999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=223.00 Aligned_cols=151 Identities=30% Similarity=0.480 Sum_probs=132.3
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..++|...+.||+|+||.||++...+++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347889999999999999999999889999999987542 233567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++ +|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 7777775432 34899999999999999999999987 99999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=231.07 Aligned_cols=154 Identities=31% Similarity=0.485 Sum_probs=135.4
Q ss_pred hccccccccccccCceeEEEEEecC--------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||+++... +..||||++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4678888999999999999998632 3579999997653 34457899999999999 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
+..++||||+++|+|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCC
Q 006563 609 DNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~ 628 (640)
++++.+||+|||+|+.+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCC
T ss_pred cCCCcEEEcccCcccccccc
Confidence 99999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=222.91 Aligned_cols=150 Identities=28% Similarity=0.395 Sum_probs=133.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc------hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.+.|...+.||+|+||.||++.... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568888999999999999999864 88999999875422 1356799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC----ceEEeeec
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DFG 620 (640)
++||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999998543 35899999999999999999999987 99999999999999887 79999999
Q ss_pred cceeccC
Q 006563 621 MARIFGG 627 (640)
Q Consensus 621 la~~~~~ 627 (640)
+++.+..
T Consensus 164 ~a~~~~~ 170 (326)
T 2y0a_A 164 LAHKIDF 170 (326)
T ss_dssp TCEECCT
T ss_pred CCeECCC
Confidence 9998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=228.05 Aligned_cols=153 Identities=25% Similarity=0.374 Sum_probs=136.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++.... ++.||+|.+..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4678899999999999999998764 889999999866555567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--CCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kI~DFGla~~~~~~ 628 (640)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+..+
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 235899999999999999999999987 999999999999974 578999999999987654
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=226.71 Aligned_cols=156 Identities=31% Similarity=0.489 Sum_probs=133.8
Q ss_pred hhccccccccccccCceeEEEEEec------CCcEEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578888999999999999999862 3568999999754 234567899999999999 8999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhcccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARA--------------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
..++||||+++|+|.+++...... ..+++..++.++.||++||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34899999999999999999999987 9999999
Q ss_pred CCCEEEcCCCceEEeeeccceeccCCc
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+|||++.++.+||+|||+++.+..+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999875443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=221.96 Aligned_cols=150 Identities=28% Similarity=0.430 Sum_probs=127.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--------------------------hhhHhHHHHHHHHh
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--------------------------QGMEEFKNEVTLIA 524 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--------------------------~~~~~f~~E~~~l~ 524 (640)
.++|...+.||+|+||.||++.... ++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678888999999999999998754 78999999865421 12357899999999
Q ss_pred hCCCCceeeeEeEEEe--CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 006563 525 RLQHRNLVKLLGCCIQ--ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (640)
Q Consensus 525 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (640)
+++||||+++++++.+ ....++||||+++++|..++ ....+++..+..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999997754 2345899999999999999999999987 9999999
Q ss_pred CCCEEEcCCCceEEeeeccceeccCC
Q 006563 603 ASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 603 p~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=224.70 Aligned_cols=151 Identities=23% Similarity=0.262 Sum_probs=128.5
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...++||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +|+||++++++|.+++..+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 58999999986532 23344556666666555 899999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+ +++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 668888876543 35899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=225.52 Aligned_cols=149 Identities=26% Similarity=0.384 Sum_probs=124.9
Q ss_pred hccccccccccccCceeEEEEEe----cCCcEEEEEEcccCC----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l----~~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||+++. ..++.||+|++.+.. ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788889999999999999987 468899999997642 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999988653 34788999999999999999999987 9999999999999999999999999998
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
...
T Consensus 170 ~~~ 172 (327)
T 3a62_A 170 ESI 172 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=225.23 Aligned_cols=154 Identities=29% Similarity=0.444 Sum_probs=133.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC-----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
.+.|...+.||+|+||.||++.... ++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3578888999999999999998754 889999998632 1224578999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc---eEEeeecc
Q 006563 546 LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGM 621 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kI~DFGl 621 (640)
+||||+++++|..++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775542 2345899999999999999999999987 999999999999986654 99999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
++.+...
T Consensus 180 a~~~~~~ 186 (351)
T 3c0i_A 180 AIQLGES 186 (351)
T ss_dssp CEECCTT
T ss_pred eeEecCC
Confidence 9987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.6e-25 Score=228.08 Aligned_cols=157 Identities=32% Similarity=0.499 Sum_probs=136.3
Q ss_pred HHhhccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
+...++|...+.||+|+||.||++.... ...||+|.+.... ....+.+.+|++++.++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445788899999999999999998743 2479999997653 34567799999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999865421 235799999999999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceeccCC
Q 006563 610 NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~~ 628 (640)
+++.+||+|||+++.+..+
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGC
T ss_pred CCCeEEECccccccccccc
Confidence 9999999999999977543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=219.17 Aligned_cols=151 Identities=28% Similarity=0.500 Sum_probs=133.3
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..++|...+.||+|+||.||++...+++.||+|++.... ...+++.+|++++.+++|+||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346788889999999999999999888899999997643 3457799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999996532 34899999999999999999999987 99999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=224.38 Aligned_cols=155 Identities=30% Similarity=0.503 Sum_probs=122.6
Q ss_pred hhccccccccccccCceeEEEEEecCCc----EEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~----~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
..++|...+.||+|+||.||++...... .||||++... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4567888999999999999999876532 7999998754 345567899999999999999999999999877655
Q ss_pred ------EEEEEccCCCChhHHHhhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 545 ------MLIYEYMPNKSLDFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 545 ------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
++||||+++|+|..++..... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999865432 225899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceeccCC
Q 006563 616 ISDFGMARIFGGD 628 (640)
Q Consensus 616 I~DFGla~~~~~~ 628 (640)
|+|||+|+.+...
T Consensus 178 l~Dfg~a~~~~~~ 190 (323)
T 3qup_A 178 VADFGLSRKIYSG 190 (323)
T ss_dssp ECCCCC-------
T ss_pred Eeecccccccccc
Confidence 9999999877443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=218.15 Aligned_cols=149 Identities=26% Similarity=0.458 Sum_probs=130.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||+||++.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578888999999999999999865 8899999987542 3345778899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++ +|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 554544332 235899999999999999999999987 99999999999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=233.21 Aligned_cols=148 Identities=28% Similarity=0.506 Sum_probs=132.8
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC-eeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 550 (640)
.++|...+.||+|+||.||+|... ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.. ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999885 7899999997643 4578999999999999999999999988765 68999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999997643 334789999999999999999999987 9999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=238.50 Aligned_cols=154 Identities=29% Similarity=0.439 Sum_probs=136.4
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+++|++++||||+++++++.+.+..+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999886 4899999998653 123456688999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886543 234899999999999999999999987 99999999999999999999999999998754
Q ss_pred Cc
Q 006563 628 DE 629 (640)
Q Consensus 628 ~~ 629 (640)
..
T Consensus 339 ~~ 340 (576)
T 2acx_A 339 GQ 340 (576)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=232.09 Aligned_cols=151 Identities=33% Similarity=0.531 Sum_probs=131.9
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||+|... .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367888899999999999999853 3568999999754 344556799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEe
Q 006563 545 MLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKIS 617 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~ 617 (640)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 245899999999999999999999987 9999999999999954 459999
Q ss_pred eeccceec
Q 006563 618 DFGMARIF 625 (640)
Q Consensus 618 DFGla~~~ 625 (640)
|||+|+.+
T Consensus 227 DFG~a~~~ 234 (367)
T 3l9p_A 227 DFGMARDI 234 (367)
T ss_dssp CCHHHHHH
T ss_pred CCcccccc
Confidence 99999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=226.97 Aligned_cols=150 Identities=29% Similarity=0.374 Sum_probs=133.2
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999865 788999998753 123456788999999988 8999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998653 24899999999999999999999987 999999999999999999999999999975
Q ss_pred c
Q 006563 626 G 626 (640)
Q Consensus 626 ~ 626 (640)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-24 Score=216.07 Aligned_cols=152 Identities=23% Similarity=0.363 Sum_probs=136.8
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||++.... ++.||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34678888999999999999998765 67899999986655567889999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~~ 626 (640)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999998888653 34899999999999999999999987 9999999999999 788999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 161 ~~ 162 (277)
T 3f3z_A 161 PG 162 (277)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=226.18 Aligned_cols=151 Identities=32% Similarity=0.590 Sum_probs=127.9
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||+|.... ++ .||+|.+... .....++|.+|++++++++||||++++++|.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568888999999999999998643 44 3688888643 3345678999999999999999999999998754 789
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999996643 35899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 169 ~~~ 171 (327)
T 3poz_A 169 AEE 171 (327)
T ss_dssp TTC
T ss_pred CCc
Confidence 544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=225.87 Aligned_cols=152 Identities=27% Similarity=0.437 Sum_probs=134.0
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
..++|...+.||+|+||.||++.... ++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35679999999999999999998754 889999998754 234456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEeeecccee
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARI 624 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~DFGla~~ 624 (640)
|||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999998888543 35899999999999999999999987 9999999999999865 4599999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=223.03 Aligned_cols=155 Identities=30% Similarity=0.512 Sum_probs=135.1
Q ss_pred hhccccccccccccCceeEEEEEec--------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~--------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 540 (640)
..++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478888999999999999999863 36789999997543 34567799999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEE
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (640)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 234899999999999999999999987 999999999999
Q ss_pred EcCCCceEEeeeccceeccCC
Q 006563 608 LDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 608 l~~~~~~kI~DFGla~~~~~~ 628 (640)
++.++.+||+|||+++.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=226.02 Aligned_cols=159 Identities=29% Similarity=0.498 Sum_probs=137.9
Q ss_pred hHHHhhccccccccccccCceeEEEEEec------CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEE
Q 006563 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (640)
Q Consensus 467 ~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 539 (640)
+.+...++|...+.||+|+||.||+|... .++.||+|++..... ....++.+|++++++++|+||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34455678999999999999999999865 267899999975432 34567899999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 540 QADESMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
+....++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999865321 245789999999999999999999987 99999999999999999
Q ss_pred ceEEeeeccceeccCC
Q 006563 613 NPKISDFGMARIFGGD 628 (640)
Q Consensus 613 ~~kI~DFGla~~~~~~ 628 (640)
.+||+|||+++.+...
T Consensus 176 ~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYET 191 (322)
T ss_dssp CEEECCTTCCCGGGGG
T ss_pred eEEECcCccccccccc
Confidence 9999999999876443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=221.35 Aligned_cols=156 Identities=31% Similarity=0.472 Sum_probs=136.6
Q ss_pred hhccccccccccccCceeEEEEEe------cCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l------~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
..++|...+.||+|+||.||++.. ..++.||+|++..... ...+.+.+|++++.++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788889999999999999985 2367899999975533 3457899999999999 9999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEE
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR---------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (640)
..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 124899999999999999999999987 999999999999
Q ss_pred EcCCCceEEeeeccceeccCCc
Q 006563 608 LDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 608 l~~~~~~kI~DFGla~~~~~~~ 629 (640)
+++++.+||+|||+++.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999999876544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=236.32 Aligned_cols=149 Identities=26% Similarity=0.333 Sum_probs=124.1
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++.... ++.||||++... .......+.+|+++++.++||||+++++++...+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3678888999999999999998754 889999998743 234456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||+++|+|..++... ..+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999888553 358999999999999999999997 66 9999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=224.61 Aligned_cols=152 Identities=30% Similarity=0.502 Sum_probs=130.3
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||+|.... ++ .|++|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 567888899999999999998754 44 38888876432 344567889999999999999999999985 566899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999986542 35889999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcc
Q 006563 627 GDEI 630 (640)
Q Consensus 627 ~~~~ 630 (640)
....
T Consensus 167 ~~~~ 170 (325)
T 3kex_A 167 PDDK 170 (325)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=224.01 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=128.6
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe----
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 543 (640)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788889999999999999997 458899999997542 2335678999999999999999999999876543
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999998653 34899999999999999999999987 9999999999999999999999999998
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-24 Score=217.52 Aligned_cols=147 Identities=29% Similarity=0.451 Sum_probs=126.5
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhh--CCCCceeeeEeEEEeC----CeeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQA----DESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 545 (640)
.++|...+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999987 6889999998643 34556667777666 7999999999997653 3479
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
+||||+++|+|.+++.. ..+++..+..++.|+++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35899999999999999999999 555 9999999999999999999999
Q ss_pred eeccceeccCCc
Q 006563 618 DFGMARIFGGDE 629 (640)
Q Consensus 618 DFGla~~~~~~~ 629 (640)
|||+|+......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998875443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=235.30 Aligned_cols=152 Identities=30% Similarity=0.557 Sum_probs=132.1
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..++|...+.||+|+||.||+|....+..||||++.... ...++|.+|+++|++++||||+++++++.+ +..+|||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999999888889999998643 345789999999999999999999999866 678999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999996432 235899999999999999999999987 999999999999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=218.43 Aligned_cols=150 Identities=26% Similarity=0.484 Sum_probs=133.9
Q ss_pred hccccccccccccCceeEEEEEecC-C-------cEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-------QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g-------~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++.... + ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578888999999999999998754 3 4799999977666667889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc--------eE
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PK 615 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~k 615 (640)
.++||||+++|+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999996643 24899999999999999999999987 999999999999998887 99
Q ss_pred Eeeeccceecc
Q 006563 616 ISDFGMARIFG 626 (640)
Q Consensus 616 I~DFGla~~~~ 626 (640)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=228.80 Aligned_cols=155 Identities=26% Similarity=0.403 Sum_probs=136.2
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC--eeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 547 (640)
.++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578888999999999999999865 8899999987542 234577889999999999999999999998765 67999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE----cCCCceEEeeeccce
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kI~DFGla~ 623 (640)
|||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555455999999999999999999999987 9999999999999 788889999999999
Q ss_pred eccCCc
Q 006563 624 IFGGDE 629 (640)
Q Consensus 624 ~~~~~~ 629 (640)
.+....
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 875543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=218.75 Aligned_cols=148 Identities=28% Similarity=0.477 Sum_probs=131.8
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||++....++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999997799999999865422 2346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
+++ +|..++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 986 8888885432 34889999999999999999999987 9999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=224.35 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+|... .++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367888899999999999999974 58899999986431 22345789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 68888887553 34899999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=221.22 Aligned_cols=150 Identities=21% Similarity=0.257 Sum_probs=132.2
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|+||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36788889999999999999986 458899999987542 235789999999999 99999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc-----eEEeeecccee
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kI~DFGla~~ 624 (640)
|+ +++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998654 345899999999999999999999987 999999999999998887 99999999998
Q ss_pred ccCCc
Q 006563 625 FGGDE 629 (640)
Q Consensus 625 ~~~~~ 629 (640)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-24 Score=219.34 Aligned_cols=152 Identities=28% Similarity=0.492 Sum_probs=120.3
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678888999999999999998754 8899999987543 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|++ |+|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599888865321 235899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=213.87 Aligned_cols=156 Identities=27% Similarity=0.408 Sum_probs=135.9
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||++... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3577888999999999999999986 5899999998754 234566788999999999 99999999999999999999
Q ss_pred EEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---------------
Q 006563 547 IYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--------------- 610 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------------- 610 (640)
||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965432 245899999999999999999999987 999999999999984
Q ss_pred ----CCceEEeeeccceeccCCc
Q 006563 611 ----DMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 611 ----~~~~kI~DFGla~~~~~~~ 629 (640)
...+||+|||+++.+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC
T ss_pred ccCCceEEEEcccccccccCCcc
Confidence 4579999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-24 Score=234.41 Aligned_cols=155 Identities=30% Similarity=0.465 Sum_probs=137.1
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+..|++++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 4678888999999999999999864 8999999996532 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=224.41 Aligned_cols=147 Identities=26% Similarity=0.352 Sum_probs=129.9
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||+++.. .++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467899999999999999999986 48899999997542 3346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc--eEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kI~DFGla~~~ 625 (640)
+++|+|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+|+..
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999988653 24899999999999999999999987 999999999999987765 999999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=224.63 Aligned_cols=157 Identities=24% Similarity=0.320 Sum_probs=133.5
Q ss_pred hHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccC-----CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe
Q 006563 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (640)
Q Consensus 467 ~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 540 (640)
++....++|...+.||+|+||.||++.... ++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 455667889999999999999999998754 788999998643 23456789999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhcc-------------------------------------ccCCCCHHHHHHHHHHHHH
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQA-------------------------------------RATFLDWQKRIHIVGGIAR 583 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~ 583 (640)
.+..++||||+++|+|.+++.... ....+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999884210 0112456778889999999
Q ss_pred HHHHHHhCCCCceEecccCCCCEEEcCCC--ceEEeeeccceecc
Q 006563 584 GILYLHQDSRMRIIHRDLKASNVLLDNDM--NPKISDFGMARIFG 626 (640)
Q Consensus 584 gL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kI~DFGla~~~~ 626 (640)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 999999987 99999999999998766 89999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=221.41 Aligned_cols=165 Identities=29% Similarity=0.465 Sum_probs=139.5
Q ss_pred ccchHhHHHhhccccccccccccCceeEEEEEe------cCCcEEEEEEcccCCc-hhhHhHHHHHHHHhhC-CCCceee
Q 006563 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVK 533 (640)
Q Consensus 462 ~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l------~~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~ 533 (640)
.++........++|...+.||+|+||.||++.. ..++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344555555678999999999999999999974 2367899999976533 3456789999999999 7999999
Q ss_pred eEeEEEeCC-eeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006563 534 LLGCCIQAD-ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (640)
Q Consensus 534 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (640)
+++++...+ ..++||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999998765 48999999999999999975432 123789999999999999999999987 9999
Q ss_pred ccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 600 Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
||||+|||++.++.+||+|||+++.+..+.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred cCccceEEECCCCCEEECCCccccccccCc
Confidence 999999999999999999999999875443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=224.82 Aligned_cols=151 Identities=18% Similarity=0.265 Sum_probs=135.3
Q ss_pred hhcccccccccccc--CceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G--~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+| +||.||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34779999999999 99999999986 48999999987542 344567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|||||++|+|.+++..... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999865432 34899999999999999999999987 999999999999999999999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=226.62 Aligned_cols=149 Identities=25% Similarity=0.334 Sum_probs=123.5
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHH-HhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4678999999999999999999865 7889999997542 2234456677776 577899999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|..++.+. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999988653 34788899999999999999999987 9999999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=222.06 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=134.5
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--------hhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
..++|...+.||+|+||.||++... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 488999999875421 1345678899999999999999999999999
Q ss_pred CeeEEEEEccCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 542 DESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 542 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
+..++||||+..| +|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 998888543 34899999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCCc
Q 006563 621 MARIFGGDE 629 (640)
Q Consensus 621 la~~~~~~~ 629 (640)
+++.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999875543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=231.70 Aligned_cols=150 Identities=29% Similarity=0.493 Sum_probs=134.4
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999986 58999999986431 223567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999998542 35899999999999999999999987 999999999999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=219.37 Aligned_cols=151 Identities=28% Similarity=0.492 Sum_probs=134.7
Q ss_pred ccccccccccccCceeEEEEEe-----cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 545 (640)
++|...+.||+|+||.||++++ ..++.||||++........+.+.+|++++++++|+||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788889999999999999984 3478999999987766667789999999999999999999999874 45689
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996533 24899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 178 ~~~ 180 (327)
T 3lxl_A 178 PLD 180 (327)
T ss_dssp CTT
T ss_pred ccC
Confidence 543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=216.47 Aligned_cols=151 Identities=31% Similarity=0.560 Sum_probs=130.8
Q ss_pred ccccccccccccCceeEEEEEe-----cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--Cee
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 544 (640)
+.|...+.||+|+||.||++++ ..++.||+|++.... ....+.+.+|++++++++|+||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 347899999987542 34457899999999999999999999999876 568
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999985533 34899999999999999999999987 99999999999999999999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 176 ~~~~ 179 (302)
T 4e5w_A 176 IETD 179 (302)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-24 Score=229.35 Aligned_cols=152 Identities=26% Similarity=0.426 Sum_probs=132.8
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
..++|...+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4577999999999999999999875 48899999987543 23456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeecccee
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARI 624 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFGla~~ 624 (640)
|||+++|+|.+.+... ..+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999998888654 34899999999999999999999987 99999999999998 467899999999988
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+..+
T Consensus 163 ~~~~ 166 (444)
T 3soa_A 163 VEGE 166 (444)
T ss_dssp CCTT
T ss_pred ecCC
Confidence 7544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=213.75 Aligned_cols=150 Identities=30% Similarity=0.405 Sum_probs=134.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888899999999999999876 4889999998643 23445788999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999888743 235899999999999999999999987 99999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=225.96 Aligned_cols=151 Identities=27% Similarity=0.375 Sum_probs=133.6
Q ss_pred hccccccccccccCceeEEEEEe----cCCcEEEEEEcccCC----chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l----~~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 542 (640)
.++|...+.||+|+||.||+++. ..++.||||++.... ....+.+.+|++++.++ +|+||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788889999999999999987 358899999987532 23456678899999999 6999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..+|||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998653 34899999999999999999999987 999999999999999999999999999
Q ss_pred eeccCC
Q 006563 623 RIFGGD 628 (640)
Q Consensus 623 ~~~~~~ 628 (640)
+.+..+
T Consensus 207 ~~~~~~ 212 (355)
T 1vzo_A 207 KEFVAD 212 (355)
T ss_dssp EECCGG
T ss_pred eecccC
Confidence 987543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-25 Score=231.36 Aligned_cols=148 Identities=20% Similarity=0.282 Sum_probs=124.6
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCC--------chhhHhHHHHHHHHhhCC---------CCceeee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQ---------HRNLVKL 534 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~niv~l 534 (640)
.++|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+++++.++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788889999999999999987 68999999997542 223477889999998885 8888888
Q ss_pred EeEEE------------------------------eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHH
Q 006563 535 LGCCI------------------------------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584 (640)
Q Consensus 535 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 584 (640)
.+++. .....+|||||+++|++...+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 87653 15779999999999976555522 357999999999999999
Q ss_pred HHHHH-hCCCCceEecccCCCCEEEcCCC--------------------ceEEeeeccceeccC
Q 006563 585 ILYLH-QDSRMRIIHRDLKASNVLLDNDM--------------------NPKISDFGMARIFGG 627 (640)
Q Consensus 585 L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kI~DFGla~~~~~ 627 (640)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=213.70 Aligned_cols=151 Identities=28% Similarity=0.436 Sum_probs=132.4
Q ss_pred cccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3444568999999999999874 478999999987656667789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGla~~~~~ 627 (640)
+++|..++........+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999976544455788999999999999999999987 999999999999987 89999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=232.66 Aligned_cols=149 Identities=26% Similarity=0.442 Sum_probs=122.0
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Ce
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 543 (640)
.++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+++|++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999875 4889999998754 233457799999999999999999999998543 46
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 6898888543 35899999999999999999999987 9999999999999999999999999999
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=222.90 Aligned_cols=151 Identities=23% Similarity=0.368 Sum_probs=130.6
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCC--CceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++...+++.||||++... ..+..+.+.+|++++.+++| +||+++++++......+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4678889999999999999999988999999998643 33456789999999999976 9999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|| +.+++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999998653 35889999999999999999999987 99999999999997 57899999999998765
Q ss_pred Ccc
Q 006563 628 DEI 630 (640)
Q Consensus 628 ~~~ 630 (640)
+..
T Consensus 160 ~~~ 162 (343)
T 3dbq_A 160 DTT 162 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=222.89 Aligned_cols=149 Identities=29% Similarity=0.425 Sum_probs=121.6
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||++.... ++.||||++.... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45678888999999999999999865 7899999997542 34678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGla~~~~ 626 (640)
|+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999988543 34899999999999999999999987 999999999999975 8899999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=229.25 Aligned_cols=150 Identities=27% Similarity=0.468 Sum_probs=130.9
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Ce
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 543 (640)
.++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|++++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999998765 788999999754 233457889999999999999999999999776 56
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||++ ++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 5999888543 35899999999999999999999987 9999999999999999999999999999
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=215.45 Aligned_cols=154 Identities=27% Similarity=0.411 Sum_probs=133.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3678888999999999999998754 8899999987543 3346789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~ 625 (640)
|+++|+|.+++.... ....+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999998886532 2356899999999999999999999987 9999999999999 45688999999999887
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=217.77 Aligned_cols=154 Identities=30% Similarity=0.517 Sum_probs=138.0
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||++.... ++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45778888999999999999999876 788999999754 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+++++|.+++.... ...+++..+..++.+++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..+.
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996543 345899999999999999999999987 9999999999999999999999999999875443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=238.40 Aligned_cols=151 Identities=30% Similarity=0.556 Sum_probs=134.4
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..++|...++||+|+||.||+|.+..+..||||++.... ...++|.+|+++|++++|+||+++++++.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788889999999999999999888899999997643 345789999999999999999999999866 678999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|++|+|.+++.... ...+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999996432 235899999999999999999999987 99999999999999999999999999987753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=215.95 Aligned_cols=148 Identities=28% Similarity=0.383 Sum_probs=129.6
Q ss_pred cccccc-ccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~-~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 549 (640)
+.|... +.||+|+||.||++... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 68999999999999865 5889999999876555677899999999885 79999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc---eEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kI~DFGla~~~~ 626 (640)
|+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998653 34899999999999999999999987 999999999999988766 9999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.31 Aligned_cols=151 Identities=33% Similarity=0.574 Sum_probs=133.6
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788889999999999999998888899999987543 34678999999999999999999999976 45689999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999985432 225899999999999999999999987 999999999999999999999999999987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=212.64 Aligned_cols=149 Identities=28% Similarity=0.530 Sum_probs=135.0
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5788889999999999999999888899999998653 334789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999986542 35889999999999999999999987 99999999999999999999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=216.76 Aligned_cols=151 Identities=28% Similarity=0.400 Sum_probs=134.5
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCch------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||++.... ++.||+|.+...... ..+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4678888999999999999999764 889999998754221 356799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC----ceEEeeec
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DFG 620 (640)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999643 35889999999999999999999987 99999999999999887 79999999
Q ss_pred cceeccCC
Q 006563 621 MARIFGGD 628 (640)
Q Consensus 621 la~~~~~~ 628 (640)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=219.25 Aligned_cols=159 Identities=29% Similarity=0.523 Sum_probs=128.0
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC----CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEE
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 539 (640)
.++....++|...+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344456788889999999999999998753 447999998754 2344577999999999999999999999998
Q ss_pred eCCe-----eEEEEEccCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC
Q 006563 540 QADE-----SMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 540 ~~~~-----~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 611 (640)
+... .++||||+++++|..++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7653 499999999999999985432 2346899999999999999999999987 9999999999999999
Q ss_pred CceEEeeeccceeccC
Q 006563 612 MNPKISDFGMARIFGG 627 (640)
Q Consensus 612 ~~~kI~DFGla~~~~~ 627 (640)
+.+||+|||+++.+..
T Consensus 184 ~~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 184 MTVCVADFGLSKKIYS 199 (313)
T ss_dssp SCEEECSCSCC-----
T ss_pred CcEEEeecCcceeccc
Confidence 9999999999987744
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=221.48 Aligned_cols=149 Identities=28% Similarity=0.491 Sum_probs=131.0
Q ss_pred ccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+.|...+.||+|+||.||+|.. .+++.||||++..... ...+++.+|++++++++||||+++++++..++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5588889999999999999986 4588999999875422 33467899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6787777543 245899999999999999999999987 99999999999999999999999999988753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=215.58 Aligned_cols=149 Identities=27% Similarity=0.421 Sum_probs=133.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||++.... ++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578888999999999999999865 88999999865432 335678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999998887543 34899999999999999999999987 99999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-23 Score=212.68 Aligned_cols=151 Identities=26% Similarity=0.372 Sum_probs=134.6
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||++...+ ++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34678888999999999999999865 788999998653 23446678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988543 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 167 ~ 167 (294)
T 2rku_A 167 Y 167 (294)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-23 Score=217.41 Aligned_cols=151 Identities=26% Similarity=0.372 Sum_probs=134.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||++...+ ++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678888999999999999999865 788999998643 23456778999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988543 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=220.66 Aligned_cols=166 Identities=27% Similarity=0.329 Sum_probs=142.2
Q ss_pred ccccccccchHhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-----CC
Q 006563 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----HR 529 (640)
Q Consensus 456 ~~~~~~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~ 529 (640)
.+.+...+++.+.....++|...++||+|+||.||+++.. +++.||||++... ....+.+..|++++.+++ |+
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3444556677766677889999999999999999999885 4889999998743 344567788999999986 99
Q ss_pred ceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 530 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
||+++++++...+..+|||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 9999999865432 34899999999999999999999987 99999999999997
Q ss_pred C-------------------------CCceEEeeeccceeccC
Q 006563 610 N-------------------------DMNPKISDFGMARIFGG 627 (640)
Q Consensus 610 ~-------------------------~~~~kI~DFGla~~~~~ 627 (640)
+ ++.+||+|||+|+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 5 78999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=211.97 Aligned_cols=152 Identities=30% Similarity=0.521 Sum_probs=134.4
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467888899999999999999874 58999999986431 2234678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998653 245899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=224.69 Aligned_cols=149 Identities=23% Similarity=0.373 Sum_probs=129.6
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCC--CCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++......+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 568889999999999999999888999999998653 3345678999999999996 599999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
| +.+++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..+
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 67889999986543 5788999999999999999999987 99999999999996 578999999999987654
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 208 ~ 208 (390)
T 2zmd_A 208 T 208 (390)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=217.28 Aligned_cols=152 Identities=32% Similarity=0.589 Sum_probs=134.4
Q ss_pred hccccccccccccCceeEEEEEe-----cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC--ee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-----~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 544 (640)
.++|...+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688889999999999999984 347899999998766667788999999999999999999999987654 68
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996543 34899999999999999999999987 99999999999999999999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+..+
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=216.69 Aligned_cols=141 Identities=28% Similarity=0.366 Sum_probs=124.8
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
+.||+|+||.||++.... ++.||||++.+ .....+.+|++++..+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 689999999999999864 88999999864 34467789999999997 99999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC---ceEEeeeccceeccCC
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFGGD 628 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kI~DFGla~~~~~~ 628 (640)
.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9998653 35899999999999999999999987 99999999999997665 8999999999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=223.22 Aligned_cols=149 Identities=29% Similarity=0.532 Sum_probs=123.1
Q ss_pred HhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCC--e
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD--E 543 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 543 (640)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.++.++. |+||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999875 4889999998643 2344567889999999997 999999999998654 6
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++|||||+ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 589888854 25889999999999999999999987 9999999999999999999999999999
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
.+.
T Consensus 158 ~~~ 160 (388)
T 3oz6_A 158 SFV 160 (388)
T ss_dssp ESS
T ss_pred ccc
Confidence 864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=211.76 Aligned_cols=152 Identities=33% Similarity=0.543 Sum_probs=124.5
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCC----chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... ++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999874 8899999987542 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--------CCceEEeee
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--------DMNPKISDF 619 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kI~DF 619 (640)
|||+++++|..++.. ..+++..+..++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999998842 35899999999999999999999987566999999999999986 678999999
Q ss_pred ccceeccCC
Q 006563 620 GMARIFGGD 628 (640)
Q Consensus 620 Gla~~~~~~ 628 (640)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=227.08 Aligned_cols=152 Identities=26% Similarity=0.378 Sum_probs=127.7
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--------chhhHhHHHHHHHHhhCCCCceeeeEeEEEe
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 540 (640)
...++|...+.||+|+||.||+|.... ++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 346789999999999999999998765 7899999986431 122346889999999999999999999975
Q ss_pred CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEe
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKIS 617 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~ 617 (640)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 55689999999999998877432 35899999999999999999999987 9999999999999654 459999
Q ss_pred eeccceeccCC
Q 006563 618 DFGMARIFGGD 628 (640)
Q Consensus 618 DFGla~~~~~~ 628 (640)
|||+|+.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.68 Aligned_cols=150 Identities=25% Similarity=0.407 Sum_probs=123.9
Q ss_pred hccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4678888999999999999998754 4579999987543 34466799999999999999999999997 4567899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999996532 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 168 ~ 168 (281)
T 1mp8_A 168 D 168 (281)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-23 Score=210.26 Aligned_cols=151 Identities=27% Similarity=0.447 Sum_probs=133.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||++.... ++.||+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4788899999999999999998765 889999998643 2344577889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc---eEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kI~DFGla~~~ 625 (640)
||+++++|...+... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888553 34899999999999999999999987 999999999999976655 999999999887
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=215.03 Aligned_cols=148 Identities=34% Similarity=0.563 Sum_probs=123.1
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||+++... .||+|++... .....+.|.+|++++++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4678888999999999999998643 6999998754 234567899999999999999999999965 4566899999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999988543 345899999999999999999999987 99999999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-23 Score=209.69 Aligned_cols=149 Identities=28% Similarity=0.411 Sum_probs=132.7
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc------hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888899999999999999986 488999999875421 13578999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC----ceEEeeecc
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGM 621 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DFGl 621 (640)
+||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999998543 35899999999999999999999987 99999999999998877 899999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
++.+..
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=238.15 Aligned_cols=151 Identities=28% Similarity=0.362 Sum_probs=133.4
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+|+||.||+++... ++.||||++.+. .....+.+..|.+++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35679999999999999999999765 788999998753 233456788899999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998654 34899999999999999999999987 999999999999999999999999999975
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 493 ~~ 494 (674)
T 3pfq_A 493 IW 494 (674)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-23 Score=218.25 Aligned_cols=157 Identities=22% Similarity=0.394 Sum_probs=137.5
Q ss_pred HhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--------hhhHhHHHHHHHHhhC-CCCceeeeE
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARL-QHRNLVKLL 535 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~niv~l~ 535 (640)
.......++|...+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 589999999875431 1245678999999999 799999999
Q ss_pred eEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceE
Q 006563 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (640)
Q Consensus 536 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (640)
+++......+|||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998643 35899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceeccCC
Q 006563 616 ISDFGMARIFGGD 628 (640)
Q Consensus 616 I~DFGla~~~~~~ 628 (640)
|+|||+++.+...
T Consensus 241 l~DfG~~~~~~~~ 253 (365)
T 2y7j_A 241 LSDFGFSCHLEPG 253 (365)
T ss_dssp ECCCTTCEECCTT
T ss_pred EEecCcccccCCC
Confidence 9999999987544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=210.69 Aligned_cols=150 Identities=29% Similarity=0.517 Sum_probs=132.2
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe---------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------- 540 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------- 540 (640)
..++|...+.||+|+||.||++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467888999999999999999986 58999999987543 467789999999999999999999864
Q ss_pred -------CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc
Q 006563 541 -------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (640)
Q Consensus 541 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (640)
....++||||+++++|.+++.... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 344799999999999999996543 345899999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceeccCC
Q 006563 614 PKISDFGMARIFGGD 628 (640)
Q Consensus 614 ~kI~DFGla~~~~~~ 628 (640)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.66 Aligned_cols=153 Identities=27% Similarity=0.418 Sum_probs=133.1
Q ss_pred hhccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 545 (640)
..++|...+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999987 4589999999876656667889999999999999999999999873 34679
Q ss_pred EEEEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 546 LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+||||+++|+|.+++.... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999886532 2346899999999999999999999987 99999999999999999999999999887
Q ss_pred cc
Q 006563 625 FG 626 (640)
Q Consensus 625 ~~ 626 (640)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=236.54 Aligned_cols=143 Identities=31% Similarity=0.565 Sum_probs=126.4
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..+|||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 35679999998653 3456889999999999999999999999976 56899999999999
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999643 345899999999999999999999987 999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=212.24 Aligned_cols=151 Identities=29% Similarity=0.419 Sum_probs=132.2
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+.++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34678888999999999999998765 6789999986431 1234678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988653 34899999999999999999999987 9999999999999999999999999997654
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 161 ~ 161 (279)
T 3fdn_A 161 S 161 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=212.75 Aligned_cols=147 Identities=35% Similarity=0.558 Sum_probs=130.2
Q ss_pred ccccccccccCceeEEEEEec-----CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEE
Q 006563 475 FASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l~-----~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (640)
|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478889999999999988653 47889999998653 34467799999999999999999999999884 56899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998543 3899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=222.91 Aligned_cols=149 Identities=30% Similarity=0.516 Sum_probs=122.7
Q ss_pred cccccccccccCceeEEEEEecC--C--cEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-CeeEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~--g--~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 547 (640)
.|...+.||+|+||.||+|...+ + ..||||.+... .....++|.+|+.++++++||||++++++|.+. +..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46667899999999999998743 2 36899998754 334567899999999999999999999998654 578999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999996532 34789999999999999999999987 99999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=217.77 Aligned_cols=151 Identities=32% Similarity=0.568 Sum_probs=127.9
Q ss_pred ccccccccccccCceeEEEEEecC-----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|...+.||+|+||.||+|.... +..||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998754 2359999987543 3345679999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999653 235899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 199 ~~ 200 (333)
T 1mqb_A 199 DD 200 (333)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=210.12 Aligned_cols=150 Identities=29% Similarity=0.470 Sum_probs=134.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.+.|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999865 48899999987543 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999998843 35899999999999999999999987 999999999999999999999999999887544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=215.37 Aligned_cols=151 Identities=25% Similarity=0.418 Sum_probs=127.0
Q ss_pred HhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhh--CCCCceeeeEeEEEeC----Ce
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQA----DE 543 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~ 543 (640)
...++|...+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++|+||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34578999999999999999999875 889999998643 23445556665554 4899999999999987 67
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCCEEEcCCCceEEee
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS-----RMRIIHRDLKASNVLLDNDMNPKISD 618 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kI~D 618 (640)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999543 4899999999999999999999871 12399999999999999999999999
Q ss_pred eccceeccCC
Q 006563 619 FGMARIFGGD 628 (640)
Q Consensus 619 FGla~~~~~~ 628 (640)
||+|+.+...
T Consensus 186 fg~a~~~~~~ 195 (337)
T 3mdy_A 186 LGLAVKFISD 195 (337)
T ss_dssp CTTCEECC--
T ss_pred CCCceeeccc
Confidence 9999887544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=227.57 Aligned_cols=151 Identities=28% Similarity=0.423 Sum_probs=129.2
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.+.|...+.||+|+||.||+++.. .++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999986 47899999987542 334677899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGla~~~ 625 (640)
||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888553 34899999999999999999999987 999999999999976 455999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 190 ~~~ 192 (494)
T 3lij_A 190 ENQ 192 (494)
T ss_dssp BTT
T ss_pred CCC
Confidence 644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=213.85 Aligned_cols=150 Identities=28% Similarity=0.480 Sum_probs=132.0
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||++.... ++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34678888999999999999999865 88999999987666667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+++++|..++.... ..+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999886532 34899999999999999999999987 999999999999999999999999998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=210.10 Aligned_cols=153 Identities=26% Similarity=0.357 Sum_probs=134.6
Q ss_pred HhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---------chhhHhHHHHHHHHhhCC-CCceeeeEeEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---------GQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~ 538 (640)
...++|...+.||+|+||.||++.... ++.||||++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345788889999999999999999864 7899999986542 122456889999999995 99999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEee
Q 006563 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (640)
Q Consensus 539 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~D 618 (640)
......++||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998653 35899999999999999999999987 99999999999999999999999
Q ss_pred eccceeccCC
Q 006563 619 FGMARIFGGD 628 (640)
Q Consensus 619 FGla~~~~~~ 628 (640)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=210.32 Aligned_cols=150 Identities=33% Similarity=0.577 Sum_probs=131.1
Q ss_pred ccccccc-cccccCceeEEEEEec---CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~-~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+ .||+|+||.||+|... .++.||||++.... ....+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999864 47789999998643 34567899999999999999999999999 56678999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999998543 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
+
T Consensus 163 ~ 163 (287)
T 1u59_A 163 D 163 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=220.15 Aligned_cols=159 Identities=25% Similarity=0.345 Sum_probs=133.1
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCc-----------hhhHhHHHHHHHHhhCCCCce
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-----------QGMEEFKNEVTLIARLQHRNL 531 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~ni 531 (640)
....++....++|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345677888899999999999999999999988899999999864321 123678999999999999999
Q ss_pred eeeEeEEEeC-----CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCE
Q 006563 532 VKLLGCCIQA-----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (640)
Q Consensus 532 v~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (640)
+++++++... ...++||||++ |+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998653 25799999998 5887777543 335899999999999999999999987 99999999999
Q ss_pred EEcCCCceEEeeeccceeccC
Q 006563 607 LLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 607 Ll~~~~~~kI~DFGla~~~~~ 627 (640)
|++.++.+||+|||+++....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp EECTTCCEEECCTTC------
T ss_pred EEcCCCCEEEEecCccccccc
Confidence 999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=216.92 Aligned_cols=162 Identities=31% Similarity=0.504 Sum_probs=136.7
Q ss_pred cccchHhHHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEE
Q 006563 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC 538 (640)
Q Consensus 461 ~~~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 538 (640)
..++..++....++|...+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34555666667889999999999999999999975 5889999998754 33457889999999999 899999999999
Q ss_pred Ee------CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 539 IQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 539 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
.. ....++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 87 457899999999999999986543 345889999999999999999999987 99999999999999999
Q ss_pred ceEEeeeccceeccC
Q 006563 613 NPKISDFGMARIFGG 627 (640)
Q Consensus 613 ~~kI~DFGla~~~~~ 627 (640)
.+||+|||+++.+..
T Consensus 167 ~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDR 181 (326)
T ss_dssp CEEECCCTTTC----
T ss_pred CEEEeeCcCceecCc
Confidence 999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-24 Score=225.36 Aligned_cols=152 Identities=16% Similarity=0.201 Sum_probs=125.4
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHH---HHHhhCCCCceeeeE-------e
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEV---TLIARLQHRNLVKLL-------G 536 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g 536 (640)
..++|...+.||+|+||.||+|... +++.||||++... .....+.|.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567888899999999999999974 4899999998743 334567899999 556666899999998 6
Q ss_pred EEEeCC-----------------eeEEEEEccCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006563 537 CCIQAD-----------------ESMLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (640)
Q Consensus 537 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (640)
++...+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 665543 278999999 6899999975422 123456888899999999999999987
Q ss_pred eEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.8e-23 Score=226.72 Aligned_cols=152 Identities=32% Similarity=0.478 Sum_probs=131.9
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-------------hhhHhHHHHHHHHhhCCCCceeeeEe
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-------------QGMEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
..++|...++||+|+||.||++.... ++.||+|++..... ...+++.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999865 78999999875321 23567899999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC---c
Q 006563 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---N 613 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~ 613 (640)
++.++...++||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999998888553 34899999999999999999999987 99999999999998775 6
Q ss_pred eEEeeeccceeccCC
Q 006563 614 PKISDFGMARIFGGD 628 (640)
Q Consensus 614 ~kI~DFGla~~~~~~ 628 (640)
+||+|||+|+.+...
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=217.61 Aligned_cols=151 Identities=32% Similarity=0.582 Sum_probs=126.1
Q ss_pred hccccccccccccCceeEEEEEecC-Cc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
.++|...+.||+|+||.||+|.... ++ .|++|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3678888999999999999998644 44 3688887643 3445678999999999999999999999998754 78
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+|+||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999986543 34899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=215.77 Aligned_cols=149 Identities=28% Similarity=0.454 Sum_probs=125.7
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||++... ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56778889999999999999874 788999998743 44578999999999999999999999876 45899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc-eEEeeeccceecc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-PKISDFGMARIFG 626 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kI~DFGla~~~~ 626 (640)
+|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+.
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999976554445889999999999999999999943334999999999999988876 7999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-23 Score=209.68 Aligned_cols=149 Identities=17% Similarity=0.306 Sum_probs=131.9
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++.. .+++.||||++... ...+.+.+|++++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788889999999999999986 45889999998653 2345788999999999 79999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc-----eEEeeecccee
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kI~DFGla~~ 624 (640)
|+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996542 34899999999999999999999987 999999999999987766 99999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 161 ~~~~ 164 (298)
T 1csn_A 161 YRDP 164 (298)
T ss_dssp SBCT
T ss_pred cccc
Confidence 7654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-23 Score=211.86 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=128.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC----chhhHhHHHHHHHHhhCCCCceeeeEeEEE--eCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCI--QADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 544 (640)
.++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++++++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999754 7899999987531 234578999999999999999999999985 34578
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||++++ |..++.... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 666665432 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=220.43 Aligned_cols=152 Identities=21% Similarity=0.308 Sum_probs=126.5
Q ss_pred hhccccccccccccCceeEEEEEecC------CcEEEEEEcccCCchhh-----------HhHHHHHHHHhhCCCCceee
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQGM-----------EEFKNEVTLIARLQHRNLVK 533 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~ 533 (640)
..++|...+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998865 36899999875432111 12345666778889999999
Q ss_pred eEeEEEeC----CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 534 LLGCCIQA----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 534 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999775 4479999999 99999998653 245899999999999999999999987 99999999999999
Q ss_pred --CCCceEEeeeccceeccCC
Q 006563 610 --NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 610 --~~~~~kI~DFGla~~~~~~ 628 (640)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=213.28 Aligned_cols=152 Identities=21% Similarity=0.254 Sum_probs=130.2
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
..++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999976 48899999987542 2234678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=228.39 Aligned_cols=148 Identities=29% Similarity=0.430 Sum_probs=124.1
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------C
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 542 (640)
.++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678889999999999999998754 889999999753 334567789999999999999999999999654 3
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..+||||||+++ |...+.. .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999875 5555522 3889999999999999999999987 999999999999999999999999999
Q ss_pred eeccCC
Q 006563 623 RIFGGD 628 (640)
Q Consensus 623 ~~~~~~ 628 (640)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=212.50 Aligned_cols=150 Identities=29% Similarity=0.493 Sum_probs=129.8
Q ss_pred hccccccc-cccccCceeEEEEEec---CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 472 TDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 472 ~~~f~~~~-~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
.++|...+ .||+|+||.||++... .++.||||++.... ....+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677766 8999999999999653 26789999987542 33467899999999999999999999999 667789
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 34899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
..+
T Consensus 168 ~~~ 170 (291)
T 1xbb_A 168 RAD 170 (291)
T ss_dssp CTT
T ss_pred ccC
Confidence 544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-23 Score=211.54 Aligned_cols=149 Identities=28% Similarity=0.474 Sum_probs=131.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ---------- 540 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------- 540 (640)
.++|...+.||+|+||.||++... +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467888999999999999999975 5889999998643 3456789999999999999999999999865
Q ss_pred ---CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 541 ---ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 541 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
....++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 345799999999999999996533 34788899999999999999999987 9999999999999999999999
Q ss_pred eeccceecc
Q 006563 618 DFGMARIFG 626 (640)
Q Consensus 618 DFGla~~~~ 626 (640)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=211.86 Aligned_cols=153 Identities=29% Similarity=0.513 Sum_probs=126.7
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-----chhhHhHHHHHHHHhhC---CCCceeeeEeEEEeC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-----~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~ 541 (640)
..++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999974 48899999986421 11234567777777666 499999999999876
Q ss_pred C-----eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEE
Q 006563 542 D-----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (640)
Q Consensus 542 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI 616 (640)
. ..++||||++ ++|..++..... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 599998865433 34899999999999999999999988 999999999999999999999
Q ss_pred eeeccceeccCC
Q 006563 617 SDFGMARIFGGD 628 (640)
Q Consensus 617 ~DFGla~~~~~~ 628 (640)
+|||+|+.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=220.79 Aligned_cols=146 Identities=25% Similarity=0.306 Sum_probs=123.5
Q ss_pred cccccc-ccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHh-hCCCCceeeeEeEEEe----CCeeE
Q 006563 473 DNFASY-NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIA-RLQHRNLVKLLGCCIQ----ADESM 545 (640)
Q Consensus 473 ~~f~~~-~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 545 (640)
++|... +.||+|+||.||++.... ++.||||++... ..+.+|++++. ..+|+||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456554 689999999999998764 889999998642 45678888874 4589999999999876 55689
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeeccc
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMA 622 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGla 622 (640)
|||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996532 235899999999999999999999987 999999999999997 789999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 98653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=218.39 Aligned_cols=153 Identities=31% Similarity=0.491 Sum_probs=126.4
Q ss_pred HHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc-----hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-----QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 542 (640)
....++|...+.||+|+||.||++.... ++.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3445789999999999999999999865 88999999875321 12346889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++||||+++ +|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 888877543 235888999999999999999999988 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+.+..
T Consensus 160 ~~~~~ 164 (346)
T 1ua2_A 160 KSFGS 164 (346)
T ss_dssp STTTS
T ss_pred eeccC
Confidence 98743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=212.13 Aligned_cols=152 Identities=30% Similarity=0.494 Sum_probs=130.3
Q ss_pred hccccccccccccCceeEEEEEecCC----cEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEe-CCeeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g----~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 545 (640)
...|...+.||+|+||.||+|...+. ..||+|.+.... ....+.+.+|++++++++||||+++++++.+ .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35677788999999999999986542 358999987643 3456789999999999999999999999765 45689
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999653 235789999999999999999999987 999999999999999999999999999977
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 179 ~~~ 181 (298)
T 3f66_A 179 YDK 181 (298)
T ss_dssp SCG
T ss_pred ccc
Confidence 543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=216.67 Aligned_cols=152 Identities=33% Similarity=0.522 Sum_probs=130.1
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||+|... .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467888899999999999999842 3678999999754 334566899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEe
Q 006563 545 MLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKIS 617 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~ 617 (640)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++ ++..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 235899999999999999999999987 99999999999998 45569999
Q ss_pred eeccceecc
Q 006563 618 DFGMARIFG 626 (640)
Q Consensus 618 DFGla~~~~ 626 (640)
|||+++.+.
T Consensus 186 Dfg~~~~~~ 194 (327)
T 2yfx_A 186 DFGMARDIY 194 (327)
T ss_dssp CCHHHHHHH
T ss_pred ccccccccc
Confidence 999998664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=212.70 Aligned_cols=149 Identities=32% Similarity=0.472 Sum_probs=129.1
Q ss_pred cccccccccccCceeEEEEEecC-C---cEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee-EEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES-MLI 547 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g---~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 547 (640)
.|...+.||+|+||.||+|...+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45556799999999999998644 2 2699999876433 4567899999999999999999999999876665 999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+||+.+|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999653 345889999999999999999999987 99999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=218.17 Aligned_cols=148 Identities=24% Similarity=0.341 Sum_probs=133.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999986 48899999987653 3445779999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|+++++|.+++... ..+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999653 2488999999999999999999985 6 999999999999999999999999999765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-23 Score=208.69 Aligned_cols=151 Identities=32% Similarity=0.601 Sum_probs=128.5
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchh-------hHhHHHHHHHHhhCCCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG-------MEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++... +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888899999999999999875 58899999986543211 267899999999999999999999986544
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc-----eEEee
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISD 618 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kI~D 618 (640)
++||||+++|+|.+++.+.. ..+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999988886543 35899999999999999999999875 35999999999999987776 99999
Q ss_pred eccceeccC
Q 006563 619 FGMARIFGG 627 (640)
Q Consensus 619 FGla~~~~~ 627 (640)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-23 Score=214.41 Aligned_cols=150 Identities=29% Similarity=0.487 Sum_probs=129.9
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||++.... ++.||||++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3678888999999999999999865 88999999865432 33556889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998876433 34899999999999999999999987 99999999999999999999999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=210.36 Aligned_cols=151 Identities=29% Similarity=0.490 Sum_probs=130.1
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
..++|...+.||+|+||.||++.... ++.||+|++... ...+++.+|++++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45779999999999999999998865 889999998753 245778999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+++++|.+++... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998532 335899999999999999999999987 999999999999999999999999999887543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-23 Score=213.70 Aligned_cols=150 Identities=34% Similarity=0.586 Sum_probs=130.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcE--EEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQE--IAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~--VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||.||++.... ++. |++|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578888999999999999998755 554 599988753 334566799999999999 899999999999999999999
Q ss_pred EEccCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
|||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceec
Q 006563 615 KISDFGMARIF 625 (640)
Q Consensus 615 kI~DFGla~~~ 625 (640)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=214.11 Aligned_cols=153 Identities=25% Similarity=0.428 Sum_probs=120.4
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..++|...+.||+|+||.||++... +++.||||++.... ....+++.+|++++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999875 58899999986542 344577899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 549 EYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988642 12345899999999999999999999987 9999999999999999999999999998
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
.+.
T Consensus 170 ~~~ 172 (303)
T 2vwi_A 170 FLA 172 (303)
T ss_dssp HCC
T ss_pred eec
Confidence 764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-23 Score=208.57 Aligned_cols=151 Identities=27% Similarity=0.459 Sum_probs=134.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888899999999999999986 58899999986431 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998653 24889999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.85 Aligned_cols=149 Identities=27% Similarity=0.513 Sum_probs=129.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------- 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 541 (640)
.++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367888999999999999999984 58899999986542 23345788999999999999999999999873
Q ss_pred -CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 542 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
+..++||||+++ +|...+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999985 6766664432 34899999999999999999999987 9999999999999999999999999
Q ss_pred cceecc
Q 006563 621 MARIFG 626 (640)
Q Consensus 621 la~~~~ 626 (640)
+|+.+.
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=215.35 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=128.4
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..++|...+.||+|+||.||++.... ++.||+|++.+... .+.+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35678889999999999999998864 88999999975432 345688888887 7999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC----CceEEeeecccee
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kI~DFGla~~ 624 (640)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ ..+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988653 35899999999999999999999987 9999999999998543 3599999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-23 Score=208.47 Aligned_cols=150 Identities=25% Similarity=0.391 Sum_probs=133.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3678888999999999999998865 7789999986431 22346789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988653 24899999999999999999999987 99999999999999999999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=210.84 Aligned_cols=153 Identities=22% Similarity=0.409 Sum_probs=127.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467888999999999999999874 5889999998753 234566789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|||+++++|.+++.... ....+++..+..++.++++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999886432 2345899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 006563 627 G 627 (640)
Q Consensus 627 ~ 627 (640)
.
T Consensus 188 ~ 188 (310)
T 2wqm_A 188 S 188 (310)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=215.83 Aligned_cols=152 Identities=32% Similarity=0.486 Sum_probs=127.1
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc--hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
....++|...+.||+|+||.||++... +++.||||++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999865 488999999975432 23456789999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE-----cCCCceEEeeec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL-----DNDMNPKISDFG 620 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~~kI~DFG 620 (640)
+||||+++ +|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999984 9988886543 4899999999999999999999987 9999999999999 455669999999
Q ss_pred cceeccC
Q 006563 621 MARIFGG 627 (640)
Q Consensus 621 la~~~~~ 627 (640)
+|+.+..
T Consensus 183 ~a~~~~~ 189 (329)
T 3gbz_A 183 LARAFGI 189 (329)
T ss_dssp HHHHHC-
T ss_pred CccccCC
Confidence 9987753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=212.76 Aligned_cols=149 Identities=25% Similarity=0.409 Sum_probs=131.4
Q ss_pred HHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhh--CCCCceeeeEeEEEeCC----
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD---- 542 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~---- 542 (640)
....++|...+.||+|+||.||+++. +++.||||++.. ...+.+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999988 589999999864 234677888888887 78999999999998876
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCCEEEcCCCce
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
..++||||+++|+|.+++.+. .+++..+..++.|+++||+||| +.+ |+||||||+|||+++++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999542 4899999999999999999999 555 9999999999999999999
Q ss_pred EEeeeccceeccCC
Q 006563 615 KISDFGMARIFGGD 628 (640)
Q Consensus 615 kI~DFGla~~~~~~ 628 (640)
||+|||+++.+...
T Consensus 187 kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 187 CIADLGLAVRHDSA 200 (342)
T ss_dssp EECCCTTCEEEETT
T ss_pred EEEECCCceecccc
Confidence 99999999887544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-23 Score=207.38 Aligned_cols=151 Identities=26% Similarity=0.415 Sum_probs=132.3
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC--CeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 548 (640)
++|...+.||+|+||.||+|+.. ++.||||++.... ....+.|.+|++++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999985 8899999987542 34466899999999999999999999999887 6789999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++|+|.+++.... ...+++..+..++.|+++||+|||+.+ .+|+||||||+|||+++++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999996533 235899999999999999999999864 459999999999999999999999999886543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-23 Score=217.68 Aligned_cols=148 Identities=26% Similarity=0.448 Sum_probs=124.2
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999875 4899999998653 2234567899999999999999999999997653
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899998854 24889999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=211.16 Aligned_cols=145 Identities=22% Similarity=0.410 Sum_probs=128.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEe--CCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ--ADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 547 (640)
.++|...+.||+|+||.||++... +++.||||++... ..+.+.+|++++.+++ |+||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367889999999999999999864 5889999998743 3467899999999997 9999999999988 5678999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceecc
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFG 626 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~ 626 (640)
|||+++++|..++. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988873 2788999999999999999999987 99999999999999776 89999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 183 ~~ 184 (330)
T 3nsz_A 183 PG 184 (330)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=215.73 Aligned_cols=148 Identities=28% Similarity=0.497 Sum_probs=127.8
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888899999999999999986 588999999875432 2223566799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++ |+|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 98 58888886542 35899999999999999999999987 9999999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=211.14 Aligned_cols=150 Identities=23% Similarity=0.405 Sum_probs=131.2
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467888899999999999999876 5889999999865444556789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999888553 34889999999999999999999987 9999999999999 7889999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=215.69 Aligned_cols=155 Identities=29% Similarity=0.388 Sum_probs=134.1
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEe--------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ-------- 540 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~-------- 540 (640)
...+|...+.||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3467888899999999999999975 58899999987666666778999999999996 9999999999953
Q ss_pred CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
....++|+||++ |+|.+++........+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 234799999996 799888866444556999999999999999999999874 359999999999999999999999999
Q ss_pred cceeccC
Q 006563 621 MARIFGG 627 (640)
Q Consensus 621 la~~~~~ 627 (640)
+++.+..
T Consensus 184 ~~~~~~~ 190 (337)
T 3ll6_A 184 SATTISH 190 (337)
T ss_dssp TCBCCSS
T ss_pred cceeccc
Confidence 9998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=235.34 Aligned_cols=143 Identities=31% Similarity=0.515 Sum_probs=125.5
Q ss_pred ccccccCceeEEEEEec---CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+++|++++|||||+++++|. .+..+||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999664 25789999997542 234678999999999999999999999986 4568999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999543 35899999999999999999999987 999999999999999999999999999987544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=217.68 Aligned_cols=152 Identities=27% Similarity=0.448 Sum_probs=133.8
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCch---h--------------hHhHHHHHHHHhhCCCCceeee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ---G--------------MEEFKNEVTLIARLQHRNLVKL 534 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~---~--------------~~~f~~E~~~l~~l~H~niv~l 534 (640)
.++|...+.||+|+||.||++.. +++.||+|++...... . .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999999998 8999999998643111 1 1789999999999999999999
Q ss_pred EeEEEeCCeeEEEEEccCCCChhHH------HhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEE
Q 006563 535 LGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVL 607 (640)
Q Consensus 535 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIL 607 (640)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.|+++||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999888 4321 24568999999999999999999998 76 999999999999
Q ss_pred EcCCCceEEeeeccceeccCC
Q 006563 608 LDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 608 l~~~~~~kI~DFGla~~~~~~ 628 (640)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999986443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-22 Score=211.43 Aligned_cols=148 Identities=34% Similarity=0.584 Sum_probs=122.1
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHH--HhhCCCCceeeeEeEEEeC-----Cee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL--IARLQHRNLVKLLGCCIQA-----DES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~-----~~~ 544 (640)
.++|...+.||+|+||.||+|+. +++.||||++... ..+.+..|.++ +..++|+||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788889999999999999976 6789999998743 23444545544 4568999999999876532 246
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecccCCCCEEEcCCCceEEee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------RMRIIHRDLKASNVLLDNDMNPKISD 618 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kI~D 618 (640)
++||||+++|+|.+++... ..++..+..++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 2588999999999999999999881 11399999999999999999999999
Q ss_pred eccceeccC
Q 006563 619 FGMARIFGG 627 (640)
Q Consensus 619 FGla~~~~~ 627 (640)
||+|+.+..
T Consensus 164 FG~a~~~~~ 172 (336)
T 3g2f_A 164 FGLSMRLTG 172 (336)
T ss_dssp CTTCEECSS
T ss_pred ccceeeccc
Confidence 999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=211.02 Aligned_cols=151 Identities=26% Similarity=0.382 Sum_probs=127.6
Q ss_pred hhccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--------chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 541 (640)
..++|...+.||+|+||.||++.... ++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34678899999999999999998765 7899999986432 12234688999999999999999999998765
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc---eEEee
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISD 618 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kI~D 618 (640)
. .++||||+++++|.+++... ..+++.....++.||++||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 89999999999999888542 35899999999999999999999987 999999999999987654 99999
Q ss_pred eccceeccCC
Q 006563 619 FGMARIFGGD 628 (640)
Q Consensus 619 FGla~~~~~~ 628 (640)
||+++.+...
T Consensus 161 fg~~~~~~~~ 170 (322)
T 2ycf_A 161 FGHSKILGET 170 (322)
T ss_dssp CTTCEECCCC
T ss_pred Cccceecccc
Confidence 9999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.8e-23 Score=212.91 Aligned_cols=162 Identities=28% Similarity=0.411 Sum_probs=136.6
Q ss_pred cchHhHHHhhcccccc-ccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhC-CCCceeeeEeE
Q 006563 463 FDFASIAKATDNFASY-NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARL-QHRNLVKLLGC 537 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~-~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~ 537 (640)
+-+...+...+.|... +.||+|+||.||++.... ++.||+|++.... ....+++.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444555566777776 789999999999998764 8899999987532 33467899999999999 56999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCce
Q 006563 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNP 614 (640)
Q Consensus 538 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ 614 (640)
+.+....++||||+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999888543 2345899999999999999999999987 999999999999988 7899
Q ss_pred EEeeeccceeccCC
Q 006563 615 KISDFGMARIFGGD 628 (640)
Q Consensus 615 kI~DFGla~~~~~~ 628 (640)
||+|||+++.+...
T Consensus 174 kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCGGGCEEC---
T ss_pred EEeeCccccccCCc
Confidence 99999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-23 Score=226.13 Aligned_cols=152 Identities=30% Similarity=0.453 Sum_probs=133.5
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
..++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467888999999999999999876 4889999998643 233457789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeecccee
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARI 624 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFGla~~ 624 (640)
|||+++|+|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888553 34899999999999999999999987 99999999999995 456799999999987
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 6543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-23 Score=208.65 Aligned_cols=157 Identities=27% Similarity=0.460 Sum_probs=132.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 546 (640)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888899999999999999876 4889999998754 23456679999999999999999999998865 567899
Q ss_pred EEEccCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 547 IYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999865432 345899999999999999999999875 2349999999999999999999999999998
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 76543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=217.16 Aligned_cols=152 Identities=23% Similarity=0.369 Sum_probs=125.2
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 541 (640)
+...++|...+.||+|+||.||++... +++.||||++.... +...+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999874 58999999986542 2234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHH
Q 006563 542 --------------------------------DESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYL 588 (640)
Q Consensus 542 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 588 (640)
...++||||++ |+|...+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5887777542 2234689999999999999999999
Q ss_pred HhCCCCceEecccCCCCEEEc-CCCceEEeeeccceeccCC
Q 006563 589 HQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 589 H~~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~~~~~ 628 (640)
|+.+ |+||||||+|||++ +++.+||+|||+|+.+...
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 195 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence 9987 99999999999997 6889999999999987544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-23 Score=218.99 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=125.6
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe------eE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------SM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 545 (640)
..+|...+.||+|+||.||+++...+..||+|++..... ...+|+++++.++|+||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356888899999999999999998878899998865322 22369999999999999999999976543 78
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEEeeecccee
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~ 624 (640)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655444433333456899999999999999999999987 99999999999999 799999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 192 ~~~~ 195 (394)
T 4e7w_A 192 LIAG 195 (394)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=211.29 Aligned_cols=148 Identities=28% Similarity=0.477 Sum_probs=124.8
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEE-----------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI----------- 539 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----------- 539 (640)
.++|...+.||+|+||.||++.... ++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3678888999999999999999876 8899999998766667788999999999999999999999873
Q ss_pred ---eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceE
Q 006563 540 ---QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPK 615 (640)
Q Consensus 540 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 615 (640)
+....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699988843 34889999999999999999999987 99999999999997 567999
Q ss_pred EeeeccceeccC
Q 006563 616 ISDFGMARIFGG 627 (640)
Q Consensus 616 I~DFGla~~~~~ 627 (640)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-23 Score=207.74 Aligned_cols=152 Identities=27% Similarity=0.452 Sum_probs=130.3
Q ss_pred hhccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678888999999999999998654 2369999987653 3456789999999999999999999999764 4578
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999996532 34899999999999999999999987 999999999999999999999999999877
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=206.54 Aligned_cols=152 Identities=26% Similarity=0.393 Sum_probs=130.0
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 545 (640)
+.|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 346777789999999999998755 778999998643 33456779999999999999999999999876 34579
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEEeeecccee
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~ 624 (640)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 34889999999999999999999874 3599999999999997 789999999999976
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=224.16 Aligned_cols=151 Identities=32% Similarity=0.456 Sum_probs=134.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888899999999999999986 58899999986532 34567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeecccee
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARI 624 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~ 624 (640)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999888553 34899999999999999999999987 9999999999999 5678999999999988
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 7543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.1e-23 Score=215.29 Aligned_cols=149 Identities=17% Similarity=0.273 Sum_probs=123.0
Q ss_pred hccccccccccccCceeEEEEEec----CCcEEEEEEcccCCch-----------hhHhHHHHHHHHhhCCCCceeeeEe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQ-----------GMEEFKNEVTLIARLQHRNLVKLLG 536 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g 536 (640)
.++|...+.||+|+||.||+|... .+..+|+|++...... ..+.+.+|+..+..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367888999999999999999986 4678999998764322 1234667888999999999999999
Q ss_pred EEEe----CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC
Q 006563 537 CCIQ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 537 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (640)
++.. ....++||||+ +++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67789999999 999999985433 5899999999999999999999987 99999999999998887
Q ss_pred --ceEEeeeccceeccC
Q 006563 613 --NPKISDFGMARIFGG 627 (640)
Q Consensus 613 --~~kI~DFGla~~~~~ 627 (640)
.+||+|||+|+.+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCP 205 (345)
T ss_dssp TTSEEECCCTTCEESSG
T ss_pred CCcEEEEeCCCceeccc
Confidence 999999999998753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=208.21 Aligned_cols=150 Identities=30% Similarity=0.518 Sum_probs=130.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888899999999999999986 48899999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|++ ++|.+++..... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 699988865432 34889999999999999999999987 99999999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.2e-23 Score=208.17 Aligned_cols=149 Identities=28% Similarity=0.505 Sum_probs=125.7
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-CeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||++.. .++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788889999999999999987 4889999998754 3457899999999999999999999997655 468999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999986542 224789999999999999999999987 99999999999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=213.90 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=130.4
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Cee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 544 (640)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999875 47889999997543 23457789999999999999999999999765 358
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||++ |+|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 5898888542 4899999999999999999999987 99999999999999999999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=206.96 Aligned_cols=151 Identities=31% Similarity=0.468 Sum_probs=124.2
Q ss_pred hccccccccccccCceeEEEEEecC--Cc--EEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--GQ--EIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--g~--~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||+|++.. ++ .||+|++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3678888999999999999998643 33 6899988754 2345678999999999999999999999987654 8
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++|+||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999986542 34889999999999999999999987 99999999999999999999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=205.85 Aligned_cols=148 Identities=25% Similarity=0.326 Sum_probs=127.6
Q ss_pred hcccccc-ccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHH-hhCCCCceeeeEeEEEe----CCee
Q 006563 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQ----ADES 544 (640)
Q Consensus 472 ~~~f~~~-~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 544 (640)
.++|... +.||+|+||.||++... +++.||+|++... ..+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556665 67999999999999875 4889999998642 4567888887 56699999999999987 5678
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeecc
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGl 621 (640)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997643 235899999999999999999999987 999999999999998 78999999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
++.....
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=219.31 Aligned_cols=148 Identities=26% Similarity=0.413 Sum_probs=121.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC----C--eeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----D--ESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 545 (640)
.+|...+.||+|+||.||+|+... ++.||||++.... +.+.+|+++|++++|+|||++++++... . ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 457788899999999999999864 8999999986532 2234799999999999999999998642 1 257
Q ss_pred EEEEccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-CceEEeeeccce
Q 006563 546 LIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kI~DFGla~ 623 (640)
+||||+++ +|...+... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 555555331 22346899999999999999999999987 9999999999999955 678999999999
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=208.40 Aligned_cols=153 Identities=27% Similarity=0.354 Sum_probs=121.0
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-h-hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-Q-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||++... +++.||+|++..... . ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 588999999875422 2 2333455556688889999999999999999999999
Q ss_pred EccCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||++ |+|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 4887777542 2334699999999999999999999997 6 9999999999999999999999999998775
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-22 Score=205.62 Aligned_cols=142 Identities=10% Similarity=0.049 Sum_probs=126.1
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||++.... ++.||||++.... ....+.|.+|++++++++|+||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 679889999999999999999865 8899999997543 233578999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
||+++++|.+++.+. ....+...++.|+++||+|||+.+ |+||||||+|||+++++.+||++++..
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999998432 345567889999999999999987 999999999999999999999987754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=214.32 Aligned_cols=147 Identities=29% Similarity=0.422 Sum_probs=124.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
.++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4678889999999999999998754 889999998753 2344567889999999999999999999997664
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++||||+++ +|..++.. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999985 67777632 3789999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=232.16 Aligned_cols=147 Identities=20% Similarity=0.324 Sum_probs=127.7
Q ss_pred ccccccccccccCceeEEEEEec--CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-----e
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-----S 544 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~--~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 544 (640)
++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67888899999999999999975 48899999987542 3445678999999999999999999999987665 6
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+|||||+++++|..++.. .+++..++.++.||++||.|||+.+ |+||||||+|||++++ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887633 5899999999999999999999987 9999999999999986 999999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 231 ~~~~ 234 (681)
T 2pzi_A 231 INSF 234 (681)
T ss_dssp TTCC
T ss_pred cccC
Confidence 7543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=212.90 Aligned_cols=159 Identities=26% Similarity=0.323 Sum_probs=120.8
Q ss_pred HhHHHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-
Q 006563 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE- 543 (640)
Q Consensus 466 ~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~- 543 (640)
.......++|...+.||+|+||.||++.... ++.||||++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3455677899999999999999999999854 889999998654 3334567788889999999999999999976443
Q ss_pred ------eEEEEEccCCCChhHHHhh-ccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecccCCCCEEEcC-CCc
Q 006563 544 ------SMLIYEYMPNKSLDFFIFD-QARATFLDWQKRIHIVGGIARGILYLH--QDSRMRIIHRDLKASNVLLDN-DMN 613 (640)
Q Consensus 544 ------~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~ 613 (640)
.++||||++++ |...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999874 4443332 233456889999999999999999999 766 999999999999996 899
Q ss_pred eEEeeeccceeccCCc
Q 006563 614 PKISDFGMARIFGGDE 629 (640)
Q Consensus 614 ~kI~DFGla~~~~~~~ 629 (640)
+||+|||+++.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEECCCTTCBCCCTTS
T ss_pred EEEeeCCCceecCCCC
Confidence 9999999999875443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=215.74 Aligned_cols=148 Identities=30% Similarity=0.466 Sum_probs=115.1
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------C
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 542 (640)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 4889999998753 233456788999999999999999999998754 5
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..++|+||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899888743 34899999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-23 Score=215.18 Aligned_cols=146 Identities=15% Similarity=0.247 Sum_probs=127.9
Q ss_pred hccccccccccccCceeEEEEEecC---------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceee---------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK--------- 533 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~---------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~--------- 533 (640)
.++|...+.||+|+||.||++.... ++.||+|++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998764 788999998753 46889999999999999988
Q ss_pred ------eEeEEEe-CCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCE
Q 006563 534 ------LLGCCIQ-ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (640)
Q Consensus 534 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (640)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778876 67889999999 999999997542 245899999999999999999999987 99999999999
Q ss_pred EEcCCC--ceEEeeeccceeccC
Q 006563 607 LLDNDM--NPKISDFGMARIFGG 627 (640)
Q Consensus 607 Ll~~~~--~~kI~DFGla~~~~~ 627 (640)
|++.++ .+||+|||+++.+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSG
T ss_pred EEcCCCCceEEEecCcceeeccC
Confidence 999998 999999999988754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=210.38 Aligned_cols=148 Identities=27% Similarity=0.427 Sum_probs=130.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Cee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 544 (640)
.++|...+.||+|+||.||++.... ++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4688889999999999999999764 8899999997543 33456788999999999999999999998764 568
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
++||||++ ++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888854 24899999999999999999999987 99999999999999999999999999998
Q ss_pred ccC
Q 006563 625 FGG 627 (640)
Q Consensus 625 ~~~ 627 (640)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=210.65 Aligned_cols=159 Identities=23% Similarity=0.363 Sum_probs=133.6
Q ss_pred cchHhHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCC--CCceeeeEeEE
Q 006563 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCC 538 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~ 538 (640)
+.++.+....++|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444556789999999999999999999988999999998643 3345678999999999997 59999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEee
Q 006563 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (640)
Q Consensus 539 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~D 618 (640)
......++||| +.+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 6788999998653 35889999999999999999999987 999999999999965 7999999
Q ss_pred eccceeccCCc
Q 006563 619 FGMARIFGGDE 629 (640)
Q Consensus 619 FGla~~~~~~~ 629 (640)
||+++.+....
T Consensus 170 fg~~~~~~~~~ 180 (313)
T 3cek_A 170 FGIANQMQPDT 180 (313)
T ss_dssp CSSSCC-----
T ss_pred ccccccccCcc
Confidence 99999875443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=209.58 Aligned_cols=153 Identities=26% Similarity=0.488 Sum_probs=128.9
Q ss_pred HhhccccccccccccCceeEEEEEec--CCcEEEEEEcccCC--chhhHhHHHHHHHHhhC---CCCceeeeEeEEE---
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCI--- 539 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~--~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~--- 539 (640)
.+.++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35578999999999999999999973 57899999986432 22234677788777666 8999999999987
Q ss_pred --eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 540 --QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 540 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
.....++||||++ |+|.+++..... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4556899999998 699998865432 34899999999999999999999987 9999999999999999999999
Q ss_pred eeccceeccC
Q 006563 618 DFGMARIFGG 627 (640)
Q Consensus 618 DFGla~~~~~ 627 (640)
|||+++.+..
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=202.30 Aligned_cols=153 Identities=29% Similarity=0.441 Sum_probs=134.2
Q ss_pred HhhccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 470 ~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
...++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 5889999998643 23456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC---CceEEeeeccce
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMAR 623 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kI~DFGla~ 623 (640)
|+||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888653 24899999999999999999999987 9999999999999754 479999999998
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.+...
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=215.71 Aligned_cols=149 Identities=28% Similarity=0.448 Sum_probs=115.9
Q ss_pred ccccc-cccccccCceeEEEEEec---CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEE
Q 006563 473 DNFAS-YNKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (640)
Q Consensus 473 ~~f~~-~~~lg~G~fg~Vy~g~l~---~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 546 (640)
+.|.. .++||+|+||.||+++.. +++.||||++.... ..+.+.+|++++++++||||+++++++.. ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34544 358999999999999976 37789999997542 23578899999999999999999999965 567899
Q ss_pred EEEccCCCChhHHHhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE----cCCCceEE
Q 006563 547 IYEYMPNKSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKI 616 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kI 616 (640)
||||+++ +|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7776664321 1224899999999999999999999988 9999999999999 77899999
Q ss_pred eeeccceeccC
Q 006563 617 SDFGMARIFGG 627 (640)
Q Consensus 617 ~DFGla~~~~~ 627 (640)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=212.94 Aligned_cols=151 Identities=13% Similarity=0.154 Sum_probs=114.4
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc---hhhHhHHHHHHHHhhC--CCCceeeeE-------eEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARL--QHRNLVKLL-------GCC 538 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~ 538 (640)
..+|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 455888899999999999999975 588999999986532 3455677885544444 699987754 455
Q ss_pred EeC-----------------CeeEEEEEccCCCChhHHHhhccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 006563 539 IQA-----------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKR------IHIVGGIARGILYLHQDSRMR 595 (640)
Q Consensus 539 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 595 (640)
... ...+|||||++ |+|.+++..... .+.+..+ +.++.||++||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23799999999 899999976432 3466666 788899999999999987
Q ss_pred eEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+||||||+||||+.++.+||+|||+|+..+..
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-22 Score=202.55 Aligned_cols=150 Identities=23% Similarity=0.384 Sum_probs=125.3
Q ss_pred hhccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEE-EeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 548 (640)
..++|...+.||+|+||.||++.. .+++.||||++.... ..+++.+|++++..++|++++..++.+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999987 458899999876432 335688999999999988877777666 5667789999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~ 625 (640)
||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999986432 34899999999999999999999987 9999999999999 78899999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 159 ~~~ 161 (296)
T 4hgt_A 159 RDA 161 (296)
T ss_dssp BCT
T ss_pred cCc
Confidence 654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=227.10 Aligned_cols=141 Identities=18% Similarity=0.242 Sum_probs=110.2
Q ss_pred cccccCceeEEEEEe-cCCcEEEEEEcccCC----------chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 480 KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
..+.|++|.+..++. .-|+.+++|.+.+.. ....++|.+|+++|+++ +|+||+++++++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 455666666655432 237889999986531 12346799999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.++|.+.. .++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999996543 35543 58899999999999998 99999999999999999999999999998765
Q ss_pred Cc
Q 006563 628 DE 629 (640)
Q Consensus 628 ~~ 629 (640)
+.
T Consensus 392 ~~ 393 (569)
T 4azs_A 392 DC 393 (569)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=226.86 Aligned_cols=152 Identities=25% Similarity=0.402 Sum_probs=131.9
Q ss_pred hhccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
..++|...+.||+|+||.||+|.... +..||||++.... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998743 4579999987543 334578999999999999999999999984 46689
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999996532 34899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 542 ~~~ 544 (656)
T 2j0j_A 542 EDS 544 (656)
T ss_dssp CC-
T ss_pred CCC
Confidence 543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-22 Score=212.81 Aligned_cols=150 Identities=21% Similarity=0.279 Sum_probs=129.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhC------CCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL------QHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 544 (640)
..+|...+.||+|+||.||+|.... ++.||||++... ....+++.+|++++..+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4678889999999999999998765 789999999753 33456777888888776 577999999999999999
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc--eEEeeeccc
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMA 622 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kI~DFGla 622 (640)
++||||+. ++|.+++..... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 688888865432 34899999999999999999999987 999999999999999887 999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=207.18 Aligned_cols=155 Identities=24% Similarity=0.397 Sum_probs=124.8
Q ss_pred HHHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc------hhhHhHHHHHHHHhhC----CCCceeeeEe
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARL----QHRNLVKLLG 536 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~------~~~~~f~~E~~~l~~l----~H~niv~l~g 536 (640)
.....++|...+.||+|+||.||++... +++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999874 488999999975422 1234566799999888 8999999999
Q ss_pred EEEeCCeeEEEEEc-cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCce
Q 006563 537 CCIQADESMLIYEY-MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNP 614 (640)
Q Consensus 537 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 614 (640)
++...+..++|+|| +++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999998653 34899999999999999999999987 99999999999999 88999
Q ss_pred EEeeeccceeccCC
Q 006563 615 KISDFGMARIFGGD 628 (640)
Q Consensus 615 kI~DFGla~~~~~~ 628 (640)
||+|||+++.+...
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.09 Aligned_cols=150 Identities=23% Similarity=0.384 Sum_probs=128.5
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEE-EeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 549 (640)
.++|...+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++++..++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47889999999999999999997 458899999987543 235689999999999988877666665 55677899999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~~ 626 (640)
|+ +++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999986432 35899999999999999999999987 9999999999999 488999999999999876
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-21 Score=213.89 Aligned_cols=150 Identities=22% Similarity=0.363 Sum_probs=128.9
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC-CceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...++||+|+||.||++.. .+++.||||++.... ..+++..|++++..++| +++..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999986 458899999876542 23568899999999976 666677777778888999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---cCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kI~DFGla~~~~ 626 (640)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999986432 35899999999999999999999987 9999999999999 688999999999999876
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-22 Score=210.87 Aligned_cols=147 Identities=27% Similarity=0.444 Sum_probs=125.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee----
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES---- 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 544 (640)
.++|...+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4678888999999999999998754 8899999997542 23457789999999999999999999999877654
Q ss_pred --EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 545 --MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 545 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
++||||++ ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57877662 23899999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 192 ~~~~~ 196 (371)
T 4exu_A 192 RHADA 196 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-22 Score=205.57 Aligned_cols=152 Identities=24% Similarity=0.371 Sum_probs=126.4
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHH-HHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999985 48899999997643 233445666665 777889999999999999999999999
Q ss_pred EccCCCChhHHHhhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 549 EYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
||+++ +|..++... .....+++..+..++.++++||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777776531 1234689999999999999999999997 6 999999999999999999999999999877
Q ss_pred cC
Q 006563 626 GG 627 (640)
Q Consensus 626 ~~ 627 (640)
..
T Consensus 177 ~~ 178 (327)
T 3aln_A 177 VD 178 (327)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-22 Score=213.95 Aligned_cols=149 Identities=25% Similarity=0.315 Sum_probs=120.2
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....+|||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34455789999999998776677999999998642 345678999999876 89999999999999999999999996
Q ss_pred CCChhHHHhhccccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC-------------CceE
Q 006563 553 NKSLDFFIFDQARAT----FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-------------MNPK 615 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~k 615 (640)
|+|.+++....... ...+..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996543211 1234456789999999999999987 9999999999999654 5899
Q ss_pred EeeeccceeccCCc
Q 006563 616 ISDFGMARIFGGDE 629 (640)
Q Consensus 616 I~DFGla~~~~~~~ 629 (640)
|+|||+|+.+....
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=202.63 Aligned_cols=150 Identities=23% Similarity=0.359 Sum_probs=129.9
Q ss_pred hccccccccccccCceeEEEEEe--cCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc------eeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL--VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l--~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46788899999999999999986 35789999998753 344577889999998887654 9999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-------------
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN------------- 610 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~------------- 610 (640)
.++||||+ +++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999886543 235889999999999999999999987 999999999999987
Q ss_pred ------CCceEEeeeccceeccC
Q 006563 611 ------DMNPKISDFGMARIFGG 627 (640)
Q Consensus 611 ------~~~~kI~DFGla~~~~~ 627 (640)
++.+||+|||+++....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 66899999999997643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-22 Score=207.64 Aligned_cols=148 Identities=30% Similarity=0.523 Sum_probs=127.0
Q ss_pred hhccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
..++|...+.||+|+||.||+|.... .+|+|.+... .....+.+.+|+.++++++|+||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45778889999999999999998754 5999998753 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999998543 235889999999999999999999987 99999999999998 6799999999988753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=209.30 Aligned_cols=135 Identities=23% Similarity=0.342 Sum_probs=113.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC--------CCceeeeEeEEE---
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--------HRNLVKLLGCCI--- 539 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~--- 539 (640)
.++|...+.||+|+||.||++.... ++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4679999999999999999998654 789999999753 344677899999999885 788999999987
Q ss_pred -eCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCC
Q 006563 540 -QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM 612 (640)
Q Consensus 540 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~ 612 (640)
.....+|||||+ +++|...+.... ...+++..+..++.||++||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 555655554432 23589999999999999999999997 6 99999999999998775
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.9e-22 Score=208.30 Aligned_cols=147 Identities=27% Similarity=0.442 Sum_probs=126.0
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe-----
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 543 (640)
.++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3678888999999999999998754 8899999987542 2345678999999999999999999999987654
Q ss_pred -eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 544 -SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 544 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
.++||||++ ++|..++. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58876662 23899999999999999999999987 999999999999999999999999999
Q ss_pred eeccC
Q 006563 623 RIFGG 627 (640)
Q Consensus 623 ~~~~~ 627 (640)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-22 Score=204.80 Aligned_cols=154 Identities=25% Similarity=0.379 Sum_probs=132.5
Q ss_pred HHhhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc------hhhHhHHHHHHHHhhCC--CCceeeeEeEEE
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQ--HRNLVKLLGCCI 539 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~ 539 (640)
....++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.+++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334577999999999999999999864 588999999875421 12356778999999996 599999999999
Q ss_pred eCCeeEEEEEccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEEe
Q 006563 540 QADESMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKIS 617 (640)
Q Consensus 540 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI~ 617 (640)
..+..++|+||+.. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999988653 35899999999999999999999987 99999999999999 78999999
Q ss_pred eeccceeccCC
Q 006563 618 DFGMARIFGGD 628 (640)
Q Consensus 618 DFGla~~~~~~ 628 (640)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.8e-22 Score=213.26 Aligned_cols=148 Identities=22% Similarity=0.354 Sum_probs=122.0
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
..+|...+.||+|+||+|+.....+++.||||++.... .+.+.+|+++++++ +|||||++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 45688889999999999766656678999999986532 24467899999999 799999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-----CCCceEEeeeccceec
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-----NDMNPKISDFGMARIF 625 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kI~DFGla~~~ 625 (640)
++ |+|.+++..... .+.+..+..++.||++||+|||+.+ |+||||||+|||++ ....+||+|||+|+.+
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 599998865432 2445566789999999999999987 99999999999994 3346889999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=200.59 Aligned_cols=150 Identities=21% Similarity=0.356 Sum_probs=115.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc-hh-hHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
.++|...+.||+|+||.||++... +++.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 588999999975432 22 233445556788889999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+ ++.+..+.... ...+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44555544322 24589999999999999999999985 6 99999999999999999999999999987644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-22 Score=223.11 Aligned_cols=154 Identities=27% Similarity=0.410 Sum_probs=131.7
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe------CCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ------ADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~ 543 (640)
.++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4789999999999999999998754 889999998754 33456779999999999999999999998755 566
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCc---eEEeeec
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFG 620 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kI~DFG 620 (640)
.++||||+++|+|.+++........+++..+..++.+++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555456899999999999999999999987 999999999999986654 9999999
Q ss_pred cceeccCC
Q 006563 621 MARIFGGD 628 (640)
Q Consensus 621 la~~~~~~ 628 (640)
+++.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-21 Score=199.78 Aligned_cols=150 Identities=25% Similarity=0.284 Sum_probs=120.9
Q ss_pred hhccccccc-cccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCee
Q 006563 471 ATDNFASYN-KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADES 544 (640)
Q Consensus 471 ~~~~f~~~~-~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 544 (640)
..++|...+ .||+|+||.||++... +++.||||++... . +...+....+..++|+||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346787754 6999999999999986 4889999998653 1 122223334567799999999999876 3457
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeecc
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGl 621 (640)
++||||+++|+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999997543 245899999999999999999999987 999999999999976 45699999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
++.....
T Consensus 178 ~~~~~~~ 184 (336)
T 3fhr_A 178 AKETTQN 184 (336)
T ss_dssp CEEC---
T ss_pred ceecccc
Confidence 9977543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-21 Score=203.30 Aligned_cols=155 Identities=23% Similarity=0.313 Sum_probs=129.9
Q ss_pred HHhhccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CC-----ceeeeEeEEEeC
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR-----NLVKLLGCCIQA 541 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~ 541 (640)
....++|...+.||+|+||.||+|.... ++.||||++... ....+++..|++++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4456889999999999999999998764 788999999753 344567788998888874 55 499999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc--CCCceEEeee
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDF 619 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kI~DF 619 (640)
+..+|||||++ ++|.+++..... ..+++..+..++.|++.||+|||.+ ..+|+||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 599988865432 3489999999999999999999953 13499999999999994 5788999999
Q ss_pred ccceeccC
Q 006563 620 GMARIFGG 627 (640)
Q Consensus 620 Gla~~~~~ 627 (640)
|+|+.+..
T Consensus 206 G~a~~~~~ 213 (382)
T 2vx3_A 206 GSSCQLGQ 213 (382)
T ss_dssp TTCEETTC
T ss_pred cCceeccc
Confidence 99998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-21 Score=199.11 Aligned_cols=150 Identities=20% Similarity=0.342 Sum_probs=127.5
Q ss_pred hccccccccccccCceeEEEEEecC-C-cEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc------eeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g-~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 543 (640)
.++|...+.||+|+||.||++.... + +.||+|++... ....+.+.+|++++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4678889999999999999998754 4 68999999753 344567889999999987766 9999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE---------------
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--------------- 608 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--------------- 608 (640)
.+|||||+ +++|..++.... ...+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 556666665432 235899999999999999999999987 9999999999999
Q ss_pred ----cCCCceEEeeeccceeccC
Q 006563 609 ----DNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 609 ----~~~~~~kI~DFGla~~~~~ 627 (640)
+.++.+||+|||+++....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6688999999999997643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=217.61 Aligned_cols=137 Identities=21% Similarity=0.286 Sum_probs=109.3
Q ss_pred cccccccccCceeEEEEEecCCcEEEEEEcccCCc--h------hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--Q------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
...++||+|+||.||++.. .++.+++|+...... . ..+.|.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999944 578888888643211 1 134589999999999999999777777788889999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+|+.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998844 4588999999999999987 999999999999999 999999999999865
Q ss_pred Cc
Q 006563 628 DE 629 (640)
Q Consensus 628 ~~ 629 (640)
.+
T Consensus 482 ~~ 483 (540)
T 3en9_A 482 DE 483 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.2e-21 Score=202.77 Aligned_cols=150 Identities=24% Similarity=0.368 Sum_probs=127.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-----------CCceeeeEeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCI 539 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~ 539 (640)
.++|...+.||+|+||.||++... +++.||||++... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367888899999999999999874 5889999998753 334567889999998886 899999999988
Q ss_pred eCC----eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEc-----
Q 006563 540 QAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLD----- 609 (640)
Q Consensus 540 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~----- 609 (640)
..+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 8899998865432 3489999999999999999999997 7 99999999999994
Q ss_pred -CCCceEEeeeccceeccC
Q 006563 610 -NDMNPKISDFGMARIFGG 627 (640)
Q Consensus 610 -~~~~~kI~DFGla~~~~~ 627 (640)
..+.+||+|||+++.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445899999999998753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.7e-21 Score=194.80 Aligned_cols=143 Identities=20% Similarity=0.206 Sum_probs=115.3
Q ss_pred HHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCc------------------hhhHhHHHHHHHHhhCCCC
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHR 529 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~ 529 (640)
+......|...+.||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444455667789999999999999996799999999864321 13456899999999999
Q ss_pred ceeeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 530 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 5 667775543 55699999999999977 411 224479999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceeccCC
Q 006563 610 NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~~ 628 (640)
++.+||+|||+|+.....
T Consensus 228 -~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp -TTEEEECCCTTCEETTST
T ss_pred -CCcEEEEECCCCeECCCC
Confidence 999999999999987543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=163.43 Aligned_cols=107 Identities=15% Similarity=0.257 Sum_probs=92.9
Q ss_pred ccccccCCCCCcCCCCEEE--eCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eE
Q 006563 16 AANDNITPSQSIRDGETLV--SVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IV 92 (640)
Q Consensus 16 ~~~~~l~~g~~l~~~~~lv--S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~ 92 (640)
++.++|.+|++|.+|++|+ |++|.|+|+|+++++ . +||++ +++||+||++.| +.++.+.+.++| ||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn---l---vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN---L---VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC---E---EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC---E---EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 5678999999999999999 999999999998763 1 68875 799999999877 345789999999 99
Q ss_pred EecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 93 LLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 93 l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
|.|.++.++|++++....+...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC----ccEeCC
Confidence 99999999999997644456689999999999997 279998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.5e-20 Score=157.94 Aligned_cols=109 Identities=19% Similarity=0.396 Sum_probs=93.1
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
+|+|.+|+.|.+|++|+ ++|.|+|+|+..++ | ++|+ ..++||+||++.|. ..+.+.+.++| |+|.|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 47899999999999999 99999999987663 1 6776 37999999998773 35689999999 999999
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCC
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPC 142 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PT 142 (640)
++.++|++++....+..+++|+|+|||||++. ++||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence 99999999987544556899999999999863 7999999984
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.80 E-value=4e-19 Score=152.10 Aligned_cols=103 Identities=19% Similarity=0.376 Sum_probs=87.9
Q ss_pred cccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCC
Q 006563 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGR 97 (640)
Q Consensus 19 ~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~ 97 (640)
|+|.+||.|.+|++|.| |.|.|.|...++ |.++. ..++||+|||+.|... .+.|.++.|| |+|.|++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence 68999999999999998 789999976552 44543 4789999999999764 4689999999 9999999
Q ss_pred CceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 98 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
+.+||+|++.......+|+|+|+|||||++. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~----~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS----DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC----cEecC
Confidence 9999999987555567899999999999963 59998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=156.33 Aligned_cols=109 Identities=18% Similarity=0.340 Sum_probs=92.1
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
.|+|.+||+|.+|++|+ +|.|+|+|++.++ . ++|+ ..++||+||++.|. .++.|.+.++| |+|.|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 48999999999999998 7999999987653 2 2465 48999999999884 45789999999 999999
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCc
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTD 143 (640)
++.++|++++.......+++|+|+|||||++. ++||||.++..
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence 89999999986434567899999999999952 79999998765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=193.36 Aligned_cols=152 Identities=18% Similarity=0.183 Sum_probs=114.9
Q ss_pred hhccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCC-Cce--------------
Q 006563 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQH-RNL-------------- 531 (640)
Q Consensus 471 ~~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H-~ni-------------- 531 (640)
.+..|...+.||+|+||.||+|... +++.||||++..... ...+.|.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456777789999999999999964 589999999874322 336789999999999987 221
Q ss_pred -eeeE------eEEEe-----CCeeEEEEEccCCCChhHHHhh----ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006563 532 -VKLL------GCCIQ-----ADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (640)
Q Consensus 532 -v~l~------g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (640)
+.+. .+... ....+++|+++ .++|.+++.. ......+++..++.++.||++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111 11111 12346666654 6899888742 122345888999999999999999999987
Q ss_pred eEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
|+||||||+||||+.++.+||+|||+++..+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecC
Confidence 9999999999999999999999999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=151.71 Aligned_cols=109 Identities=19% Similarity=0.416 Sum_probs=91.3
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
+|+|.+||+|.+|++| ++|.|+|+|+++++ . +||++ .++||+||++.+ +.++.+.+.++| |+|.|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn---l---vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN---L---VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC---E---EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc---E---EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 58999999998774 1 46764 689999999764 345789999999 99999
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCC
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~P 141 (640)
++.++|++++....+..+++|+++|||||++. .+.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence 88899999876434456899999999999985 367899999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=174.54 Aligned_cols=139 Identities=16% Similarity=0.168 Sum_probs=107.0
Q ss_pred ccccccccccCceeEEEEEe-cCCcE--EEEEEcccCCch------------------------hhHhHHHHHHHHhhCC
Q 006563 475 FASYNKLGEGGFGPVYKGTL-VEGQE--IAVKRLSKGSGQ------------------------GMEEFKNEVTLIARLQ 527 (640)
Q Consensus 475 f~~~~~lg~G~fg~Vy~g~l-~~g~~--VavK~l~~~~~~------------------------~~~~f~~E~~~l~~l~ 527 (640)
|...+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999998 67888 999987543111 1135789999999998
Q ss_pred CCce--eeeEeEEEeCCeeEEEEEccCC-C----ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEec
Q 006563 528 HRNL--VKLLGCCIQADESMLIYEYMPN-K----SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHR 599 (640)
Q Consensus 528 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~ 599 (640)
|+++ ..++.. ...+|||||+.+ | +|..+... .++.....++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 334432 356899999942 4 56554422 224456789999999999999 776 9999
Q ss_pred ccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 600 DLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 600 Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||||+|||+++ .++|+|||+|.....+
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 99999999998 9999999999987544
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-17 Score=142.67 Aligned_cols=103 Identities=23% Similarity=0.344 Sum_probs=85.7
Q ss_pred cccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCC
Q 006563 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGR 97 (640)
Q Consensus 19 ~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~ 97 (640)
++|.+||+|.+|++|+ +|.|+|.|...++ .+ .|.. .++||++|++.| +..+.|.+.++| |+|.|.+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lv---ly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LV---LYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---EE---EEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EE---EEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 6899999999999997 7999999987763 33 2654 689999999876 345789999999 9999999
Q ss_pred CceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeec
Q 006563 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (640)
Q Consensus 98 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSF 138 (640)
+.++|++++.......+|+|+|+|||||++. ++|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~----~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT----ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES----CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC----CEEeCC
Confidence 9999999986433446899999999999973 699983
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=7.9e-16 Score=133.55 Aligned_cols=95 Identities=21% Similarity=0.374 Sum_probs=77.6
Q ss_pred CCCCCcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecce
Q 006563 76 PLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRN 154 (640)
Q Consensus 76 Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~ 154 (640)
|+.+....|.+..+| |+|.+. +++||++++.......+|+|+|+|||||++ .+.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~--------------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS--GSRAIWASNT--------------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE--TTEEEEECCC---------------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc--CCEEEEECCc---------------
Confidence 343455789999999 999987 789999998643345789999999999998 3679999993
Q ss_pred eccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEe-CCEEEeecCCCCC
Q 006563 155 FKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK-GSVLQYRAGSWNG 206 (640)
Q Consensus 155 ~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~-~~~~~~~~~~~~~ 206 (640)
+|++|.|++.|+++|+ ++++. +...||++++|+|
T Consensus 77 ----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567889999999998 55665 4678999999986
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.6e-16 Score=132.57 Aligned_cols=103 Identities=20% Similarity=0.335 Sum_probs=82.7
Q ss_pred cccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEec
Q 006563 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLD 95 (640)
Q Consensus 17 ~~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d 95 (640)
+.|+|.+||+|..|+.|+|. .|.|-|...+ + |.+ |.. ++||.+|++.. +..+.+.+.++| |+|.|
T Consensus 5 ~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dG---n--Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 5 TNNLLFSGQVLYGDGRLTAK--NHQLVMQGDC---N--LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp BTTEEETTCEEETTEEEECS--SCEEEECTTS---C--EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred ccCEECCCCEecCCCEEEeC--CEEEEEcCCC---e--EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 57999999999999999984 5888664433 2 333 543 48999999863 334689999999 99999
Q ss_pred CCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 96 GRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 96 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec----CCEecC
Confidence 99999999998643445789999999999996 379997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-15 Score=128.83 Aligned_cols=106 Identities=20% Similarity=0.266 Sum_probs=85.9
Q ss_pred cccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEec
Q 006563 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLD 95 (640)
Q Consensus 17 ~~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d 95 (640)
+.|+|.+||.|..|+.|.+ |.|.|-|...++ |.++ .. ...++||.+|+..+- ....+.+.++| |+|.|
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~~-~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-KG-SKTNIVWESGTSGRG--QHCFMRLGHSGELDITD 73 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-ET-TTTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-EC-CCCEEEEECCcccCC--cCEEEEEeCCCcEEEEC
Confidence 5789999999999999975 889888865542 4443 32 147899999998763 35789999999 99999
Q ss_pred CCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 96 GRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 96 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec----CCEecC
Confidence 99999999998643445789999999999996 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.3e-15 Score=130.05 Aligned_cols=88 Identities=25% Similarity=0.347 Sum_probs=72.8
Q ss_pred CcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccC
Q 006563 80 QSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTG 158 (640)
Q Consensus 80 ~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg 158 (640)
....|.+..+| |+|.| .+++||++++.......+++|+|+|||||++. .+.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~-~~~~~W~S~-------------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ-SNRVIWQTK-------------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC-CCcEEEecC--------------------
Confidence 45679999999 99998 57899999986434457899999999999986 467999999
Q ss_pred CceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCC
Q 006563 159 MDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (640)
Q Consensus 159 ~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~ 204 (640)
+++++|.|+++|+++|+ ++++++ .||+++++
T Consensus 78 -----------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34567899999999997 556665 79998875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.9e-16 Score=162.42 Aligned_cols=139 Identities=13% Similarity=0.168 Sum_probs=98.0
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCCc--------------hhhHhH--------HHHHHHHhhCCCCce
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------------QGMEEF--------KNEVTLIARLQHRNL 531 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~--------------~~~~~f--------~~E~~~l~~l~H~ni 531 (640)
-|...+.||+|+||.||+|...+|+.||||+++.... ...... ..|...|.++++.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4788899999999999999998999999998753210 001111 234555555544333
Q ss_pred eeeEeEEEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCC
Q 006563 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (640)
Q Consensus 532 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 611 (640)
....-+.. ...+|||||+++++|..+. .......++.|++.+|.|||+.+ ||||||||.||||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 21111111 2347999999998875432 11223467899999999999987 9999999999999877
Q ss_pred C----------ceEEeeeccceecc
Q 006563 612 M----------NPKISDFGMARIFG 626 (640)
Q Consensus 612 ~----------~~kI~DFGla~~~~ 626 (640)
+ .+.|+||+-+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999887653
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.9e-15 Score=125.94 Aligned_cols=107 Identities=21% Similarity=0.383 Sum_probs=85.6
Q ss_pred cccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEec
Q 006563 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLD 95 (640)
Q Consensus 17 ~~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d 95 (640)
+.|+|.+||.|..|+.| .+|.|.|.|...++ . +.|.. +|.+|+..+ +....|.+.++| |+|.|
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN---L---vl~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN---L---VLYNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC---E---EEETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe---E---EEEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 57899999999999999 57999999966552 2 22432 699998865 335789999999 99999
Q ss_pred CCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCC
Q 006563 96 GRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPG 148 (640)
Q Consensus 96 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg 148 (640)
.++.++|++++.......+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 99999999998643445689999999999996 479997 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=3e-14 Score=124.61 Aligned_cols=85 Identities=20% Similarity=0.253 Sum_probs=70.5
Q ss_pred ceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCc
Q 006563 82 GLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (640)
Q Consensus 82 ~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~ 160 (640)
..|.+..+| |+|.+. +++||++++.......+|+|+|+|||||++. .+.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECS----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-CCcEEEcCC----------------------
Confidence 468888999 999987 8899999986433457899999999999986 467999999
Q ss_pred eEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 161 ~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
++|++|.|+++|+++|+ +++++ ..||++|+
T Consensus 88 ---------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678899999999998 55565 38999876
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=4.3e-14 Score=123.14 Aligned_cols=90 Identities=24% Similarity=0.359 Sum_probs=73.8
Q ss_pred cceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCC
Q 006563 81 SGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (640)
Q Consensus 81 ~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~ 159 (640)
...|.+..+| |+|.+ .++++|++++........++|+|+|||||++. .+.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH-NNNDVWGSACW------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT-TCCEEEECCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC-CceEEEEcCCC-------------------
Confidence 3568888899 99998 57899999986433457899999999999986 46799999997
Q ss_pred ceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCCCCC
Q 006563 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGL 207 (640)
Q Consensus 160 ~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 207 (640)
+++|.|++.++++|+ +++++. .||++++|...
T Consensus 80 ------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346789999999997 556655 89999999753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.36 E-value=2e-12 Score=111.51 Aligned_cols=102 Identities=12% Similarity=0.228 Sum_probs=79.9
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
.|+|.+||.|.+|+.| .+|.|.|-|...++ . +-|.. .. ||.+|+..| +....+.+.++| |+|.|.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn---L---vl~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN---L---VLYNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC---E---EEECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe---E---EEECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5789999999999999 47899999965542 2 22543 33 999999876 234689999999 999998
Q ss_pred CCc-eEEeecccc--CCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 97 RDR-IFWSSNTSI--TMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 97 ~~~-~vWst~~~~--~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
++. ++|++++.. .....+++|+|+|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 876 599999632 2345689999999999996 479997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.5e-11 Score=121.68 Aligned_cols=148 Identities=16% Similarity=0.080 Sum_probs=114.6
Q ss_pred HHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEE
Q 006563 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 469 ~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 547 (640)
......|.....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344566776677888888999998754 6889999986532233456889999999884 67888999999988899999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------------------------------------ 591 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------ 591 (640)
|||+++.+|...+. +......++.+++++|+.||..
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999876531 1122346788999999999981
Q ss_pred --------------------CCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 592 --------------------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 592 --------------------~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
.+..++|+|++|.|||++++..+.|.||+.+..-
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 1134899999999999988766789999998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-11 Score=105.29 Aligned_cols=94 Identities=21% Similarity=0.292 Sum_probs=71.0
Q ss_pred CCCCCCCcceEEEecCC-eEEecC-CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCee
Q 006563 74 ETPLTDQSGLLNVTSKG-IVLLDG-RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKL 151 (640)
Q Consensus 74 ~~Pv~~~~~~l~~~~~G-L~l~d~-~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l 151 (640)
+.|+.+....|.+..|| |+|.+. .+.++|++++........++|+|+|||||++. .+.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-~~~~iW~S~t~----------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-RLNTVFVSNTV----------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECSCC-----------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-CCCEEEECCCc-----------
Confidence 45555556789999999 999998 58899999986433456899999999999986 46789997211
Q ss_pred cceeccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 152 GRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 152 ~~~~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
...|.|.+.++.+|+..+ |+ ...|.+++
T Consensus 86 --------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp --------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred --------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 012458899999998554 44 47788764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.7e-11 Score=120.82 Aligned_cols=112 Identities=17% Similarity=0.309 Sum_probs=87.4
Q ss_pred ccccccCCCCC----cCCCCEEEeCCCeeEEeeeCCC--CCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecC
Q 006563 16 AANDNITPSQS----IRDGETLVSVNGTFELGFFSPG--TSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSK 89 (640)
Q Consensus 16 ~~~~~l~~g~~----l~~~~~lvS~~g~F~lGF~~~~--~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~ 89 (640)
...|++.||+. |..|+.|.| ..+++.|+|... ...+.+ + |.+ ..+++|.+++..+- . ..+.++.+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEECTT
T ss_pred ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEcCC
Confidence 45799999999 888999865 467777776542 222333 3 332 36899999998762 2 67999999
Q ss_pred C-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccC
Q 006563 90 G-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (640)
Q Consensus 90 G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~ 140 (640)
| |++.|.++.++|++++.. ....+|+|+|+|||||++. .++||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 9 999999889999999764 3457899999999999974 589999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.17 E-value=8.4e-11 Score=101.32 Aligned_cols=93 Identities=15% Similarity=0.196 Sum_probs=68.6
Q ss_pred CCCCCcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecce
Q 006563 76 PLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRN 154 (640)
Q Consensus 76 Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~ 154 (640)
|+......|.+..|| |+|.+.++ +|++++........++|+|+|||||++.+.+.++|||..+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-------------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-------------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS--------------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc--------------
Confidence 333445679999999 99999877 9999986433457899999999999986433459998621
Q ss_pred eccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 155 FKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 155 ~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
.....|.|.+.++.+|+..+ |. ..+|.++.
T Consensus 80 ---------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred ---------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 11134789999999998555 44 57888764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=115.51 Aligned_cols=132 Identities=17% Similarity=0.211 Sum_probs=99.3
Q ss_pred ccc-ccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc--eeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 480 KLG-EGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 480 ~lg-~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
.++ .|..+.||+....+|+.+++|..... ....+..|+++++.+.+.+ +.+++++...++..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998777888999987643 3356788999999886444 55688888877788999999999887
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS-------------------------------------------- 592 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 592 (640)
. . .. .+ ...++.++++.|..||...
T Consensus 103 ~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 2 10 11 2256677788888888642
Q ss_pred -----------CCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 593 -----------RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 593 -----------~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+..++|+|++|.|||++++..++|.||+.+..-
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988777789999998764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.02 E-value=1e-09 Score=94.39 Aligned_cols=84 Identities=23% Similarity=0.391 Sum_probs=63.1
Q ss_pred cceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCC
Q 006563 81 SGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (640)
Q Consensus 81 ~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~ 159 (640)
.-.|.+..|| |+|.+. .++|++++........++|+|+|||||++. .+.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-DFKTIWSSRSSS------------------ 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-TCCEEEECCCCC------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-CCCEEEEcCCcC------------------
Confidence 3568999999 999887 589999986433346899999999999986 467899984210
Q ss_pred ceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecC
Q 006563 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (640)
Q Consensus 160 ~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~ 202 (640)
..|.|.+.++.+|+..+ ++ ...|.+|
T Consensus 84 -------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~ 109 (110)
T 3r0e_B 84 -------------KQGEYVLILQDDGFGVI--YG--PAIFETS 109 (110)
T ss_dssp -------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred -------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence 12458899999998554 44 3678765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-09 Score=93.51 Aligned_cols=85 Identities=19% Similarity=0.296 Sum_probs=63.6
Q ss_pred cceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCC
Q 006563 81 SGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (640)
Q Consensus 81 ~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~ 159 (640)
...|.+..+| |+|.+. ++++|++++........++|+|+|||||++. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG------------------ 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-TSCEEEECCCCC------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-CCCEEEECCCCC------------------
Confidence 3578999999 999987 6899999986433457899999999999986 467899984211
Q ss_pred ceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecC
Q 006563 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (640)
Q Consensus 160 ~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~ 202 (640)
..+.|.+.++.+|+..+ ++. ..|.++
T Consensus 80 -------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~ 105 (109)
T 3dzw_A 80 -------------ENGNYVCVLQKDRNVVI--YGT--ARWATG 105 (109)
T ss_dssp -------------SSSCEEEEECTTSCEEE--EES--CCCCCC
T ss_pred -------------CCCCEEEEEeCCCEEEE--ECC--CEEeCC
Confidence 12467899999998554 443 456554
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.6e-09 Score=90.70 Aligned_cols=91 Identities=24% Similarity=0.404 Sum_probs=67.4
Q ss_pred CCCCCCCcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeec
Q 006563 74 ETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLG 152 (640)
Q Consensus 74 ~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~ 152 (640)
+.|+......|.+..|| |+|.++ +|++++........++|+++|||||++. .+.++|+|-.
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-~~~~vWss~t------------- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-DGSTVWKSGA------------- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECCC-------------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-CCCEEEcCCC-------------
Confidence 34444455679999999 999985 7999987533457899999999999986 4678997611
Q ss_pred ceeccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCC
Q 006563 153 RNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (640)
Q Consensus 153 ~~~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~ 204 (640)
....+.|.+.++.+|+..+ +. ...|.+++|
T Consensus 77 ------------------~~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ------------------QSVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW 106 (109)
T ss_dssp ------------------CCSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred ------------------cCCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence 0023568899999997554 44 578999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.8e-09 Score=110.13 Aligned_cols=142 Identities=16% Similarity=0.235 Sum_probs=106.0
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcc--cCC-chhhHhHHHHHHHHhhCC--CCceeeeEeEEEeC---CeeEEEE
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLS--KGS-GQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQA---DESMLIY 548 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 548 (640)
..+.|+.|.+..||+....+ ..+++|+.. ... ......+.+|.++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678999999999988754 577888765 321 123457888999999887 46688899988776 3479999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------ 592 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 592 (640)
||+++..+... ....++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999877321 1123677888889999999999999731
Q ss_pred -------------------CCceEecccCCCCEEEcCCCc--eEEeeecccee
Q 006563 593 -------------------RMRIIHRDLKASNVLLDNDMN--PKISDFGMARI 624 (640)
Q Consensus 593 -------------------~~~ivH~Dlkp~NILl~~~~~--~kI~DFGla~~ 624 (640)
+..++|+|++|.|||++.+.. +.|.||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 69999999985
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.69 E-value=9.4e-08 Score=81.18 Aligned_cols=76 Identities=25% Similarity=0.373 Sum_probs=57.9
Q ss_pred ceEEEecCC-eEEecCCCceEEeeccccC-CCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCC
Q 006563 82 GLLNVTSKG-IVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (640)
Q Consensus 82 ~~l~~~~~G-L~l~d~~~~~vWst~~~~~-~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~ 159 (640)
-.|.+..|| |+|.+. +.+||++++... .....++|.++|||||.|. .+.++|+|=
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-~~~~vWss~--------------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-SGRSLWASH--------------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-TCCEEEECC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-CcEEEEEec---------------------
Confidence 358889999 999985 578999998633 3456899999999999997 467899861
Q ss_pred ceEEEeccCCCCCCCCceEEeecCCCCceEE
Q 006563 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (640)
Q Consensus 160 ~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~ 190 (640)
+....+.|.+.++.+|+..++
T Consensus 78 ----------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 ----------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----------CCCCSSCEEEEECTTSCEEEE
T ss_pred ----------CCCCCCCEEEEEeCCCeEEEE
Confidence 111346688999999985543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=3.4e-07 Score=90.05 Aligned_cols=87 Identities=23% Similarity=0.297 Sum_probs=66.2
Q ss_pred ceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCc
Q 006563 82 GLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (640)
Q Consensus 82 ~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~ 160 (640)
-.|.+..+| |+|.+. +++||.+|+... ....++|+++|||||+|+ .+.++|+|+++
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~-------------------- 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTA-QNTIRWSSGTK-------------------- 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCT-TTCCSCCCCCC--------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcC-CCcEEEeCCcc--------------------
Confidence 346666777 888876 689999998643 567899999999999996 46789999864
Q ss_pred eEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCCCC
Q 006563 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNG 206 (640)
Q Consensus 161 ~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~~~ 206 (640)
.++|.|.+.|+.+|+..+ +.. .+|.+..+..
T Consensus 85 -----------~~~~~~~~~l~d~Gnlvl--~~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 85 -----------GSIGNYVLVLQPDRTVTI--YGP--GLWDSGTSNK 115 (236)
T ss_dssp -----------CCSSCCEEEECSSSCEEE--ECS--EEEECSCCCS
T ss_pred -----------ccCCcEEEEEeCCCCEEE--ecC--CEEECCCCCC
Confidence 123567899999998555 432 7899877654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.35 E-value=1e-06 Score=89.98 Aligned_cols=137 Identities=21% Similarity=0.253 Sum_probs=96.6
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCc--eeeeEeEEEeCC---eeEEEEEcc
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRN--LVKLLGCCIQAD---ESMLIYEYM 551 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~ 551 (640)
.+.++.|....||+.. +.+++|+... ......+.+|.++++.+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999763 4578887542 23456788999999887 3433 344554433332 348899999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---------------------------------------- 591 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 591 (640)
++.+|..... ..++..++..++.++++.|+.||..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864332 1255666677777777777777751
Q ss_pred ---------------CCCceEecccCCCCEEEcC--CCceEEeeeccceec
Q 006563 592 ---------------SRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIF 625 (640)
Q Consensus 592 ---------------~~~~ivH~Dlkp~NILl~~--~~~~kI~DFGla~~~ 625 (640)
.+..++|+|++|.||++++ ...+.|.||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 566899999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=9.5e-06 Score=82.93 Aligned_cols=136 Identities=21% Similarity=0.168 Sum_probs=88.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCC---ceeeeEeEEE-eCCeeEEEEEccCCC
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCI-QADESMLIYEYMPNK 554 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~g 554 (640)
+.++.|....||+. ++.+++|+-. .......+..|.++|..+.+. .+.+.+.++. ..+..++||||+++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46778888889987 5667788742 233456789999999998642 3556676664 334578999999998
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 006563 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------------------------------------------- 591 (640)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 591 (640)
.|...... .++...+..++.++++.|+.||..
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 87652111 112222333333333333333321
Q ss_pred --------------CCCceEecccCCCCEEEcC---CCc-eEEeeeccceec
Q 006563 592 --------------SRMRIIHRDLKASNVLLDN---DMN-PKISDFGMARIF 625 (640)
Q Consensus 592 --------------~~~~ivH~Dlkp~NILl~~---~~~-~kI~DFGla~~~ 625 (640)
.+..++|+|++|.|||++. ++. ..|.||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2345799999999999987 345 589999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.1e-05 Score=80.64 Aligned_cols=136 Identities=18% Similarity=0.160 Sum_probs=94.4
Q ss_pred cccccCce-eEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 480 KLGEGGFG-PVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 480 ~lg~G~fg-~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
.+..|..+ .||+..... +..+.+|+-.. ....++..|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 689876654 56788887542 23456888999988774 45577889999999999999999999887
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 006563 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD--------------------------------------------- 591 (640)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 591 (640)
....... ......+..++++.|.-||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6544211 111223444555555555532
Q ss_pred ----------CCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 592 ----------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 592 ----------~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
.+..++|+|+.+.|||++++..+-|.||+.+..-
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123799999999999998877889999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=8e-06 Score=85.24 Aligned_cols=79 Identities=6% Similarity=-0.003 Sum_probs=54.5
Q ss_pred ccc-cccCceeEEEEEec-------CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCC-C--CceeeeEeEEEeC---
Q 006563 479 NKL-GEGGFGPVYKGTLV-------EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQA--- 541 (640)
Q Consensus 479 ~~l-g~G~fg~Vy~g~l~-------~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~--- 541 (640)
+.| +.|....+|+.... +++.+++|+..... ......+..|.++++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 78888999988765 25678888754321 111256788888888874 3 3567788887655
Q ss_pred CeeEEEEEccCCCChh
Q 006563 542 DESMLIYEYMPNKSLD 557 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~ 557 (640)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=7.7e-05 Score=78.96 Aligned_cols=75 Identities=9% Similarity=0.190 Sum_probs=49.9
Q ss_pred cccccccCceeEEEEEec-CCcEEEEEEcccCCc-------hhhHhHHHHHHHHhhCCC--Cc-eeeeEeEEEeCCeeEE
Q 006563 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-------QGMEEFKNEVTLIARLQH--RN-LVKLLGCCIQADESML 546 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 546 (640)
.+.||.|..+.||++... +++.++||....... ...+.+..|.+++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999765 367899997653211 123456788888887732 33 3455544 4556789
Q ss_pred EEEccCCC
Q 006563 547 IYEYMPNK 554 (640)
Q Consensus 547 V~Ey~~~g 554 (640)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00022 Score=73.33 Aligned_cols=141 Identities=13% Similarity=0.184 Sum_probs=79.8
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC--CCceeeeEe------EEEeCCeeEEEEEc
Q 006563 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--HRNLVKLLG------CCIQADESMLIYEY 550 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g------~~~~~~~~~lV~Ey 550 (640)
+.|+.|....||+....++ .+++|+.... .+++..|..++..+. .-.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4565567889999877554 5888888652 133344555554442 112333332 12346678999999
Q ss_pred cCCCChh-----------HHH---hhc-c----c------cCCCCHHHHH------------------------------
Q 006563 551 MPNKSLD-----------FFI---FDQ-A----R------ATFLDWQKRI------------------------------ 575 (640)
Q Consensus 551 ~~~gsL~-----------~~l---~~~-~----~------~~~l~~~~~~------------------------------ 575 (640)
+++..+. ..| +.. . . ...-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 011 110 0 0 0112343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 576 -HIVGGIARGILYLHQ----------DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 576 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
.+...+.+++++|++ ..+..++|+|+++.|||++.+..+.|.||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123446667763 1235699999999999998888999999999865
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00031 Score=70.78 Aligned_cols=79 Identities=18% Similarity=0.221 Sum_probs=58.0
Q ss_pred cccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC---CceeeeEeEEEeCCeeEEEEEc
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH---RNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.......+|.|..+.||+.++.+|+.+.+|+...........|..|.+.|+.|.- .-+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4555678999999999999999999999998765444444568889998887742 2344555542 34789999
Q ss_pred cCCCCh
Q 006563 551 MPNKSL 556 (640)
Q Consensus 551 ~~~gsL 556 (640)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00066 Score=69.25 Aligned_cols=139 Identities=19% Similarity=0.130 Sum_probs=92.1
Q ss_pred ccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC---CCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
..+.|+.|....+|+... +++.+++|+.... ....|..|.+.|+.|. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345788999999999876 4677888876532 3566888988888773 36788899988888889999999998
Q ss_pred CChh--------HH---Hhhccc-c------------------CCCCHHHHHH---HHH----------------HHHHH
Q 006563 554 KSLD--------FF---IFDQAR-A------------------TFLDWQKRIH---IVG----------------GIARG 584 (640)
Q Consensus 554 gsL~--------~~---l~~~~~-~------------------~~l~~~~~~~---i~~----------------~ia~g 584 (640)
..+. .. |+.... . -.-+|...+. +.. .+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 11 111110 0 0124654321 111 11111
Q ss_pred -HHHHHh-CCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 585 -ILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 585 -L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123422 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00091 Score=71.27 Aligned_cols=73 Identities=11% Similarity=0.159 Sum_probs=44.6
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccC----Cch-----hhHhHHHHHHHHh-hCCCCceeeeEeEEEeCCeeEEE
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQ-----GMEEFKNEVTLIA-RLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~----~~~-----~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.+.||.|....||+... +++.++||..... ... ....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45789999999999864 4678999943211 010 2223333433222 22234566777664 5667999
Q ss_pred EEcc-CC
Q 006563 548 YEYM-PN 553 (640)
Q Consensus 548 ~Ey~-~~ 553 (640)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0056 Score=62.31 Aligned_cols=159 Identities=14% Similarity=0.130 Sum_probs=86.7
Q ss_pred cchHhHHHhhccccc-----cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc--eeeeE
Q 006563 463 FDFASIAKATDNFAS-----YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLL 535 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~-----~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~ 535 (640)
++.+++......|.. .+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344445444444432 34566777789999887665 5778887642 12244566777776653212 23333
Q ss_pred eE------EEeCCeeEEEEEccCCCChhH----H----------Hhhcc-c---c-----CCCCHHHHHH----------
Q 006563 536 GC------CIQADESMLIYEYMPNKSLDF----F----------IFDQA-R---A-----TFLDWQKRIH---------- 576 (640)
Q Consensus 536 g~------~~~~~~~~lV~Ey~~~gsL~~----~----------l~~~~-~---~-----~~l~~~~~~~---------- 576 (640)
.. ....+..++++||+++..+.. . ++... . . ....|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999999865421 0 11100 0 0 0112332111
Q ss_pred --HHHHHHHHHHHHHhC----CCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 577 --IVGGIARGILYLHQD----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 577 --i~~~ia~gL~yLH~~----~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+...+.+.++++++. .+..++|+|+.+.|||++++..+.|.||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666532 234699999999999999876668999998865
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0073 Score=61.88 Aligned_cols=142 Identities=15% Similarity=0.100 Sum_probs=73.1
Q ss_pred ccccccCce-eEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC--CCceeeeEeEEEeCCeeEEEEEccCCCC
Q 006563 479 NKLGEGGFG-PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKS 555 (640)
Q Consensus 479 ~~lg~G~fg-~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gs 555 (640)
+.|+.|... .+|+....+++.+++|...... .+++..|+.++..+. .-.+.+++.+.. ...+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 455555433 3667665446677777544321 134455666666653 234556666633 23378999997766
Q ss_pred hhHHHhhccc-----------------------cCCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 006563 556 LDFFIFDQAR-----------------------ATFLDWQKRI--------------------HIVGGIARGILYLH--- 589 (640)
Q Consensus 556 L~~~l~~~~~-----------------------~~~l~~~~~~--------------------~i~~~ia~gL~yLH--- 589 (640)
+...+..... ...++..... .....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6443321100 0011111000 00011122223331
Q ss_pred hCCCCceEecccCCCCEEEcCC----CceEEeeeccceec
Q 006563 590 QDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARIF 625 (640)
Q Consensus 590 ~~~~~~ivH~Dlkp~NILl~~~----~~~kI~DFGla~~~ 625 (640)
...+..++|+|+.+.|||++.+ ..+.|.||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224569999999999999874 68999999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0018 Score=69.25 Aligned_cols=72 Identities=19% Similarity=0.297 Sum_probs=47.9
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEE
Q 006563 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 549 (640)
+.|+.|-...+|+....+ ++.+.+|+.... ...+.+..|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 467778788999998753 468888887431 112456678888887743333 56676543 2 38999
Q ss_pred ccCCCCh
Q 006563 550 YMPNKSL 556 (640)
Q Consensus 550 y~~~gsL 556 (640)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.014 Score=59.51 Aligned_cols=141 Identities=13% Similarity=0.148 Sum_probs=80.6
Q ss_pred cccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC--CceeeeEeE-----EEeCCeeEEEEEccC
Q 006563 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGC-----CIQADESMLIYEYMP 552 (640)
Q Consensus 480 ~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~Ey~~ 552 (640)
.++ |....||+....+|+.+++|...... ...+.+..|..++..+.. -.+.+++.. ....+..+++|||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77788998877777789999886331 233566678777776642 224444442 122455688999998
Q ss_pred CCChh-----HH------H---hhc----c--ccCCCCHHHHH----HH---------------HHHHHHHHHHHHh---
Q 006563 553 NKSLD-----FF------I---FDQ----A--RATFLDWQKRI----HI---------------VGGIARGILYLHQ--- 590 (640)
Q Consensus 553 ~gsL~-----~~------l---~~~----~--~~~~l~~~~~~----~i---------------~~~ia~gL~yLH~--- 590 (640)
+..+. .. | +.. . .....++.... .+ ...+.+.++.+.+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 11 1 100 0 01112222110 00 0011122333322
Q ss_pred -CCCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 591 -DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 591 -~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
..+..++|+|+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0035 Score=63.32 Aligned_cols=139 Identities=13% Similarity=0.119 Sum_probs=74.4
Q ss_pred cccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEEcc-CCCC
Q 006563 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYM-PNKS 555 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 555 (640)
.+.|+.|-...+|+. +.+.+|+....... ......|..+++.+...++ .+++++ ..+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 467888888999988 45778876543211 1223567777766642222 355554 344467899999 5544
Q ss_pred hhHH--------H----------hhccc--cCCCCHHHHH-HHH--------------HHHHHHHH----HHHh-CCCCc
Q 006563 556 LDFF--------I----------FDQAR--ATFLDWQKRI-HIV--------------GGIARGIL----YLHQ-DSRMR 595 (640)
Q Consensus 556 L~~~--------l----------~~~~~--~~~l~~~~~~-~i~--------------~~ia~gL~----yLH~-~~~~~ 595 (640)
|... . +.... ....+....+ ... ..+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 0 00000 0001111111 000 00111111 1111 22345
Q ss_pred eEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 596 IIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
++|+|+.+.||+ .+++.+.|.||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55667899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0056 Score=65.81 Aligned_cols=73 Identities=14% Similarity=0.091 Sum_probs=46.4
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
+.|+.|-...+|+....+ ++.+.+|+........ -.-..|..++..+...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467778888999988765 4678888764432111 122578888888865444 46777652 2 359999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0054 Score=64.20 Aligned_cols=141 Identities=17% Similarity=0.217 Sum_probs=79.7
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc-eeeeEeEEEeCCeeEEEEE
Q 006563 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 549 (640)
+.|..|-...+|+....+ ++.+.+|+.... ......+.+|.++++.+.-.+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356667777889887652 467888886432 223456678998888774222 3566666543 29999
Q ss_pred ccCCCChhH--------------HH---hhcc--ccCCCC--HHHHHHHHHHH-------------------HHHHHHHH
Q 006563 550 YMPNKSLDF--------------FI---FDQA--RATFLD--WQKRIHIVGGI-------------------ARGILYLH 589 (640)
Q Consensus 550 y~~~gsL~~--------------~l---~~~~--~~~~l~--~~~~~~i~~~i-------------------a~gL~yLH 589 (640)
|+++..|.. .| +... ..+... |.+..+...++ .+.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765531 01 0100 011112 23333333222 12233332
Q ss_pred ----hC-CCCceEecccCCCCEEEcCC----CceEEeeecccee
Q 006563 590 ----QD-SRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (640)
Q Consensus 590 ----~~-~~~~ivH~Dlkp~NILl~~~----~~~kI~DFGla~~ 624 (640)
.. .+..++|+|+.+.|||++.+ ..+.|.||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23468999999999999876 7899999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0078 Score=62.69 Aligned_cols=73 Identities=14% Similarity=0.148 Sum_probs=42.8
Q ss_pred ccccccCceeEEEEEecC---------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc-eeeeEeEEEeCCeeEEEE
Q 006563 479 NKLGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIY 548 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~---------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 548 (640)
..|+.|-.-.+|+....+ ++.+.+|+..... ........|.+++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 456777778899887654 2678888765432 22223467888887774333 34666543 2 36899
Q ss_pred EccCCCCh
Q 006563 549 EYMPNKSL 556 (640)
Q Consensus 549 Ey~~~gsL 556 (640)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.093 Score=53.81 Aligned_cols=33 Identities=27% Similarity=0.409 Sum_probs=28.9
Q ss_pred CCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+..++|+|+.+.||++++++.+.|.||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.10 E-value=0.67 Score=48.93 Aligned_cols=73 Identities=16% Similarity=0.205 Sum_probs=45.3
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCc-eeeeEeEEEeCCeeEEEEE
Q 006563 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 549 (640)
+.+..|--..+|+....+ ++.+.+|+...... ..-.-.+|.++++.+.-.+ ..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456667777889887753 57788888644322 2223357888877774222 34555532 2 378999
Q ss_pred ccCCCCh
Q 006563 550 YMPNKSL 556 (640)
Q Consensus 550 y~~~gsL 556 (640)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.16 E-value=1.3 Score=46.18 Aligned_cols=30 Identities=23% Similarity=0.380 Sum_probs=25.8
Q ss_pred ceEecccCCCCEEE------cCCCceEEeeecccee
Q 006563 595 RIIHRDLKASNVLL------DNDMNPKISDFGMARI 624 (640)
Q Consensus 595 ~ivH~Dlkp~NILl------~~~~~~kI~DFGla~~ 624 (640)
-++|+|+.+.|||+ +++..+++.||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999999875
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=85.90 E-value=0.18 Score=40.16 Aligned_cols=47 Identities=23% Similarity=0.547 Sum_probs=37.1
Q ss_pred cCCCCcccccCCCCccccC--CCCCcCCCCCCCccCCCCCCCcCcccCccccccC
Q 006563 274 PLDRCDLYSVCGANARCTT--NSSRRCDCLEGFVPKSPNNWSEGCVRERELKCRN 326 (640)
Q Consensus 274 p~~~C~~~~~CG~~g~C~~--~~~~~C~C~~GF~~~~~~~w~~GC~r~~~~~C~~ 326 (640)
+...| ++..|+.|+.|-. +..+.|.|+.||... ...|+++...+|..
T Consensus 3 ~~h~C-~~tkcp~NA~Cyr~~dg~EecRCllnykk~-----~~kCV~~~~~~C~~ 51 (95)
T 1b9w_A 3 SEHRC-IDTNVPENAACYRYLDGTEEWRCLLYFKED-----AGKCVPAPNMTCKD 51 (95)
T ss_dssp GGGSC-SSCCCCTTEEEEECTTSCEEEEECTTEEEE-----TTEEEECTTCCTTT
T ss_pred cCccc-ccCCCCCCcCeEEEcCCCEEEEEECCeEec-----CCEEEcCCCCCccc
Confidence 45668 6669999999953 467899999999974 56799988778853
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.10 E-value=1.3 Score=34.85 Aligned_cols=34 Identities=24% Similarity=0.477 Sum_probs=27.9
Q ss_pred cCChhHHHHHhhcCCCceeeecccCCCCCceeeeccc
Q 006563 349 SMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFG 385 (640)
Q Consensus 349 ~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~ 385 (640)
..++++|++.|+.+=.|.||.|.. ....|+++.+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 468999999999999999999852 3457998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 640 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-18 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 4e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-11 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 4e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 2e-48
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 13/180 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++G G FG VYKG + + ++ + Q ++ FKNEV
Sbjct: 3 WEIPD-------GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 55
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ + +H N++ +G + ++ ++ SL + T + K I I
Sbjct: 56 GVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQ 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
A+G+ YLH IIHRDLK++N+ L D+ KI DFG+A + ++ G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-46
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++ WE + +LG G FG V+ G ++AVK L +GS
Sbjct: 3 WWEDE---WEVPR-------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MS 51
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ F E L+ +LQH+ LV+L Q + +I EYM N SL F+ L
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTIN 109
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
K + + IA G+ ++ + IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E
Sbjct: 110 KLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
Query: 633 NTHKVVGT 640
Sbjct: 167 REG-AKFP 173
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-46
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 6/164 (3%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D + +LG+G FG VYK E A K + S + +E++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + ++ E+ ++D + + R L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+IIHRDLKA N+L D + K++DFG++ + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQH 528
D+F ++LG G G V+K + G +A K + + + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+V G E + E+M SLD + R + Q + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +I+HRD+K SN+L+++ K+ DFG++ I + + VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 5e-45
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 16/173 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S Q ++ EV + +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH +IHRD+KA N+LL K+ DFG A I + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 6e-45
Identities = 49/176 (27%), Positives = 87/176 (49%), Gaps = 13/176 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + + +KLG G +G VY+G + +AVK L + + + +EEF E
Sbjct: 12 WEMER-------TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 63
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMAT 122
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 1e-44
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 463 FDFASIAKATDNFASY---------NKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG- 508
F F +A FA +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
+ + +F +E +++ + H N++ L G ++ M+I E+M N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ + ++ GIA G+ YL M +HRDL A N+L+++++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 629 EIQTNTHKVVG 639
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 7/168 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++G G FG V+ G + ++A+K + +G+ E+F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C++ L++E+M + L ++ Q + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG---MAYLE 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+IHRDL A N L+ + K+SDFGM R D+ T++
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFP 165
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 13/178 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ KLG+G FG V+ GT +A+K L G+ E F E
Sbjct: 12 WEIPR-------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 64 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQ 121
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
IA G+ Y+ + M +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-43
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
+++ LGEG +G V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ I HRD+K N+LLD N KISDFG+A +F + + +K+ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-43
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K G+ + K L GS + +EV L+ L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
H+ D ++HRDLK +NV LD N K+ DFG+ARI D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 8e-43
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
+ +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C + +I EYM N L ++ + Q+ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ +HRDL A N L+++ K+SDFG++R DE ++
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFP 164
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + +G+G FG V G G ++AVK + + + F E
Sbjct: 2 WALNM-------KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 51
Query: 521 TLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ + ++ EYM SL ++ + R + L +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSL 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ + YL +HRDL A NVL+ D K+SDFG+ + +
Sbjct: 111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-42
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 471 ATDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQG-MEEFKNEVTLIAR 525
DN + +LG G FG V +G + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L + +V+L+G C QA+ ML+ E L F+ + + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGT 640
YL + +HRDL A NVLL N KISDFG+++ G D+ T
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 2e-41
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 38/208 (18%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME 514
E+ +N +GEG FG V++ +AVK L + + M+
Sbjct: 8 LEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 515 -EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
+F+ E L+A + N+VKLLG C L++EYM L+ F+ + T
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 569 ----------------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L +++ I +A G+ YL + + +HRDL N L+ +M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGT 640
KI+DFG++R +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIP 205
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 50/208 (24%), Positives = 77/208 (37%), Gaps = 38/208 (18%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQG-M 513
WEF +N LG G FG V T ++AVK L + +
Sbjct: 32 WEFPR-------ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--------- 563
E +E+ ++ +L H N+V LLG C + LI+EY L ++ +
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 564 -----------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGK 201
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGT 640
KI DFG+AR D
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLP 229
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 34/212 (16%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRL 505
+ + D + WEF + + LG G FG V + T +AVK L
Sbjct: 10 TQLPYDHK-WEFPR-------NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 506 SKGSGQG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
+ E +E+ +++ L H N+V LLG C +++I EY L F+ +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 564 ---------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608
LD + + +A+G+ +L IHRDL A N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ KI DFG+AR D
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 17/172 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 540 QADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---- 591
+ + + L+ +Y + SL ++ + + I + A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGT 640
+ I HRDLK+ N+L+ + I+D G+A D I + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 5e-40
Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 10/175 (5%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL + + D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+LH ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 13/168 (7%)
Query: 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + +AVK L + +E E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGT 640
+HRDL A NVLL KISDFG+++ DE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+++L G A LI EY P ++ + ++ D Q+ + +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
H R+IHRD+K N+LL + KI+DFG + + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGT 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-39
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 16/170 (9%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G F VYKG E E+A L + + FK E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 536 GCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ +L+ E M + +L ++ + + I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR 131
Query: 592 SRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ IIHRDLK N+ + + KI D G+A + + V+GT
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGT 176
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-39
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 13/179 (7%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + E +A+K L + S + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++A + + ++ +LLG C+ LI + MP L ++ + + Q ++ I
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQI 120
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
A+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 24/186 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-Q 527
++ + +GEG FG V K + + + A+KR+ + S +F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------------FDQARATFLDWQKR 574
H N++ LLG C L EY P+ +L F+ + A+ L Q+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+H +ARG+ YL Q + IHRDL A N+L+ + KI+DFG++R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 635 HKVVGT 640
Sbjct: 184 TMGRLP 189
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-38
Identities = 49/175 (28%), Positives = 72/175 (41%), Gaps = 13/175 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L HRNL++L G + ++ E P SL + L R + +A G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
YL R IHRDL A N+LL KI DFG+ R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 10/174 (5%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
K ++F LGEG F V L +E A+K L K + E +++R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L H VKL ++ Y N L +I D I +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VG
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (357), Expect = 7e-38
Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 8/166 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L +E ++IYE+M L + D+ + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTH 635
+H DLK N++ + K+ DFG+ + T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-38
Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 24/194 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKG-SGQGM 513
WE + +LG+G FG VY+G +A+K +++ S +
Sbjct: 15 WEVAR-------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
EF NE +++ ++V+LLG Q +++I E M L ++ A
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 569 --LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
K I + G IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 627 GDEIQTNTHKVVGT 640
+ K +
Sbjct: 185 ETDYYRKGGKGLLP 198
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI ++ + + + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK--VVGT 640
+ +HRDL A N +LD K++DFG+AR E + +K
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 5/166 (3%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHR 529
+ + + +GEG +G V V +A+K++S Q + E+ ++ R +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N++ + + Y+ + ++ + L + + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++HRDLK SN+LL+ + KI DFG+AR+ D T
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (353), Expect = 3e-37
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 11/171 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D + +LG G FG V++ G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L E +LI E++ L I A + + I+ + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
I+H D+K N++ + KI DFG+A DEI T
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTAT 191
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 8e-37
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 19/185 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
+E + +GEG FG V++G + +A+K + + E+
Sbjct: 2 YEIQR-------ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 54
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ + + LD I
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLI 111
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R D
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 167
Query: 636 KVVGT 640
K
Sbjct: 168 KGKLP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 51/206 (24%), Positives = 76/206 (36%), Gaps = 32/206 (15%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 4 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 56
Query: 511 QG-MEEFKNEVTLIAR-LQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQ---- 563
+E+ ++ H N+V LLG C + M+I E+ +L ++ +
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 564 ---------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
FL + I +A+G+ +L + IHRDL A N+LL
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV 173
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGT 640
KI DFG+AR D
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLP 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 5e-36
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ- 527
++F+ + +G GGFG VY + G+ A+K L K QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 528 --HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + D+ I + M L + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
++H +++RDLK +N+LLD + +ISD G+A F + H VGT
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGT 168
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-36
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQGM-EEFKNEVTLIARL 526
+G G FG VYKG L +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+++L G + M+I EYM N +LD F+ ++ + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMK 124
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
YL M +HRDL A N+L+++++ K+SDFG++R+ D T T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 5e-34
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 10/160 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
+F LG G FG V+ G+ A+K L K + +E +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
++++ G A + +I +Y+ L + R + V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
II+RDLK N+LLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 9/166 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + LG G FG V++ + K + G K E++++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L +E ++I+E++ + I A L+ ++ + V + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTH 635
I H D++ N++ + KI +FG AR +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (317), Expect = 4e-33
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 20/179 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EEFKNEVTL 522
+N+ LG G V + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 523 IARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ ++ H N+++L L+++ M L ++ ++ L ++ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I LH ++ I+HRDLK N+LLD+DMN K++DFG + E +V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 33/203 (16%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKG-SGQ 511
WE D LGEG FG V + ++AVK L + +
Sbjct: 8 WELPR-------DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++ +
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 569 -----------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
L + + +ARG+ YL + IHRDL A NVL+ D KI+
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIA 177
Query: 618 DFGMARIFGGDEIQTNTHKVVGT 640
DFG+AR + T
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 8e-33
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 8/165 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+GEG +G VYK G+ A+K RL K E++++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKL +L++E++ + L+ + + GI Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
R++HRDLK N+L++ + KI+DFG+AR FG +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-33
Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 15/171 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++ +G G FG VY+ L + G+ +A+K++ + E+ ++ +L H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 532 VKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
V+L + E L+ +Y+P L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTH 635
Y+H I HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 3e-32
Identities = 34/171 (19%), Positives = 67/171 (39%), Gaps = 8/171 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHR 529
D + + LG G F V + +A+K ++K + +G E +NE+ ++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V L LI + + L I ++ + ++ + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ + LD D ISDFG++++ + GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIAR-LQ 527
++F + LG+G FG V+ + Q A+K L K +E E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H L + + + EY+ L + I + D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
LH I++RDLK N+LLD D + KI+DFGM + + +TNT GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-----FKNEVTLIARLQHRNLV 532
+ LGEG F VYK Q +A+K++ G ++ E+ L+ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LL L++++M + L + +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I+HRDLK +N+LLD + K++DFG+A+ FG V T
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVT 163
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (302), Expect = 4e-31
Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 15/178 (8%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
+D + LG GG V+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 528 HRNLVKLLGCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
H +V + + ++ EY+ +L + + + ++ I ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-GDEIQTNTHKVVGT 640
+ + H + IIHRD+K +N+++ K+ DFG+AR T T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-31
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+NF K+GEG +G VYK G+ +A+K++ + E++L+ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKLL ++ L++E++ F D + T + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
R++HRDLK N+L++ + K++DFG+AR FG
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-30
Identities = 41/181 (22%), Positives = 82/181 (45%), Gaps = 19/181 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHR 529
+ K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 530 NLVKLLGCCIQADESM--------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
N+V L+ C L++++ + + T + ++ + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVVG 639
+ L+ R +I+HRD+KA+NVL+ D K++DFG+AR F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 640 T 640
T
Sbjct: 184 T 184
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 12/172 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L L D + EY L F + +R ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+++RD+K N++LD D + KI+DFG+ + D GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGM--EEFKNEVTLIAR 525
+A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 526 L---QHRNLVKLLGCCIQADESMLIYEYMPNKSLD---FFIFDQARATFLDWQKRIHIVG 579
L +H N+V+L C + + + +D D+ + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+ Q VV
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177
Query: 640 T 640
T
Sbjct: 178 T 178
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 6e-28
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 11/178 (6%)
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SG 510
++ ++ WE + A+ D F LG G FG V E G A+K L K
Sbjct: 24 EDFLKKWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ +E NE ++ + LVKL ++ EY+ + + R
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FS 139
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
I YLH + +I+RDLK N+L+D +++DFG A+ G
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 7e-28
Identities = 42/171 (24%), Positives = 65/171 (38%), Gaps = 19/171 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE------FKNEVTLIARLQ--HRN 530
LG GGFG VY G V +A+K + K E EV L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+++LL + D +LI E F + A L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128
Query: 591 DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
++HRD+K N+L+D N K+ DFG + T GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 9e-28
Identities = 38/164 (23%), Positives = 64/164 (39%), Gaps = 18/164 (10%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC 538
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 539 IQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+++ E + L I D+ F ++ I+ I I YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 595 RIIHRDLKASNVLLDNDMNP---KISDFGMARIFGGDEIQTNTH 635
I HRD+K N+L + K++DFG A+ T
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 3e-27
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 9/166 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ K+GEG +G V+K E + +A+KR+ E+ L+ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V+L + L++E+ +F + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++HRDLK N+L++ + K+++FG+AR FG +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-27
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS------GQGMEEFKNEVTLIAR 525
D + + +LG G F V K G + A K + K G E+ + EV+++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+QH N++ L + +LI E + L F+ ++ L ++ + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGT 640
++ ++I H DLK N++L + P KI DFG+A + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 2e-26
Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 11/160 (6%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG +Y GT + G+E+A+K + + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ + SL+ +R + + + + I Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 599 RDLKASNVL---LDNDMNPKISDFGMARIFGGDEIQTNTH 635
RD+K N L I DFG+A+ + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G +G V G ++A+K+L + S + E+ L+ ++H N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 537 CCIQADESMLIYE-YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + Y+ + + + L + +V + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
IIHRDLK N+ ++ D KI DFG+AR +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (265), Expect = 4e-26
Identities = 30/172 (17%), Positives = 67/172 (38%), Gaps = 18/172 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
++GEG FG +++GT L+ Q++A+K + S + ++E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q ++ + SL+ + R + + + +H+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 599 RDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQTNTHK-----VVGT 640
RD+K N L+ + + DFGM + + + + + GT
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (262), Expect = 2e-25
Identities = 36/194 (18%), Positives = 78/194 (40%), Gaps = 21/194 (10%)
Query: 453 HMKEDMELWEFDFASIA-KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG 510
+ E W+++ + D++ KLG G + V++ + +++ VK L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK- 72
Query: 511 QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARAT 567
++ K E+ ++ L+ N++ L L++E++ N
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------Q 124
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFG 626
L + I + + Y H M I+HRD+K NV++D++ ++ D+G+A +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 627 GDEIQTNTHKVVGT 640
+ V +
Sbjct: 182 PGQEYNV---RVAS 192
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-25
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
+NF LG G +G V+ + G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 525 RLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LV L + LI +Y+ L + + R T + Q +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+L L ++ II+RD+K N+LLD++ + ++DFG+++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G G V V + +A+K+LS+ + + E+ L+ + H+N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 537 CCI------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L+ E M + D ++ +++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHS 137
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IIHRDLK SN+++ +D KI DFG+AR G + T V T
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVT 181
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 32/155 (20%), Positives = 48/155 (30%), Gaps = 20/155 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARLQH 528
+GEG V+ + E VK G G F AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R L KL G + +Y + N L I + ++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ I+H DL NVL+ + I DF +
Sbjct: 120 YH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 3e-23
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH 528
+ + + + +G G +G V + G +AVK+LS+ S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 529 RNLVKLLGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
N++ LL A Y+ + + + + L ++ I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (211), Expect = 1e-18
Identities = 29/175 (16%), Positives = 59/175 (33%), Gaps = 18/175 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLG G F V+ +V +A+K + E ++E+ L+ R+ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 539 I-------------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+ ++ + + + + I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 586 LYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
Y+H+ R IIH D+K NVL++ D + +A + + +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 78.8 bits (194), Expect = 2e-18
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 11/115 (9%)
Query: 27 IRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNV 86
+ +GE L + ++ + L ++ T W +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD----HSTSVWASNTGILGKKGCKA-VL 57
Query: 87 TSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
S G V+ D R W+S++ N V+ L + GN+V+ Y S +W + +
Sbjct: 58 QSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 68.9 bits (168), Expect = 6e-15
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 16/123 (13%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L G+F L ++ W N
Sbjct: 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS 49
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L T +V+ + ++ W+SNT N V L N+V+ Y + W +
Sbjct: 50 RS-CFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI----YGTDRWAT 104
Query: 138 FDH 140
H
Sbjct: 105 GTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.6 bits (165), Expect = 2e-14
Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I Y + L L++ + ++L RD WS+NT+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 117 LMDSGNLVLTDGNYNSLLWQSFD--HPCDTLL 146
L +G + + N +W S + +
Sbjct: 72 LQPNGRMDVLTNQ-NIAVWTSGNSRSAGRYVF 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 66.7 bits (162), Expect = 4e-14
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 14/125 (11%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D + + G +L G + + + Y W + +
Sbjct: 2 DRLNSGHQLDTGGSLA--EGGYLFIIQNDCNL------VLY---DNNRAVWASGTNGKAS 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 51 GCV--LKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATH 107
Query: 139 DHPCD 143
+ +
Sbjct: 108 TNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 57.7 bits (139), Expect = 6e-11
Identities = 20/130 (15%), Positives = 41/130 (31%), Gaps = 20/130 (15%)
Query: 11 ILGASAANDNITPSQSIRDGETL--VSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVA 68
I+ + +DN Q + E+L + + + L ++
Sbjct: 3 IIFSKQPDDN--HPQILHATESLEILFGTHVYRFIMQTDCN-----LVLY----DNNNPI 51
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
W N + G +V++ + W S + + V+ L N+V+
Sbjct: 52 WATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI-- 107
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 108 --YGDALWAT 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.6 bits (126), Expect = 4e-09
Identities = 17/84 (20%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I + + + L S + S ++L D W+SNT+
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGA-TGCRAV 61
Query: 117 LMDSGNLVLTDGNYNSLLWQSFDH 140
L G LV+ N++ W S
Sbjct: 62 LQSDGLLVILTAQ-NTIRWSSGTK 84
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 640 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.96 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.95 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.94 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.94 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.94 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.94 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.93 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.93 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.93 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.92 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.92 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.91 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.91 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.78 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.68 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.53 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.46 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.16 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.87 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.75 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.72 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.8 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.92 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.04 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.61 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.94 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.57 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 82.5 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 81.7 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.61 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.92 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.1e-32 Score=271.22 Aligned_cols=163 Identities=29% Similarity=0.396 Sum_probs=139.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|+..+.||+|+||+||+|+.. +++.||||++.... .+..+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357888999999999999999975 48999999987542 3345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999998843 335899999999999999999999987 9999999999999999999999999999886554
Q ss_pred cccccceeeeC
Q 006563 630 IQTNTHKVVGT 640 (640)
Q Consensus 630 ~~~~~~~~~Gt 640 (640)
........+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 44444556676
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=4.8e-32 Score=275.15 Aligned_cols=154 Identities=30% Similarity=0.515 Sum_probs=138.4
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||+||+|.+.. ++.||||++... ....++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4678888999999999999999865 889999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCcc
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~~ 630 (640)
+++|+|..++.... ...+++..++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+..
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999986543 346899999999999999999999987 99999999999999999999999999998765543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=268.51 Aligned_cols=151 Identities=28% Similarity=0.551 Sum_probs=130.7
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|+..+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 567788899999999999999988889999999764 3445789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
+|+|.+++... ...++|..++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999988653 345899999999999999999999987 9999999999999999999999999999875443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.2e-31 Score=273.72 Aligned_cols=151 Identities=31% Similarity=0.549 Sum_probs=124.9
Q ss_pred cccccccccccCceeEEEEEecC-C---cEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g---~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+|...++||+|+||+||+|.+.. + ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 44556799999999999998754 2 25899998754 3445678999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|||++|+|..++.... ..++|.+++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999886533 35899999999999999999999987 999999999999999999999999999988654
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 182 ~ 182 (299)
T d1jpaa_ 182 T 182 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=267.58 Aligned_cols=152 Identities=34% Similarity=0.577 Sum_probs=134.6
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
.++|...+.||+|+||.||+|.+++++.||||++... ....++|.+|++++++++|||||+++|++.+ +..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888899999999999999988889999999764 3446789999999999999999999998754 5679999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
++|+|.+++..... ..++|..++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 90 ~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999988754332 34899999999999999999999987 9999999999999999999999999999986544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-31 Score=268.46 Aligned_cols=161 Identities=31% Similarity=0.507 Sum_probs=131.5
Q ss_pred hccccccccccccCceeEEEEEecCCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...+.||+|+||+||+|++. ..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 366888899999999999999874 36999998744 34567889999999999999999999999754 56899999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+++|+|.+++.... ..+++..++.++.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999996543 35899999999999999999999987 9999999999999999999999999999876544
Q ss_pred cccccceeeeC
Q 006563 630 IQTNTHKVVGT 640 (640)
Q Consensus 630 ~~~~~~~~~Gt 640 (640)
......+..||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 43334445554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=264.42 Aligned_cols=150 Identities=27% Similarity=0.490 Sum_probs=136.1
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
++|...++||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999875 48999999987655555678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
++|+|..++.+ ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999988754 24899999999999999999999987 9999999999999999999999999999885443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-31 Score=266.56 Aligned_cols=149 Identities=29% Similarity=0.456 Sum_probs=136.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+.|+..+.||+|+||.||+|+... ++.||||++........+.|.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 468888999999999999999754 8899999998766677789999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++|+|..++.+.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence 9999999875532 35899999999999999999999987 9999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-30 Score=259.18 Aligned_cols=151 Identities=29% Similarity=0.515 Sum_probs=137.1
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|+..++||+|+||+||+|++++++.||||++++. ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 678888999999999999999988889999999864 3446789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
+|+|..++.... ..+++..+.+++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999876543 34889999999999999999999987 9999999999999999999999999999875443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=262.97 Aligned_cols=162 Identities=30% Similarity=0.420 Sum_probs=136.7
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57888999999999999999975 4889999998643 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 35899999999999999999999987 999999999999999999999999999998655
Q ss_pred ccccccceeeeC
Q 006563 629 EIQTNTHKVVGT 640 (640)
Q Consensus 629 ~~~~~~~~~~Gt 640 (640)
..........||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444344455665
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-30 Score=269.66 Aligned_cols=149 Identities=24% Similarity=0.329 Sum_probs=134.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|+..++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 48899999987543 3445679999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||++|+|.+++.+. ..+++..+..++.|+++||.|||+. + |+||||||+||||++++.+||+|||+|+.+.
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999654 3489999999999999999999974 5 9999999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-30 Score=258.48 Aligned_cols=150 Identities=29% Similarity=0.420 Sum_probs=134.7
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 578888999999999999999864 889999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998653 34899999999999999999999987 999999999999999999999999999887544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.5e-30 Score=259.38 Aligned_cols=151 Identities=31% Similarity=0.556 Sum_probs=130.0
Q ss_pred ccccccc-cccccCceeEEEEEecC---CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYN-KLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~-~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
+++...+ +||+|+||.||+|.+.. +..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455555 49999999999998643 4579999997653 3456789999999999999999999999864 568999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||+++|+|.+++... ...+++..+..++.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999988543 235899999999999999999999987 99999999999999999999999999998865
Q ss_pred Cc
Q 006563 628 DE 629 (640)
Q Consensus 628 ~~ 629 (640)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 43
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-30 Score=260.19 Aligned_cols=157 Identities=27% Similarity=0.456 Sum_probs=126.9
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEe--CCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 547 (640)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67899999999999999999875 48899999987542 3445679999999999999999999999875 3457999
Q ss_pred EEccCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 548 YEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
|||+++|+|.+++.+.. ....+++..+..++.||+.||+|||+.+ ..+|+||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 3456999999999999999999999864 23599999999999999999999999999998
Q ss_pred ccCCc
Q 006563 625 FGGDE 629 (640)
Q Consensus 625 ~~~~~ 629 (640)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 75443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-30 Score=261.08 Aligned_cols=151 Identities=30% Similarity=0.559 Sum_probs=131.4
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 552 (640)
++|...+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|+|||+++|+|. .++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 578888999999999999999988889999999754 345678999999999999999999999985 456899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
+|+|..++.... ...++|..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999998886543 235999999999999999999999987 9999999999999999999999999999875443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.4e-30 Score=264.23 Aligned_cols=166 Identities=29% Similarity=0.423 Sum_probs=137.0
Q ss_pred hccccccccccccCceeEEEEEecCC------cEEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVEG------QEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~g------~~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.++|...++||+|+||+||+|+.... ..||||++... .....+.|.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46788889999999999999987542 36999998654 334556799999999998 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 006563 544 SMLIYEYMPNKSLDFFIFDQAR--------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKA 603 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 603 (640)
.+|||||+++|+|.++|..... ...+++..++.++.||++||+|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965421 235899999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEeeeccceeccCCccccccceeeeC
Q 006563 604 SNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 604 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+|||++.++.+||+|||+|+............+..||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999987655443333344454
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.1e-30 Score=257.25 Aligned_cols=144 Identities=31% Similarity=0.512 Sum_probs=125.6
Q ss_pred ccccccCceeEEEEEecC---CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEccCC
Q 006563 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~---g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 553 (640)
++||+|+||+||+|.+.. ++.||||++... .....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998754 467999998653 23446789999999999999999999999864 567899999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
|+|.+++... ..+++..++.++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 9999998653 34899999999999999999999987 9999999999999999999999999999886544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.8e-30 Score=258.86 Aligned_cols=152 Identities=32% Similarity=0.566 Sum_probs=128.3
Q ss_pred ccccccccccccCceeEEEEEecCC-----cEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g-----~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
+.|+..++||+|+||.||+|.+... ..||||++.... ....++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677788999999999999987652 369999987543 3445679999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||++++++..++.... ..++|..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999988875543 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=3.9e-30 Score=263.06 Aligned_cols=159 Identities=30% Similarity=0.524 Sum_probs=138.4
Q ss_pred HHHhhccccccccccccCceeEEEEEec------CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhCCCCceeeeEeEEEe
Q 006563 468 IAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (640)
Q Consensus 468 l~~~~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 540 (640)
++...++|...+.||+|+||+||+|+.. +++.||||++..... +..++|.+|+++|++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3445678999999999999999999864 356899999976433 346789999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006563 541 ADESMLIYEYMPNKSLDFFIFDQA---------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (640)
Q Consensus 541 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (640)
.+..++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+.+ ||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999986432 1234899999999999999999999987 9999
Q ss_pred ccCCCCEEEcCCCceEEeeeccceeccCCc
Q 006563 600 DLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (640)
Q Consensus 600 Dlkp~NILl~~~~~~kI~DFGla~~~~~~~ 629 (640)
||||+||||+.++.+||+|||+|+.+....
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~ 194 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSAD 194 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred EEcccceEECCCCcEEEccchhheeccCCc
Confidence 999999999999999999999999875443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=2.2e-29 Score=262.27 Aligned_cols=153 Identities=24% Similarity=0.411 Sum_probs=137.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999875 4889999999876656677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc--CCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kI~DFGla~~~~~~ 628 (640)
|++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ ||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 235899999999999999999999988 99999999999995 4578999999999988654
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1e-29 Score=260.32 Aligned_cols=149 Identities=29% Similarity=0.531 Sum_probs=132.7
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc---hhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888899999999999999875 488899999875432 33567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
|||++|+|+.++... ..+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999997766443 35899999999999999999999988 99999999999999999999999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-29 Score=252.92 Aligned_cols=149 Identities=27% Similarity=0.404 Sum_probs=127.5
Q ss_pred cccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEe----CCeeEEEE
Q 006563 476 ASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIY 548 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 548 (640)
...++||+|+||+||+|.... ++.||+|++... .....+.|.+|+++|++++|||||++++++.. +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 344589999999999999764 789999998653 33456679999999999999999999999875 34579999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc-CCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kI~DFGla~~~~~ 627 (640)
||+++|+|.+++.+. ..+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999998653 35899999999999999999999875 4699999999999996 578999999999987543
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=3.7e-29 Score=260.70 Aligned_cols=153 Identities=25% Similarity=0.375 Sum_probs=136.7
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||.||+|... +++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357899999999999999999875 5899999999876555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc--CCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kI~DFGla~~~~~~ 628 (640)
+++|+|.+++... ...+++.....|+.||+.||+|||+.+ |+||||||+||||+ +++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998877443 335899999999999999999999987 99999999999997 6789999999999998655
Q ss_pred c
Q 006563 629 E 629 (640)
Q Consensus 629 ~ 629 (640)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=5.7e-29 Score=250.78 Aligned_cols=150 Identities=27% Similarity=0.394 Sum_probs=134.2
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc---------hhhHhHHHHHHHHhhCC-CCceeeeEeEEEeC
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---------QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA 541 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 541 (640)
++|...+.||+|+||+||+++.. +++.||||++.+... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999874 588999999875421 12345889999999997 99999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
+..+||||||++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
|+.+...
T Consensus 157 a~~~~~~ 163 (277)
T d1phka_ 157 SCQLDPG 163 (277)
T ss_dssp CEECCTT
T ss_pred eeEccCC
Confidence 9988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-29 Score=257.61 Aligned_cols=161 Identities=25% Similarity=0.340 Sum_probs=139.6
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (640)
.++|...+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999874 5899999999753 233457789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||||++|+|..++.+. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999988653 34788899999999999999999988 99999999999999999999999999998654
Q ss_pred CccccccceeeeC
Q 006563 628 DEIQTNTHKVVGT 640 (640)
Q Consensus 628 ~~~~~~~~~~~Gt 640 (640)
... ......||
T Consensus 158 ~~~--~~~~~~GT 168 (337)
T d1o6la_ 158 DGA--TMKTFCGT 168 (337)
T ss_dssp TTC--CBCCCEEC
T ss_pred CCc--ccccceeC
Confidence 332 23345665
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.9e-29 Score=258.12 Aligned_cols=152 Identities=24% Similarity=0.359 Sum_probs=122.6
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
.+.|...+.||+|+||+||+|+... ++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3668888999999999999999764 8899999987543 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeeccceecc
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFG 626 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFGla~~~~ 626 (640)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999653 35899999999999999999999987 99999999999994 57899999999999875
Q ss_pred CCc
Q 006563 627 GDE 629 (640)
Q Consensus 627 ~~~ 629 (640)
...
T Consensus 162 ~~~ 164 (307)
T d1a06a_ 162 PGS 164 (307)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-29 Score=255.15 Aligned_cols=166 Identities=28% Similarity=0.460 Sum_probs=140.0
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCee
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 544 (640)
.++|...+.||+|+||.||+|.+. +++.||||+++... .+....|.+|++++++++|||||+++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999874 25689999997543 34456799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 545 MLIYEYMPNKSLDFFIFDQA-------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
++|||||++|+|.+++.... ....+++..+..++.|+|+||.|||+++ |+||||||+||||++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432 2235799999999999999999999987 9999999999999999999999
Q ss_pred eeccceeccCCccccccceeeeC
Q 006563 618 DFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 618 DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
|||+|+.+..........+..||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEEC
T ss_pred ecccceeccCCcceeeccceecc
Confidence 99999988655443333334443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=249.22 Aligned_cols=150 Identities=29% Similarity=0.412 Sum_probs=133.8
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC------chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
+.|...+.||+|+||+||+|+.. +|+.||||++.+.. ....+.|.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57888899999999999999975 48999999986532 123577999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC----ceEEeeecc
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGM 621 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kI~DFGl 621 (640)
||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999998653 35899999999999999999999987 99999999999998776 499999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
|+.+...
T Consensus 164 a~~~~~~ 170 (293)
T d1jksa_ 164 AHKIDFG 170 (293)
T ss_dssp CEECTTS
T ss_pred hhhcCCC
Confidence 9987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=9.2e-29 Score=254.09 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=133.5
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|...+.||+|+||+||+++... |+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 578889999999999999999754 899999998743 2334577999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+++|+|..++.... .+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999998885533 4788888899999999999999987 99999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.8e-29 Score=256.16 Aligned_cols=162 Identities=30% Similarity=0.531 Sum_probs=131.7
Q ss_pred ccccccccccccCceeEEEEEecC-Cc----EEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~----~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
++|+..++||+|+||+||+|.+.. |+ .||+|++... ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 458888999999999999998754 43 5899998754 345677899999999999999999999999865 5678
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
++||+.+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887654 345899999999999999999999987 9999999999999999999999999999986
Q ss_pred CCccccccceeeeC
Q 006563 627 GDEIQTNTHKVVGT 640 (640)
Q Consensus 627 ~~~~~~~~~~~~Gt 640 (640)
.......+...+||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544444444554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.7e-29 Score=253.65 Aligned_cols=166 Identities=28% Similarity=0.429 Sum_probs=129.4
Q ss_pred hccccccccccccCceeEEEEEecC------CcEEEEEEcccCC-chhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCC-
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD- 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~------g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~- 542 (640)
.++|...++||+|+||.||+|.... ++.||||++.... ....+++..|...+.++ +|+|||.+++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4678889999999999999998643 4689999997543 34456788888888777 7899999999987654
Q ss_pred eeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (640)
..++|||||++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 58999999999999999975432 235899999999999999999999987 99999999999999
Q ss_pred CCCceEEeeeccceeccCCccccccceeeeC
Q 006563 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 610 ~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+++.+||+|||+|+...............||
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred CCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999987655444444445554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=247.30 Aligned_cols=152 Identities=31% Similarity=0.454 Sum_probs=124.7
Q ss_pred ccccccccccccCceeEEEEEecC--C--cEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~--g--~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|+..+.||+|+||.||+|++.. + .+||||++.+. ..+..++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998643 2 37899998753 33456789999999999999999999999965 4678
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+||||+++|+|.+++.... ..+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876533 35899999999999999999999987 999999999999999999999999999998
Q ss_pred cCCcc
Q 006563 626 GGDEI 630 (640)
Q Consensus 626 ~~~~~ 630 (640)
.....
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 65543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.6e-28 Score=248.84 Aligned_cols=151 Identities=21% Similarity=0.325 Sum_probs=133.5
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
.++|...+.||+|+||+||+|.... ++.||||.+.... .....+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4678889999999999999998764 7899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC--CCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kI~DFGla~~~~~~ 628 (640)
|++|+|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999988543 235899999999999999999999987 999999999999985 458999999999987544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=246.33 Aligned_cols=151 Identities=25% Similarity=0.404 Sum_probs=123.9
Q ss_pred hccccccccccccCceeEEEEEecC----CcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~----g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 546 (640)
.++|...+.||+|+||.||+|++.. +..||||.+.... ....+.|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998754 3468999987543 344677999999999999999999999985 567899
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~ 626 (640)
||||+++|+|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999887543 335899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006563 627 GD 628 (640)
Q Consensus 627 ~~ 628 (640)
..
T Consensus 160 ~~ 161 (273)
T d1mp8a_ 160 DS 161 (273)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=249.60 Aligned_cols=151 Identities=34% Similarity=0.590 Sum_probs=131.1
Q ss_pred ccccccccccccCceeEEEEEecC-Cc--EEEEEEcccC-CchhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~--~VavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (640)
++|+..++||+|+||.||+|++.+ +. .||||++... .....++|.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567777899999999999999865 33 5788988654 344567899999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCce
Q 006563 548 YEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (640)
|||+++|+|.++|... .....+++..+.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 22456999999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecc
Q 006563 615 KISDFGMARIFG 626 (640)
Q Consensus 615 kI~DFGla~~~~ 626 (640)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=5e-28 Score=252.01 Aligned_cols=149 Identities=26% Similarity=0.336 Sum_probs=134.6
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC---CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (640)
++|..++.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+++|+.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 4899999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||+.+|+|..++.+.. .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999886543 4899999999999999999999987 99999999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.3e-28 Score=247.34 Aligned_cols=145 Identities=30% Similarity=0.535 Sum_probs=127.4
Q ss_pred ccccccCceeEEEEEecCC----cEEEEEEcccC-CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-CeeEEEEEccC
Q 006563 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYMP 552 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g----~~VavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~ 552 (640)
++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+. ...++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 5899999999999997552 25899999754 445568899999999999999999999998874 57899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+|+|.+++.... ..+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 113 ~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 113 HGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred cCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999886543 34788999999999999999999987 999999999999999999999999999987544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=4.4e-28 Score=253.81 Aligned_cols=151 Identities=25% Similarity=0.358 Sum_probs=130.2
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccCC---chhhHhHH---HHHHHHhhCCCCceeeeEeEEEeCCeeE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFK---NEVTLIARLQHRNLVKLLGCCIQADESM 545 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~---~~~~~~f~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 545 (640)
++|...++||+|+||.||+|+... |+.||||++.+.. ......+. .|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 678899999999999999999764 8999999986421 11222333 4467778889999999999999999999
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999998653 34789999999999999999999988 999999999999999999999999999988
Q ss_pred cCCc
Q 006563 626 GGDE 629 (640)
Q Consensus 626 ~~~~ 629 (640)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=249.82 Aligned_cols=166 Identities=29% Similarity=0.420 Sum_probs=140.3
Q ss_pred hccccccccccccCceeEEEEEec------CCcEEEEEEcccCCc-hhhHhHHHHHHHHhhC-CCCceeeeEeEEEeCCe
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~------~g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 543 (640)
.++|...++||+|+||.||+|++. .++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367788889999999999999863 356899999976533 4456799999999999 69999999999999999
Q ss_pred eEEEEEccCCCChhHHHhhcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 544 SMLIYEYMPNKSLDFFIFDQA---------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
.+||||||++|+|..++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 1235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCCccccccceeeeC
Q 006563 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt 640 (640)
+.++.+||+|||+++.+.............||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999988655444334444544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=244.98 Aligned_cols=148 Identities=28% Similarity=0.509 Sum_probs=125.6
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-CeeEEEEEcc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYM 551 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 551 (640)
++|+..+.||+|+||.||+|.+ .|..||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4577778999999999999998 5788999999753 3457899999999999999999999999764 5689999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
++|+|.+++.... ...++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999996543 235899999999999999999999987 99999999999999999999999999998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.4e-28 Score=246.04 Aligned_cols=148 Identities=25% Similarity=0.398 Sum_probs=124.8
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHH--HHHHHhhCCCCceeeeEeEEEeCC----eeEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLGCCIQAD----ESML 546 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l 546 (640)
++|...+.||+|+||.||+|++ +|+.||||++... ..+++.. |+..+.+++|||||+++|+|.+.+ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566778999999999999987 6889999998643 2234444 455556789999999999998754 5799
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecccCCCCEEEcCCCceEEeeecc
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kI~DFGl 621 (640)
|||||++|+|..++.+. .++|..+++++.++|.||+|||+. ...+|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999653 489999999999999999999974 124699999999999999999999999999
Q ss_pred ceeccCC
Q 006563 622 ARIFGGD 628 (640)
Q Consensus 622 a~~~~~~ 628 (640)
++.+...
T Consensus 155 ~~~~~~~ 161 (303)
T d1vjya_ 155 AVRHDSA 161 (303)
T ss_dssp CEEEETT
T ss_pred cccccCC
Confidence 9988544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5e-28 Score=246.96 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=129.5
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|+..++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999974 58999999996532 2346789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
|+.++.+. ++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99865444 33332 2345899999999999999999999988 999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-27 Score=245.37 Aligned_cols=150 Identities=27% Similarity=0.418 Sum_probs=131.3
Q ss_pred ccccccccccccCceeEEEEEecC-CcEEEEEEcccC---CchhhHhHHHHHHHHh-hCCCCceeeeEeEEEeCCeeEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIA-RLQHRNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 547 (640)
++|...+.||+|+||+||+|+... ++.||||++.+. .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578888999999999999999864 889999999743 1234456777777665 68999999999999999999999
Q ss_pred EEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccC
Q 006563 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (640)
Q Consensus 548 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~ 627 (640)
||||++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999986533 4788999999999999999999987 99999999999999999999999999997654
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 156 ~ 156 (320)
T d1xjda_ 156 G 156 (320)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.8e-28 Score=244.79 Aligned_cols=157 Identities=30% Similarity=0.476 Sum_probs=131.4
Q ss_pred hccccccccccccCceeEEEEEecC--------CcEEEEEEcccCCc-hhhHhHHHHHHHHhhC-CCCceeeeEeEEEeC
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~--------g~~VavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 541 (640)
.++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888899999999999998643 24799999976543 4567899999999888 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEE
Q 006563 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (640)
Q Consensus 542 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (640)
...++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975432 245899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeeccceeccCCccc
Q 006563 609 DNDMNPKISDFGMARIFGGDEIQ 631 (640)
Q Consensus 609 ~~~~~~kI~DFGla~~~~~~~~~ 631 (640)
+.++.+||+|||+++........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~ 191 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY 191 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT
T ss_pred cCCCCeEeccchhhccccccccc
Confidence 99999999999999988654433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.94 E-value=1.5e-27 Score=241.85 Aligned_cols=150 Identities=27% Similarity=0.453 Sum_probs=133.7
Q ss_pred ccccccccccccCceeEEEEEecCCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 550 (640)
++|..+++||+|+||+||+|+..+++.||||++.... ....+.+.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999889999999997542 23357899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+.++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 998777666533 345899999999999999999999987 999999999999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.94 E-value=2.5e-27 Score=239.08 Aligned_cols=150 Identities=23% Similarity=0.372 Sum_probs=131.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC---chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCe----
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 543 (640)
.++|...+.||+|+||.||+|+.. .++.||||++.... ....+.|.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367888999999999999999874 58899999997542 2345679999999999999999999999886543
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.+|||||+++++|..++... ..+++.++..++.||++||+|||+.+ |+||||||+||||+.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888553 34899999999999999999999987 9999999999999999999999999998
Q ss_pred eccC
Q 006563 624 IFGG 627 (640)
Q Consensus 624 ~~~~ 627 (640)
.+..
T Consensus 160 ~~~~ 163 (277)
T d1o6ya_ 160 AIAD 163 (277)
T ss_dssp ECC-
T ss_pred hhcc
Confidence 7743
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-27 Score=244.60 Aligned_cols=145 Identities=30% Similarity=0.446 Sum_probs=124.0
Q ss_pred cccccccCceeEEEEEecC-CcEEEEEEcccCCch-----hhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEEcc
Q 006563 478 YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (640)
Q Consensus 478 ~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 551 (640)
+++||+|+||+||+|+... ++.||||++...... ..+.+.+|++++++++|||||++++++..++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4689999999999999755 899999998754221 2356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
+++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 9887765542 2345888999999999999999999988 999999999999999999999999999987544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.3e-27 Score=241.37 Aligned_cols=149 Identities=25% Similarity=0.315 Sum_probs=126.6
Q ss_pred hccccccc-cccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhC-CCCceeeeEeEEEe----CCee
Q 006563 472 TDNFASYN-KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ----ADES 544 (640)
Q Consensus 472 ~~~f~~~~-~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 544 (640)
.++|.... .||+|+||+||+|+.. +++.||||++... +.+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46787765 5999999999999874 5899999998642 4577899887655 89999999999865 3568
Q ss_pred EEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC---CCceEEeeecc
Q 006563 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (640)
Q Consensus 545 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kI~DFGl 621 (640)
+||||||++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 245899999999999999999999988 999999999999985 56799999999
Q ss_pred ceeccCCc
Q 006563 622 ARIFGGDE 629 (640)
Q Consensus 622 a~~~~~~~ 629 (640)
|+.+....
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99875543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-26 Score=241.48 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=124.1
Q ss_pred cccccccccccCceeEEEEEecC-CcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------eeEE
Q 006563 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESML 546 (640)
Q Consensus 474 ~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 546 (640)
+|...++||+|+||+||+|+... ++.||||++..... .+.+|+++|++++|+||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57777899999999999999864 89999999975432 2347999999999999999999986532 3689
Q ss_pred EEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceec
Q 006563 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (640)
Q Consensus 547 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~ 625 (640)
|||||+++.+..+.........+++..+..++.||++||+|||+.+ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433334456999999999999999999999987 99999999999999774 8999999999987
Q ss_pred cCCc
Q 006563 626 GGDE 629 (640)
Q Consensus 626 ~~~~ 629 (640)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-26 Score=233.82 Aligned_cols=149 Identities=26% Similarity=0.381 Sum_probs=127.9
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCc------hhhHhHHHHHHHHhhCC--CCceeeeEeEEEeCCe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 543 (640)
++|...++||+|+||.||+|+.. +++.||||++.+... ...+++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888899999999999999875 589999999864311 12345778999999996 8999999999999999
Q ss_pred eEEEEEccCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-CCceEEeeecc
Q 006563 544 SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGM 621 (640)
Q Consensus 544 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kI~DFGl 621 (640)
.++||||+.+ +++..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999986 5777776443 35899999999999999999999987 999999999999985 47999999999
Q ss_pred ceeccC
Q 006563 622 ARIFGG 627 (640)
Q Consensus 622 a~~~~~ 627 (640)
|+....
T Consensus 158 a~~~~~ 163 (273)
T d1xwsa_ 158 GALLKD 163 (273)
T ss_dssp CEECCS
T ss_pred ceeccc
Confidence 998643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5.6e-26 Score=230.80 Aligned_cols=150 Identities=25% Similarity=0.442 Sum_probs=133.7
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCCeeEEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 549 (640)
++|..+++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++|+||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999975 4889999998643 23446789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceeccCC
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~~~~ 628 (640)
++.+++|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988777433 34789999999999999999999987 999999999999999999999999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-26 Score=238.46 Aligned_cols=150 Identities=25% Similarity=0.417 Sum_probs=126.7
Q ss_pred hccccccccccccCceeEEEEEe-cCCcEEEEEEcccCC-chhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC----eeE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESM 545 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l-~~g~~VavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 545 (640)
+++|..+++||+|+||+||+|.. .+++.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788999999999999999986 458999999997543 344667899999999999999999999987643 235
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccceec
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~~ 625 (640)
+++||+.+|+|.+++... .+++..+..++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 566778899999998542 4899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 006563 626 GGD 628 (640)
Q Consensus 626 ~~~ 628 (640)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=9.1e-26 Score=233.30 Aligned_cols=144 Identities=22% Similarity=0.417 Sum_probs=126.2
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeC--CeeEEEE
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLIY 548 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 548 (640)
++|...++||+|+||+||+|+.. .++.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999975 4889999998753 3467889999999995 99999999999854 4589999
Q ss_pred EccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCC-ceEEeeeccceeccC
Q 006563 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGG 627 (640)
Q Consensus 549 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kI~DFGla~~~~~ 627 (640)
||+++++|..+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999996653 24889999999999999999999988 99999999999998654 699999999998754
Q ss_pred C
Q 006563 628 D 628 (640)
Q Consensus 628 ~ 628 (640)
.
T Consensus 183 ~ 183 (328)
T d3bqca1 183 G 183 (328)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.2e-25 Score=229.33 Aligned_cols=151 Identities=26% Similarity=0.478 Sum_probs=126.6
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------- 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 541 (640)
.++|+..++||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|+||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 5899999998643 233456789999999999999999999998653
Q ss_pred -CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeec
Q 006563 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (640)
Q Consensus 542 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFG 620 (640)
...++||||++++.+..+.. ....++......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 45799999999887764442 2335788889999999999999999987 9999999999999999999999999
Q ss_pred cceeccCC
Q 006563 621 MARIFGGD 628 (640)
Q Consensus 621 la~~~~~~ 628 (640)
+|+.+...
T Consensus 163 ~~~~~~~~ 170 (318)
T d3blha1 163 LARAFSLA 170 (318)
T ss_dssp TCEECCC-
T ss_pred eeeecccc
Confidence 99887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-25 Score=233.25 Aligned_cols=149 Identities=26% Similarity=0.452 Sum_probs=123.3
Q ss_pred hccccccccccccCceeEEEEEecC-CcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeCC------
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 542 (640)
.++|..+++||+|+||+||+|.... ++.||||++... .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4679999999999999999999754 899999999754 2334567899999999999999999999997654
Q ss_pred eeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccc
Q 006563 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (640)
Q Consensus 543 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla 622 (640)
..+|||||+ +.+|..+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 4567666533 34899999999999999999999988 999999999999999999999999999
Q ss_pred eeccCC
Q 006563 623 RIFGGD 628 (640)
Q Consensus 623 ~~~~~~ 628 (640)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9e-26 Score=232.29 Aligned_cols=151 Identities=27% Similarity=0.398 Sum_probs=131.9
Q ss_pred ccccccccccccCceeEEEEEec----CCcEEEEEEcccCC----chhhHhHHHHHHHHhhCCC-CceeeeEeEEEeCCe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~----~g~~VavK~l~~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~ 543 (640)
++|...+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 37899999986431 2345678899999999966 899999999999999
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.+++|||+.+|+|..++.... .+.......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999886543 3577888889999999999999987 9999999999999999999999999999
Q ss_pred eccCCc
Q 006563 624 IFGGDE 629 (640)
Q Consensus 624 ~~~~~~ 629 (640)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=7e-25 Score=222.74 Aligned_cols=149 Identities=18% Similarity=0.306 Sum_probs=128.8
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCC-CceeeeEeEEEeCCeeEEEEE
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 549 (640)
.++|...++||+|+||+||+|+.. +++.||||++.... ..+.+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367889999999999999999975 48899999886532 33567889999999965 999999999999999999999
Q ss_pred ccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcC-----CCceEEeeecccee
Q 006563 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (640)
Q Consensus 550 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kI~DFGla~~ 624 (640)
|+ +++|..++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689988875533 35899999999999999999999987 999999999999974 57899999999998
Q ss_pred ccCC
Q 006563 625 FGGD 628 (640)
Q Consensus 625 ~~~~ 628 (640)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 7543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.2e-25 Score=227.99 Aligned_cols=151 Identities=25% Similarity=0.451 Sum_probs=124.0
Q ss_pred hccccccccccccCceeEEEEEec-C-CcEEEEEEcccC--CchhhHhHHHHHHHHhhC---CCCceeeeEeEEEeC---
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-E-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA--- 541 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~-g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~--- 541 (640)
.++|..+++||+|+||+||+|+.. . ++.||||++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 3 567999998643 222334566777776655 799999999998642
Q ss_pred --CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeee
Q 006563 542 --DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (640)
Q Consensus 542 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DF 619 (640)
...++++||++++.+...... ....+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 357999999999877654433 3345899999999999999999999987 999999999999999999999999
Q ss_pred ccceeccC
Q 006563 620 GMARIFGG 627 (640)
Q Consensus 620 Gla~~~~~ 627 (640)
|+++....
T Consensus 161 g~~~~~~~ 168 (305)
T d1blxa_ 161 GLARIYSF 168 (305)
T ss_dssp CSCCCCCG
T ss_pred hhhhhhcc
Confidence 99997643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.91 E-value=2.8e-24 Score=218.96 Aligned_cols=149 Identities=23% Similarity=0.371 Sum_probs=121.9
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCceeee-EeEEEeCCeeEEEEEc
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL-LGCCIQADESMLIYEY 550 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey 550 (640)
++|...+.||+|+||.||+|+.. +++.||||++.... ..+++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 48899999887542 33568899999999987765554 5555777888999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEc---CCCceEEeeeccceeccC
Q 006563 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFGG 627 (640)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kI~DFGla~~~~~ 627 (640)
+. ++|...+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 4565555432 235899999999999999999999988 99999999999985 456799999999999864
Q ss_pred Cc
Q 006563 628 DE 629 (640)
Q Consensus 628 ~~ 629 (640)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.7e-25 Score=227.38 Aligned_cols=148 Identities=28% Similarity=0.420 Sum_probs=125.3
Q ss_pred hccccccccccccCceeEEEEEec-CCcEEEEEEcccCC--chhhHhHHHHHHHHhhCCCCceeeeEeEEEeC-----Ce
Q 006563 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (640)
Q Consensus 472 ~~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 543 (640)
.++|...++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+++|++++|+|+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999864 58999999997542 23456788999999999999999999998643 33
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677888899999998843 24899999999999999999999988 9999999999999999999999999998
Q ss_pred ecc
Q 006563 624 IFG 626 (640)
Q Consensus 624 ~~~ 626 (640)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.5e-24 Score=222.85 Aligned_cols=147 Identities=29% Similarity=0.437 Sum_probs=120.3
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccC--CchhhHhHHHHHHHHhhCCCCceeeeEeEEEeC------Ce
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DE 543 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 543 (640)
++|..+++||+|+||+||+|... +|+.||||++... .....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 4899999999754 234456789999999999999999999998643 57
Q ss_pred eEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEeeeccce
Q 006563 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (640)
Q Consensus 544 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~ 623 (640)
.++||||+.++.+.. +. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 899999997765543 31 24789999999999999999999988 9999999999999999999999999999
Q ss_pred eccCC
Q 006563 624 IFGGD 628 (640)
Q Consensus 624 ~~~~~ 628 (640)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 87543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=9.2e-21 Score=179.53 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=106.4
Q ss_pred cccccccccCceeEEEEEecCCcEEEEEEcccCCc------------------hhhHhHHHHHHHHhhCCCCceeeeEeE
Q 006563 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHRNLVKLLGC 537 (640)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 537 (640)
...++||+|+||.||+|...+|++||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34578999999999999998899999998753210 011234568888999999999988765
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCEEEcCCCceEEe
Q 006563 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (640)
Q Consensus 538 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kI~ 617 (640)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 2 2379999998865422 344455678999999999999987 9999999999999865 58999
Q ss_pred eeccceeccCC
Q 006563 618 DFGMARIFGGD 628 (640)
Q Consensus 618 DFGla~~~~~~ 628 (640)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999987544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=8.3e-20 Score=156.56 Aligned_cols=111 Identities=20% Similarity=0.417 Sum_probs=92.7
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
+|+|.|||.|..|++|+| |.|+|.|...++ |.++. ..++||.||++.|.. .+.+.++.+| |+|.|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 489999999999999985 999999987763 44543 478999999998854 4679999999 999997
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCc
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTD 143 (640)
+..+|++++....+..+|+|+|+|||||++. .+.++|||+.+|++
T Consensus 68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence 4677887766545667899999999999986 47789999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.80 E-value=7.5e-20 Score=190.88 Aligned_cols=150 Identities=21% Similarity=0.285 Sum_probs=119.9
Q ss_pred ccccccccccccCceeEEEEEec-CCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-----------CCceeeeEeEEEe
Q 006563 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCIQ 540 (640)
Q Consensus 473 ~~f~~~~~lg~G~fg~Vy~g~l~-~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~ 540 (640)
++|...++||+|+||+||+|+.. +|+.||||++.+. ....+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35888999999999999999975 5899999999754 233467788998888775 5789999998865
Q ss_pred C--CeeEEEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCEEEcCCC-----
Q 006563 541 A--DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDM----- 612 (640)
Q Consensus 541 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~----- 612 (640)
. ...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777665544443333444568889999999999999999998 55 99999999999997654
Q ss_pred -ceEEeeeccceecc
Q 006563 613 -NPKISDFGMARIFG 626 (640)
Q Consensus 613 -~~kI~DFGla~~~~ 626 (640)
.+|++|||.|+...
T Consensus 169 ~~~kl~dfg~s~~~~ 183 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD 183 (362)
T ss_dssp EEEEECCCTTCEETT
T ss_pred ceeeEeecccccccc
Confidence 39999999998764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.78 E-value=3.3e-19 Score=151.39 Aligned_cols=106 Identities=22% Similarity=0.343 Sum_probs=89.7
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
+|+|.+||.|.+|++|. +|.|.|.|...++ |.|+. ..++||.||++.|- ..+.+.++.+| |+|.|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 47899999999999995 6999999998773 45654 46889999999884 34679999999 999999
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccC
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~ 140 (640)
+|.++|++++.......+|+|+|+|||||++. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~----~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT----DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence 99999999976544556789999999999964 48999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.78 E-value=1.1e-18 Score=148.20 Aligned_cols=107 Identities=20% Similarity=0.316 Sum_probs=89.5
Q ss_pred ccccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecC
Q 006563 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDG 96 (640)
Q Consensus 18 ~~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~ 96 (640)
.|+|.+||.|.+|++|.+ |.|.|+|...++ |.++. ..++||+||++.|+.. .+.|.++++| |+|.|+
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 378999999999999974 889999976553 33432 4689999999999864 4679999999 999999
Q ss_pred CCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccC
Q 006563 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (640)
Q Consensus 97 ~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~ 140 (640)
+|.++|+++++...++.+|+|+|+|||||+++ .+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~----~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS----DIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence 99999999987545667899999999999963 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.68 E-value=2.9e-17 Score=141.53 Aligned_cols=101 Identities=18% Similarity=0.235 Sum_probs=85.5
Q ss_pred EEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceee
Q 006563 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135 (640)
Q Consensus 57 Iw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lW 135 (640)
|||.++++++.+|++|++.|+....-+|.+..|| |+|.+. +.++|++++.......+|+|+|+|||||++. .+.++|
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-~~~~lW 89 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-QNIAVW 89 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-TTEEEE
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-CCCEEE
Confidence 9999999999999999999999877899999999 999986 6789999987655567899999999999997 478999
Q ss_pred eeccCCCcccCCCCeecceeccCCceEEEeccCCCCCCCCceEEeecCCCCceEE
Q 006563 136 QSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (640)
Q Consensus 136 QSFd~PTDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~ 190 (640)
|||. +.++|.|.|.||+||+..++
T Consensus 90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9973 34568899999999986543
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=1.9e-15 Score=128.66 Aligned_cols=109 Identities=20% Similarity=0.239 Sum_probs=91.0
Q ss_pred EEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceee
Q 006563 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135 (640)
Q Consensus 57 Iw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lW 135 (640)
|||.-.++.+..|+.+.+.|+....-+|.+..|| |+|.++ +.++|++++.+ ..+..|.|+|+|||||++. .+.+||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~-~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTA-QNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCT-TTCCSC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEcc-CCCEEE
Confidence 7887777888889999999998888899999999 999884 67899999864 5678899999999999987 477899
Q ss_pred eeccCCCcccCCCCeecceeccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 136 QSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 136 QSFd~PTDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
||+. +.++|.|.|.|+++|+.. +|. ..+|.+|.
T Consensus 80 sS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY~--~~~Wssgt 112 (115)
T d1dlpa1 80 SSGT-------------------------------KGSIGNYVLVLQPDRTVT--IYG--PGLWDSGT 112 (115)
T ss_dssp CCCC-------------------------------CCCSSCCEEEECSSSCEE--EEC--SEEEECSC
T ss_pred EcCC-------------------------------CCCCCCEEEEECCCCcEE--EeC--CCeecCCC
Confidence 9863 346799999999999854 453 36888775
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=2.5e-13 Score=116.18 Aligned_cols=102 Identities=15% Similarity=0.267 Sum_probs=80.1
Q ss_pred cccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCC
Q 006563 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGR 97 (640)
Q Consensus 19 ~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~ 97 (640)
++|.++|+| ...+..|.|.|.|...|+ |.+ |. ..++||.||+..|.. ...|.+..+| |+|.|++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence 455555555 346789999999988764 223 43 478999999987743 4689999999 9999999
Q ss_pred CceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeecc
Q 006563 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (640)
Q Consensus 98 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd 139 (640)
|.++|++++.......+|+|+|+|||||++ ..+|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC----CCEeccCC
Confidence 999999998754455679999999999985 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=3.3e-11 Score=102.01 Aligned_cols=97 Identities=23% Similarity=0.356 Sum_probs=73.0
Q ss_pred CCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCCCceEEe
Q 006563 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWS 103 (640)
Q Consensus 25 ~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~~~~vWs 103 (640)
|+|.+++.| .+|.|.|.|...|+ |.++. ...+||.+|...+ ..+.+.+.++| |+|.|.++.+||+
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEE
Confidence 444444444 35779999987763 44543 3578999986542 34679999999 9999999999999
Q ss_pred eccccCCCCceEEEeecccEEEEeCCCCceeeeecc
Q 006563 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (640)
Q Consensus 104 t~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd 139 (640)
+++....+..+++|+++|||||++ ..+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~----~~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence 998755566679999999999985 36999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=3.7e-09 Score=90.01 Aligned_cols=96 Identities=19% Similarity=0.332 Sum_probs=68.2
Q ss_pred cccCCCCCcCCCCEEEeCCCeeEEeeeCCCCCCceEEEEEEeeCCCCeEEEEecCCCCCCCCcceEEEecCC-eEEecCC
Q 006563 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGR 97 (640)
Q Consensus 19 ~~l~~g~~l~~~~~lvS~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~Pv~~~~~~l~~~~~G-L~l~d~~ 97 (640)
+++.++|+|+. |.|.|.|-.-++ |.++. ...+||.+|- +..+....+.+.++| |+|.|.+
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEETTTEEEEEETT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCC
Confidence 45666666654 446666644331 23332 3467898874 333445679999999 9999999
Q ss_pred CceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeee
Q 006563 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (640)
Q Consensus 98 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQS 137 (640)
+.++|++++.......+++|+++|||||++. .+|.|
T Consensus 85 ~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~----~~W~t 120 (120)
T d1dlpa2 85 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG----ALWTT 120 (120)
T ss_dssp TEEEEECCCCCSSSCCEEEECSSSCEEEECC----CCCBC
T ss_pred CCEEEEeCCCCCCCcEEEEECCCCcEEEeCC----CcccC
Confidence 9999999986545666899999999999953 58875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=5.2e-09 Score=88.78 Aligned_cols=84 Identities=19% Similarity=0.239 Sum_probs=64.8
Q ss_pred eEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCce
Q 006563 83 LLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (640)
Q Consensus 83 ~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~~ 161 (640)
.|.+..|| |+|.++ +.++|++++.+......+.|.++|||||.+. .+.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~----------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECS-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC-CCcEEEECC-----------------------
Confidence 57889999 999876 5689999987655568899999999999997 467899862
Q ss_pred EEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 162 ~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
+.-+.|.|.+.|+.+|+..+ +. ...|.++.
T Consensus 88 --------t~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 88 --------VAGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp --------CCCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred --------CcCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 11245678999999998655 43 35787764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.75 E-value=1.8e-08 Score=84.14 Aligned_cols=76 Identities=20% Similarity=0.324 Sum_probs=59.3
Q ss_pred ceEEEecCC-eEEecCCCceEEeeccccCCCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCCc
Q 006563 82 GLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (640)
Q Consensus 82 ~~l~~~~~G-L~l~d~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~~ 160 (640)
-.|.+..|| |+|.+. +.+||++++.+......++|.++|||||.+. .+.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-~g~~vWsS----------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-SNKPIWAS----------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEEC-----------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC-CccceEEc-----------------------
Confidence 358889999 999874 5789999987544567899999999999997 47889986
Q ss_pred eEEEeccCCCCCCCCceEEeecCCCCceEE
Q 006563 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (640)
Q Consensus 161 ~~l~S~~s~~dps~G~f~l~~~~~g~~~~~ 190 (640)
.+...++.|.+.|+.+|+..++
T Consensus 76 --------~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 --------NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp --------CCCCSCSCEEEEECTTSCEEEE
T ss_pred --------cccCCCCcEEEEEcCCCCEEEe
Confidence 1122456788999999985543
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.72 E-value=4.4e-08 Score=81.73 Aligned_cols=85 Identities=25% Similarity=0.348 Sum_probs=63.0
Q ss_pred ceEEEecCC-eEEecCCCceEEeeccccC-CCCceEEEeecccEEEEeCCCCceeeeeccCCCcccCCCCeecceeccCC
Q 006563 82 GLLNVTSKG-IVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (640)
Q Consensus 82 ~~l~~~~~G-L~l~d~~~~~vWst~~~~~-~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~tg~ 159 (640)
-.|.+..|| |+|.+ .+.+||++++... ..+..+.|.++|||||+++ .+.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s---------------------- 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWAS---------------------- 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEEC----------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-CCcEEEEE----------------------
Confidence 357788899 99986 4578999998642 3456799999999999997 47889986
Q ss_pred ceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCC
Q 006563 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (640)
Q Consensus 160 ~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~ 203 (640)
.+....|.|.+.|+++|+..+ ++ ...|.++.
T Consensus 77 ---------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t 107 (109)
T d1kj1a_ 77 ---------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGT 107 (109)
T ss_dssp ---------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCC
T ss_pred ---------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCC
Confidence 111234678999999998554 43 35787765
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.54 E-value=2.1e-07 Score=78.08 Aligned_cols=110 Identities=12% Similarity=0.099 Sum_probs=68.3
Q ss_pred CcccCCCCeecceeccCCceEEEeccCCCCCCCCceEEeecCCCCceEEEEeCCEEEeecCCCCCCCccCCCCCCcCcce
Q 006563 142 CDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPL 221 (640)
Q Consensus 142 TDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (640)
||||+|||.|..+. .|++ |.|+|.|+.||+ +++|.....+|.++......-. ...+...
T Consensus 1 tDtL~~gq~L~~g~------~l~~---------g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~-~l~l~~d--- 59 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG------SLAE---------GGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASGC-VLKMQND--- 59 (112)
T ss_dssp CCEEETTEEECTTC------EEEE---------TTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSE-EEEECTT---
T ss_pred CCEecCCCEecCCC------EEEE---------CCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCCc-EEEEecc---
Confidence 79999999998765 5653 999999999997 4567788899987654321100 0001100
Q ss_pred eeeEEEeeCCeEEEEEecCCC-ceEEEEEccCCCEEEEEEeCCCCcEEEEEEecCCCC
Q 006563 222 CDYKFVINENEVYYECDAKGP-AVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRC 278 (640)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~-~~~r~~l~~~G~l~~~~~~~~~~~w~~~w~~p~~~C 278 (640)
-.+. +.+.+...+....... ...+++|..||++.+|. . .....|+...++|
T Consensus 60 GnLv-l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~--~---~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 60 GNLV-IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYD--N---SNNAIWATHTNVG 111 (112)
T ss_dssp SCEE-EEETTEEEEECCCCCSCCCCEEEECTTSCEEEEC--T---TSCEEEECCCCCC
T ss_pred ccEE-EEecCCeEEEEeeccCCCceEEEEcCCCCEEEEC--C---CCcEEecCCCccC
Confidence 1111 2233333333232323 45799999999999983 2 1246788777766
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=1.5e-06 Score=84.02 Aligned_cols=149 Identities=17% Similarity=0.118 Sum_probs=98.7
Q ss_pred hHHHhhccccccccccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC-CCceeeeEeEEEeCCeeE
Q 006563 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (640)
Q Consensus 467 ~l~~~~~~f~~~~~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 545 (640)
++.+....|...+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444455565544433344568998764 45667888876554444556788888887764 545677888888888899
Q ss_pred EEEEccCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 006563 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS--------------------------------- 592 (640)
Q Consensus 546 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 592 (640)
+|||++++..+....... .....++.++++.|+.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998775433110 111223444455555555321
Q ss_pred -----------------------CCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 593 -----------------------RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 593 -----------------------~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+..++|+|+.|.|||++++..+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999887778999998876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=0.00011 Score=70.03 Aligned_cols=142 Identities=16% Similarity=0.169 Sum_probs=86.1
Q ss_pred cccccC-ceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCC--CCceeeeEeEEEeCCeeEEEEEccCCCCh
Q 006563 480 KLGEGG-FGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (640)
Q Consensus 480 ~lg~G~-fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 556 (640)
.+..|. -+.||+.....+..+.+|.-.... ...+..|.+.++.+. ...+.+++++..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 367899988778788888765432 345677887777663 34466788888888889999999987665
Q ss_pred hH--------------HHhh--c-c-ccCCC--CHHHHHHHHH--------------------HHHHHHHHHHhC----C
Q 006563 557 DF--------------FIFD--Q-A-RATFL--DWQKRIHIVG--------------------GIARGILYLHQD----S 592 (640)
Q Consensus 557 ~~--------------~l~~--~-~-~~~~l--~~~~~~~i~~--------------------~ia~gL~yLH~~----~ 592 (640)
.. .+.+ . . ..... .+.....-.. .....+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 22 0100 0 0 00000 0111100000 012223333332 1
Q ss_pred CCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
+..++|+|+.|.|||++++..+-|.||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22379999999999999887788999999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.0011 Score=67.59 Aligned_cols=75 Identities=12% Similarity=0.210 Sum_probs=48.1
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEcccC-------CchhhHhHHHHHHHHhhC-CC--CceeeeEeEEEeCCeeEEE
Q 006563 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-------SGQGMEEFKNEVTLIARL-QH--RNLVKLLGCCIQADESMLI 547 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~-g~~VavK~l~~~-------~~~~~~~f~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~lV 547 (640)
+.||.|..-.||+....+ ++.++||.-... -+...+....|.+.|+.+ .+ ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998765 678899864321 011234455677777665 23 345556554 45667899
Q ss_pred EEccCCCC
Q 006563 548 YEYMPNKS 555 (640)
Q Consensus 548 ~Ey~~~gs 555 (640)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0063 Score=59.83 Aligned_cols=135 Identities=13% Similarity=0.155 Sum_probs=77.5
Q ss_pred eeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce--eeeEe-----EEEeCCeeEEEEEccCCCChh--
Q 006563 487 GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL--VKLLG-----CCIQADESMLIYEYMPNKSLD-- 557 (640)
Q Consensus 487 g~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~-- 557 (640)
-.||+....+|+.+++|..... ....+++..|...+..|...++ +..+. .....+..+.+++++++..++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987654 2345677888888877642222 11111 123456678899999764431
Q ss_pred ---HH------H---hh------ccccCCCCHHH-------------------HHHHHHHHHHHHHHHH----hCCCCce
Q 006563 558 ---FF------I---FD------QARATFLDWQK-------------------RIHIVGGIARGILYLH----QDSRMRI 596 (640)
Q Consensus 558 ---~~------l---~~------~~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH----~~~~~~i 596 (640)
.+ + +. ...+..+++.. +-.+...+.+.++.+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 0 00 00111122111 1111112222333332 2224468
Q ss_pred EecccCCCCEEEcCCCceEEeeecccee
Q 006563 597 IHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 597 vH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.63 E-value=0.013 Score=59.14 Aligned_cols=72 Identities=19% Similarity=0.280 Sum_probs=46.1
Q ss_pred ccccccCceeEEEEEecCC--------cEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-eeeEeEEEeCCeeEEEEE
Q 006563 479 NKLGEGGFGPVYKGTLVEG--------QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (640)
Q Consensus 479 ~~lg~G~fg~Vy~g~l~~g--------~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 549 (640)
+.|+-|--=.+|+....++ +.|.+++.. ... ......+|.++++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677677788999887542 456665554 222 23345678888887743344 477777632 68999
Q ss_pred ccCCCCh
Q 006563 550 YMPNKSL 556 (640)
Q Consensus 550 y~~~gsL 556 (640)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.80 E-value=0.33 Score=46.42 Aligned_cols=159 Identities=11% Similarity=0.027 Sum_probs=80.5
Q ss_pred cchHhHHHhhccccccc-----cccccCceeEEEEEecCCcEEEEEEcccCCchhhHhHHHHHHHHhhCCCCce-----e
Q 006563 463 FDFASIAKATDNFASYN-----KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-----V 532 (640)
Q Consensus 463 ~~~~~l~~~~~~f~~~~-----~lg~G~fg~Vy~g~l~~g~~VavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-----v 532 (640)
.+.++++....+|...+ .|..|---+.|+.+..+|+ .++|+..... ..+++..|+++|..+...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 34566666667775432 2345555678888876665 7788775431 23445556666666532221 1
Q ss_pred eeE-e--EEEeCCeeEEEEEccCCCChhH-----------HH---hh--c----c-ccC-----------------CCCH
Q 006563 533 KLL-G--CCIQADESMLIYEYMPNKSLDF-----------FI---FD--Q----A-RAT-----------------FLDW 571 (640)
Q Consensus 533 ~l~-g--~~~~~~~~~lV~Ey~~~gsL~~-----------~l---~~--~----~-~~~-----------------~l~~ 571 (640)
... | +.........++.+..+..... .+ .. . . ... ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 1122445566777766543310 00 00 0 0 000 0011
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCEEEcCCCceEEeeecccee
Q 006563 572 QKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (640)
Q Consensus 572 ~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kI~DFGla~~ 624 (640)
......+..+...+.-.+.. -+..+||+|+.+.||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11112222222222222221 234599999999999999988889999999864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.92 E-value=0.027 Score=34.35 Aligned_cols=32 Identities=34% Similarity=0.858 Sum_probs=25.8
Q ss_pred CCCcccccCCCCccccCC-CCCcCCCCCCCccCC
Q 006563 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFVPKS 308 (640)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~~~~ 308 (640)
|+|.+-..||. |.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 68999999996 889753 344799999999853
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.04 E-value=0.042 Score=35.82 Aligned_cols=30 Identities=33% Similarity=0.930 Sum_probs=24.2
Q ss_pred CCCcc-cccCCCCccccCC-CCCcCCCCCCCc
Q 006563 276 DRCDL-YSVCGANARCTTN-SSRRCDCLEGFV 305 (640)
Q Consensus 276 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~GF~ 305 (640)
|+|.. ...|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 67876 4689999999765 345899999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.61 E-value=0.12 Score=32.96 Aligned_cols=29 Identities=38% Similarity=0.987 Sum_probs=22.5
Q ss_pred CCCcccccCCCCccccCC-CCCcCCCCCCCc
Q 006563 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFV 305 (640)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~ 305 (640)
|+|. ...|...|.|... ..-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 4779999999754 456899999997
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.94 E-value=0.3 Score=31.68 Aligned_cols=31 Identities=26% Similarity=0.696 Sum_probs=23.7
Q ss_pred CCCCcccccCCCCccccCC-CCCcCCCCCCCcc
Q 006563 275 LDRCDLYSVCGANARCTTN-SSRRCDCLEGFVP 306 (640)
Q Consensus 275 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~~ 306 (640)
.|+|..+. |+.++.|... ++-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47897654 5578999765 4568999999986
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.57 E-value=0.17 Score=32.12 Aligned_cols=29 Identities=24% Similarity=0.737 Sum_probs=22.2
Q ss_pred CCCcccccCCCCccccCC-CCCcCCCCCCCc
Q 006563 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFV 305 (640)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~ 305 (640)
|+|. ...|...|.|... ..-.|.|++||.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 5564 4679999999754 345899999997
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.50 E-value=0.29 Score=31.42 Aligned_cols=30 Identities=30% Similarity=0.740 Sum_probs=22.6
Q ss_pred CCCcccccCCCCccccCC-CCCcCCCCCCCccC
Q 006563 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFVPK 307 (640)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~~~ 307 (640)
|+|...+.| ..+|... ++-.|.|++||+..
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678777666 4588754 45689999999974
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.70 E-value=0.17 Score=32.20 Aligned_cols=30 Identities=30% Similarity=0.661 Sum_probs=23.7
Q ss_pred CCCCcccccCCCCccccCC-CCCcCCCCCCCc
Q 006563 275 LDRCDLYSVCGANARCTTN-SSRRCDCLEGFV 305 (640)
Q Consensus 275 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~ 305 (640)
.|+|. ...|-..|.|... ..-.|.|++||+
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence 36786 5779999999754 456899999996
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.61 E-value=0.14 Score=33.39 Aligned_cols=32 Identities=25% Similarity=0.607 Sum_probs=24.2
Q ss_pred CCCCcccccCCCCccccCC-CCCcCCCCCCCccC
Q 006563 275 LDRCDLYSVCGANARCTTN-SSRRCDCLEGFVPK 307 (640)
Q Consensus 275 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~GF~~~ 307 (640)
.|+|.....| -.+.|... ..-.|.|++||+..
T Consensus 3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 3678877666 47899754 45689999999875
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.92 E-value=0.26 Score=32.19 Aligned_cols=32 Identities=25% Similarity=0.769 Sum_probs=23.3
Q ss_pred CCCccc-ccCCCCccccCC-CCCcCCCCCCCccCC
Q 006563 276 DRCDLY-SVCGANARCTTN-SSRRCDCLEGFVPKS 308 (640)
Q Consensus 276 ~~C~~~-~~CG~~g~C~~~-~~~~C~C~~GF~~~~ 308 (640)
|+|... ..| .++.|... ++-.|.|++||+...
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF 37 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence 678764 456 47899754 456899999998643
|